CN1367785A - Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group - Google Patents
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group Download PDFInfo
- Publication number
- CN1367785A CN1367785A CN99815998A CN99815998A CN1367785A CN 1367785 A CN1367785 A CN 1367785A CN 99815998 A CN99815998 A CN 99815998A CN 99815998 A CN99815998 A CN 99815998A CN 1367785 A CN1367785 A CN 1367785A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- chloro
- carbon atom
- thioureido
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001529453 unidentified herpesvirus Species 0.000 title claims abstract description 11
- -1 Heterocyclic carboxamide Chemical class 0.000 title claims description 319
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title description 23
- 239000003112 inhibitor Substances 0.000 title description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title description 5
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical group NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 115
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 51
- 239000001257 hydrogen Substances 0.000 claims abstract description 48
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 48
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 24
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 21
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims abstract description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000700584 Simplexvirus Species 0.000 claims abstract description 15
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 15
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 14
- 241000282414 Homo sapiens Species 0.000 claims abstract description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 259
- 229910052799 carbon Inorganic materials 0.000 claims description 133
- 150000001721 carbon Chemical group 0.000 claims description 120
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 150000002431 hydrogen Chemical class 0.000 claims description 25
- 229910052736 halogen Inorganic materials 0.000 claims description 20
- 150000002367 halogens Chemical class 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 19
- 241000700605 Viruses Species 0.000 claims description 18
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 125000000304 alkynyl group Chemical group 0.000 claims description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 206010011831 Cytomegalovirus infection Diseases 0.000 claims description 4
- 208000029433 Herpesviridae infectious disease Diseases 0.000 claims description 4
- 125000002971 oxazolyl group Chemical group 0.000 claims description 4
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 230000029812 viral genome replication Effects 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract description 31
- 201000010099 disease Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 8
- 125000001424 substituent group Chemical group 0.000 abstract description 6
- 241000701044 Human gammaherpesvirus 4 Species 0.000 abstract description 5
- 125000003282 alkyl amino group Chemical group 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004001 thioalkyl group Chemical group 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 283
- 239000000243 solution Substances 0.000 description 232
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 183
- 239000002904 solvent Substances 0.000 description 154
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 142
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 138
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 135
- 239000000203 mixture Substances 0.000 description 111
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 110
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 102
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 94
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 87
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 80
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 75
- 239000000463 material Substances 0.000 description 73
- 239000000047 product Substances 0.000 description 64
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 60
- 238000006243 chemical reaction Methods 0.000 description 59
- 235000019439 ethyl acetate Nutrition 0.000 description 59
- 238000001035 drying Methods 0.000 description 57
- 125000000068 chlorophenyl group Chemical group 0.000 description 52
- 238000010992 reflux Methods 0.000 description 52
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 46
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 43
- 150000001412 amines Chemical class 0.000 description 42
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 42
- 230000000875 corresponding effect Effects 0.000 description 41
- 238000005406 washing Methods 0.000 description 41
- 239000002585 base Substances 0.000 description 40
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 40
- 239000007787 solid Substances 0.000 description 40
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 39
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 38
- 238000003756 stirring Methods 0.000 description 37
- 229960001866 silicon dioxide Drugs 0.000 description 34
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 239000000741 silica gel Substances 0.000 description 33
- 229910002027 silica gel Inorganic materials 0.000 description 33
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 31
- 239000003921 oil Substances 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 30
- KGGHWIKBOIQEAJ-UHFFFAOYSA-N 2-fluorobenzamide Chemical compound NC(=O)C1=CC=CC=C1F KGGHWIKBOIQEAJ-UHFFFAOYSA-N 0.000 description 29
- 238000004587 chromatography analysis Methods 0.000 description 29
- 235000011121 sodium hydroxide Nutrition 0.000 description 29
- 239000002253 acid Substances 0.000 description 28
- 239000007864 aqueous solution Substances 0.000 description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 26
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 25
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 25
- 238000001704 evaporation Methods 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- 230000008020 evaporation Effects 0.000 description 23
- 238000001953 recrystallisation Methods 0.000 description 23
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 22
- 238000003810 ethyl acetate extraction Methods 0.000 description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 20
- 238000001816 cooling Methods 0.000 description 20
- 238000001914 filtration Methods 0.000 description 20
- 235000011167 hydrochloric acid Nutrition 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 20
- 239000000284 extract Substances 0.000 description 19
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 17
- 239000012265 solid product Substances 0.000 description 16
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 16
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 230000008859 change Effects 0.000 description 14
- 235000002639 sodium chloride Nutrition 0.000 description 14
- 239000003513 alkali Substances 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 239000012044 organic layer Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- 229940124530 sulfonamide Drugs 0.000 description 13
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 12
- 150000003512 tertiary amines Chemical class 0.000 description 12
- FVTWJXMFYOXOKK-UHFFFAOYSA-N 2-fluoroacetamide Chemical class NC(=O)CF FVTWJXMFYOXOKK-UHFFFAOYSA-N 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 11
- 150000001408 amides Chemical class 0.000 description 11
- 229910052786 argon Inorganic materials 0.000 description 11
- YKOMOGKWTRYSHD-UHFFFAOYSA-N n-methoxypentan-3-imine Chemical compound CCC(CC)=NOC YKOMOGKWTRYSHD-UHFFFAOYSA-N 0.000 description 11
- 235000015320 potassium carbonate Nutrition 0.000 description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 11
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- 239000011877 solvent mixture Substances 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 239000012362 glacial acetic acid Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 229960003742 phenol Drugs 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 230000003612 virological effect Effects 0.000 description 9
- HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 description 8
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 8
- 230000001476 alcoholic effect Effects 0.000 description 8
- 230000000840 anti-viral effect Effects 0.000 description 8
- 229910052794 bromium Inorganic materials 0.000 description 8
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 8
- 238000009834 vaporization Methods 0.000 description 8
- 230000008016 vaporization Effects 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 125000004803 chlorobenzyl group Chemical group 0.000 description 7
- 239000012230 colorless oil Substances 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 125000004494 ethyl ester group Chemical group 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052763 palladium Inorganic materials 0.000 description 7
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 235000011181 potassium carbonates Nutrition 0.000 description 7
- 235000011118 potassium hydroxide Nutrition 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 125000004175 fluorobenzyl group Chemical group 0.000 description 6
- VQMSRUREDGBWKT-UHFFFAOYSA-N quinoline-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=NC2=C1 VQMSRUREDGBWKT-UHFFFAOYSA-N 0.000 description 6
- 239000012279 sodium borohydride Substances 0.000 description 6
- 229910000033 sodium borohydride Inorganic materials 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 6
- JBCFJMYPJJWIRG-UHFFFAOYSA-N 1,3-oxazole-4-carboxylic acid Chemical compound OC(=O)C1=COC=N1 JBCFJMYPJJWIRG-UHFFFAOYSA-N 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 108010060309 Glucuronidase Proteins 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 5
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 5
- 125000001207 fluorophenyl group Chemical group 0.000 description 5
- 229940095102 methyl benzoate Drugs 0.000 description 5
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 5
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 5
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 5
- 229920002554 vinyl polymer Polymers 0.000 description 5
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 4
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 4
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 4
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 4
- HRCOEVSFYVJQMT-UHFFFAOYSA-N 2-butyl-1,3-thiazole-4-carboxylic acid Chemical compound CCCCC1=NC(C(O)=O)=CS1 HRCOEVSFYVJQMT-UHFFFAOYSA-N 0.000 description 4
- IBUSLNJQKLZPNR-UHFFFAOYSA-N 2-phenyl-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC(C=2C=CC=CC=2)=N1 IBUSLNJQKLZPNR-UHFFFAOYSA-N 0.000 description 4
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- 241000701022 Cytomegalovirus Species 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 102000053187 Glucuronidase Human genes 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000005708 Sodium hypochlorite Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 150000001733 carboxylic acid esters Chemical class 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 210000003953 foreskin Anatomy 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 4
- 239000000391 magnesium silicate Substances 0.000 description 4
- 229910052919 magnesium silicate Inorganic materials 0.000 description 4
- 235000019792 magnesium silicate Nutrition 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 150000003335 secondary amines Chemical class 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- DPLIMKBGTYIUCB-UHFFFAOYSA-N 1-[2-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=CC=C1C(F)(F)F DPLIMKBGTYIUCB-UHFFFAOYSA-N 0.000 description 3
- ZHDRDZMTEOIWSX-UHFFFAOYSA-N 2-methyl-1,3-thiazole-4-carboxylic acid Chemical compound CC1=NC(C(O)=O)=CS1 ZHDRDZMTEOIWSX-UHFFFAOYSA-N 0.000 description 3
- ONZHMGRKWJMTDE-UHFFFAOYSA-N 3-chloro-4-iodoaniline Chemical compound NC1=CC=C(I)C(Cl)=C1 ONZHMGRKWJMTDE-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- VLLDXAYRHQBRAG-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)I)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)I)Cl)(C)C)=O VLLDXAYRHQBRAG-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
- FJGATDISEXKPPR-UHFFFAOYSA-N ClI(=O)=O Chemical compound ClI(=O)=O FJGATDISEXKPPR-UHFFFAOYSA-N 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- GKKZMYDNDDMXSE-UHFFFAOYSA-N Ethyl 3-oxo-3-phenylpropanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CC=C1 GKKZMYDNDDMXSE-UHFFFAOYSA-N 0.000 description 3
- 241001502974 Human gammaherpesvirus 8 Species 0.000 description 3
- 241000701027 Human herpesvirus 6 Species 0.000 description 3
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 3
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- AYDQIZKZTQHYIY-UHFFFAOYSA-N OC(=O)C1(C)CC(C(O)=O)=CC=C1 Chemical compound OC(=O)C1(C)CC(C(O)=O)=CC=C1 AYDQIZKZTQHYIY-UHFFFAOYSA-N 0.000 description 3
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 3
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000031709 bromination Effects 0.000 description 3
- 238000005893 bromination reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 3
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 3
- 229960002963 ganciclovir Drugs 0.000 description 3
- 125000005597 hydrazone group Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- RRHNGIRRWDWWQQ-UHFFFAOYSA-N n-iodoaniline Chemical compound INC1=CC=CC=C1 RRHNGIRRWDWWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 3
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 3
- 229910000105 potassium hydride Inorganic materials 0.000 description 3
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 3
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 3
- QRDZFPUVLYEQTA-UHFFFAOYSA-N quinoline-8-carboxylic acid Chemical compound C1=CN=C2C(C(=O)O)=CC=CC2=C1 QRDZFPUVLYEQTA-UHFFFAOYSA-N 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- XBXCNNQPRYLIDE-UHFFFAOYSA-N tert-butylcarbamic acid Chemical compound CC(C)(C)NC(O)=O XBXCNNQPRYLIDE-UHFFFAOYSA-N 0.000 description 3
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 239000011592 zinc chloride Substances 0.000 description 3
- 235000005074 zinc chloride Nutrition 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- MIIQJAUWHSUTIT-UHFFFAOYSA-N 1,2-oxazole-5-carboxylic acid Chemical compound OC(=O)C1=CC=NO1 MIIQJAUWHSUTIT-UHFFFAOYSA-N 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- DSAXBVQQKYZELF-UHFFFAOYSA-N 1-(2-bromophenyl)ethanamine Chemical compound CC(N)C1=CC=CC=C1Br DSAXBVQQKYZELF-UHFFFAOYSA-N 0.000 description 2
- LIBZHYLTOAGURM-UHFFFAOYSA-N 1-(3-bromophenyl)ethanamine Chemical compound CC(N)C1=CC=CC(Br)=C1 LIBZHYLTOAGURM-UHFFFAOYSA-N 0.000 description 2
- ODZXRBRYQGYVJY-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=CC(C(F)(F)F)=C1 ODZXRBRYQGYVJY-UHFFFAOYSA-N 0.000 description 2
- GUMZDWPMXGQNBG-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=C(C(F)(F)F)C=C1 GUMZDWPMXGQNBG-UHFFFAOYSA-N 0.000 description 2
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 description 2
- DYSJMQABFPKAQM-UHFFFAOYSA-N 1-benzothiophene-2-carboxylic acid Chemical compound C1=CC=C2SC(C(=O)O)=CC2=C1 DYSJMQABFPKAQM-UHFFFAOYSA-N 0.000 description 2
- XJAUKWKZKRKWBD-UHFFFAOYSA-N 1-bromo-2,4-dimethoxy-5-nitrobenzene Chemical compound COC1=CC(OC)=C([N+]([O-])=O)C=C1Br XJAUKWKZKRKWBD-UHFFFAOYSA-N 0.000 description 2
- CUZGLTCGJFTYLD-UHFFFAOYSA-N 1-iodo-2,4-dimethoxy-5-nitrobenzene Chemical compound COC1=CC(OC)=C([N+]([O-])=O)C=C1I CUZGLTCGJFTYLD-UHFFFAOYSA-N 0.000 description 2
- PQXKWPLDPFFDJP-UHFFFAOYSA-N 2,3-dimethyloxirane Chemical compound CC1OC1C PQXKWPLDPFFDJP-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- DPHCXXYPSYMICK-UHFFFAOYSA-N 2-chloro-1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(Cl)=C1 DPHCXXYPSYMICK-UHFFFAOYSA-N 0.000 description 2
- DKEQQAIVWBYFBO-UHFFFAOYSA-N 2-fluoro-n-(2-methyl-4-nitrophenyl)benzamide Chemical compound CC1=CC([N+]([O-])=O)=CC=C1NC(=O)C1=CC=CC=C1F DKEQQAIVWBYFBO-UHFFFAOYSA-N 0.000 description 2
- HMVZENAQAARVSZ-UHFFFAOYSA-N 2-fluoro-n-(3-methyl-4-nitrophenyl)benzamide Chemical compound C1=C([N+]([O-])=O)C(C)=CC(NC(=O)C=2C(=CC=CC=2)F)=C1 HMVZENAQAARVSZ-UHFFFAOYSA-N 0.000 description 2
- PJAOUMCNXYMMDA-UHFFFAOYSA-N 2-fluoro-n-[(4-nitrophenyl)methyl]benzamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNC(=O)C1=CC=CC=C1F PJAOUMCNXYMMDA-UHFFFAOYSA-N 0.000 description 2
- ZJAQLFXJDGNPLK-UHFFFAOYSA-N 2-fluoro-n-[4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F ZJAQLFXJDGNPLK-UHFFFAOYSA-N 0.000 description 2
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 2
- BXRDRYLJKVRXHE-UHFFFAOYSA-N 2-methyl-n-(4-nitrophenyl)propanamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C=C1 BXRDRYLJKVRXHE-UHFFFAOYSA-N 0.000 description 2
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NYAAGBAMENVXCE-UHFFFAOYSA-N 3-(dimethylamino)-5-(trifluoromethyl)benzonitrile Chemical compound CN(C)C1=CC(C#N)=CC(C(F)(F)F)=C1 NYAAGBAMENVXCE-UHFFFAOYSA-N 0.000 description 2
- VQQLWBUTTMNMFT-UHFFFAOYSA-N 3-bromothiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC=CC=1Br VQQLWBUTTMNMFT-UHFFFAOYSA-N 0.000 description 2
- JSHWVUGYYWWQCV-UHFFFAOYSA-N 3-chloro-4-ethenylaniline Chemical compound NC1=CC=C(C=C)C(Cl)=C1 JSHWVUGYYWWQCV-UHFFFAOYSA-N 0.000 description 2
- DFYGKOSCBJDERW-UHFFFAOYSA-N 3-n,3-n-dimethyl-5-(trifluoromethyl)benzene-1,3-diamine Chemical class CN(C)C1=CC(N)=CC(C(F)(F)F)=C1 DFYGKOSCBJDERW-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- OAMILPMFQFIAPO-UHFFFAOYSA-N 4-(aminomethyl)-n,n-dimethyl-2-(trifluoromethyl)aniline Chemical compound CN(C)C1=CC=C(CN)C=C1C(F)(F)F OAMILPMFQFIAPO-UHFFFAOYSA-N 0.000 description 2
- UUKQLJHJAVCMSX-UHFFFAOYSA-N 4-(dimethylamino)-3-(trifluoromethyl)benzonitrile Chemical compound CN(C)C1=CC=C(C#N)C=C1C(F)(F)F UUKQLJHJAVCMSX-UHFFFAOYSA-N 0.000 description 2
- 229940044174 4-phenylenediamine Drugs 0.000 description 2
- VCNGNQLPFHVODE-UHFFFAOYSA-N 5-methylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)S1 VCNGNQLPFHVODE-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- KZLFUBXUDMQMJZ-UHFFFAOYSA-N C(N)(OC(C(C)C)C1=CC=C(C=C1)N)=O Chemical compound C(N)(OC(C(C)C)C1=CC=C(C=C1)N)=O KZLFUBXUDMQMJZ-UHFFFAOYSA-N 0.000 description 2
- BHTIKQGZSJBFCY-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)C(=O)C=CN(C)C)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)C(=O)C=CN(C)C)Cl)(C)C)=O BHTIKQGZSJBFCY-UHFFFAOYSA-N 0.000 description 2
- GEORMUBVJRRCPZ-UHFFFAOYSA-N C(N)(OC(CC1=CC(=CC(=C1)Cl)N)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=CC(=C1)Cl)N)(C)C)=O GEORMUBVJRRCPZ-UHFFFAOYSA-N 0.000 description 2
- IJRLBVPLFFOSBG-UHFFFAOYSA-N CC(C(C(C)C1=CC=C(C(F)(F)F)C=C1)=NOC)C1=CC=C(C(F)(F)F)C=C1 Chemical compound CC(C(C(C)C1=CC=C(C(F)(F)F)C=C1)=NOC)C1=CC=C(C(F)(F)F)C=C1 IJRLBVPLFFOSBG-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 2
- RUHKUUFAKLLDEY-UHFFFAOYSA-N FC(C1=CC=CC=C1)(F)F.[Br] Chemical compound FC(C1=CC=CC=C1)(F)F.[Br] RUHKUUFAKLLDEY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- MLBGPAVOSUISOC-UHFFFAOYSA-N I(=O)(=O)[O-].Cl[NH2+]Cl.C[NH+](C)C.I(=O)(=O)[O-] Chemical compound I(=O)(=O)[O-].Cl[NH2+]Cl.C[NH+](C)C.I(=O)(=O)[O-] MLBGPAVOSUISOC-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000003810 Jones reagent Substances 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010027906 Monocytosis Diseases 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- QGBYRJALOXFMOM-UHFFFAOYSA-N N,N-dimethylmethanamine trifluoromethylsilane Chemical compound CN(C)C.FC(F)(F)[SiH3] QGBYRJALOXFMOM-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- OQRLOOWTJHHORN-UHFFFAOYSA-N N-methoxy-2,4-bis[2-(trifluoromethyl)phenyl]pentan-3-imine Chemical compound CON=C(C(C)C1=C(C=CC=C1)C(F)(F)F)C(C)C1=C(C=CC=C1)C(F)(F)F OQRLOOWTJHHORN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010038910 Retinitis Diseases 0.000 description 2
- XHQYBDSXTDXSHY-UHFFFAOYSA-N Semicarbazide hydrochloride Chemical compound Cl.NNC(N)=O XHQYBDSXTDXSHY-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- KGTIIVZGFBUCTQ-UHFFFAOYSA-N [1-[3-bromo-5-(trifluoromethyl)phenyl]-2-methylpropan-2-yl] carbamate Chemical compound C(N)(OC(CC1=CC(=CC(=C1)C(F)(F)F)Br)(C)C)=O KGTIIVZGFBUCTQ-UHFFFAOYSA-N 0.000 description 2
- CMPMDZBMMUHQMI-UHFFFAOYSA-N [2-methyl-1-[3-(2-methylpropyl)-5-(trifluoromethyl)phenyl]propan-2-yl] carbamate Chemical compound C(N)(OC(CC1=CC(=CC(=C1)C(F)(F)F)CC(C)C)(C)C)=O CMPMDZBMMUHQMI-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 125000005604 azodicarboxylate group Chemical group 0.000 description 2
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 125000004799 bromophenyl group Chemical group 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- GCUVBACNBHGZRS-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopenta-2,4-dien-1-yl(diphenyl)phosphane iron(2+) Chemical compound [Fe++].c1cc[cH-]c1.c1cc[c-](c1)P(c1ccccc1)c1ccccc1 GCUVBACNBHGZRS-UHFFFAOYSA-N 0.000 description 2
- 229960005081 diclofenamide Drugs 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- HUUHHZKHOIYIMQ-UHFFFAOYSA-N ethanamine 1-fluoro-3-(trifluoromethyl)benzene Chemical compound C(C)N.FC=1C=CC=C(C1)C(F)(F)F HUUHHZKHOIYIMQ-UHFFFAOYSA-N 0.000 description 2
- XDOKFEJMEJKVGX-UHFFFAOYSA-N ethyl 1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C1=CSC=N1 XDOKFEJMEJKVGX-UHFFFAOYSA-N 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- BTZNPZMHENLISZ-UHFFFAOYSA-N fluoromethanesulfonic acid Chemical compound OS(=O)(=O)CF BTZNPZMHENLISZ-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- GSTNAAOCEHQZDY-UHFFFAOYSA-N formic acid phosphane Chemical compound [PH4+].[O-]C=O GSTNAAOCEHQZDY-UHFFFAOYSA-N 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 2
- RBBOWEDMXHTEPA-UHFFFAOYSA-N hexane;toluene Chemical compound CCCCCC.CC1=CC=CC=C1 RBBOWEDMXHTEPA-UHFFFAOYSA-N 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000088 lip Anatomy 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 description 2
- RVJSRDPYONLFNB-UHFFFAOYSA-N methanamine;trifluoromethylbenzene Chemical compound NC.FC(F)(F)C1=CC=CC=C1 RVJSRDPYONLFNB-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- LKKTYMNXCFDLCX-UHFFFAOYSA-N methyl n-(4-acetamidophenyl)-n'-(5-chloro-2,4-dimethoxyphenyl)carbamimidothioate Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1N=C(SC)NC1=CC=C(NC(C)=O)C=C1 LKKTYMNXCFDLCX-UHFFFAOYSA-N 0.000 description 2
- GWDLNAXAUYHNCV-UHFFFAOYSA-N n,n-dimethyl-3-(2-nitroethenyl)-5-(trifluoromethyl)aniline Chemical compound CN(C)C1=CC(C=C[N+]([O-])=O)=CC(C(F)(F)F)=C1 GWDLNAXAUYHNCV-UHFFFAOYSA-N 0.000 description 2
- LTKXHVNDJVDNCZ-UHFFFAOYSA-N n-(4-amino-2-methylphenyl)-2-fluorobenzamide Chemical compound CC1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F LTKXHVNDJVDNCZ-UHFFFAOYSA-N 0.000 description 2
- DRQLMGGEDKYWTF-UHFFFAOYSA-N n-(4-aminophenyl)-2-fluorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F DRQLMGGEDKYWTF-UHFFFAOYSA-N 0.000 description 2
- YZENEPXJSXLINE-UHFFFAOYSA-N n-(4-aminophenyl)-2-methylpropanamide Chemical compound CC(C)C(=O)NC1=CC=C(N)C=C1 YZENEPXJSXLINE-UHFFFAOYSA-N 0.000 description 2
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- ZYXPMOIHQRKWGT-UHFFFAOYSA-N silver;2,2,2-trifluoroacetic acid Chemical compound [Ag].OC(=O)C(F)(F)F ZYXPMOIHQRKWGT-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 2
- YNVOMSDITJMNET-UHFFFAOYSA-N thiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-N 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- WHKVGIDSQKDXEE-UHFFFAOYSA-N (4-amino-2-chlorophenyl)carbamic acid Chemical compound NC1=CC=C(NC(O)=O)C(Cl)=C1 WHKVGIDSQKDXEE-UHFFFAOYSA-N 0.000 description 1
- IQFUADQPSYSDIP-UHFFFAOYSA-N (4-aminophenyl)carbamic acid Chemical compound NC1=CC=C(NC(O)=O)C=C1 IQFUADQPSYSDIP-UHFFFAOYSA-N 0.000 description 1
- HHLCSFGOTLUREE-UHFFFAOYSA-N 1,2,3-trichloro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(Cl)C(Cl)=C1 HHLCSFGOTLUREE-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- DBUAYOWCIUQXQW-UHFFFAOYSA-N 1,3-benzodioxole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1OCO2 DBUAYOWCIUQXQW-UHFFFAOYSA-N 0.000 description 1
- CASYPDKXSSJANQ-UHFFFAOYSA-N 1-(2-bromo-4-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(F)C=C1Br CASYPDKXSSJANQ-UHFFFAOYSA-N 0.000 description 1
- JTMGFESJCXOUCW-UHFFFAOYSA-N 1-(2-chloro-4-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(F)C=C1Cl JTMGFESJCXOUCW-UHFFFAOYSA-N 0.000 description 1
- GVLPPGZUPRQNNB-UHFFFAOYSA-N 1-(2-chloro-4-nitrophenyl)-3,4,4a,5,6,7,8,8a-octahydro-2h-quinoline Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1N1C2CCCCC2CCC1 GVLPPGZUPRQNNB-UHFFFAOYSA-N 0.000 description 1
- AIZKHORWEJERNY-UHFFFAOYSA-N 1-(2-chloro-4-nitrophenyl)piperidine Chemical class ClC1=CC([N+](=O)[O-])=CC=C1N1CCCCC1 AIZKHORWEJERNY-UHFFFAOYSA-N 0.000 description 1
- RJPLGQTZHLRZGX-UHFFFAOYSA-N 1-(2-chlorophenyl)ethanamine Chemical compound CC(N)C1=CC=CC=C1Cl RJPLGQTZHLRZGX-UHFFFAOYSA-N 0.000 description 1
- ZCDYTNZJBGSKFI-UHFFFAOYSA-N 1-(2-methylphenyl)ethanamine Chemical compound CC(N)C1=CC=CC=C1C ZCDYTNZJBGSKFI-UHFFFAOYSA-N 0.000 description 1
- QHARBBFZGIDKLK-UHFFFAOYSA-N 1-(3-chloro-4-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(F)C(Cl)=C1 QHARBBFZGIDKLK-UHFFFAOYSA-N 0.000 description 1
- DQEYVZASLGNODG-UHFFFAOYSA-N 1-(3-chlorophenyl)ethanamine Chemical compound CC(N)C1=CC=CC(Cl)=C1 DQEYVZASLGNODG-UHFFFAOYSA-N 0.000 description 1
- ASNVMKIDRJZXQZ-UHFFFAOYSA-N 1-(3-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=CC(F)=C1 ASNVMKIDRJZXQZ-UHFFFAOYSA-N 0.000 description 1
- HQQVIKFUKBTOLA-UHFFFAOYSA-N 1-(4-amino-2-chlorophenyl)ethanol Chemical compound CC(O)C1=CC=C(N)C=C1Cl HQQVIKFUKBTOLA-UHFFFAOYSA-N 0.000 description 1
- BRPFKIPSXUHGSH-UHFFFAOYSA-N 1-(4-bromo-2-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(Br)C=C1F BRPFKIPSXUHGSH-UHFFFAOYSA-N 0.000 description 1
- SRVZZCBLNXFARS-UHFFFAOYSA-N 1-(4-chloro-3-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(Cl)C(F)=C1 SRVZZCBLNXFARS-UHFFFAOYSA-N 0.000 description 1
- LYNHBBICXLUZHS-UHFFFAOYSA-N 1-(4-fluorophenyl)-2-phenylethanamine Chemical compound C=1C=C(F)C=CC=1C(N)CC1=CC=CC=C1 LYNHBBICXLUZHS-UHFFFAOYSA-N 0.000 description 1
- JISSZMBAZDURRH-UHFFFAOYSA-N 1-(4-fluorophenyl)-n-methoxy-1-phenylmethanimine Chemical compound C=1C=C(F)C=CC=1C(=NOC)C1=CC=CC=C1 JISSZMBAZDURRH-UHFFFAOYSA-N 0.000 description 1
- QGCLEUGNYRXBMZ-UHFFFAOYSA-N 1-(4-fluorophenyl)ethanamine Chemical compound CC(N)C1=CC=C(F)C=C1 QGCLEUGNYRXBMZ-UHFFFAOYSA-N 0.000 description 1
- HCJGKNUUHOOUJS-UHFFFAOYSA-N 1-(4-fluorophenyl)pentan-1-amine Chemical compound CCCCC(N)C1=CC=C(F)C=C1 HCJGKNUUHOOUJS-UHFFFAOYSA-N 0.000 description 1
- DCVWMMMKFZVEDP-UHFFFAOYSA-N 1-(cyclobutylmethyl)triazole-4-carboxylic acid Chemical compound N1=NC(C(=O)O)=CN1CC1CCC1 DCVWMMMKFZVEDP-UHFFFAOYSA-N 0.000 description 1
- FYDUUODXZQITBF-UHFFFAOYSA-N 1-[2-(trifluoromethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC=C1C(F)(F)F FYDUUODXZQITBF-UHFFFAOYSA-N 0.000 description 1
- XTBKFZDHIZYROB-UHFFFAOYSA-N 1-[2-fluoro-4-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=C(C(F)(F)F)C=C1F XTBKFZDHIZYROB-UHFFFAOYSA-N 0.000 description 1
- UQYFFQLBPVBKOF-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC(C(F)(F)F)=CC=C1F UQYFFQLBPVBKOF-UHFFFAOYSA-N 0.000 description 1
- PFVWEAYXWZFSSK-UHFFFAOYSA-N 1-[3,5-bis(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 PFVWEAYXWZFSSK-UHFFFAOYSA-N 0.000 description 1
- JGOIWTAAYYAMKP-UHFFFAOYSA-N 1-[3-fluoro-4-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=C(C(F)(F)F)C(F)=C1 JGOIWTAAYYAMKP-UHFFFAOYSA-N 0.000 description 1
- CYBTYBCFSPUKPL-UHFFFAOYSA-N 1-[3-fluoro-5-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC(F)=CC(C(F)(F)F)=C1 CYBTYBCFSPUKPL-UHFFFAOYSA-N 0.000 description 1
- AJLHHPIUEHCVMQ-UHFFFAOYSA-N 1-[4-fluoro-2-(trifluoromethyl)phenyl]ethanamine Chemical compound CC(N)C1=CC=C(F)C=C1C(F)(F)F AJLHHPIUEHCVMQ-UHFFFAOYSA-N 0.000 description 1
- RMDLJKUKXHHAKP-UHFFFAOYSA-N 1-benzyl-n-(2-chloro-4-nitrophenyl)piperidin-4-amine Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NC1CCN(CC=2C=CC=CC=2)CC1 RMDLJKUKXHHAKP-UHFFFAOYSA-N 0.000 description 1
- LGEUGPOQHYXLJY-UHFFFAOYSA-N 1-butoxy-2-chloro-4-nitrobenzene Chemical compound CCCCOC1=CC=C([N+]([O-])=O)C=C1Cl LGEUGPOQHYXLJY-UHFFFAOYSA-N 0.000 description 1
- MCDOADUSEVWUIQ-UHFFFAOYSA-N 1-butylsulfanyl-2-chloro-4-nitrobenzene Chemical compound CCCCSC1=CC=C([N+]([O-])=O)C=C1Cl MCDOADUSEVWUIQ-UHFFFAOYSA-N 0.000 description 1
- OACCRGFGCIQFNR-UHFFFAOYSA-N 1-chloro-2,4-dimethoxybenzene Chemical compound COC1=CC=C(Cl)C(OC)=C1 OACCRGFGCIQFNR-UHFFFAOYSA-N 0.000 description 1
- KADJLLXINJRFKF-UHFFFAOYSA-N 1-fluoro-2,4-dimethoxy-5-nitrobenzene Chemical compound COC1=CC(OC)=C([N+]([O-])=O)C=C1F KADJLLXINJRFKF-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- FLVFPAIGVBQGET-UHFFFAOYSA-N 1-methylpyrrolidin-3-ol Chemical compound CN1CCC(O)C1 FLVFPAIGVBQGET-UHFFFAOYSA-N 0.000 description 1
- KHSYYLCXQKCYQX-UHFFFAOYSA-N 1-naphthalen-2-ylethanamine Chemical compound C1=CC=CC2=CC(C(N)C)=CC=C21 KHSYYLCXQKCYQX-UHFFFAOYSA-N 0.000 description 1
- 125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- LBNZBEIUYGEZRD-UHFFFAOYSA-N 2,3-dimethyloxirane Chemical compound CC1OC1C.CC1OC1C LBNZBEIUYGEZRD-UHFFFAOYSA-N 0.000 description 1
- NGCLXDXSRKQDJX-UHFFFAOYSA-N 2,4-bis[3,5-bis(trifluoromethyl)phenyl]-N-methoxypentan-3-imine Chemical compound CON=C(C(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F NGCLXDXSRKQDJX-UHFFFAOYSA-N 0.000 description 1
- LGMNBLFPWQROHD-UHFFFAOYSA-N 2-(1-aminoethyl)benzonitrile Chemical compound CC(N)C1=CC=CC=C1C#N LGMNBLFPWQROHD-UHFFFAOYSA-N 0.000 description 1
- RIKUOLJPJNVTEP-UHFFFAOYSA-N 2-(2-fluorophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1F RIKUOLJPJNVTEP-UHFFFAOYSA-N 0.000 description 1
- CYZKZWUUVPAPEJ-UHFFFAOYSA-N 2-(3,5-dichlorophenyl)sulfanylacetonitrile Chemical compound ClC1=CC(Cl)=CC(SCC#N)=C1 CYZKZWUUVPAPEJ-UHFFFAOYSA-N 0.000 description 1
- IFFLTPZWIVJXTO-UHFFFAOYSA-N 2-(3-bromothiophen-2-yl)acetonitrile Chemical compound BrC=1C=CSC=1CC#N IFFLTPZWIVJXTO-UHFFFAOYSA-N 0.000 description 1
- BVSQAZYETHNSGE-UHFFFAOYSA-N 2-(3-bromothiophen-2-yl)ethanamine Chemical compound NCCC=1SC=CC=1Br BVSQAZYETHNSGE-UHFFFAOYSA-N 0.000 description 1
- IWXYHROBLDJMLK-UHFFFAOYSA-N 2-(3-chlorothiophen-2-yl)acetonitrile Chemical compound ClC=1C=CSC=1CC#N IWXYHROBLDJMLK-UHFFFAOYSA-N 0.000 description 1
- FAVKMXKQDGUREZ-UHFFFAOYSA-N 2-(3-chlorothiophen-2-yl)ethanamine Chemical compound NCCC=1SC=CC=1Cl FAVKMXKQDGUREZ-UHFFFAOYSA-N 0.000 description 1
- LPLDAFPYOIWSDP-UHFFFAOYSA-N 2-(4-amino-2-chlorophenyl)ethanol Chemical compound NC1=CC=C(CCO)C(Cl)=C1 LPLDAFPYOIWSDP-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical group NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- MOMFXATYAINJML-UHFFFAOYSA-N 2-Acetylthiazole Chemical group CC(=O)C1=NC=CS1 MOMFXATYAINJML-UHFFFAOYSA-N 0.000 description 1
- IZPQWTTYWHTPJP-UHFFFAOYSA-N 2-[(2-chloro-4-nitrophenyl)methylamino]ethanol Chemical compound OCCNCC1=CC=C([N+]([O-])=O)C=C1Cl IZPQWTTYWHTPJP-UHFFFAOYSA-N 0.000 description 1
- PVFOAANMPYRWGW-UHFFFAOYSA-N 2-[(2-fluorobenzoyl)amino]-n-phenylbenzamide Chemical compound FC1=CC=CC=C1C(=O)NC1=CC=CC=C1C(=O)NC1=CC=CC=C1 PVFOAANMPYRWGW-UHFFFAOYSA-N 0.000 description 1
- HDHFDYKLGFXOBO-UHFFFAOYSA-N 2-[(4-amino-2-chlorophenyl)methylamino]ethanol Chemical compound NC1=CC(=C(C=C1)CNCCO)Cl HDHFDYKLGFXOBO-UHFFFAOYSA-N 0.000 description 1
- SRAQMSPJVHGYHT-UHFFFAOYSA-N 2-[2,4-bis(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=C(C(F)(F)F)C=C1C(F)(F)F SRAQMSPJVHGYHT-UHFFFAOYSA-N 0.000 description 1
- ZNLRMZROBWXJCG-UHFFFAOYSA-N 2-[2-chloro-n-(2-hydroxyethyl)-4-nitroanilino]ethanol Chemical compound OCCN(CCO)C1=CC=C([N+]([O-])=O)C=C1Cl ZNLRMZROBWXJCG-UHFFFAOYSA-N 0.000 description 1
- JYTRLSGPDLBTDC-UHFFFAOYSA-N 2-[2-fluoro-3-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC(C(F)(F)F)=C1F JYTRLSGPDLBTDC-UHFFFAOYSA-N 0.000 description 1
- MKGPQHMICKVZJU-UHFFFAOYSA-N 2-[3-(trifluoromethyl)thiophen-2-yl]acetonitrile Chemical compound FC(C1=C(SC=C1)CC#N)(F)F MKGPQHMICKVZJU-UHFFFAOYSA-N 0.000 description 1
- QLDSXXKKKMQRKB-UHFFFAOYSA-N 2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC(F)=CC(C(F)(F)F)=C1 QLDSXXKKKMQRKB-UHFFFAOYSA-N 0.000 description 1
- HMFOBPNVAAAACP-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=C(C(F)(F)F)C=C1 HMFOBPNVAAAACP-UHFFFAOYSA-N 0.000 description 1
- AQUZPBABSUBRLS-UHFFFAOYSA-N 2-[4-amino-2-chloro-n-(2-hydroxyethyl)anilino]ethanol Chemical compound NC1=CC=C(N(CCO)CCO)C(Cl)=C1 AQUZPBABSUBRLS-UHFFFAOYSA-N 0.000 description 1
- AZVSPCBSDCVZKX-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=C(F)C(C(F)(F)F)=C1 AZVSPCBSDCVZKX-UHFFFAOYSA-N 0.000 description 1
- UJDLFYYJADKNFC-UHFFFAOYSA-N 2-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]carbamoyl]benzoic acid Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1NC(=O)C1=CC=CC=C1C(O)=O UJDLFYYJADKNFC-UHFFFAOYSA-N 0.000 description 1
- SAICOQSBWZZZFS-UHFFFAOYSA-N 2-[[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]carbamoyl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C(O)=O SAICOQSBWZZZFS-UHFFFAOYSA-N 0.000 description 1
- HJRYAGVNRREVDZ-UHFFFAOYSA-N 2-acetamido-5-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C(C(O)=O)=C1 HJRYAGVNRREVDZ-UHFFFAOYSA-N 0.000 description 1
- VENSKZQVHFCKNZ-UHFFFAOYSA-N 2-acetamido-5-aminobenzoic acid Chemical compound CC(=O)NC1=CC=C(N)C=C1C(O)=O VENSKZQVHFCKNZ-UHFFFAOYSA-N 0.000 description 1
- VUGRVSFLXPSOJI-UHFFFAOYSA-N 2-acetamido-5-nitro-n-phenylbenzamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C=C1C(=O)NC1=CC=CC=C1 VUGRVSFLXPSOJI-UHFFFAOYSA-N 0.000 description 1
- QKTQWLSLKHKTST-UHFFFAOYSA-N 2-acetamido-5-nitrobenzoic acid Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C=C1C(O)=O QKTQWLSLKHKTST-UHFFFAOYSA-N 0.000 description 1
- BPCYWJYTOHXEHM-UHFFFAOYSA-N 2-acetamido-n-(4-aminophenyl)benzamide Chemical compound CC(=O)NC1=CC=CC=C1C(=O)NC1=CC=C(N)C=C1 BPCYWJYTOHXEHM-UHFFFAOYSA-N 0.000 description 1
- DQNJUHQSIUTPQW-UHFFFAOYSA-N 2-acetamido-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1NC(C)=O DQNJUHQSIUTPQW-UHFFFAOYSA-N 0.000 description 1
- HXXRFGWYDDSWHL-UHFFFAOYSA-N 2-amino-n-(4-aminophenyl)benzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1N HXXRFGWYDDSWHL-UHFFFAOYSA-N 0.000 description 1
- LVBZJIZRIUGQDR-UHFFFAOYSA-N 2-amino-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-methylsulfonylbenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(S(C)(=O)=O)=C1N LVBZJIZRIUGQDR-UHFFFAOYSA-N 0.000 description 1
- QLXMFSMNSLICGU-UHFFFAOYSA-N 2-amino-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1N QLXMFSMNSLICGU-UHFFFAOYSA-N 0.000 description 1
- UMQOTOKWDXNIRY-UHFFFAOYSA-N 2-bromo-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Br UMQOTOKWDXNIRY-UHFFFAOYSA-N 0.000 description 1
- CCMQBFUTGYIKCY-UHFFFAOYSA-N 2-bromo-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Br CCMQBFUTGYIKCY-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- NGULVTOQNLILMZ-UHFFFAOYSA-N 2-bromobenzene-1,4-diamine Chemical class NC1=CC=C(N)C(Br)=C1 NGULVTOQNLILMZ-UHFFFAOYSA-N 0.000 description 1
- MGLZGLAFFOMWPB-UHFFFAOYSA-N 2-chloro-1,4-phenylenediamine Chemical class NC1=CC=C(N)C(Cl)=C1 MGLZGLAFFOMWPB-UHFFFAOYSA-N 0.000 description 1
- VTDPYWSUHNIECT-UHFFFAOYSA-N 2-chloro-3-methyl-6-nitrophenol Chemical compound Cc1ccc(c(O)c1Cl)[N+]([O-])=O VTDPYWSUHNIECT-UHFFFAOYSA-N 0.000 description 1
- AWHVKDQOMNBUIO-UHFFFAOYSA-N 2-chloro-4-nitro-1-propoxybenzene Chemical compound CCCOC1=CC=C([N+]([O-])=O)C=C1Cl AWHVKDQOMNBUIO-UHFFFAOYSA-N 0.000 description 1
- OYJJPFCGGNTTTO-UHFFFAOYSA-N 2-chloro-4-nitro-n,n-dipropylaniline Chemical compound CCCN(CCC)C1=CC=C([N+]([O-])=O)C=C1Cl OYJJPFCGGNTTTO-UHFFFAOYSA-N 0.000 description 1
- AMHCHWZVYGFSNK-UHFFFAOYSA-N 2-chloro-n,n-dimethyl-6-nitroaniline Chemical compound CN(C)C1=C(Cl)C=CC=C1[N+]([O-])=O AMHCHWZVYGFSNK-UHFFFAOYSA-N 0.000 description 1
- LGKLKAQMOASLBD-UHFFFAOYSA-N 2-chloro-n-(2-chloro-4-nitrophenyl)acetamide Chemical compound [O-][N+](=O)C1=CC=C(NC(=O)CCl)C(Cl)=C1 LGKLKAQMOASLBD-UHFFFAOYSA-N 0.000 description 1
- ORAHOABYCNJMSD-UHFFFAOYSA-N 2-chloro-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Cl ORAHOABYCNJMSD-UHFFFAOYSA-N 0.000 description 1
- WWDHHBHBXBZBAS-UHFFFAOYSA-N 2-chloro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Cl WWDHHBHBXBZBAS-UHFFFAOYSA-N 0.000 description 1
- CXIWDQIZHQEWCW-UHFFFAOYSA-N 2-chloro-n-cyclohexyl-4-nitroaniline Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NC1CCCCC1 CXIWDQIZHQEWCW-UHFFFAOYSA-N 0.000 description 1
- USKLKBAEUBKUOZ-UHFFFAOYSA-N 2-chloro-n-cyclohexyl-n-ethyl-4-nitroaniline Chemical compound C=1C=C([N+]([O-])=O)C=C(Cl)C=1N(CC)C1CCCCC1 USKLKBAEUBKUOZ-UHFFFAOYSA-N 0.000 description 1
- ZJKOSGOSCWKMMZ-UHFFFAOYSA-N 2-chloro-n-cyclohexyl-n-methyl-4-nitroaniline Chemical compound C=1C=C([N+]([O-])=O)C=C(Cl)C=1N(C)C1CCCCC1 ZJKOSGOSCWKMMZ-UHFFFAOYSA-N 0.000 description 1
- BTUPOKNGPMPSJN-UHFFFAOYSA-N 2-chloro-n-cyclopentyl-n-methyl-4-nitroaniline Chemical compound C=1C=C([N+]([O-])=O)C=C(Cl)C=1N(C)C1CCCC1 BTUPOKNGPMPSJN-UHFFFAOYSA-N 0.000 description 1
- BYXQHIOMCSYHNV-UHFFFAOYSA-N 2-chloro-n-methyl-4-nitro-n-phenylaniline Chemical compound C=1C=C([N+]([O-])=O)C=C(Cl)C=1N(C)C1=CC=CC=C1 BYXQHIOMCSYHNV-UHFFFAOYSA-N 0.000 description 1
- SFOGVXWJPPNGSP-UHFFFAOYSA-N 2-chloro-n-methyl-n-(2-methylpropyl)-4-nitroaniline Chemical compound CC(C)CN(C)C1=CC=C([N+]([O-])=O)C=C1Cl SFOGVXWJPPNGSP-UHFFFAOYSA-N 0.000 description 1
- MNURPFVONZPVLA-UHFFFAOYSA-N 2-chlorobenzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1Cl MNURPFVONZPVLA-UHFFFAOYSA-N 0.000 description 1
- FALORQLHHBVZNN-UHFFFAOYSA-N 2-fluoro-N-[4-(2-isoquinolin-1-ylethylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCCC1=NC=CC2=CC=CC=C12 FALORQLHHBVZNN-UHFFFAOYSA-N 0.000 description 1
- KRDJTADXMPSTNG-UHFFFAOYSA-N 2-fluoro-N-[4-nitro-2-(trifluoromethyl)phenyl]acetamide Chemical compound FCC(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])C(F)(F)F KRDJTADXMPSTNG-UHFFFAOYSA-N 0.000 description 1
- SRPDVHWYBMGCOW-UHFFFAOYSA-N 2-fluoro-n-(4-nitronaphthalen-1-yl)benzamide Chemical compound C12=CC=CC=C2C([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F SRPDVHWYBMGCOW-UHFFFAOYSA-N 0.000 description 1
- UECPCVPPHQJPEM-UHFFFAOYSA-N 2-fluoro-n-(5-nitropyridin-2-yl)benzamide Chemical compound N1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F UECPCVPPHQJPEM-UHFFFAOYSA-N 0.000 description 1
- CJHCDXCWGMOBKJ-UHFFFAOYSA-N 2-fluoro-n-[4-(1-phenylethylcarbamothioylamino)phenyl]benzamide Chemical compound C=1C=CC=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F CJHCDXCWGMOBKJ-UHFFFAOYSA-N 0.000 description 1
- NXQYDRDCCHELPZ-UHFFFAOYSA-N 2-fluoro-n-[4-(1-pyridin-4-ylethylcarbamothioylamino)phenyl]benzamide Chemical compound C=1C=NC=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F NXQYDRDCCHELPZ-UHFFFAOYSA-N 0.000 description 1
- JRQTYQXLIHTOJO-UHFFFAOYSA-N 2-fluoro-n-[4-(1-thiophen-3-ylethylcarbamothioylamino)phenyl]benzamide Chemical compound C1=CSC=C1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JRQTYQXLIHTOJO-UHFFFAOYSA-N 0.000 description 1
- UCMWVHFKPQDSNT-UHFFFAOYSA-N 2-fluoro-n-[4-(1h-indazol-5-ylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(NN=C2)C2=C1 UCMWVHFKPQDSNT-UHFFFAOYSA-N 0.000 description 1
- XQWJTWOOBFFTOG-UHFFFAOYSA-N 2-fluoro-n-[4-(n-methoxy-c-methylcarbonimidoyl)phenyl]benzamide Chemical compound C1=CC(C(C)=NOC)=CC=C1NC(=O)C1=CC=CC=C1F XQWJTWOOBFFTOG-UHFFFAOYSA-N 0.000 description 1
- OXRVUFVSKGWCRE-UHFFFAOYSA-N 2-fluoro-n-[4-(phenylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CC=C1 OXRVUFVSKGWCRE-UHFFFAOYSA-N 0.000 description 1
- VKDXIQXXPFWKQT-UHFFFAOYSA-N 2-fluoro-n-[4-(pyridin-3-ylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CN=C1 VKDXIQXXPFWKQT-UHFFFAOYSA-N 0.000 description 1
- JETZYHJPWPNFLL-UHFFFAOYSA-N 2-fluoro-n-[4-(pyridin-3-ylmethylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=CN=C1 JETZYHJPWPNFLL-UHFFFAOYSA-N 0.000 description 1
- ZQUZBUHGMVGSOC-UHFFFAOYSA-N 2-fluoro-n-[4-(pyridin-4-ylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=NC=C1 ZQUZBUHGMVGSOC-UHFFFAOYSA-N 0.000 description 1
- XYNBCQKLNWNSJS-UHFFFAOYSA-N 2-fluoro-n-[4-(pyridin-4-ylmethylcarbamothioylamino)phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=NC=C1 XYNBCQKLNWNSJS-UHFFFAOYSA-N 0.000 description 1
- DDFYMRONNCBCBY-UHFFFAOYSA-N 2-fluoro-n-[4-[(2-hydroxy-1-phenylethyl)carbamothioylamino]phenyl]benzamide Chemical compound C=1C=CC=CC=1C(CO)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F DDFYMRONNCBCBY-UHFFFAOYSA-N 0.000 description 1
- BKJWSTYYRNWKAC-UHFFFAOYSA-N 2-fluoro-n-[4-[(3-fluoro-4-methylphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(F)C(C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F BKJWSTYYRNWKAC-UHFFFAOYSA-N 0.000 description 1
- XAZVWWUMJFKGHO-UHFFFAOYSA-N 2-fluoro-n-[4-[(3-fluorophenyl)carbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 XAZVWWUMJFKGHO-UHFFFAOYSA-N 0.000 description 1
- PYFCUWBHRSUVGU-UHFFFAOYSA-N 2-fluoro-n-[4-[(3-hydroxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound OC1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 PYFCUWBHRSUVGU-UHFFFAOYSA-N 0.000 description 1
- DDPDJFFYINQJJJ-UHFFFAOYSA-N 2-fluoro-n-[4-[(3-iodophenyl)methylcarbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=CC(I)=C1 DDPDJFFYINQJJJ-UHFFFAOYSA-N 0.000 description 1
- JBJVVMJVXXCKJJ-UHFFFAOYSA-N 2-fluoro-n-[4-[(3-nitrophenyl)carbamothioylamino]phenyl]benzamide Chemical compound [O-][N+](=O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 JBJVVMJVXXCKJJ-UHFFFAOYSA-N 0.000 description 1
- HHFJNIYKTRCGSG-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(1,3-thiazol-2-yl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound N=1C=CSC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F HHFJNIYKTRCGSG-UHFFFAOYSA-N 0.000 description 1
- OJRURTRRAYQONT-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(2-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=CC=C(F)C=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F OJRURTRRAYQONT-UHFFFAOYSA-N 0.000 description 1
- LUACNYLGVFZBPQ-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(2-methylphenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=CC=C(C)C=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F LUACNYLGVFZBPQ-UHFFFAOYSA-N 0.000 description 1
- MCHKDYGHJSWNSQ-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2,3,5,6-tetramethylphenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C(=C1C)C)=C(C)C(C)=C1NC(=O)C1=CC=CC=C1F MCHKDYGHJSWNSQ-UHFFFAOYSA-N 0.000 description 1
- ARPUOKDCCUBVPO-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2,5-dimethoxyphenyl]benzamide Chemical compound COC=1C=C(NC(=S)NC(C)C=2C=CC(F)=CC=2)C(OC)=CC=1NC(=O)C1=CC=CC=C1F ARPUOKDCCUBVPO-UHFFFAOYSA-N 0.000 description 1
- MDUDHPUGGCLMJR-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-(trifluoromethyl)phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1C(F)(F)F)=CC=C1NC(=O)C1=CC=CC=C1F MDUDHPUGGCLMJR-UHFFFAOYSA-N 0.000 description 1
- PDCXXGAUIABRGY-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-methylphenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1C)=CC=C1NC(=O)C1=CC=CC=C1F PDCXXGAUIABRGY-UHFFFAOYSA-N 0.000 description 1
- OYIMPFKPTDVWJZ-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-phenylmethoxyphenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1OCC=2C=CC=CC=2)=CC=C1NC(=O)C1=CC=CC=C1F OYIMPFKPTDVWJZ-UHFFFAOYSA-N 0.000 description 1
- IQCJFHBKUFEGQB-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2-phenylphenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1C=2C=CC=CC=2)=CC=C1NC(=O)C1=CC=CC=C1F IQCJFHBKUFEGQB-UHFFFAOYSA-N 0.000 description 1
- HTVPKXUFEKZHIE-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-3-methylphenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C(=C1)C)=CC=C1NC(=O)C1=CC=CC=C1F HTVPKXUFEKZHIE-UHFFFAOYSA-N 0.000 description 1
- IVSFAYVOGHVSMI-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F IVSFAYVOGHVSMI-UHFFFAOYSA-N 0.000 description 1
- JBAVFKKQNLPAOH-UHFFFAOYSA-N 2-fluoro-n-[4-[1-(4-methylphenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(C)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JBAVFKKQNLPAOH-UHFFFAOYSA-N 0.000 description 1
- URIVRPICAKEUJT-UHFFFAOYSA-N 2-fluoro-n-[4-[1-[2-(trifluoromethyl)phenyl]ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=CC=C(C(F)(F)F)C=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F URIVRPICAKEUJT-UHFFFAOYSA-N 0.000 description 1
- GMWFSIOKZKGREQ-UHFFFAOYSA-N 2-fluoro-n-[4-[1-[3-(trifluoromethyl)phenyl]ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=CC(C(F)(F)F)=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F GMWFSIOKZKGREQ-UHFFFAOYSA-N 0.000 description 1
- QDQNTSLGFZNXCF-UHFFFAOYSA-N 2-fluoro-n-[4-[1-[4-(trifluoromethyl)phenyl]ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(C(F)(F)F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F QDQNTSLGFZNXCF-UHFFFAOYSA-N 0.000 description 1
- GMIHCFZCKGLGCM-UHFFFAOYSA-N 2-fluoro-n-[4-[2-(2-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC=C1CCNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F GMIHCFZCKGLGCM-UHFFFAOYSA-N 0.000 description 1
- SMCJVSMKMQPYFU-UHFFFAOYSA-N 2-fluoro-n-[4-[2-(3-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC(CCNC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 SMCJVSMKMQPYFU-UHFFFAOYSA-N 0.000 description 1
- JTHLGMLZIIEEBQ-UHFFFAOYSA-N 2-fluoro-n-[4-[2-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C1=CC(F)=CC=C1CCNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JTHLGMLZIIEEBQ-UHFFFAOYSA-N 0.000 description 1
- JBAVFKKQNLPAOH-MRXNPFEDSA-N 2-fluoro-n-[4-[[(1r)-1-(4-methylphenyl)ethyl]carbamothioylamino]phenyl]benzamide Chemical compound N([C@H](C)C=1C=CC(C)=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JBAVFKKQNLPAOH-MRXNPFEDSA-N 0.000 description 1
- CJHCDXCWGMOBKJ-OAHLLOKOSA-N 2-fluoro-n-[4-[[(1r)-1-phenylethyl]carbamothioylamino]phenyl]benzamide Chemical compound N([C@H](C)C=1C=CC=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F CJHCDXCWGMOBKJ-OAHLLOKOSA-N 0.000 description 1
- CJHCDXCWGMOBKJ-HNNXBMFYSA-N 2-fluoro-n-[4-[[(1s)-1-phenylethyl]carbamothioylamino]phenyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F CJHCDXCWGMOBKJ-HNNXBMFYSA-N 0.000 description 1
- QGETXAOCPVGMCM-UHFFFAOYSA-N 2-fluoro-n-[4-[[(4-fluorophenyl)-phenylmethyl]carbamothioylamino]phenyl]benzamide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC=CC=1)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F QGETXAOCPVGMCM-UHFFFAOYSA-N 0.000 description 1
- KVPDWPONYGLREP-UHFFFAOYSA-N 2-fluoro-n-[4-[[1-(4-fluorophenyl)-2-phenylethyl]carbamothioylamino]phenyl]benzamide Chemical compound C1=CC(F)=CC=C1C(NC(=S)NC=1C=CC(NC(=O)C=2C(=CC=CC=2)F)=CC=1)CC1=CC=CC=C1 KVPDWPONYGLREP-UHFFFAOYSA-N 0.000 description 1
- OFORWHPUXKLTEF-UHFFFAOYSA-N 2-fluoro-n-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=C(C(F)(F)F)C=C1CNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F OFORWHPUXKLTEF-UHFFFAOYSA-N 0.000 description 1
- BBXXRZMLJGNUQR-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(1-hydroxyethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound CC(O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 BBXXRZMLJGNUQR-UHFFFAOYSA-N 0.000 description 1
- UQTNDAFCTSPFPK-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(2-hydroxyethylsulfonyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound OCCS(=O)(=O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 UQTNDAFCTSPFPK-UHFFFAOYSA-N 0.000 description 1
- MHXSJAVVYQTCTH-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(2-methylbutyl)-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound FC(F)(F)C1=CC(CC(C)CC)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 MHXSJAVVYQTCTH-UHFFFAOYSA-N 0.000 description 1
- PZNYIPCHDRIJKP-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(2-methylpropyl)-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound FC(F)(F)C1=CC(CC(C)C)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 PZNYIPCHDRIJKP-UHFFFAOYSA-N 0.000 description 1
- LMLLPSUJGKOUIS-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound C1CN(C)CCN1C1=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=CC(C(F)(F)F)=C1 LMLLPSUJGKOUIS-UHFFFAOYSA-N 0.000 description 1
- ATBJGJWHERJTST-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(hydrazinecarbonyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound NNC(=O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 ATBJGJWHERJTST-UHFFFAOYSA-N 0.000 description 1
- ITFZRRMTMYJDPI-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(hydroxymethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound OCC1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 ITFZRRMTMYJDPI-UHFFFAOYSA-N 0.000 description 1
- NHKPKVBHWVECST-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(trifluoromethoxy)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CC(OC(F)(F)F)=C1 NHKPKVBHWVECST-UHFFFAOYSA-N 0.000 description 1
- GOAYILFNFRXTCN-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CC(C(F)(F)F)=C1 GOAYILFNFRXTCN-UHFFFAOYSA-N 0.000 description 1
- JYTBXQUVDYWJOE-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-[methyl(2-methylpropyl)amino]-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]benzamide Chemical compound FC(F)(F)C1=CC(N(C)CC(C)C)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 JYTBXQUVDYWJOE-UHFFFAOYSA-N 0.000 description 1
- NLPXBOBMIPWVRG-UHFFFAOYSA-N 2-fluoro-n-[4-[[3-fluoro-5-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]benzamide Chemical compound FC(F)(F)C1=CC(F)=CC(CNC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 NLPXBOBMIPWVRG-UHFFFAOYSA-N 0.000 description 1
- AVNWHPITOLCPML-UHFFFAOYSA-N 2-fluoro-n-[4-[[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]benzamide Chemical compound C1CN(C)CCN1C(C(=C1)C(F)(F)F)=CC=C1CNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F AVNWHPITOLCPML-UHFFFAOYSA-N 0.000 description 1
- RCSRJSMISTXMSO-UHFFFAOYSA-N 2-fluoro-n-[4-[[4-fluoro-3-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=C(F)C(C(F)(F)F)=C1 RCSRJSMISTXMSO-UHFFFAOYSA-N 0.000 description 1
- KPLNWCJPXDRPDH-UHFFFAOYSA-N 2-fluoro-n-[4-nitro-2-(trifluoromethyl)phenyl]benzamide Chemical compound FC(F)(F)C1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F KPLNWCJPXDRPDH-UHFFFAOYSA-N 0.000 description 1
- ZKNZYJYUHVNGNT-UHFFFAOYSA-N 2-fluoro-n-[4-nitro-3-(trifluoromethyl)phenyl]benzamide Chemical compound C1=C(C(F)(F)F)C([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F ZKNZYJYUHVNGNT-UHFFFAOYSA-N 0.000 description 1
- RAAGZOYMEQDCTD-UHFFFAOYSA-N 2-fluorobenzoyl chloride Chemical compound FC1=CC=CC=C1C(Cl)=O RAAGZOYMEQDCTD-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BDCRZIZHSVWNQZ-UHFFFAOYSA-N 2-methyl-n-(5-nitropyridin-2-yl)benzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C([N+]([O-])=O)C=N1 BDCRZIZHSVWNQZ-UHFFFAOYSA-N 0.000 description 1
- QOAHVMYUFDSBQW-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O.CC1=CC=CC=C1C(N)=O QOAHVMYUFDSBQW-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- HVLUYXIJZLDNIS-UHFFFAOYSA-N 2-thiophen-2-ylethanamine Chemical compound NCCC1=CC=CS1 HVLUYXIJZLDNIS-UHFFFAOYSA-N 0.000 description 1
- GTODOEDLCNTSLG-UHFFFAOYSA-N 2h-triazole-4-carboxylic acid Chemical compound OC(=O)C1=CNN=N1 GTODOEDLCNTSLG-UHFFFAOYSA-N 0.000 description 1
- YEMNVCITOAWNKC-UHFFFAOYSA-N 3-(1-aminoethyl)-n,n-dimethylaniline Chemical compound CC(N)C1=CC=CC(N(C)C)=C1 YEMNVCITOAWNKC-UHFFFAOYSA-N 0.000 description 1
- UTDRNGQVIRUPOC-UHFFFAOYSA-N 3-(1-aminoethyl)benzonitrile Chemical compound CC(N)C1=CC=CC(C#N)=C1 UTDRNGQVIRUPOC-UHFFFAOYSA-N 0.000 description 1
- WIHPAWIMAQLJNH-UHFFFAOYSA-N 3-(2-aminoethyl)-n,n-dimethyl-5-(trifluoromethyl)aniline Chemical compound CN(C)C1=CC(CCN)=CC(C(F)(F)F)=C1 WIHPAWIMAQLJNH-UHFFFAOYSA-N 0.000 description 1
- QAWLKTDBUQOFEF-UHFFFAOYSA-N 3-(4-bromophenyl)propanenitrile Chemical compound BrC1=CC=C(CCC#N)C=C1 QAWLKTDBUQOFEF-UHFFFAOYSA-N 0.000 description 1
- HBYUIYJDNZSPBU-UHFFFAOYSA-N 3-(N-methoxy-C-methylcarbonimidoyl)benzonitrile Chemical compound CON=C(C)C1=CC=CC(C#N)=C1 HBYUIYJDNZSPBU-UHFFFAOYSA-N 0.000 description 1
- MQSZATJRGUVKII-UHFFFAOYSA-N 3-(aminomethyl)-n,n-dimethyl-5-(trifluoromethyl)aniline Chemical compound CN(C)C1=CC(CN)=CC(C(F)(F)F)=C1 MQSZATJRGUVKII-UHFFFAOYSA-N 0.000 description 1
- OSLFKRUDXPALFD-UHFFFAOYSA-N 3-[[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]carbamoyl]benzoic acid Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(C(O)=O)=C1 OSLFKRUDXPALFD-UHFFFAOYSA-N 0.000 description 1
- YRYSHMZGTGLBHC-UHFFFAOYSA-N 3-acetamido-n-(4-aminophenyl)benzamide Chemical compound CC(=O)NC1=CC=CC(C(=O)NC=2C=CC(N)=CC=2)=C1 YRYSHMZGTGLBHC-UHFFFAOYSA-N 0.000 description 1
- DWJYPTFINXRQBH-UHFFFAOYSA-N 3-acetamido-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(NC(C)=O)=C1 DWJYPTFINXRQBH-UHFFFAOYSA-N 0.000 description 1
- HJTLKVYOWNTDPF-UHFFFAOYSA-N 3-bromo-5-(trifluoromethyl)aniline Chemical compound NC1=CC(Br)=CC(C(F)(F)F)=C1 HJTLKVYOWNTDPF-UHFFFAOYSA-N 0.000 description 1
- AYRFQLRYTJYNPA-UHFFFAOYSA-N 3-bromo-n,n-dimethyl-5-(trifluoromethyl)aniline Chemical compound CN(C)C1=CC(Br)=CC(C(F)(F)F)=C1 AYRFQLRYTJYNPA-UHFFFAOYSA-N 0.000 description 1
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 1
- OOZHTWCSBRHXNG-UHFFFAOYSA-N 3-butoxy-n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound CCCCOC1=CC=CC(C(=O)NC=2C=CC(NC(=S)NC=3C(=CC(OC)=C(Cl)C=3)OC)=CC=2)=C1 OOZHTWCSBRHXNG-UHFFFAOYSA-N 0.000 description 1
- TZPCFRIDTOFKIB-UHFFFAOYSA-N 3-chloro-1-n,1-n-dimethylbenzene-1,2-diamine Chemical class CN(C)C1=CC=CC(Cl)=C1N TZPCFRIDTOFKIB-UHFFFAOYSA-N 0.000 description 1
- BEZGHDRLDURVRK-UHFFFAOYSA-N 3-chloro-2,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C(OC)=C1Cl BEZGHDRLDURVRK-UHFFFAOYSA-N 0.000 description 1
- LOCKPKWGFIBYLB-UHFFFAOYSA-N 3-chloro-4-(4-methylpiperazin-1-yl)aniline Chemical compound C1CN(C)CCN1C1=CC=C(N)C=C1Cl LOCKPKWGFIBYLB-UHFFFAOYSA-N 0.000 description 1
- KZAMRRANXJVDCD-UHFFFAOYSA-N 3-chloro-4-(trifluoromethyl)aniline Chemical compound NC1=CC=C(C(F)(F)F)C(Cl)=C1 KZAMRRANXJVDCD-UHFFFAOYSA-N 0.000 description 1
- YXBDJALKYPUAFT-UHFFFAOYSA-N 3-chloro-4-propan-2-yloxyaniline Chemical compound CC(C)OC1=CC=C(N)C=C1Cl YXBDJALKYPUAFT-UHFFFAOYSA-N 0.000 description 1
- BNPSPBWNZBGVDT-UHFFFAOYSA-N 3-chloro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(Cl)=C1 BNPSPBWNZBGVDT-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- BAAGJAICOJJCDT-UHFFFAOYSA-N 3-ethoxycarbonyl-2-methoxybenzoic acid Chemical compound C(C)OC(=O)C=1C(=C(C(=O)O)C=CC=1)OC BAAGJAICOJJCDT-UHFFFAOYSA-N 0.000 description 1
- YWOKYZJJNQBVFT-UHFFFAOYSA-N 3-fluoro-2-methylbenzamide Chemical compound CC1=C(F)C=CC=C1C(N)=O YWOKYZJJNQBVFT-UHFFFAOYSA-N 0.000 description 1
- KLIRZBPSXYYRIN-UHFFFAOYSA-N 3-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(F)=C1 KLIRZBPSXYYRIN-UHFFFAOYSA-N 0.000 description 1
- VDOKYXHLVQGSJQ-UHFFFAOYSA-N 4-(1-aminoethyl)-n,n-dimethylaniline Chemical compound CC(N)C1=CC=C(N(C)C)C=C1 VDOKYXHLVQGSJQ-UHFFFAOYSA-N 0.000 description 1
- CANLULJYEHSQFU-UHFFFAOYSA-N 4-(1-aminoethyl)benzonitrile Chemical compound CC(N)C1=CC=C(C#N)C=C1 CANLULJYEHSQFU-UHFFFAOYSA-N 0.000 description 1
- XROJZLIRJNNLMR-UHFFFAOYSA-N 4-(2-aminoethyl)-n,n,2-trimethylaniline Chemical compound CN(C)C1=CC=C(CCN)C=C1C XROJZLIRJNNLMR-UHFFFAOYSA-N 0.000 description 1
- XPETWYGRHDZKKO-UHFFFAOYSA-N 4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)benzonitrile Chemical compound C1CN(C)CCN1C1=CC=C(C#N)C=C1C(F)(F)F XPETWYGRHDZKKO-UHFFFAOYSA-N 0.000 description 1
- FVRVFRZKHOOQBD-UHFFFAOYSA-N 4-(dimethylamino)-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(N(C)C)C=C1 FVRVFRZKHOOQBD-UHFFFAOYSA-N 0.000 description 1
- HSJDBAMBLBCEFW-UHFFFAOYSA-N 4-(n-methoxy-c-methylcarbonimidoyl)benzonitrile Chemical compound CON=C(C)C1=CC=C(C#N)C=C1 HSJDBAMBLBCEFW-UHFFFAOYSA-N 0.000 description 1
- HFOFVIVGYAEWAV-UHFFFAOYSA-N 4-[(4-acetamidophenyl)carbamothioylamino]-2-chlorobenzoic acid Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(C(O)=O)C(Cl)=C1 HFOFVIVGYAEWAV-UHFFFAOYSA-N 0.000 description 1
- ZYZQSCWSPFLAFM-UHFFFAOYSA-N 4-amino-2-chlorophenol Chemical class NC1=CC=C(O)C(Cl)=C1 ZYZQSCWSPFLAFM-UHFFFAOYSA-N 0.000 description 1
- IVWSVUAULSWZNB-UHFFFAOYSA-N 4-bromo-2,4-dimethoxycyclohexa-1,5-dien-1-amine Chemical compound COC1=C(N)C=CC(Br)(OC)C1 IVWSVUAULSWZNB-UHFFFAOYSA-N 0.000 description 1
- ZMXJMNASZAAMSC-UHFFFAOYSA-N 4-chloro-1-n,1-n-dimethylbenzene-1,2-diamine Chemical class CN(C)C1=CC=C(Cl)C=C1N ZMXJMNASZAAMSC-UHFFFAOYSA-N 0.000 description 1
- QOMAYFFYZHAPEH-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-2-nitroaniline Chemical compound CN(C)C1=CC=C(Cl)C=C1[N+]([O-])=O QOMAYFFYZHAPEH-UHFFFAOYSA-N 0.000 description 1
- NBXIUZZKRDDNRX-UHFFFAOYSA-N 4-chloro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C=C1 NBXIUZZKRDDNRX-UHFFFAOYSA-N 0.000 description 1
- KTPUYLDGSBNXDE-UHFFFAOYSA-N 4-fluoro-n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(F)C=C1 KTPUYLDGSBNXDE-UHFFFAOYSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- PIIZYNQECPTVEO-UHFFFAOYSA-N 4-nitro-m-cresol Chemical compound CC1=CC(O)=CC=C1[N+]([O-])=O PIIZYNQECPTVEO-UHFFFAOYSA-N 0.000 description 1
- QSUILVWOWLUOEU-GOVZDWNOSA-N 4-nitrophenyl beta-D-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 QSUILVWOWLUOEU-GOVZDWNOSA-N 0.000 description 1
- UBNWPQXLFRMMEI-GQCTYLIASA-N 5-[3-[(e)-3-(3-hydroxy-2-methoxycarbonylphenoxy)prop-1-enyl]phenyl]-1,2-oxazole-3-carboxylic acid Chemical compound COC(=O)C1=C(O)C=CC=C1OC\C=C\C1=CC=CC(C=2ON=C(C=2)C(O)=O)=C1 UBNWPQXLFRMMEI-GQCTYLIASA-N 0.000 description 1
- CNKPBVNYMYYYPA-UHFFFAOYSA-N 5-chloro-3-n,3-n-dimethylbenzene-1,3-diamine Chemical class CN(C)C1=CC(N)=CC(Cl)=C1 CNKPBVNYMYYYPA-UHFFFAOYSA-N 0.000 description 1
- QOIDQMOZTRAYET-UHFFFAOYSA-N 5-fluoro-2,4-dimethoxyaniline Chemical compound COC1=CC(OC)=C(F)C=C1N QOIDQMOZTRAYET-UHFFFAOYSA-N 0.000 description 1
- NRTULWPODYLFOJ-UHFFFAOYSA-N 5-methoxy-2-nitrophenol Chemical compound COC1=CC=C([N+]([O-])=O)C(O)=C1 NRTULWPODYLFOJ-UHFFFAOYSA-N 0.000 description 1
- BOFRXDMCQRTGII-UHFFFAOYSA-N 619-08-9 Chemical class OC1=CC=C([N+]([O-])=O)C=C1Cl BOFRXDMCQRTGII-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010001779 Ancrod Proteins 0.000 description 1
- 241001132374 Asta Species 0.000 description 1
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- QZDFQNDMQHSXKY-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)OCOC(CC)C Chemical compound C(C1=CC=CC=C1)(=O)OCOC(CC)C QZDFQNDMQHSXKY-UHFFFAOYSA-N 0.000 description 1
- MDDLAUQTWQEXTF-UHFFFAOYSA-N C(N)(OC(C(C)C)C1=CC=C(C=C1)[N+](=O)[O-])=O Chemical compound C(N)(OC(C(C)C)C1=CC=C(C=C1)[N+](=O)[O-])=O MDDLAUQTWQEXTF-UHFFFAOYSA-N 0.000 description 1
- XPZIIDBEAKXZEP-UHFFFAOYSA-N C(N)(OC(CC1=C(C=C(C=C1)Cl)[N+](=O)[O-])(C)C)=O Chemical compound C(N)(OC(CC1=C(C=C(C=C1)Cl)[N+](=O)[O-])(C)C)=O XPZIIDBEAKXZEP-UHFFFAOYSA-N 0.000 description 1
- SZJQLKOMGHNDEB-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)Br)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)Br)Cl)(C)C)=O SZJQLKOMGHNDEB-UHFFFAOYSA-N 0.000 description 1
- QCRDGZUQZNBHRT-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)C1=NNC=C1)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)C1=NNC=C1)Cl)(C)C)=O QCRDGZUQZNBHRT-UHFFFAOYSA-N 0.000 description 1
- XCCTYIKOPASWPS-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)C=C)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)C=C)Cl)(C)C)=O XCCTYIKOPASWPS-UHFFFAOYSA-N 0.000 description 1
- HMOWFMWTUNXSNY-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)CCO)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)CCO)Cl)(C)C)=O HMOWFMWTUNXSNY-UHFFFAOYSA-N 0.000 description 1
- AOUVCPSYMPUIOA-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)N)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)N)Cl)(C)C)=O AOUVCPSYMPUIOA-UHFFFAOYSA-N 0.000 description 1
- WRAFTTKVIRQTMN-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)S(=O)(=O)C)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)S(=O)(=O)C)Cl)(C)C)=O WRAFTTKVIRQTMN-UHFFFAOYSA-N 0.000 description 1
- CDJKSIGZTXKQTA-UHFFFAOYSA-N C(N)(OC(CC1=CC(=C(C=C1)S(=O)C)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=C(C=C1)S(=O)C)Cl)(C)C)=O CDJKSIGZTXKQTA-UHFFFAOYSA-N 0.000 description 1
- YEDGUZXOPSGHNP-UHFFFAOYSA-N C(N)(OC(CC1=CC(=CC(=C1)Cl)NC(=O)OC(C)(C)C)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=CC(=C1)Cl)NC(=O)OC(C)(C)C)(C)C)=O YEDGUZXOPSGHNP-UHFFFAOYSA-N 0.000 description 1
- DDBAORSSMHNARW-UHFFFAOYSA-N C(N)(OC(CC1=CC(=CC(=C1)N(C)C)Cl)(C)C)=O Chemical compound C(N)(OC(CC1=CC(=CC(=C1)N(C)C)Cl)(C)C)=O DDBAORSSMHNARW-UHFFFAOYSA-N 0.000 description 1
- WAIPKIIIFNRGGM-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(=O)OC1=CC=CC=C1)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(=O)OC1=CC=CC=C1)(C)C)=O WAIPKIIIFNRGGM-UHFFFAOYSA-N 0.000 description 1
- IJPMXOBYASQSRM-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(C(C)(C)C)=O)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(C(C)(C)C)=O)(C)C)=O IJPMXOBYASQSRM-UHFFFAOYSA-N 0.000 description 1
- PJEKSTTZCYHAFG-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(CBr)=O)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(CBr)=O)(C)C)=O PJEKSTTZCYHAFG-UHFFFAOYSA-N 0.000 description 1
- MQKGJKSWTCIOPI-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(CC1=CC=CC=C1)=O)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(CC1=CC=CC=C1)=O)(C)C)=O MQKGJKSWTCIOPI-UHFFFAOYSA-N 0.000 description 1
- VXEIDSWMNIRYJO-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(CCCCC)=O)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(CCCCC)=O)(C)C)=O VXEIDSWMNIRYJO-UHFFFAOYSA-N 0.000 description 1
- BKSSVURVTIOSIT-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NC(CN(C)C)=O)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NC(CN(C)C)=O)(C)C)=O BKSSVURVTIOSIT-UHFFFAOYSA-N 0.000 description 1
- RDXWHPVIGRXDKJ-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NS(=O)(=O)C)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NS(=O)(=O)C)(C)C)=O RDXWHPVIGRXDKJ-UHFFFAOYSA-N 0.000 description 1
- FWEOADMHZJXGNV-UHFFFAOYSA-N C(N)(OC(CC1=CC=C(C=C1)NS(=O)(=O)C1=CC=CC=C1)(C)C)=O Chemical compound C(N)(OC(CC1=CC=C(C=C1)NS(=O)(=O)C1=CC=CC=C1)(C)C)=O FWEOADMHZJXGNV-UHFFFAOYSA-N 0.000 description 1
- HLLXDJFCXXGGLG-UHFFFAOYSA-N C(N)(OC1=C(C=CC=C1)C1=CC=C(C=C1)N)=O Chemical compound C(N)(OC1=C(C=CC=C1)C1=CC=C(C=C1)N)=O HLLXDJFCXXGGLG-UHFFFAOYSA-N 0.000 description 1
- CAQWNKXTMBFBGI-UHFFFAOYSA-N C.[Na] Chemical compound C.[Na] CAQWNKXTMBFBGI-UHFFFAOYSA-N 0.000 description 1
- YOYBCTAZHSRFRK-UHFFFAOYSA-N C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(=S)NCCC3=C(C=CS3)Br)F Chemical compound C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(=S)NCCC3=C(C=CS3)Br)F YOYBCTAZHSRFRK-UHFFFAOYSA-N 0.000 description 1
- OXNLEDQFDCTCLK-UHFFFAOYSA-N C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(=S)NCCC3=CC=CS3)F Chemical compound C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(=S)NCCC3=CC=CS3)F OXNLEDQFDCTCLK-UHFFFAOYSA-N 0.000 description 1
- SEYDZSSDMNMNAS-UHFFFAOYSA-N C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(NNC3=CC(=CC=C3)Cl)S(=O)(=O)O)F Chemical compound C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)NC(NNC3=CC(=CC=C3)Cl)S(=O)(=O)O)F SEYDZSSDMNMNAS-UHFFFAOYSA-N 0.000 description 1
- PSXLCTPHDAEPLK-UHFFFAOYSA-N CC(C)[Mg] Chemical compound CC(C)[Mg] PSXLCTPHDAEPLK-UHFFFAOYSA-N 0.000 description 1
- NEFGQTUKVSCJRA-UHFFFAOYSA-N CC1=CC(Br)=CC(N(C)C)=C1.F.F.F Chemical compound CC1=CC(Br)=CC(N(C)C)=C1.F.F.F NEFGQTUKVSCJRA-UHFFFAOYSA-N 0.000 description 1
- XQCKXOKBWVXUJH-UHFFFAOYSA-N CCOC([O])=O Chemical compound CCOC([O])=O XQCKXOKBWVXUJH-UHFFFAOYSA-N 0.000 description 1
- COIZNNUTZDCUTH-UHFFFAOYSA-N CON=C(C(C)C1=C(C=CC=C1)C)C(C)C1=C(C=CC=C1)C Chemical compound CON=C(C(C)C1=C(C=CC=C1)C)C(C)C1=C(C=CC=C1)C COIZNNUTZDCUTH-UHFFFAOYSA-N 0.000 description 1
- XQWKOJWRCOMRGY-UHFFFAOYSA-N CON=C(C(C)C1=C(C=CC=C1)Cl)C(C)C1=C(C=CC=C1)Cl Chemical compound CON=C(C(C)C1=C(C=CC=C1)Cl)C(C)C1=C(C=CC=C1)Cl XQWKOJWRCOMRGY-UHFFFAOYSA-N 0.000 description 1
- XTAJTQPZFHRHTF-UHFFFAOYSA-N CON=C(C(C)C1=C(C=CC=C1)F)C(C)C1=C(C=CC=C1)F Chemical compound CON=C(C(C)C1=C(C=CC=C1)F)C(C)C1=C(C=CC=C1)F XTAJTQPZFHRHTF-UHFFFAOYSA-N 0.000 description 1
- GJBHYWRDMHFBQV-UHFFFAOYSA-N CON=C(C(C)C1=CC(=CC=C1)Br)C(C)C1=CC(=CC=C1)Br Chemical compound CON=C(C(C)C1=CC(=CC=C1)Br)C(C)C1=CC(=CC=C1)Br GJBHYWRDMHFBQV-UHFFFAOYSA-N 0.000 description 1
- FLNKAYVYSNAZRZ-UHFFFAOYSA-N CON=C(C(C)C1=CC(=CC=C1)Cl)C(C)C1=CC(=CC=C1)Cl Chemical compound CON=C(C(C)C1=CC(=CC=C1)Cl)C(C)C1=CC(=CC=C1)Cl FLNKAYVYSNAZRZ-UHFFFAOYSA-N 0.000 description 1
- LVPJNUHUULIWAK-UHFFFAOYSA-N CON=C(C(C)C1=CC=C(C=C1)C)C(C)C1=CC=C(C=C1)C Chemical compound CON=C(C(C)C1=CC=C(C=C1)C)C(C)C1=CC=C(C=C1)C LVPJNUHUULIWAK-UHFFFAOYSA-N 0.000 description 1
- DHXFMMUWIPXGHU-UHFFFAOYSA-N CON=C(C(C)C1=CC=C(C=C1)CN)C(C)C1=CC=C(C=C1)CN Chemical compound CON=C(C(C)C1=CC=C(C=C1)CN)C(C)C1=CC=C(C=C1)CN DHXFMMUWIPXGHU-UHFFFAOYSA-N 0.000 description 1
- BXWWCERBJFZUAW-UHFFFAOYSA-N CON=C(C(C)C1=CC=C(C=C1)N(C)C)C(C)C1=CC=C(C=C1)N(C)C Chemical compound CON=C(C(C)C1=CC=C(C=C1)N(C)C)C(C)C1=CC=C(C=C1)N(C)C BXWWCERBJFZUAW-UHFFFAOYSA-N 0.000 description 1
- PJEBARJLXNIEMJ-UHFFFAOYSA-N CON=C(C(C)C1=CC=NC=C1)C(C)C1=CC=NC=C1 Chemical compound CON=C(C(C)C1=CC=NC=C1)C(C)C1=CC=NC=C1 PJEBARJLXNIEMJ-UHFFFAOYSA-N 0.000 description 1
- WAPVWDUKFBRYIY-UHFFFAOYSA-N CON=C(C(CC1=CC=CC=C1)C1=CC=C(C=C1)F)C(CC1=CC=CC=C1)C1=CC=C(C=C1)F Chemical compound CON=C(C(CC1=CC=CC=C1)C1=CC=C(C=C1)F)C(CC1=CC=CC=C1)C1=CC=C(C=C1)F WAPVWDUKFBRYIY-UHFFFAOYSA-N 0.000 description 1
- GNMLCXAGLUURCK-UHFFFAOYSA-N CON=C=C.FC(C=1C=C(C=CC1)C(C)C(=O)C(C)C1=CC(=CC=C1)C(F)(F)F)(F)F Chemical compound CON=C=C.FC(C=1C=C(C=CC1)C(C)C(=O)C(C)C1=CC(=CC=C1)C(F)(F)F)(F)F GNMLCXAGLUURCK-UHFFFAOYSA-N 0.000 description 1
- 208000014912 Central Nervous System Infections Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
- 206010062343 Congenital infection Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 201000005866 Exanthema Subitum Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- PFCBJIMGKOBTQZ-UHFFFAOYSA-N FC1=C(C(=O)NC=2CC(C(=CC2)NC(=S)NC(C)C2=CC=C(C=C2)F)(C)Cl)C=C(C(=C1F)F)F Chemical compound FC1=C(C(=O)NC=2CC(C(=CC2)NC(=S)NC(C)C2=CC=C(C=C2)F)(C)Cl)C=C(C(=C1F)F)F PFCBJIMGKOBTQZ-UHFFFAOYSA-N 0.000 description 1
- YBDRMLLINFZMJM-UHFFFAOYSA-N FC1=C(C(=O)NC=2CC(C(=CC2)NC(=S)NC(C)C2=CC=C(C=C2)F)(C)Cl)C=CC=C1 Chemical compound FC1=C(C(=O)NC=2CC(C(=CC2)NC(=S)NC(C)C2=CC=C(C=C2)F)(C)Cl)C=CC=C1 YBDRMLLINFZMJM-UHFFFAOYSA-N 0.000 description 1
- IJKZXBGMVBXNGU-UHFFFAOYSA-N FCC(=O)NC1=NC=C(C=C1)[N+](=O)[O-] Chemical compound FCC(=O)NC1=NC=C(C=C1)[N+](=O)[O-] IJKZXBGMVBXNGU-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229940126656 GS-4224 Drugs 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 238000001321 HNCO Methods 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
- 241000701041 Human betaherpesvirus 7 Species 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- GBUXQAQXDAOWBY-UHFFFAOYSA-N N-[3-chloro-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]-2,5-dimethoxyphenyl]-2-fluorobenzamide Chemical compound ClC=1C(=C(C=C(C1NC(=S)NC(C)C1=CC=C(C=C1)F)OC)NC(C1=C(C=CC=C1)F)=O)OC GBUXQAQXDAOWBY-UHFFFAOYSA-N 0.000 description 1
- REOAQNNWUWKCOG-UHFFFAOYSA-N N-methoxy-2,4-bis[3-(trifluoromethyl)phenyl]pentan-3-imine Chemical compound CON=C(C(C)C1=CC(=CC=C1)C(F)(F)F)C(C)C1=CC(=CC=C1)C(F)(F)F REOAQNNWUWKCOG-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- IFFIJLKQGIOOAC-UHFFFAOYSA-N NC(=O)NN=C(OCC)CC(=O)C1=CC=CC=C1 Chemical compound NC(=O)NN=C(OCC)CC(=O)C1=CC=CC=C1 IFFIJLKQGIOOAC-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical group [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 241001635574 Sabatia angularis Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101150023587 US10 gene Proteins 0.000 description 1
- 101150085955 US11 gene Proteins 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- VKSSTUXEJWINNH-UHFFFAOYSA-N [(4-nitrobenzoyl)amino]carbamic acid Chemical compound OC(=O)NNC(=O)C1=CC=C([N+]([O-])=O)C=C1 VKSSTUXEJWINNH-UHFFFAOYSA-N 0.000 description 1
- HMIVFXVKQHCVNT-UHFFFAOYSA-N [1-[2-amino-3-chloro-5-(trifluoromethyl)phenyl]-2-methylpropan-2-yl] carbamate Chemical compound C(N)(OC(CC1=C(C(=CC(=C1)C(F)(F)F)Cl)N)(C)C)=O HMIVFXVKQHCVNT-UHFFFAOYSA-N 0.000 description 1
- JZXPTHQXUGLFQY-UHFFFAOYSA-N [2-chloro-4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]carbamic acid Chemical compound CC(C)(C)OC(=O)NC1=CC=C(NC(O)=O)C(Cl)=C1 JZXPTHQXUGLFQY-UHFFFAOYSA-N 0.000 description 1
- WVLRUKNKVKVYGU-UHFFFAOYSA-N [2-methyl-1-[3-(2-methylbutyl)-5-(trifluoromethyl)phenyl]propan-2-yl] carbamate Chemical compound C(N)(OC(CC1=CC(=CC(=C1)C(F)(F)F)CC(CC)C)(C)C)=O WVLRUKNKVKVYGU-UHFFFAOYSA-N 0.000 description 1
- GVHPPVRLIPOTES-UHFFFAOYSA-N [2-methyl-4-(4-nitrophenyl)butan-2-yl] carbamate Chemical compound C(N)(OC(CCC1=CC=C(C=C1)[N+](=O)[O-])(C)C)=O GVHPPVRLIPOTES-UHFFFAOYSA-N 0.000 description 1
- AVBBIJMVLMAATM-UHFFFAOYSA-N [4-[(4-acetamidophenyl)carbamothioylamino]-3-hydroxyphenyl] benzoate Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C(=C1)O)=CC=C1OC(=O)C1=CC=CC=C1 AVBBIJMVLMAATM-UHFFFAOYSA-N 0.000 description 1
- FBFGVGVGZFZACF-UHFFFAOYSA-N [O-][N+](C(C=C(C=C1)Cl)=C1OS(CF)(=O)=O)=O Chemical class [O-][N+](C(C=C(C=C1)Cl)=C1OS(CF)(=O)=O)=O FBFGVGVGZFZACF-UHFFFAOYSA-N 0.000 description 1
- VLBOASKXOLJFJE-UHFFFAOYSA-N [O-][N+](C1=CC=CC(Cl)=C1OS(CF)(=O)=O)=O Chemical class [O-][N+](C1=CC=CC(Cl)=C1OS(CF)(=O)=O)=O VLBOASKXOLJFJE-UHFFFAOYSA-N 0.000 description 1
- ODOTZUXGBIFQEE-UHFFFAOYSA-N [O]C1CCCCC1Cl Chemical compound [O]C1CCCCC1Cl ODOTZUXGBIFQEE-UHFFFAOYSA-N 0.000 description 1
- WRWYGOVGIGCDLE-UHFFFAOYSA-N [O]c1ccccc1F Chemical group [O]c1ccccc1F WRWYGOVGIGCDLE-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003622 anti-hsv Effects 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- QNEFNFIKZWUAEQ-UHFFFAOYSA-N carbonic acid;potassium Chemical compound [K].OC(O)=O QNEFNFIKZWUAEQ-UHFFFAOYSA-N 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 229960000724 cidofovir Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 1
- DGVMNQYBHPSIJS-UHFFFAOYSA-N dimagnesium;2,2,6,6-tetraoxido-1,3,5,7-tetraoxa-2,4,6-trisilaspiro[3.3]heptane;hydrate Chemical compound O.[Mg+2].[Mg+2].O1[Si]([O-])([O-])O[Si]21O[Si]([O-])([O-])O2 DGVMNQYBHPSIJS-UHFFFAOYSA-N 0.000 description 1
- FFHWGQQFANVOHV-UHFFFAOYSA-N dimethyldioxirane Chemical compound CC1(C)OO1 FFHWGQQFANVOHV-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- RCFKEIREOSXLET-UHFFFAOYSA-N disulfamide Chemical compound CC1=CC(Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O RCFKEIREOSXLET-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000019479 dysautonomia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 1
- BNSOYWDFFBDEFB-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O BNSOYWDFFBDEFB-UHFFFAOYSA-L 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 150000002545 isoxazoles Chemical class 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- HSEHOLYDJIEPDD-UHFFFAOYSA-N methyl 3-[(4-aminophenyl)carbamoyl]benzoate Chemical class COC(=O)C1=CC=CC(C(=O)NC=2C=CC(N)=CC=2)=C1 HSEHOLYDJIEPDD-UHFFFAOYSA-N 0.000 description 1
- WTMLYBLWYPOMAY-UHFFFAOYSA-N methyl 3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]carbamoyl]benzoate Chemical class COC(=O)C1=CC=CC(C(=O)NC=2C=CC(NC(=O)OC(C)(C)C)=CC=2)=C1 WTMLYBLWYPOMAY-UHFFFAOYSA-N 0.000 description 1
- MNDFXDXRMYURMC-UHFFFAOYSA-N methyl 3-carbamoylbenzoate Chemical class COC(=O)C1=CC=CC(C(N)=O)=C1 MNDFXDXRMYURMC-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- MSZVDVDSZPGORZ-UHFFFAOYSA-N n'-(2-chloro-4-nitrophenyl)-n,n'-dimethylethane-1,2-diamine Chemical class CNCCN(C)C1=CC=C([N+]([O-])=O)C=C1Cl MSZVDVDSZPGORZ-UHFFFAOYSA-N 0.000 description 1
- CZGIEJXGCLWRPY-UHFFFAOYSA-N n,1-dimethylpyrrolidin-3-amine Chemical compound CNC1CCN(C)C1 CZGIEJXGCLWRPY-UHFFFAOYSA-N 0.000 description 1
- PANNTDUSGRIIHO-UHFFFAOYSA-N n,n,2-trimethyl-4-(2-nitroethenyl)aniline Chemical compound CN(C)C1=CC=C(C=C[N+]([O-])=O)C=C1C PANNTDUSGRIIHO-UHFFFAOYSA-N 0.000 description 1
- KLZIXMYSWQOJTE-UHFFFAOYSA-N n-(2,5-dimethoxy-4-nitrophenyl)-2-fluorobenzamide Chemical compound COC1=CC([N+]([O-])=O)=C(OC)C=C1NC(=O)C1=CC=CC=C1F KLZIXMYSWQOJTE-UHFFFAOYSA-N 0.000 description 1
- WHTRRTVHRZCJPZ-UHFFFAOYSA-N n-(2-benzoyl-4-nitrophenyl)-2-fluorobenzamide Chemical compound C=1C=CC=CC=1C(=O)C1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F WHTRRTVHRZCJPZ-UHFFFAOYSA-N 0.000 description 1
- PGXLULGZZOZXRW-UHFFFAOYSA-N n-(2-benzoyl-4-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C=C1C(=O)C1=CC=CC=C1 PGXLULGZZOZXRW-UHFFFAOYSA-N 0.000 description 1
- NKZYZRBGQRYFJZ-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-2-(diethylamino)acetamide Chemical compound CCN(CC)CC(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl NKZYZRBGQRYFJZ-UHFFFAOYSA-N 0.000 description 1
- VVCGJQIIQTWQGL-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-2-(dimethylamino)acetamide Chemical compound CN(C)CC(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl VVCGJQIIQTWQGL-UHFFFAOYSA-N 0.000 description 1
- PLLPZGHFQKAGOY-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-2-fluorobenzamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F PLLPZGHFQKAGOY-UHFFFAOYSA-N 0.000 description 1
- RLIOIYJZOFNHIR-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-n',n'-dimethylpropane-1,3-diamine Chemical class CN(C)CCCNC1=CC=C([N+]([O-])=O)C=C1Cl RLIOIYJZOFNHIR-UHFFFAOYSA-N 0.000 description 1
- QVYPSAYJQHOBCR-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)-n,1-dimethylpiperidin-4-amine Chemical compound C=1C=C([N+]([O-])=O)C=C(Cl)C=1N(C)C1CCN(C)CC1 QVYPSAYJQHOBCR-UHFFFAOYSA-N 0.000 description 1
- BCTFYSXVHAFEGT-UHFFFAOYSA-N n-(2-chloro-4-nitrophenyl)benzamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1 BCTFYSXVHAFEGT-UHFFFAOYSA-N 0.000 description 1
- MXNYLGHRJVOJMI-UHFFFAOYSA-N n-(3-amino-5-chlorophenyl)acetamide Chemical compound CC(=O)NC1=CC(N)=CC(Cl)=C1 MXNYLGHRJVOJMI-UHFFFAOYSA-N 0.000 description 1
- GSDRUMSAEJWDLM-UHFFFAOYSA-N n-(3-chloro-4-nitrophenyl)-2-fluorobenzamide Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC=C1NC(=O)C1=CC=CC=C1F GSDRUMSAEJWDLM-UHFFFAOYSA-N 0.000 description 1
- HTOMFNRBNSBPIU-UHFFFAOYSA-N n-(3-methyl-4-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C(C)=C1 HTOMFNRBNSBPIU-UHFFFAOYSA-N 0.000 description 1
- ZIRIWBRGXVHVIL-UHFFFAOYSA-N n-(4-amino-2,5-dimethoxyphenyl)-2-fluorobenzamide Chemical compound C1=C(N)C(OC)=CC(NC(=O)C=2C(=CC=CC=2)F)=C1OC ZIRIWBRGXVHVIL-UHFFFAOYSA-N 0.000 description 1
- ARRUFMIDFANXSZ-UHFFFAOYSA-N n-(4-amino-2-benzoylphenyl)-2-fluorobenzamide Chemical compound C=1C=CC=CC=1C(=O)C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F ARRUFMIDFANXSZ-UHFFFAOYSA-N 0.000 description 1
- JFIICRGSBZIZGC-UHFFFAOYSA-N n-(4-amino-2-benzoylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1C(=O)C1=CC=CC=C1 JFIICRGSBZIZGC-UHFFFAOYSA-N 0.000 description 1
- MYZYGTNEFGLCTJ-UHFFFAOYSA-N n-(4-amino-2-chlorophenyl)-2-(diethylamino)acetamide Chemical compound CCN(CC)CC(=O)NC1=CC=C(N)C=C1Cl MYZYGTNEFGLCTJ-UHFFFAOYSA-N 0.000 description 1
- HGOZHNFXVDBFMC-UHFFFAOYSA-N n-(4-amino-2-chlorophenyl)-2-(dimethylamino)acetamide Chemical compound CN(C)CC(=O)NC1=CC=C(N)C=C1Cl HGOZHNFXVDBFMC-UHFFFAOYSA-N 0.000 description 1
- DUHPYDJTWXYDHN-UHFFFAOYSA-N n-(4-amino-2-chlorophenyl)-2-fluorobenzamide Chemical compound ClC1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F DUHPYDJTWXYDHN-UHFFFAOYSA-N 0.000 description 1
- LWAYASXDHDEGAO-UHFFFAOYSA-N n-(4-amino-2-chlorophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1Cl LWAYASXDHDEGAO-UHFFFAOYSA-N 0.000 description 1
- ZYAVWGWJKCHJLF-UHFFFAOYSA-N n-(4-amino-2-chlorophenyl)benzamide Chemical compound ClC1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1 ZYAVWGWJKCHJLF-UHFFFAOYSA-N 0.000 description 1
- GWFPMSIIVJMYRZ-UHFFFAOYSA-N n-(4-amino-2-methylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1C GWFPMSIIVJMYRZ-UHFFFAOYSA-N 0.000 description 1
- QQMYMLJHLLHUJU-UHFFFAOYSA-N n-(4-amino-3-chlorophenyl)-2-fluorobenzamide Chemical compound C1=C(Cl)C(N)=CC=C1NC(=O)C1=CC=CC=C1F QQMYMLJHLLHUJU-UHFFFAOYSA-N 0.000 description 1
- LISQUUFCHAYXBI-UHFFFAOYSA-N n-(4-amino-3-cyanophenyl)-2-fluorobenzamide Chemical compound C1=C(C#N)C(N)=CC=C1NC(=O)C1=CC=CC=C1F LISQUUFCHAYXBI-UHFFFAOYSA-N 0.000 description 1
- YLVCZCUKLPNFJK-UHFFFAOYSA-N n-(4-amino-3-methylphenyl)-2-fluorobenzamide Chemical compound C1=C(N)C(C)=CC(NC(=O)C=2C(=CC=CC=2)F)=C1 YLVCZCUKLPNFJK-UHFFFAOYSA-N 0.000 description 1
- QXWUFIZOBXUMSM-UHFFFAOYSA-N n-(4-amino-3-methylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C(C)=C1 QXWUFIZOBXUMSM-UHFFFAOYSA-N 0.000 description 1
- ASHJJOKSWWDZDY-UHFFFAOYSA-N n-(4-amino-5-chloro-2-hydroxyphenyl)-2-fluorobenzamide Chemical compound C1=C(Cl)C(N)=CC(O)=C1NC(=O)C1=CC=CC=C1F ASHJJOKSWWDZDY-UHFFFAOYSA-N 0.000 description 1
- LWCFVBHTQMSJCN-UHFFFAOYSA-N n-(4-amino-5-chloro-2-hydroxyphenyl)acetamide Chemical compound CC(=O)NC1=CC(Cl)=C(N)C=C1O LWCFVBHTQMSJCN-UHFFFAOYSA-N 0.000 description 1
- IVWGCRQHEPZIHB-UHFFFAOYSA-N n-(4-amino-5-chloro-2-methylphenyl)-2-fluorobenzamide Chemical compound CC1=CC(N)=C(Cl)C=C1NC(=O)C1=CC=CC=C1F IVWGCRQHEPZIHB-UHFFFAOYSA-N 0.000 description 1
- NDEZAKJVTYETNC-UHFFFAOYSA-N n-(4-amino-5-chloro-2-methylphenyl)acetamide Chemical compound CC(=O)NC1=CC(Cl)=C(N)C=C1C NDEZAKJVTYETNC-UHFFFAOYSA-N 0.000 description 1
- BTXKLYXFRMMSHB-UHFFFAOYSA-N n-(4-aminonaphthalen-1-yl)-2-fluorobenzamide Chemical compound C12=CC=CC=C2C(N)=CC=C1NC(=O)C1=CC=CC=C1F BTXKLYXFRMMSHB-UHFFFAOYSA-N 0.000 description 1
- QDDUVLAJKGAIJX-UHFFFAOYSA-N n-(4-aminonaphthalen-1-yl)acetamide Chemical compound C1=CC=C2C(NC(=O)C)=CC=C(N)C2=C1 QDDUVLAJKGAIJX-UHFFFAOYSA-N 0.000 description 1
- CQBPZUVCJMMOLJ-UHFFFAOYSA-N n-(4-aminophenyl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=C(N)C=C1 CQBPZUVCJMMOLJ-UHFFFAOYSA-N 0.000 description 1
- DBPBUEDZCTUMIM-UHFFFAOYSA-N n-(4-aminophenyl)-2-(hydroxymethyl)benzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1CO DBPBUEDZCTUMIM-UHFFFAOYSA-N 0.000 description 1
- BKDOLJNIDBPTJO-UHFFFAOYSA-N n-(4-aminophenyl)-2-(trifluoromethyl)benzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1C(F)(F)F BKDOLJNIDBPTJO-UHFFFAOYSA-N 0.000 description 1
- AXYRMIUIAXJTSG-UHFFFAOYSA-N n-(4-aminophenyl)-2-bromobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1Br AXYRMIUIAXJTSG-UHFFFAOYSA-N 0.000 description 1
- LFTPGONCZMIVID-UHFFFAOYSA-N n-(4-aminophenyl)-2-chlorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1Cl LFTPGONCZMIVID-UHFFFAOYSA-N 0.000 description 1
- ACVACKIEZDGXND-UHFFFAOYSA-N n-(4-aminophenyl)-2-hydroxybenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1O ACVACKIEZDGXND-UHFFFAOYSA-N 0.000 description 1
- GPYUULOPLFNAJD-UHFFFAOYSA-N n-(4-aminophenyl)-2-iodobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1I GPYUULOPLFNAJD-UHFFFAOYSA-N 0.000 description 1
- FIIPAURDZWJJIB-UHFFFAOYSA-N n-(4-aminophenyl)-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(N)C=C1 FIIPAURDZWJJIB-UHFFFAOYSA-N 0.000 description 1
- ZLSOEKCTQPDZRN-UHFFFAOYSA-N n-(4-aminophenyl)-2-methylsulfinylbenzamide Chemical compound CS(=O)C1=CC=CC=C1C(=O)NC1=CC=C(N)C=C1 ZLSOEKCTQPDZRN-UHFFFAOYSA-N 0.000 description 1
- OKNVOLKFTGXHAJ-UHFFFAOYSA-N n-(4-aminophenyl)-2-nitrobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1[N+]([O-])=O OKNVOLKFTGXHAJ-UHFFFAOYSA-N 0.000 description 1
- LLIVNUAEZMDIOP-UHFFFAOYSA-N n-(4-aminophenyl)-2-phenylacetamide Chemical compound C1=CC(N)=CC=C1NC(=O)CC1=CC=CC=C1 LLIVNUAEZMDIOP-UHFFFAOYSA-N 0.000 description 1
- ZJXUFSXHCYNOFI-UHFFFAOYSA-N n-(4-aminophenyl)-3-(dimethylamino)benzamide Chemical compound CN(C)C1=CC=CC(C(=O)NC=2C=CC(N)=CC=2)=C1 ZJXUFSXHCYNOFI-UHFFFAOYSA-N 0.000 description 1
- MILNZYWWUTXRSO-UHFFFAOYSA-N n-(4-aminophenyl)-3-(trifluoromethoxy)benzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC(OC(F)(F)F)=C1 MILNZYWWUTXRSO-UHFFFAOYSA-N 0.000 description 1
- QEXWYOQRSGNLDI-UHFFFAOYSA-N n-(4-aminophenyl)-3-(trifluoromethyl)benzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC(C(F)(F)F)=C1 QEXWYOQRSGNLDI-UHFFFAOYSA-N 0.000 description 1
- ZZTYLVPKTRGIJK-UHFFFAOYSA-N n-(4-aminophenyl)-3-butoxybenzamide Chemical compound CCCCOC1=CC=CC(C(=O)NC=2C=CC(N)=CC=2)=C1 ZZTYLVPKTRGIJK-UHFFFAOYSA-N 0.000 description 1
- QWHNNYUNGVIXJA-UHFFFAOYSA-N n-(4-aminophenyl)-3-chlorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC(Cl)=C1 QWHNNYUNGVIXJA-UHFFFAOYSA-N 0.000 description 1
- RHYMJCVNNLZTOC-UHFFFAOYSA-N n-(4-aminophenyl)-3-fluorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC(F)=C1 RHYMJCVNNLZTOC-UHFFFAOYSA-N 0.000 description 1
- SARCTPGWMZKFDJ-UHFFFAOYSA-N n-(4-aminophenyl)-3-nitrobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC([N+]([O-])=O)=C1 SARCTPGWMZKFDJ-UHFFFAOYSA-N 0.000 description 1
- PZWVZNOOMPSLDB-UHFFFAOYSA-N n-(4-aminophenyl)-3-phenylmethoxybenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=CC(OCC=2C=CC=CC=2)=C1 PZWVZNOOMPSLDB-UHFFFAOYSA-N 0.000 description 1
- AHPLRRZFNOKGCC-UHFFFAOYSA-N n-(4-aminophenyl)-4-(dimethylamino)benzamide Chemical compound C1=CC(N(C)C)=CC=C1C(=O)NC1=CC=C(N)C=C1 AHPLRRZFNOKGCC-UHFFFAOYSA-N 0.000 description 1
- CYSQNIFSCOEHDN-UHFFFAOYSA-N n-(4-aminophenyl)-4-chlorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=C(Cl)C=C1 CYSQNIFSCOEHDN-UHFFFAOYSA-N 0.000 description 1
- GXGWMNAUQNALTP-UHFFFAOYSA-N n-(4-aminophenyl)-4-fluorobenzamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=C(F)C=C1 GXGWMNAUQNALTP-UHFFFAOYSA-N 0.000 description 1
- CHMBIJAOCISYEW-UHFFFAOYSA-N n-(4-aminophenyl)acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1 CHMBIJAOCISYEW-UHFFFAOYSA-N 0.000 description 1
- WNVPACYPJUPHON-UHFFFAOYSA-N n-(4-aminophenyl)prop-2-enamide Chemical compound NC1=CC=C(NC(=O)C=C)C=C1 WNVPACYPJUPHON-UHFFFAOYSA-N 0.000 description 1
- UIBFGQPYFGQNJD-UHFFFAOYSA-N n-(4-aminophenyl)pyridine-4-carboxamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=NC=C1 UIBFGQPYFGQNJD-UHFFFAOYSA-N 0.000 description 1
- CKLIFWGHVLSLGH-UHFFFAOYSA-N n-(4-fluorophenyl)-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1C(=O)NC1=CC=C(F)C=C1 CKLIFWGHVLSLGH-UHFFFAOYSA-N 0.000 description 1
- DFKKBOJXPCXEGX-UHFFFAOYSA-N n-(4-nitrophenyl)prop-2-enamide Chemical compound [O-][N+](=O)C1=CC=C(NC(=O)C=C)C=C1 DFKKBOJXPCXEGX-UHFFFAOYSA-N 0.000 description 1
- HYXYCQCFKUGWEZ-UHFFFAOYSA-N n-(5-aminopyridin-2-yl)-2-fluorobenzamide Chemical compound N1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F HYXYCQCFKUGWEZ-UHFFFAOYSA-N 0.000 description 1
- UFIPXKPFRUHDCU-UHFFFAOYSA-N n-(5-aminopyridin-2-yl)-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NC1=CC=C(N)C=N1 UFIPXKPFRUHDCU-UHFFFAOYSA-N 0.000 description 1
- ZRKSZPLEOLVMNL-UHFFFAOYSA-N n-(5-chloro-2-hydroxy-4-nitrophenyl)-2-fluorobenzamide Chemical compound OC1=CC([N+]([O-])=O)=C(Cl)C=C1NC(=O)C1=CC=CC=C1F ZRKSZPLEOLVMNL-UHFFFAOYSA-N 0.000 description 1
- UUFBMTVMATXMHL-UHFFFAOYSA-N n-(5-chloro-2-hydroxy-4-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC(Cl)=C([N+]([O-])=O)C=C1O UUFBMTVMATXMHL-UHFFFAOYSA-N 0.000 description 1
- RVFZGXPTZKYZKT-UHFFFAOYSA-N n-(5-chloro-2-methyl-4-nitrophenyl)-2-fluorobenzamide Chemical compound CC1=CC([N+]([O-])=O)=C(Cl)C=C1NC(=O)C1=CC=CC=C1F RVFZGXPTZKYZKT-UHFFFAOYSA-N 0.000 description 1
- YHFABDFGYMFOOD-UHFFFAOYSA-N n-[2-(dimethylamino)-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1N(C)C)=CC=C1NC(=O)C1=CC=CC=C1F YHFABDFGYMFOOD-UHFFFAOYSA-N 0.000 description 1
- OXRBJLLOCBPADW-UHFFFAOYSA-N n-[2-benzoyl-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1C(=O)C=2C=CC=CC=2)=CC=C1NC(=O)C1=CC=CC=C1F OXRBJLLOCBPADW-UHFFFAOYSA-N 0.000 description 1
- LBBVCHPZOXWXDY-UHFFFAOYSA-N n-[2-benzoyl-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C(C(=O)C=2C=CC=CC=2)=C1 LBBVCHPZOXWXDY-UHFFFAOYSA-N 0.000 description 1
- NKUKBLWOOUNLPG-UHFFFAOYSA-N n-[2-benzoyl-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1C(=O)C=2C=CC=CC=2)=CC=C1NC(=O)C1=CC=CC=C1F NKUKBLWOOUNLPG-UHFFFAOYSA-N 0.000 description 1
- MINUESQUQRTPLR-UHFFFAOYSA-N n-[2-butoxy-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(NC(=O)C=2C(=CC=CC=2)F)C(OCCCC)=CC=1NC(=S)NC(C)C1=CC=C(F)C=C1 MINUESQUQRTPLR-UHFFFAOYSA-N 0.000 description 1
- CASPJLHFQLZFRR-UHFFFAOYSA-N n-[2-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1Cl)=CC=C1NC(=O)C1=CC=CC=C1F CASPJLHFQLZFRR-UHFFFAOYSA-N 0.000 description 1
- KHEXVDMWIAFDOU-UHFFFAOYSA-N n-[2-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C(Cl)=C1 KHEXVDMWIAFDOU-UHFFFAOYSA-N 0.000 description 1
- MXCWBWVHMUGQAA-UHFFFAOYSA-N n-[2-chloro-4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1Cl)=CC=C1NC(=O)C1=CC=CC=C1F MXCWBWVHMUGQAA-UHFFFAOYSA-N 0.000 description 1
- WACMRFMFJHWMPZ-UHFFFAOYSA-N n-[3-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=CC(NC(C)=O)=C1 WACMRFMFJHWMPZ-UHFFFAOYSA-N 0.000 description 1
- ZVJDULDRODKUIJ-UHFFFAOYSA-N n-[3-chloro-4-[(3-chloro-4-methylphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=S)NC(C(=C1)Cl)=CC=C1NC(=O)C1=CC=CC=C1F ZVJDULDRODKUIJ-UHFFFAOYSA-N 0.000 description 1
- NPZHFWHOVNAVCF-UHFFFAOYSA-N n-[3-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C(=C1)Cl)=CC=C1NC(=O)C1=CC=CC=C1F NPZHFWHOVNAVCF-UHFFFAOYSA-N 0.000 description 1
- YDOAEKQCEWFTFB-UHFFFAOYSA-N n-[3-chloro-5-(dimethylamino)phenyl]acetamide Chemical compound CN(C)C1=CC(Cl)=CC(NC(C)=O)=C1 YDOAEKQCEWFTFB-UHFFFAOYSA-N 0.000 description 1
- XCFJHUUAFAFTND-UHFFFAOYSA-N n-[4-(1,3-benzodioxol-5-ylmethylcarbamothioylamino)phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=C(OCO2)C2=C1 XCFJHUUAFAFTND-UHFFFAOYSA-N 0.000 description 1
- RBARUADTZUPJEU-UHFFFAOYSA-N n-[4-(aminomethyl)phenyl]-2-fluorobenzamide Chemical compound C1=CC(CN)=CC=C1NC(=O)C1=CC=CC=C1F RBARUADTZUPJEU-UHFFFAOYSA-N 0.000 description 1
- CREVGCYXCRCFJW-UHFFFAOYSA-N n-[4-(benzylcarbamothioylamino)phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=CC=C1 CREVGCYXCRCFJW-UHFFFAOYSA-N 0.000 description 1
- BHHCZUMCEGEZIU-UHFFFAOYSA-N n-[4-(phenylcarbamothioylamino)phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=CC=C1 BHHCZUMCEGEZIU-UHFFFAOYSA-N 0.000 description 1
- CEDSRSBAWVUZEN-UHFFFAOYSA-N n-[4-[(2,4-dihydroxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(O)C=C1O CEDSRSBAWVUZEN-UHFFFAOYSA-N 0.000 description 1
- KOTCUYOPZWWQLD-UHFFFAOYSA-N n-[4-[(2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound COC1=CC(OC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 KOTCUYOPZWWQLD-UHFFFAOYSA-N 0.000 description 1
- PWQGUYKNRUJAKH-UHFFFAOYSA-N n-[4-[(2,6-dimethoxypyridin-3-yl)carbamothioylamino]phenyl]acetamide Chemical compound COC1=NC(OC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 PWQGUYKNRUJAKH-UHFFFAOYSA-N 0.000 description 1
- ISDHYVVYRCMZBL-UHFFFAOYSA-N n-[4-[(2-amino-5-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=CC=C(Cl)C=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F ISDHYVVYRCMZBL-UHFFFAOYSA-N 0.000 description 1
- AQYKJMOSYVEXMK-UHFFFAOYSA-N n-[4-[(2-amino-5-fluorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=CC=C(F)C=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F AQYKJMOSYVEXMK-UHFFFAOYSA-N 0.000 description 1
- GEJSLOKWFLBRNV-UHFFFAOYSA-N n-[4-[(2-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CC=C1Cl GEJSLOKWFLBRNV-UHFFFAOYSA-N 0.000 description 1
- MBWCWENAJWPYOQ-UHFFFAOYSA-N n-[4-[(2-nitrophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=CC=C1[N+]([O-])=O MBWCWENAJWPYOQ-UHFFFAOYSA-N 0.000 description 1
- UTFZNELXHKXLDB-UHFFFAOYSA-N n-[4-[(3,4,5-trimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound COC1=C(OC)C(OC)=CC(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)=C1 UTFZNELXHKXLDB-UHFFFAOYSA-N 0.000 description 1
- BYOXFBXBCBBRPX-UHFFFAOYSA-N n-[4-[(3,5-dimethylphenyl)methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CC1=CC(C)=CC(CNC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 BYOXFBXBCBBRPX-UHFFFAOYSA-N 0.000 description 1
- PAGNWPPWZVKTLS-UHFFFAOYSA-N n-[4-[(3-acetamidophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CC(=O)NC1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 PAGNWPPWZVKTLS-UHFFFAOYSA-N 0.000 description 1
- FNCYDOXQZSNMDC-UHFFFAOYSA-N n-[4-[(3-acetylphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CC(=O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 FNCYDOXQZSNMDC-UHFFFAOYSA-N 0.000 description 1
- SDYQOVUAEGRODH-UHFFFAOYSA-N n-[4-[(3-amino-5-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=CC(Cl)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 SDYQOVUAEGRODH-UHFFFAOYSA-N 0.000 description 1
- MXDFQVKHONLKLY-UHFFFAOYSA-N n-[4-[(3-aminophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 MXDFQVKHONLKLY-UHFFFAOYSA-N 0.000 description 1
- VFTKAGFBKDXXQM-UHFFFAOYSA-N n-[4-[(3-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound COC1=C(Cl)C(OC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 VFTKAGFBKDXXQM-UHFFFAOYSA-N 0.000 description 1
- VSDYXOSAMMYMII-UHFFFAOYSA-N n-[4-[(3-chloro-4-ethenylphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(C=C)C(Cl)=C1 VSDYXOSAMMYMII-UHFFFAOYSA-N 0.000 description 1
- JUPMFYAEFAOITF-UHFFFAOYSA-N n-[4-[(3-chloro-4-fluorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(F)C(Cl)=C1 JUPMFYAEFAOITF-UHFFFAOYSA-N 0.000 description 1
- DZBXBBOCBCCHOY-UHFFFAOYSA-N n-[4-[(3-chloro-4-fluorophenyl)methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(F)=CC=C1CNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F DZBXBBOCBCCHOY-UHFFFAOYSA-N 0.000 description 1
- SGHJQAMRGOJWSI-UHFFFAOYSA-N n-[4-[(3-chloro-4-iodophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(I)C(Cl)=C1 SGHJQAMRGOJWSI-UHFFFAOYSA-N 0.000 description 1
- UAUOPWDADDLRDP-UHFFFAOYSA-N n-[4-[(3-chloro-4-iodophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(I)C(Cl)=C1 UAUOPWDADDLRDP-UHFFFAOYSA-N 0.000 description 1
- TWYCXOOIVLDZOZ-UHFFFAOYSA-N n-[4-[(3-chloro-4-methylphenyl)carbamothioylamino]-2-methylphenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=S)NC(C=C1C)=CC=C1NC(=O)C1=CC=CC=C1F TWYCXOOIVLDZOZ-UHFFFAOYSA-N 0.000 description 1
- KDORCFHEBHHIML-UHFFFAOYSA-N n-[4-[(3-chloro-4-methylphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F KDORCFHEBHHIML-UHFFFAOYSA-N 0.000 description 1
- OVEZYAVCJYOATK-UHFFFAOYSA-N n-[4-[(3-chloro-4-methylphenyl)carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C OVEZYAVCJYOATK-UHFFFAOYSA-N 0.000 description 1
- PNAZJOJGELIJIO-UHFFFAOYSA-N n-[4-[(3-chloro-4-methylphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(C)C(Cl)=C1 PNAZJOJGELIJIO-UHFFFAOYSA-N 0.000 description 1
- FWIJFVJYQKXCEA-UHFFFAOYSA-N n-[4-[(3-chloro-4-phenylmethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1OCC1=CC=CC=C1 FWIJFVJYQKXCEA-UHFFFAOYSA-N 0.000 description 1
- YKFXQJYLHKBVHJ-UHFFFAOYSA-N n-[4-[(3-chloro-4-propan-2-yloxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F YKFXQJYLHKBVHJ-UHFFFAOYSA-N 0.000 description 1
- LHZCIDIFZSXEES-UHFFFAOYSA-N n-[4-[(3-chloro-4-propoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OCCC)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F LHZCIDIFZSXEES-UHFFFAOYSA-N 0.000 description 1
- ZRBCZPPODWRKBV-UHFFFAOYSA-N n-[4-[(3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=CC(Cl)=C1 ZRBCZPPODWRKBV-UHFFFAOYSA-N 0.000 description 1
- ZTYVECSYNJQCKI-UHFFFAOYSA-N n-[4-[(3-chlorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=CC(Cl)=C1 ZTYVECSYNJQCKI-UHFFFAOYSA-N 0.000 description 1
- RAEFYYFFJDZYEY-UHFFFAOYSA-N n-[4-[(3-chlorophenyl)methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC=CC(Cl)=C1 RAEFYYFFJDZYEY-UHFFFAOYSA-N 0.000 description 1
- QKBOPUWYSUCOCO-UHFFFAOYSA-N n-[4-[(3-nitrophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=CC([N+]([O-])=O)=C1 QKBOPUWYSUCOCO-UHFFFAOYSA-N 0.000 description 1
- BWMXZVNBPVXTID-UHFFFAOYSA-N n-[4-[(4-acetamido-3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(NC(=O)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F BWMXZVNBPVXTID-UHFFFAOYSA-N 0.000 description 1
- VWCTZRSFGUVPPG-UHFFFAOYSA-N n-[4-[(4-acetamido-3-chlorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C(Cl)=C1 VWCTZRSFGUVPPG-UHFFFAOYSA-N 0.000 description 1
- QAGHUWYORRLFED-UHFFFAOYSA-N n-[4-[(4-acetamidophenyl)carbamothioylamino]-2-chlorophenyl]-2-(diethylamino)acetamide Chemical compound C1=C(Cl)C(NC(=O)CN(CC)CC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 QAGHUWYORRLFED-UHFFFAOYSA-N 0.000 description 1
- ZSSNYHICZDIZED-UHFFFAOYSA-N n-[4-[(4-acetamidophenyl)carbamothioylamino]-2-chlorophenyl]benzamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1NC(=O)C1=CC=CC=C1 ZSSNYHICZDIZED-UHFFFAOYSA-N 0.000 description 1
- IYVPPVGHOCLOTD-UHFFFAOYSA-N n-[4-[(4-amino-3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(N)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F IYVPPVGHOCLOTD-UHFFFAOYSA-N 0.000 description 1
- KOHNKJILNJBMFN-UHFFFAOYSA-N n-[4-[(4-bromo-3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(Br)C(Cl)=C1 KOHNKJILNJBMFN-UHFFFAOYSA-N 0.000 description 1
- BWNPCGXFQSTPIN-UHFFFAOYSA-N n-[4-[(4-bromo-3-chlorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(Br)C(Cl)=C1 BWNPCGXFQSTPIN-UHFFFAOYSA-N 0.000 description 1
- KXRPODARNOZDIC-UHFFFAOYSA-N n-[4-[(4-butan-2-yloxy-3-chlorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OC(C)CC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 KXRPODARNOZDIC-UHFFFAOYSA-N 0.000 description 1
- FCCZKNCSWYOTBH-UHFFFAOYSA-N n-[4-[(4-butoxy-3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OCCCC)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F FCCZKNCSWYOTBH-UHFFFAOYSA-N 0.000 description 1
- YXOUMPBNNPLLLD-UHFFFAOYSA-N n-[4-[(4-butoxy-3-chlorophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OCCCC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 YXOUMPBNNPLLLD-UHFFFAOYSA-N 0.000 description 1
- NXZYRFJUGVKZPP-UHFFFAOYSA-N n-[4-[(4-butylsulfanyl-3-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(SCCCC)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F NXZYRFJUGVKZPP-UHFFFAOYSA-N 0.000 description 1
- DZQICPIWBXZAFK-UHFFFAOYSA-N n-[4-[(4-chloro-2,5-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)=C1OC DZQICPIWBXZAFK-UHFFFAOYSA-N 0.000 description 1
- HHSGJHLUQYANAG-UHFFFAOYSA-N n-[4-[(4-chlorophenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(Cl)C=C1 HHSGJHLUQYANAG-UHFFFAOYSA-N 0.000 description 1
- ARQSCHDEZDAJFE-UHFFFAOYSA-N n-[4-[(4-nitrophenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C([N+]([O-])=O)C=C1 ARQSCHDEZDAJFE-UHFFFAOYSA-N 0.000 description 1
- ILPIEBXGOHJZQB-UHFFFAOYSA-N n-[4-[(5-bromo-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Br)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F ILPIEBXGOHJZQB-UHFFFAOYSA-N 0.000 description 1
- ZMECEJVYPWBXCI-UHFFFAOYSA-N n-[4-[(5-bromo-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C1=C(Br)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C ZMECEJVYPWBXCI-UHFFFAOYSA-N 0.000 description 1
- UFUWRBZVRMUAEQ-UHFFFAOYSA-N n-[4-[(5-bromo-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Br)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 UFUWRBZVRMUAEQ-UHFFFAOYSA-N 0.000 description 1
- VEFPZVDGZQDEKV-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2,5-dimethoxyphenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C(=C1)OC)=CC(OC)=C1NC(=O)C1=CC=CC=C1F VEFPZVDGZQDEKV-UHFFFAOYSA-N 0.000 description 1
- RGITYOKYWDJAOG-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2,5-dimethoxyphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC(OC)=C(NC(C)=O)C=C1OC RGITYOKYWDJAOG-UHFFFAOYSA-N 0.000 description 1
- TVFJIJYFUVVWKE-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-(trifluoromethyl)phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C(C(F)(F)F)=C1 TVFJIJYFUVVWKE-UHFFFAOYSA-N 0.000 description 1
- JXSCBJYCNOLNDN-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-methylphenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1C)=CC=C1NC(=O)C1=CC=CC=C1F JXSCBJYCNOLNDN-UHFFFAOYSA-N 0.000 description 1
- GFBPVDJAUSCCJH-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-methylphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C(C)=C1 GFBPVDJAUSCCJH-UHFFFAOYSA-N 0.000 description 1
- IKRZQZULFIBDGC-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-3-(trifluoromethyl)phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C(=C1)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC=C1F IKRZQZULFIBDGC-UHFFFAOYSA-N 0.000 description 1
- KIMDZSMWMIFCHG-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-3-(trifluoromethyl)phenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1C(F)(F)F KIMDZSMWMIFCHG-UHFFFAOYSA-N 0.000 description 1
- MLQRHVUFKRFNLS-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-3-methylphenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C(=C1)C)=CC=C1NC(=O)C1=CC=CC=C1F MLQRHVUFKRFNLS-UHFFFAOYSA-N 0.000 description 1
- DQEDPEUMWANTNQ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-3-methylphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1C DQEDPEUMWANTNQ-UHFFFAOYSA-N 0.000 description 1
- SGUXECYTYFUQOY-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]naphthalen-1-yl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C1=CC=CC=C11)=CC=C1NC(=O)C1=CC=CC=C1F SGUXECYTYFUQOY-UHFFFAOYSA-N 0.000 description 1
- SMSBXMKSTSOVRJ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]naphthalen-1-yl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C2=CC=CC=C12 SMSBXMKSTSOVRJ-UHFFFAOYSA-N 0.000 description 1
- YAFBOBJTFGUEFR-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F YAFBOBJTFGUEFR-UHFFFAOYSA-N 0.000 description 1
- NDUZZYXHABZKKP-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-hydroxy-3-methylbenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(C)=C1O NDUZZYXHABZKKP-UHFFFAOYSA-N 0.000 description 1
- KKIBDJYZVDPZDR-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-hydroxybenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1O KKIBDJYZVDPZDR-UHFFFAOYSA-N 0.000 description 1
- ZUUZCZVHKGESRS-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C ZUUZCZVHKGESRS-UHFFFAOYSA-N 0.000 description 1
- RMWVUFFNLOTBJA-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-methylsulfinylbenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1S(C)=O RMWVUFFNLOTBJA-UHFFFAOYSA-N 0.000 description 1
- JDUZJLKXSFRGHY-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-2-nitrobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1[N+]([O-])=O JDUZJLKXSFRGHY-UHFFFAOYSA-N 0.000 description 1
- HXFUYPSLRRCWDE-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-(dimethylamino)benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(N(C)C)=C1 HXFUYPSLRRCWDE-UHFFFAOYSA-N 0.000 description 1
- JFPOQURRTKLHGY-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(F)=C1 JFPOQURRTKLHGY-UHFFFAOYSA-N 0.000 description 1
- SWCCUVOINRWBPJ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-hydroxybenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(O)=C1 SWCCUVOINRWBPJ-UHFFFAOYSA-N 0.000 description 1
- IKSYYHAKGCLTJQ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-nitrobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC([N+]([O-])=O)=C1 IKSYYHAKGCLTJQ-UHFFFAOYSA-N 0.000 description 1
- UTWOGADCMOFQCD-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-3-phenylmethoxybenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC(OCC=2C=CC=CC=2)=C1 UTWOGADCMOFQCD-UHFFFAOYSA-N 0.000 description 1
- AFBZEKPCYRRGCE-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-4-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(F)C=C1 AFBZEKPCYRRGCE-UHFFFAOYSA-N 0.000 description 1
- AETVFOIOAPCFRZ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]-n-methylacetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(N(C)C(C)=O)C=C1 AETVFOIOAPCFRZ-UHFFFAOYSA-N 0.000 description 1
- QKMDDLJQZUXSCG-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]benzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1 QKMDDLJQZUXSCG-UHFFFAOYSA-N 0.000 description 1
- AOPBMGONNRNYLQ-UHFFFAOYSA-N n-[4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]pyridine-4-carboxamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=NC=C1 AOPBMGONNRNYLQ-UHFFFAOYSA-N 0.000 description 1
- GXXXPEKVXGHZLD-UHFFFAOYSA-N n-[4-[(5-chloro-2-hydroxyphenyl)carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound OC1=CC=C(Cl)C=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F GXXXPEKVXGHZLD-UHFFFAOYSA-N 0.000 description 1
- AVXMQRHKZSQDFG-UHFFFAOYSA-N n-[4-[(5-chloro-2-hydroxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC(Cl)=CC=C1O AVXMQRHKZSQDFG-UHFFFAOYSA-N 0.000 description 1
- VMEZJDUENKODEB-UHFFFAOYSA-N n-[4-[(5-chloro-2-methylphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC(Cl)=CC=C1C VMEZJDUENKODEB-UHFFFAOYSA-N 0.000 description 1
- CHOAFNBZWWGXLN-UHFFFAOYSA-N n-[4-[(5-fluoro-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(F)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 CHOAFNBZWWGXLN-UHFFFAOYSA-N 0.000 description 1
- YJPFMQOCSCJOAN-UHFFFAOYSA-N n-[4-[(5-iodo-2,4-dimethoxyphenyl)carbamothioylamino]phenyl]acetamide Chemical compound C1=C(I)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 YJPFMQOCSCJOAN-UHFFFAOYSA-N 0.000 description 1
- CKUDUAKETAJLBX-UHFFFAOYSA-N n-[4-[1-(2-bromophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=CC=C(Br)C=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F CKUDUAKETAJLBX-UHFFFAOYSA-N 0.000 description 1
- KBWINLUUBUWJRE-UHFFFAOYSA-N n-[4-[1-(2-chlorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=CC=C(Cl)C=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F KBWINLUUBUWJRE-UHFFFAOYSA-N 0.000 description 1
- LVJGIQGHPJNMNE-UHFFFAOYSA-N n-[4-[1-(3-bromophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=CC(Br)=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F LVJGIQGHPJNMNE-UHFFFAOYSA-N 0.000 description 1
- JDPIWHGWTZUGBW-UHFFFAOYSA-N n-[4-[1-(3-chlorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=CC(Cl)=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JDPIWHGWTZUGBW-UHFFFAOYSA-N 0.000 description 1
- NJFRXNVWXSLAHB-UHFFFAOYSA-N n-[4-[1-(4-bromophenyl)ethylcarbamothioylamino]-2-(trifluoromethyl)phenyl]-2-fluorobenzamide Chemical compound C=1C=C(Br)C=CC=1C(C)NC(=S)NC(C=C1C(F)(F)F)=CC=C1NC(=O)C1=CC=CC=C1F NJFRXNVWXSLAHB-UHFFFAOYSA-N 0.000 description 1
- IXGBWHVCTCVPOU-UHFFFAOYSA-N n-[4-[1-(4-bromophenyl)ethylcarbamothioylamino]-2-methylphenyl]-2-fluorobenzamide Chemical compound C=1C=C(Br)C=CC=1C(C)NC(=S)NC(C=C1C)=CC=C1NC(=O)C1=CC=CC=C1F IXGBWHVCTCVPOU-UHFFFAOYSA-N 0.000 description 1
- SUWGJAQKGMMPAP-UHFFFAOYSA-N n-[4-[1-(4-chlorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F SUWGJAQKGMMPAP-UHFFFAOYSA-N 0.000 description 1
- FEGFRCNPRNZYCH-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-iodobenzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1I FEGFRCNPRNZYCH-UHFFFAOYSA-N 0.000 description 1
- ONDOYRGFZVQXCE-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-2-phenylacetamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)CC1=CC=CC=C1 ONDOYRGFZVQXCE-UHFFFAOYSA-N 0.000 description 1
- HNWMYUNXUZWIFV-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-4-(trifluoromethyl)benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(C(F)(F)F)C=C1 HNWMYUNXUZWIFV-UHFFFAOYSA-N 0.000 description 1
- RRAPFJYFONPTTE-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]-4-hydroxybenzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=C(O)C=C1 RRAPFJYFONPTTE-UHFFFAOYSA-N 0.000 description 1
- GQUSQJFKONMTAD-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC1=CC=C(NC(C)=O)C=C1 GQUSQJFKONMTAD-UHFFFAOYSA-N 0.000 description 1
- IEZAHSYLYAEHSK-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]benzamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1 IEZAHSYLYAEHSK-UHFFFAOYSA-N 0.000 description 1
- SIQPNKLVSCWWGH-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]propanamide Chemical compound C1=CC(NC(=O)CC)=CC=C1NC(=S)NC(C)C1=CC=C(F)C=C1 SIQPNKLVSCWWGH-UHFFFAOYSA-N 0.000 description 1
- YJSUVOYUNHXRHO-UHFFFAOYSA-N n-[4-[1-(4-fluorophenyl)ethylcarbamothioylamino]phenyl]pyridine-4-carboxamide Chemical compound C=1C=C(F)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=NC=C1 YJSUVOYUNHXRHO-UHFFFAOYSA-N 0.000 description 1
- KEFLYAXBYLYEMC-UHFFFAOYSA-N n-[4-[1-[3-(dimethylamino)phenyl]ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=CC(N(C)C)=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F KEFLYAXBYLYEMC-UHFFFAOYSA-N 0.000 description 1
- SMDGODVCAWMWEY-UHFFFAOYSA-N n-[4-[1-[4-(dimethylamino)phenyl]ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(N(C)C)C=CC=1C(C)NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F SMDGODVCAWMWEY-UHFFFAOYSA-N 0.000 description 1
- XSKHYHAWELOMNX-UHFFFAOYSA-N n-[4-[2-(3-chlorophenyl)ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCCC1=CC=CC(Cl)=C1 XSKHYHAWELOMNX-UHFFFAOYSA-N 0.000 description 1
- RQOUSIHIHNTMGE-UHFFFAOYSA-N n-[4-[2-[3-(dimethylamino)-5-(trifluoromethyl)phenyl]ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC(F)(F)C1=CC(N(C)C)=CC(CCNC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 RQOUSIHIHNTMGE-UHFFFAOYSA-N 0.000 description 1
- NCWCKRFTMUODFL-UHFFFAOYSA-N n-[4-[2-[4-(dimethylamino)-3-methylphenyl]ethylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(C)C(N(C)C)=CC=C1CCNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F NCWCKRFTMUODFL-UHFFFAOYSA-N 0.000 description 1
- SUWGJAQKGMMPAP-CQSZACIVSA-N n-[4-[[(1r)-1-(4-chlorophenyl)ethyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound N([C@H](C)C=1C=CC(Cl)=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F SUWGJAQKGMMPAP-CQSZACIVSA-N 0.000 description 1
- WWTKCTKITFWCDO-AWEZNQCLSA-N n-[4-[[(1s)-1-(4-bromophenyl)ethyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound N([C@@H](C)C=1C=CC(Br)=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F WWTKCTKITFWCDO-AWEZNQCLSA-N 0.000 description 1
- SUWGJAQKGMMPAP-AWEZNQCLSA-N n-[4-[[(1s)-1-(4-chlorophenyl)ethyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F SUWGJAQKGMMPAP-AWEZNQCLSA-N 0.000 description 1
- HFJBAUQMZVLTTR-UHFFFAOYSA-N n-[4-[[2,4-dimethoxy-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound COC1=CC(OC)=C(C(F)(F)F)C=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 HFJBAUQMZVLTTR-UHFFFAOYSA-N 0.000 description 1
- ADHPFUSAVVJINP-UHFFFAOYSA-N n-[4-[[2-amino-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=CC=C(C(F)(F)F)C=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F ADHPFUSAVVJINP-UHFFFAOYSA-N 0.000 description 1
- MAMBARVCFNMILI-UHFFFAOYSA-N n-[4-[[2-chloro-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC(C(F)(F)F)=CC=C1Cl MAMBARVCFNMILI-UHFFFAOYSA-N 0.000 description 1
- FJFOACNNYIIPDJ-UHFFFAOYSA-N n-[4-[[3,5-bis(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 FJFOACNNYIIPDJ-UHFFFAOYSA-N 0.000 description 1
- CBPPMIPSNKRMEJ-UHFFFAOYSA-N n-[4-[[3,5-bis(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NCC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 CBPPMIPSNKRMEJ-UHFFFAOYSA-N 0.000 description 1
- ASEHSSHDTQMKIJ-UHFFFAOYSA-N n-[4-[[3-(butylsulfamoyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CCCCNS(=O)(=O)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 ASEHSSHDTQMKIJ-UHFFFAOYSA-N 0.000 description 1
- HHUOJWOEXIOLBM-UHFFFAOYSA-N n-[4-[[3-(dimethylamino)-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC(F)(F)C1=CC(N(C)C)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 HHUOJWOEXIOLBM-UHFFFAOYSA-N 0.000 description 1
- VADBKKZCLSNAHS-UHFFFAOYSA-N n-[4-[[3-(dimethylamino)-5-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC(F)(F)C1=CC(N(C)C)=CC(CNC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 VADBKKZCLSNAHS-UHFFFAOYSA-N 0.000 description 1
- OFRIYOPIHMUDLE-UHFFFAOYSA-N n-[4-[[3-(dimethylamino)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CN(C)C1=CC=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 OFRIYOPIHMUDLE-UHFFFAOYSA-N 0.000 description 1
- NGGMBOVVPWXDHM-UHFFFAOYSA-N n-[4-[[3-[butyl(methyl)amino]-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC(F)(F)C1=CC(N(C)CCCC)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 NGGMBOVVPWXDHM-UHFFFAOYSA-N 0.000 description 1
- MYSQSDDSWHPMRG-UHFFFAOYSA-N n-[4-[[3-bromo-4-(trifluoromethoxy)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(OC(F)(F)F)C(Br)=C1 MYSQSDDSWHPMRG-UHFFFAOYSA-N 0.000 description 1
- KJOFLPMJQXPCOA-UHFFFAOYSA-N n-[4-[[3-bromo-5-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC(Br)=CC(C(F)(F)F)=C1 KJOFLPMJQXPCOA-UHFFFAOYSA-N 0.000 description 1
- JRUUBDQAEFJKPD-UHFFFAOYSA-N n-[4-[[3-chloro-4-(1-hydroxyethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(C(O)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F JRUUBDQAEFJKPD-UHFFFAOYSA-N 0.000 description 1
- KTJJVWHLYNCTCR-UHFFFAOYSA-N n-[4-[[3-chloro-4-(1-hydroxyethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(C(O)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 KTJJVWHLYNCTCR-UHFFFAOYSA-N 0.000 description 1
- VSZIEFLXLCODOL-UHFFFAOYSA-N n-[4-[[3-chloro-4-(1h-pyrazol-5-yl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1C1=NNC=C1 VSZIEFLXLCODOL-UHFFFAOYSA-N 0.000 description 1
- MDZCAGYLVWARNM-UHFFFAOYSA-N n-[4-[[3-chloro-4-(2-hydroxyethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(CCO)C(Cl)=C1 MDZCAGYLVWARNM-UHFFFAOYSA-N 0.000 description 1
- PPZKIYGBNYLPOA-UHFFFAOYSA-N n-[4-[[3-chloro-4-(2-methylpropoxy)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OCC(C)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F PPZKIYGBNYLPOA-UHFFFAOYSA-N 0.000 description 1
- VBZXKUIALMOUPG-UHFFFAOYSA-N n-[4-[[3-chloro-4-(4-methylpiperazin-1-yl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1CN(C)CCN1C(C(=C1)Cl)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 VBZXKUIALMOUPG-UHFFFAOYSA-N 0.000 description 1
- DUBVMDIQCJKJPE-UHFFFAOYSA-N n-[4-[[3-chloro-4-(cyclohexylamino)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1NC1CCCCC1 DUBVMDIQCJKJPE-UHFFFAOYSA-N 0.000 description 1
- VRAIMOGNYDZQGZ-UHFFFAOYSA-N n-[4-[[3-chloro-4-(diethylamino)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(CC)CC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 VRAIMOGNYDZQGZ-UHFFFAOYSA-N 0.000 description 1
- CJNKFSAGCDPJLF-UHFFFAOYSA-N n-[4-[[3-chloro-4-(dimethylamino)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(N(C)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F CJNKFSAGCDPJLF-UHFFFAOYSA-N 0.000 description 1
- AYDFYRGKYARHIJ-UHFFFAOYSA-N n-[4-[[3-chloro-4-(dimethylamino)phenyl]carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C1=C(Cl)C(N(C)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1C AYDFYRGKYARHIJ-UHFFFAOYSA-N 0.000 description 1
- DIIVMKYDRTUBBU-UHFFFAOYSA-N n-[4-[[3-chloro-4-(dimethylamino)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(C)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 DIIVMKYDRTUBBU-UHFFFAOYSA-N 0.000 description 1
- LZAQKUNWKGNVOE-UHFFFAOYSA-N n-[4-[[3-chloro-4-(dipropylamino)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(CCC)CCC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 LZAQKUNWKGNVOE-UHFFFAOYSA-N 0.000 description 1
- ABLXTILENPDUHD-UHFFFAOYSA-N n-[4-[[3-chloro-4-(methanesulfonamido)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(NS(=O)(=O)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F ABLXTILENPDUHD-UHFFFAOYSA-N 0.000 description 1
- MWRVGBVWOCDENO-UHFFFAOYSA-N n-[4-[[3-chloro-4-(methanesulfonamido)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(NS(C)(=O)=O)C(Cl)=C1 MWRVGBVWOCDENO-UHFFFAOYSA-N 0.000 description 1
- HWJQWSYHRJKZAG-UHFFFAOYSA-N n-[4-[[3-chloro-4-(n-methylanilino)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)C=C(Cl)C=1N(C)C1=CC=CC=C1 HWJQWSYHRJKZAG-UHFFFAOYSA-N 0.000 description 1
- QQIOCFBCHQLBTE-UHFFFAOYSA-N n-[4-[[3-chloro-4-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(C(F)(F)F)C(Cl)=C1 QQIOCFBCHQLBTE-UHFFFAOYSA-N 0.000 description 1
- NBOLXIZMRYDZPT-UHFFFAOYSA-N n-[4-[[3-chloro-4-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(C(F)(F)F)C(Cl)=C1 NBOLXIZMRYDZPT-UHFFFAOYSA-N 0.000 description 1
- GJNCTIXXFRGRFV-UHFFFAOYSA-N n-[4-[[3-chloro-4-[2-(dimethylamino)ethyl-methylamino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(C)CCN(C)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 GJNCTIXXFRGRFV-UHFFFAOYSA-N 0.000 description 1
- FIHKXDPQXUEFBO-UHFFFAOYSA-N n-[4-[[3-chloro-4-[2-(dimethylamino)ethylamino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(NCCN(C)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 FIHKXDPQXUEFBO-UHFFFAOYSA-N 0.000 description 1
- DYJXJGIRBLTVQO-UHFFFAOYSA-N n-[4-[[3-chloro-4-[2-hydroxyethyl(methyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(CCO)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 DYJXJGIRBLTVQO-UHFFFAOYSA-N 0.000 description 1
- WUJHGRYDUSDUHM-UHFFFAOYSA-N n-[4-[[3-chloro-4-[[2-(diethylamino)acetyl]amino]phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(NC(=O)CN(CC)CC)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F WUJHGRYDUSDUHM-UHFFFAOYSA-N 0.000 description 1
- QEVGUWIVFCPHLZ-UHFFFAOYSA-N n-[4-[[3-chloro-4-[[2-(dimethylamino)acetyl]amino]phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(NC(=O)CN(C)C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F QEVGUWIVFCPHLZ-UHFFFAOYSA-N 0.000 description 1
- XTGNWKDNRQENIS-UHFFFAOYSA-N n-[4-[[3-chloro-4-[cyclohexyl(ethyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)C=C(Cl)C=1N(CC)C1CCCCC1 XTGNWKDNRQENIS-UHFFFAOYSA-N 0.000 description 1
- WPYDYBBVUFVUKU-UHFFFAOYSA-N n-[4-[[3-chloro-4-[cyclohexyl(methyl)amino]phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)C=C(Cl)C=1N(C)C1CCCCC1 WPYDYBBVUFVUKU-UHFFFAOYSA-N 0.000 description 1
- JLTGXKKEIIPOLX-UHFFFAOYSA-N n-[4-[[3-chloro-4-[cyclohexyl(methyl)amino]phenyl]carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)C)=CC=2)C=C(Cl)C=1N(C)C1CCCCC1 JLTGXKKEIIPOLX-UHFFFAOYSA-N 0.000 description 1
- XNBUSZVHSRETFI-UHFFFAOYSA-N n-[4-[[3-chloro-4-[cyclohexyl(methyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)C=C(Cl)C=1N(C)C1CCCCC1 XNBUSZVHSRETFI-UHFFFAOYSA-N 0.000 description 1
- TXZBFXJOYGVEGC-UHFFFAOYSA-N n-[4-[[3-chloro-4-[cyclopentyl(methyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)C=C(Cl)C=1N(C)C1CCCC1 TXZBFXJOYGVEGC-UHFFFAOYSA-N 0.000 description 1
- XBESGIDESYTIAS-UHFFFAOYSA-N n-[4-[[3-chloro-4-[hexyl(methyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(C)CCCCCC)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 XBESGIDESYTIAS-UHFFFAOYSA-N 0.000 description 1
- LJLKEZNGPHGUJT-UHFFFAOYSA-N n-[4-[[3-chloro-4-[methyl(2-methylpropyl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=C(Cl)C(N(C)CC(C)C)=CC=C1NC(=S)NC1=CC=C(NC(C)=O)C=C1 LJLKEZNGPHGUJT-UHFFFAOYSA-N 0.000 description 1
- UTAXXWYGDXSGFZ-UHFFFAOYSA-N n-[4-[[3-chloro-4-[methyl-(1-methylpiperidin-4-yl)amino]phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)C=C(Cl)C=1N(C)C1CCN(C)CC1 UTAXXWYGDXSGFZ-UHFFFAOYSA-N 0.000 description 1
- XUYGKPABAXLTML-UHFFFAOYSA-N n-[4-[[3-chloro-4-[methyl-(1-methylpiperidin-4-yl)amino]phenyl]carbamothioylamino]phenyl]-2-methylbenzamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)C)=CC=2)C=C(Cl)C=1N(C)C1CCN(C)CC1 XUYGKPABAXLTML-UHFFFAOYSA-N 0.000 description 1
- XETUWKMUGXMMNU-UHFFFAOYSA-N n-[4-[[3-chloro-4-[methyl-(1-methylpiperidin-4-yl)amino]phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C=1C=C(NC(=S)NC=2C=CC(NC(C)=O)=CC=2)C=C(Cl)C=1N(C)C1CCN(C)CC1 XETUWKMUGXMMNU-UHFFFAOYSA-N 0.000 description 1
- QZHCRVZKZKLNDB-UHFFFAOYSA-N n-[4-[[3-chloro-5-(dimethylamino)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CN(C)C1=CC(Cl)=CC(NC(=S)NC=2C=CC(NC(=O)C=3C(=CC=CC=3)F)=CC=2)=C1 QZHCRVZKZKLNDB-UHFFFAOYSA-N 0.000 description 1
- PJKZXPGUYFYLJM-UHFFFAOYSA-N n-[4-[[4-(1-azidoethyl)-3-chlorophenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(C(N=[N+]=[N-])C)=CC=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F PJKZXPGUYFYLJM-UHFFFAOYSA-N 0.000 description 1
- MFDWVRVQANOAOA-UHFFFAOYSA-N n-[4-[[4-(2-aminopyrimidin-4-yl)-3-chlorophenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound NC1=NC=CC(C=2C(=CC(NC(=S)NC=3C=CC(NC(=O)C=4C(=CC=CC=4)F)=CC=3)=CC=2)Cl)=N1 MFDWVRVQANOAOA-UHFFFAOYSA-N 0.000 description 1
- DJZFRFOAILHKJU-UHFFFAOYSA-N n-[4-[[4-(3,4,4a,5,6,7,8,8a-octahydro-2h-quinolin-1-yl)-3-chlorophenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1N1C2CCCCC2CCC1 DJZFRFOAILHKJU-UHFFFAOYSA-N 0.000 description 1
- NMHGDMRLSRPXDU-UHFFFAOYSA-N n-[4-[[4-(benzylamino)-3-chlorophenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1NCC1=CC=CC=C1 NMHGDMRLSRPXDU-UHFFFAOYSA-N 0.000 description 1
- LWYOSBMHXMMNFE-UHFFFAOYSA-N n-[4-[[4-(dimethylamino)-3-(trifluoromethyl)phenyl]methylcarbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound C1=C(C(F)(F)F)C(N(C)C)=CC=C1CNC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F LWYOSBMHXMMNFE-UHFFFAOYSA-N 0.000 description 1
- WTBZYZHCLKQQTO-UHFFFAOYSA-N n-[4-[[4-[(1-benzylpiperidin-4-yl)amino]-3-chlorophenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC(C=C1Cl)=CC=C1NC1CCN(CC=2C=CC=CC=2)CC1 WTBZYZHCLKQQTO-UHFFFAOYSA-N 0.000 description 1
- MQNWVWVVXUSCBL-UHFFFAOYSA-N n-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1NC(=S)NC1=CC=C(Cl)C(C(F)(F)F)=C1 MQNWVWVVXUSCBL-UHFFFAOYSA-N 0.000 description 1
- ZLJAZBIYYGENAH-UHFFFAOYSA-N n-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamothioylamino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1NC(=S)NC1=CC=C(Cl)C(C(F)(F)F)=C1 ZLJAZBIYYGENAH-UHFFFAOYSA-N 0.000 description 1
- BQULNSFGDUQVDS-UHFFFAOYSA-N n-[4-[[5-chloro-2-(dimethylamino)phenyl]carbamothioylamino]phenyl]-2-fluorobenzamide Chemical compound CN(C)C1=CC=C(Cl)C=C1NC(=S)NC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1F BQULNSFGDUQVDS-UHFFFAOYSA-N 0.000 description 1
- WLPITKOWLYNTKY-UHFFFAOYSA-N n-[4-[[[3,5-bis(trifluoromethyl)phenyl]carbamothioylamino]methyl]phenyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NC(C=C1)=CC=C1CNC(=S)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 WLPITKOWLYNTKY-UHFFFAOYSA-N 0.000 description 1
- JLKCPDDWAAZHQD-UHFFFAOYSA-N n-[4-amino-2-(trifluoromethyl)phenyl]-2-fluoro-n-(2-fluorobenzoyl)benzamide Chemical compound FC(F)(F)C1=CC(N)=CC=C1N(C(=O)C=1C(=CC=CC=1)F)C(=O)C1=CC=CC=C1F JLKCPDDWAAZHQD-UHFFFAOYSA-N 0.000 description 1
- CHNIMVRIVYWUKR-UHFFFAOYSA-N n-[4-amino-2-(trifluoromethyl)phenyl]-2-fluorobenzamide Chemical compound FC(F)(F)C1=CC(N)=CC=C1NC(=O)C1=CC=CC=C1F CHNIMVRIVYWUKR-UHFFFAOYSA-N 0.000 description 1
- WTUVWNQWAIVCDO-UHFFFAOYSA-N n-[4-amino-2-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(N)C=C1C(F)(F)F WTUVWNQWAIVCDO-UHFFFAOYSA-N 0.000 description 1
- MDAIYWARQVPUHU-UHFFFAOYSA-N n-[4-amino-3-(trifluoromethyl)phenyl]-2-fluorobenzamide Chemical compound C1=C(C(F)(F)F)C(N)=CC=C1NC(=O)C1=CC=CC=C1F MDAIYWARQVPUHU-UHFFFAOYSA-N 0.000 description 1
- QMCLCXKXDXBQLB-UHFFFAOYSA-N n-[4-amino-3-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(N)C(C(F)(F)F)=C1 QMCLCXKXDXBQLB-UHFFFAOYSA-N 0.000 description 1
- RBEVUHKSMGYLIF-UHFFFAOYSA-N n-[4-nitro-2-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C=C1C(F)(F)F RBEVUHKSMGYLIF-UHFFFAOYSA-N 0.000 description 1
- MIHJCLQINRFOLX-UHFFFAOYSA-N n-[4-nitro-3-(trifluoromethyl)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MIHJCLQINRFOLX-UHFFFAOYSA-N 0.000 description 1
- HHEOPDJUDPSZCP-UHFFFAOYSA-N n-[5-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]pyridin-2-yl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C=N1)=CC=C1NC(=O)C1=CC=CC=C1F HHEOPDJUDPSZCP-UHFFFAOYSA-N 0.000 description 1
- HXYJCDRXSKAAEX-UHFFFAOYSA-N n-[5-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]pyridin-2-yl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC=C(NC(C)=O)N=C1 HXYJCDRXSKAAEX-UHFFFAOYSA-N 0.000 description 1
- LJPVGDIWLZZHOZ-UHFFFAOYSA-N n-[5-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-hydroxyphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC(O)=C(NC(C)=O)C=C1Cl LJPVGDIWLZZHOZ-UHFFFAOYSA-N 0.000 description 1
- UAKKCEKMYCLDHQ-UHFFFAOYSA-N n-[5-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-methylphenyl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(C(=C1)Cl)=CC(C)=C1NC(=O)C1=CC=CC=C1F UAKKCEKMYCLDHQ-UHFFFAOYSA-N 0.000 description 1
- QEUZZGGWDYJHQM-UHFFFAOYSA-N n-[5-chloro-4-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]-2-methylphenyl]acetamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC1=CC(C)=C(NC(C)=O)C=C1Cl QEUZZGGWDYJHQM-UHFFFAOYSA-N 0.000 description 1
- AWPXBVFMDACJGY-UHFFFAOYSA-N n-[6-[(5-chloro-2,4-dimethoxyphenyl)carbamothioylamino]pyridin-3-yl]-2-fluorobenzamide Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=S)NC(N=C1)=CC=C1NC(=O)C1=CC=CC=C1F AWPXBVFMDACJGY-UHFFFAOYSA-N 0.000 description 1
- SHNIRXYDMJCBIS-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]methylidene]hydroxylamine Chemical compound ON=CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 SHNIRXYDMJCBIS-UHFFFAOYSA-N 0.000 description 1
- RXDKWNPDGOXZON-UHFFFAOYSA-N n-benzyl-2-chloro-4-nitroaniline Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NCC1=CC=CC=C1 RXDKWNPDGOXZON-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- XIFJZJPMHNUGRA-UHFFFAOYSA-N n-methyl-4-nitroaniline Chemical compound CNC1=CC=C([N+]([O-])=O)C=C1 XIFJZJPMHNUGRA-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- GDJYIXGPYCKDOV-UHFFFAOYSA-N n-phenylthiohydroxylamine Chemical compound SNC1=CC=CC=C1 GDJYIXGPYCKDOV-UHFFFAOYSA-N 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 208000018290 primary dysautonomia Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 1
- VXGYRCVTBHVXMZ-UHFFFAOYSA-N quinoline-6-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CC=C21 VXGYRCVTBHVXMZ-UHFFFAOYSA-N 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003349 semicarbazides Chemical class 0.000 description 1
- 150000007659 semicarbazones Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical class [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- KZZHPWMVEVZEFG-UHFFFAOYSA-N tert-butyl n-phenylcarbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1 KZZHPWMVEVZEFG-UHFFFAOYSA-N 0.000 description 1
- 150000004867 thiadiazoles Chemical class 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000005309 thioalkoxy group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical class Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229950004288 tosilate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Abstract
Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, or substituents R9-R12 are independently hydrogen, or substituents provided that at least one of R9-12 is not hydrogen; G is a monocyclic heteroaryl: X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, or thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl, useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.
Description
Background of invention
Identified the viral member (Roizman of 8 kinds of herpetoviridaes, B.1996, Herpesviridae, p.2221-2230, B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia summarizes among the PA).Each member's of this section feature is the envelope virus that contains outer quilt of protein and nucleocapsid, carries the relatively large double-stranded DNA genome (promptly about 80-250 kilobase) of virus in the nucleocapsid.The member of people's Alphaherpesviridae is neurotropic, comprises herpes simplex types 1 virus (HSV-1) and 2 types (HSV-2) and varicella zoster virus (VZV).People β-simplexvirus is cytomegalovirus (HCMV), herpes virus hominis 6 (HHV-6) and herpes virus hominis 7 (HHV-7).Gamma herpes viruses is that the parent is lymphatic, comprises Epstein-Barr virus (EBV) and Kaposi herpesvirus (HHV-8).Each all has cause-effect relationship with human diseases these simplexviruss, comprise herpes labialis and genital herpes (HSV-1 and HSV-2[Whitley, R.J.1996.Herpes Simplex Viruses, p.2297-2342, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume) Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); Chicken pox and zoster (VZV[Arvin.A.1996.Varicella-Zoster Virus, p.2547-2585, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-RavenPublishers, Philadelphia, PA]); Infectious monocytosis (EBV[Rickinson, A.B. and Kieff, Virus E.1996.Epstein-Barr, p.2397-2446, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); Pneumonia and the retinitis (HCMV[(Britt, W.J. and Alford, C.A.1996.Cytomegalovirus, p.2493-2523, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA)]); Roseola infantum (HHV-6[(Pellet, P.E. and Black, J.B.1996.Human Herpesvirus 6, p.2587-2608, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA)] and HHV-7[Frenkel, N., and Roffman, E.1996.Human Herpesvirus 7, p.2609-2622, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), Fields Virology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA]); And Kaposi (HHV-8[Neipel, F., Albrecht, J.C., and Fleckenstein, B.1997, the cell homologous genes of the rhadinovirus human herpes virus 8 that Kaposi is relevant: its pathogenicity bo determinant? J.Virol.7l:4187-92,1997]).Considered HCMV hereinafter in more detail.After the primary infection, simplexvirus is set up in infected individuality and hides, and will have the remaining time in all one's life in his body.Regularly reactivating of latent virus is clinical relevant.With regard to HSV, the virus that reactivates can pass to fetus at birth, causes skin or ocular infection, central nervous system infection, or disseminated infections (being a plurality of organs or whole body).Zoster is the clinical manifestation that VZV reactivates.Antiviral is used in the treatment of HSV and VZV usually, and as acyclovir (Glaxo Wellcome), ganciclovir (Roche) and phosphine formic acid (foscamet) (Astra), their target is the archaeal dna polymerase of encoding viral.
HCMV is a kind of ubiquitous opportunistic pathogen, infects the crowd's of growing up 50-90% (Britt, W.J. and Alford, C.A.1996. cytomegalovirus, p.2493-2523, in B.N.Fields, D.M.Knipe, and P.M.Howley (volume), open-air virusology, the third edition, Lippincott-Raven Publishers, Philadelphia, PA).The primary infection of HCMV usually is asymptomatic, though observe the monocytosis of heterophil feminine gender.Pass through sexual intercourse, breast milk and saliva that virus is horizontal are transmitted.The intrauterine HCMV of existence from pregnant woman to the fetus transmits, and it usually is the reason of serious clinical consequences.HCMV is in infected human body, and its residue is all kept latent state throughout one's life eventually.Cell-mediated immunity is hidden in control and played central role in being brought back to life.The impaired HCMV that causes the seropositivity philtrum to be hidden of cellular immunity brings back to life.
The HCMV disease is relevant with defective or jejune cellular immunization.The people who suffers from the HCMV disease mainly contains three classes (Britt and Alford summary, 1996).(1) at immunocompromised host (AIDS) philtrum, HCMV is one of two kinds of modal pathogenic agent that cause clinical disease (another kind is the lung sac worm).HCMV modal performance in patient AIDS is the retinitis, though other organ comprises that the infection of suprarenal gland, lung, gi tract and central nervous system also often is in the news.90% patient AIDS suffers from active HCMV and infects; 25-40% (about~85,000 patient of the U.S.) suffers from the HCMV disease of threat to life or vision.HCMV is patient's 10%AIDS the cause of death.(2) owing to for the danger that suppresses transplant rejection suppresses immunity system, HCMV bring back to life or again subinfection be common among the patient of kidney, liver, heart and simplified marrow transplanting.Pneumonia is a modal HCMV disease among these patients, reaches 70% in these transplant patients.(3) because the congenital infection that causes of HCMV takes place approximately annual 40,000 in neonatal 1% at all.Reach 25% among these babies and have the symptom of HCMV disease between year at 0-3.The HCMV disease is progressive, causes children's backwardness and dysautonomia.Recent research prompting can reduce these children's sickness rate with anti-HCMV pharmacological agent.
That sells at present has several antiviral (Bron, D., R.Snoeck and L.Lagneaux, 1996, the new viewpoint of cytomegalovirus pathogeny and treatment, an Exp.Opin.Invest.Drugs 5:337-344; Crumpacker, C.1996. treating herpes: summary, Exp.Opin.Invest.Drugs 5:169-183).These comprise: ganciclovir (Roche), the toxic nucleosides congener of a kind of tool hematopoietic cell; Phosphine formic acid (Asta), a kind of tetra-sodium congener of tool Toxicity of Kidney; And Xi Duofuwei (cidofovir) (Gilead), the toxic nucleoside phosphonate of a kind of tool acute renal.Each target of these medicines all is the archaeal dna polymerase of encoding viral, because their low biological effectiveness, usually intravenously is used, and as mentioned above, is the source of serious toxicity.The ganciclovir resistant mutants of clinical generation usually has crossed resistance to Xi Duofuwei.Therefore, need safer (being that toxicity is less), oral biology effectively at the antiviral of new virus target.
Disclose and be used for the phenylthiourea that various pharmacology are used.Armistead etc., WO 97/40028 have explained phenylurea or the thiocarbamide as the inhibitor of xanthoglobulin monophosphate dehydrogenase (IMPDH) enzyme (it is in the virus replication disease, as working in the bleb).
Widdowson etc., WO96/25157 have explained the phenylurea and the thiourea compound of following formula, are used for the treatment of the disease of chemokine interleukin 8 mediation.
Morin, Jr. etc., U.S. Patent number 5,593,993 have explained some phenylthiourea compound, are used for the treatment of AIDS and suppress duplicating of HIV and correlated virus.
Therefore, an object of the present invention is to provide acceptable salt on compound and the pharmacology thereof, suppress and/or treatment and simplexvirus, as human cytomegalic inclusion disease virus, hsv, Epstein-Barr virus, varicella zoster virus, herpes virus hominis-6 and-7, the disease relevant with Kaposi herpesvirus.
Invention is described
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
R
9-R
12Be respectively perhaloalkyl radical, the halogen of alkyl, a 1-4 carbon atom of hydrogen, a 1-4 carbon atom, the alkoxyl group or the cyano group of a 1-4 carbon atom, or R
9And R
10Or R
11And R
12Can form the aryl of 5-7 carbon atom altogether; Condition is R
9-R
12In at least one is not a hydrogen;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is 1-6;
Or the salt on its pharmacology.
In preferences more of the present invention, R
1-R
5In at least one is not a hydrogen.In other embodiments of the invention, R
1-R
5Be respectively alkyl, the halogen of hydrogen, a 1-6 carbon atom, perhaloalkyl radical, the OR of a 1-6 carbon atom
6Or N (R
7R
8).Preferably, R
1-R
5Middle 1-3 is not hydrogen.Most preferred, R
1-R
5In 2 be not hydrogen.In preference of the present invention, R
3And R
5, or R
4And R
5Be respectively halogen or CF
3
In preferences more of the present invention, R
9-R
12Be selected from halogen, methyl, methoxyl group, cyano group.
In some embodiments of the invention, G is thiazolyl, thiadiazolyl group, oxazolyl or furyl.Most preferred G is a furans.G preferably is not substituted.
In some embodiments of the invention, X is a key or C1-C4 alkyl.Preferably when X was the C1-C4 alkyl, described alkyl was a straight chained alkyl.
Preferred compounds of the invention are following compounds, comprise the salt on its pharmacology:
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido] and-2,5-dimethoxy-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-acid amides
Furans-2-carboxylic acid 3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-acid amides
Furans-2-carboxylic acid 2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-acid amides
5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-[(furans-2-carbonyl)-amino]-phenylformic acid
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-phenyl amino formyl radical-phenyl }-acid amides
Furans-2-carboxylic acid 2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-acid amides; With
Salt on furans-2-carboxylic acid { 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-phenyl }-acid amides and its pharmacology.
Alkyl used herein refers to the straight or branched low alkyl group of 1-6 carbon atom.Exemplary alkyl comprises methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-, the tertiary butyl, amyl group and hexyl.
Alkenyl used herein refers to the straight or branched of 2-6 carbon atom, contains the low alkyl group of at least one carbon-carbon double bond.Alkenyl comprises vinyl.
Alkynyl used herein refers to 2-6 carbon atom, contains at least one carbon carbon triple-linked straight or branched low alkyl group.
Alkyl of the present invention, alkenyl and alkynyl can be that replace or unsubstituted.
Cycloalkyl refers to the saturated monocycle or the bicyclic system of 3-10 carbon atom.Exemplary cycloalkyl comprises cyclopentyl, cyclohexyl and suberyl.Cycloalkyl of the present invention can be that replace or unsubstituted.
Heterocyclylalkyl refers to 3-10 unit, have 1-3 heteroatomic saturated monocycle or bicyclic system that is selected from N, S and O, include but not limited to: '-aziridino, azetidinyl, imidazolidyl, morpholinyl, thio-morpholinyl, piperazinyl, pyrazolidyl, piperidyl and pyrrolidyl.Heterocyclylalkyl of the present invention can be that replace or unsubstituted.
Aryl used herein refers to the aromatic monocyclic or the dicyclo of 5-10 carbon atom.Exemplary aryl comprises phenyl, naphthyl and xenyl.Aryl of the present invention can be that replace or unsubstituted.
Heteroaryl used herein refers to 5-10 unit, has 1-3 heteroatomic aromatic monocyclic or dicyclo that is selected from N, S or O, includes but not limited to: thiazolyl, thiadiazolyl group, oxazolyl, furyl, indyl, benzothiazolyl, benzotriazole base, benzo dioxolyl (benzodioxyl), indazolyl and benzofuryl.Preferred heteroaryl comprises quinolyl, isoquinolyl, naphthyl (napthalenyl), benzofuryl, benzothienyl, indyl, pyridyl, pyrazinyl, thienyl, furyl, pyrryl, isoxazolyl, oxazolyl, isothiazolyl, thiazolyl, pyrazolyl, triazolyl, thiadiazolyl group and imidazolyl.Heteroaryl of the present invention can be that replace or unsubstituted.
Perhaloalkyl radical refers to the alkyl of 1-6 carbon atom, and wherein three or more hydrogen is replaced by halogen.
Phenyl used herein refers to 6 yuan of aromatic rings.
Halogen used herein refers to chlorine, bromine, iodine and fluorine.
Unless otherwise defined, substituting group is unsubstituted, and can comprise cycloalkyl, the 1-6 unit Heterocyclylalkyl of alkyl, a 1-6 carbon atom of 1-6 carbon atom, perhaloalkyl radical, alkylamino, dialkyl amido, aryl or the heteroaryl of a 1-6 carbon atom.
Carbon number refers to the carbonatoms in the carbon skeleton, does not comprise being present in substituting group, as the carbon atom in alkyl or the alkoxy substituent.
When uniting the use term, the definition of this combination each several part is all worked, unless otherwise defined.For example, alkyl-cycloalkyl is an alkyl-group of naphthene base, and wherein alkyl and cycloalkyl are all as previously mentioned.
Acceptable salt is acid salt on the pharmacology, it can form as acid such as phosphoric acid, sulfuric acid, hydrochloric acid, Hydrogen bromide, citric acid, toxilic acid, succsinic acid, fumaric acid, acetate, lactic acid, nitric acid, sulfonic acid, tosic acid, methylsulfonic acids from acceptable acid on the compound of above-mentioned general formula and a kind of pharmacology.
Compound of the present invention contains chiral centre, and the various stereoisomeric forms in any ratio of compound are provided, as racemic mixture and optical isomer separately.In preferences more of the present invention, compound of the present invention is pure optical isomer on substantially.Substantially the pure composition that means contains desired isomer more than 75%, and can comprise and be lower than 25% unwanted isomer.In preferred embodiment, pure optical isomer is a desired isomer more than 90%.In some preferences, when target was VZV, (S) isomer was preferred.Can be directly with asymmetric or stereospecificity synthetic, or from racemic mixture conventional separating optical isomeric body, prepare various isomer.
Unless describe in addition, can use following method by the technician in organic synthesis field, utilize the reagent and the parent material that obtain easily, prepare compound of the present invention.Therefore, according to following flow preparation compound of the present invention.
Prepared compounds of the present invention according to following reaction process.
According to method 31 and 34, make suitable replacement amine 2 (substituent R wherein
1-R
5With X as mentioned above) and the lsothiocyanates 3 of suitable replacement (substituent R wherein
9-R
12With G as mentioned above) reaction under solvent-free condition or in the suitable solvent (as tetrahydrofuran (THF), acetonitrile, ethyl acetate, methylene dichloride or N, dinethylformamide), obtain desired thiocarbamide 1.Similarly, as mentioned above, make the lsothiocyanates 4 (substituent R wherein of suitable replacement
1-R
5With X as mentioned above) and the aniline 5 of suitable replacement (substituent R wherein
9-R
12With G as mentioned above) in solvent (as above listing) reaction easily, obtain desired thiocarbamide 1.
Method 31 and 34
In addition, can be as the thiocarbamide 1 of the suitable replacement of preparation as described in method 32 and 33, by making aniline 2 and 5 (R wherein
1-R
5, R
9-R
12With G as mentioned above) at 1 of 1 molar equivalent, 1 '-the thio-carbonyldiimidazole existence is down, in suitable solvent (in methylene dichloride and tetrahydrofuran (THF) or its mixture), or at 1 of 1 molar equivalent, 1 '-existence of thiocarbonyl-two-(1,2,4)-triazole under, in suitable solvent (as methylene dichloride and tetrahydrofuran (THF) or its mixture) solution, reaction at room temperature.
In some example, need subsequently final thiocarbamide 1 to be carried out chemically modified.These methods have hereinafter been summed up, method 35-39.
Can be from corresponding alkyl ester, by with sodium hydroxide or potassium hydroxide aqueous solution in suitable solvent (as methyl alcohol, tetrahydrofuran (THF) or its mixture), according to method 35 and 36 basic hydrolysis at room temperature, preparation thiocarbamide 1 (at least one R wherein
1-R
5Substituting group is 1-hydroxyl-oxethyl or carboxyl-methoxyl group, R
9-R
12As above define with G, X is a key).
Can be from corresponding 1-'-hydroxyethoxy radical derivative; by with suitable acylating agent (as Benzoyl chloride or methylsulfonyl chloride) in the presence of suitable tertiary amine base (as triethylamine or diisopropyl ethyl amine); in suitable solvent (as methylene dichloride etc.); according to method 37 and 38 acidylate at room temperature, preparation thiocarbamide 1 (at least one R wherein
1-R
5Substituting group is 1-acyloxy oxyethyl group or mesyloxy oxyethyl group, R
9-R
12As above define with G, X is a key).
Can be from corresponding 1-mesyloxy oxyethyl group derivative, by with suitable secondary amine (as dimethyl amine) at suitable solvent mixture (as tetrahydrofuran (THF) and water etc.), at room temperature react preparation thiocarbamide 1 (R wherein according to method 39
1-R
5In at least one substituting group be the 1-amino ethoxy, R
9-R
12As above define with G, X is a key).
Can be from corresponding 1-alkyl azide derivative, by with tin protochloride in suitable solvent (as methyl alcohol, ethanol etc.), at room temperature react preparation thiocarbamide 1 (R wherein according to method 40
1-R
5In at least one substituting group be the 1-aminoalkyl group, R
9-R
12As above define with G, X is a key).
According to method 41 (hereinafter),, H.A. and Walther, G.Justus Liebigs Ann.Chem.657,104 (1962) mainly according to Staab) program, (the R wherein of the amine 5 or 2 by making suitable replacement respectively
1-R
5, R
9-R
12With G as mentioned above, X as above defines) and 1 molar equivalent 1,1 '-thio-carbonyldiimidazole reacts in suitable solvent (as methylene dichloride and tetrahydrofuran (THF) or its mixture etc.), prepared the intermediate lsothiocyanates 3 and 4 shown in the method 31 and 34.
Can prepare intermediate 2 and 5 according to following scheme:
According to method 1A-1G, can pass through according to various programs well known by persons skilled in the art, and R.J.Lindsay, Comprehensive Organic Chemistry (Sutherland volume), volume 2,6.3.1 chapter, aromatic amine, 1979 is described, and the oil of mirbane of suitable replacement of reducing prepares amine 2 (R wherein
1-R
5As above definition, X as above defines) and amine 5 (R wherein
9-R
12As above definition).These programs comprise reduction oil of mirbane, behind the following material of contact, form aniline:
A) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and strong acid (example hydrochloric acid) (method 1A), or;
B) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and Glacial acetic acid (method 1B), or;
C) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or iron powder in alcoholic solvent (as methyl alcohol or ethanol) and aqueous ammonium chloride solution (method 1C), or;
D) in room temperature arrives the temperature range of solvent refluxing temperature, solvent-free or tin in alcoholic solvent (as methyl alcohol or ethanol) and strong mineral acid (example hydrochloric acid) (method 1D), or;
E) work as R
1-R
5And R
9-R
12Be selected from Cl, Br, I ,-(OSO
2)-CF
3, or-(OSO
2During)-1-(4-aminomethyl phenyl),, in the atmosphere of one or more barometric points, use hydrogen and palladium carbon catalytic reduction (method 1E) by in suitable solvent (as methyl alcohol, ethanol or ethyl acetate), or;
F) work as R
1-R
5And R
9-R
12Be selected from Cl, Br, I ,-(OSO
2)-CF
3, or-(OSO
2During)-1-(4-aminomethyl phenyl),, in the scope of solvent refluxing temperature, use tetrahydrobenzene and palladium carbon catalytic reduction (method 1F) in room temperature by in suitable solvent (as methyl alcohol or ethanol), or;
G) in room temperature arrives the scope of solvent refluxing temperature, the aqueous solution of sodium bisulfite in alcoholic solvent (method 1G).
In addition, according to method 3A-3C, can pass through according to various programs well known by persons skilled in the art, and Greene, Protective Groups in Organic Synthesis, volume 2, chapter 7,1991 described and reference wherein, cut the acid amides of these aniline and the aniline nitrogen-carbon bond of carbamate derivatives, prepare amine 2 (R wherein
1-R
5As above definition, X as above defines) and aniline 5 (R wherein
9-R
12As above definition).These programs comprise:
A) solvent-free or in suitable solvent (as methylene dichloride), between 0 ℃ and room temperature, make suitable substituted aryl amino-t-butyl carbamate contact (method 3A) with strong acid (as trifluoroacetic acid), or;
B) in acetonitrile solution or tetrahydrofuran (THF) or its mixture, in the temperature range of room temperature between the solvent refluxing temperature, make arylamino-(2-trimethyl silyl ethyl) carbamate of suitable replacement contact (method 3B) with fluoride sources (as tetrabutyl ammonium fluoride or Potassium monofluoride), or;
C) in alcoholic solvent (as methyl alcohol or ethanol), in the temperature range of room temperature between the solvent refluxing temperature, make the arylamino-trifluoroacetamide of suitable replacement and highly basic (as sodium hydroxide or potassium hydroxide, or yellow soda ash or salt of wormwood) contact (method 3C).
In addition, according to method 11, can be mainly according to V.Farina and G.P.Roth in Advances in Metal-Organic Chemistry, volume 5,1-53,1996 and reference wherein, by using palladium catalyst (as three (dibenzalacetone)-two palladiums) and part (as triphenylarsine), in suitable solvent (as tetrahydrofuran (THF) or N-Methyl pyrrolidone), in room temperature arrives the scope of solvent refluxing temperature, make the bromo-or the iodo-aniline (as 3-chloro-4-iodo-aniline) of a kind of vinyl trialkyltin reagent (as tributylvinyl tin) and a kind of suitable replacement carry out the palladium catalytic coupling, prepare amine 2 (R wherein
1-R
5As above definition, X as above defines, R
1-R
5In at least one substituting group be vinyl).
In addition, according to method 42, can be mainly according to J.F.Hartwig and J.Louie Tetrahedron Letters36 (21), 3609 (1995) program, by in the temperature range of room temperature to 100 ℃, in suitable solvent (as tetrahydrofuran (THF) or toluene), using palladium catalyst (as two (dibenzalacetone) palladium) and part (as three-o-tolylphosphine), under the condition of the highly basic of at least 2 molar equivalents (as two (trimethyl silyl lithamides) in tube sealing), with 3-bromine or 5-bromo-or the iodo-aniline (as 3-amino-5-5 bromine benzotrifluoride) of secondary amine, prepare amine 2 (R wherein by the suitable replacement of palladium Study on Catalytic Amination of Alcohols
1-R
5As above definition, X is a key, R
2Or R
4In at least one substituting group be defined as dialkyl amido).
In addition, according to method 43, can be by in room temperature arrives the temperature range of solvent refluxing temperature, in suitable solvent (as tetrahydrofuran (THF) etc.), using palladium catalyst (as 1,1 '-two (diphenylphosphino) ferrocene] Palladous chloride (II)-methylene dichloride mixture, under the condition that exists at assorted two ring [3.3.1] nonanes of 9-boron and suitable alkali (as aqueous sodium hydroxide solution), pass through palladium catalysis with alkene, the 3-of the replacement that alkylation is suitable or 5-bromo-or iodo-aniline (as 3-amino-5-5 bromine benzotrifluoride) prepare amine 2 (R wherein
1-R
5As above definition, X as above defines, R
2Or R
4In at least one substituting group be defined as alkyl).
2A-2G is described as method; according to various well known by persons skilled in the art and at Greene; Protective Groups in Organic Synthesis; volume 2; chapter 7; 1991 and the described program of reference, by the derivatize of corresponding amine, preparation is used as the acyl group and the carbamyl sulfonamide derivatives of parent material in method 3A-3C.These programs comprise:
A) one or the tertiary amine of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) under existence or the non-existent condition, in suitable solvent (as acetone, tetrahydrofuran (THF), dimethyl formamide, methylene dichloride etc.), in room temperature arrives the scope of solvent refluxing temperature, make the amine and the Di-tert butyl pyrocarbonate reaction (method 2A) of suitable replacement, produce corresponding arylamino-t-butyl carbamate, or;
B) in the presence of tertiary amine (as triethylamine or diisopropylethylamine), in suitable solvent (as dimethyl formamide), at room temperature make the aniline and 1-[2-(trimethyl silyl) ethoxy carbonyl-oxygen base of suitable replacement] benzotriazole reaction (method 2B), produce corresponding arylamino-(2-trimethyl silyl ethyl) carbamate, or;
C) solvent-free or in suitable solvent (as tetrahydrofuran (THF), dimethyl formamide, methylene dichloride, pyridine etc.), one or the tertiary amine base of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) exists down, make aniline and the carboxylic acid chloride or the anhydride reaction (method 2C) of suitable replacement, produce corresponding arylamino acid amides, or;
D) one or the tertiary amine base of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) do not exist down, solvent-free or at suitable solvent (as tetrahydrofuran (THF), 1,4-diox etc.) in, in room temperature arrives the scope of solvent refluxing temperature, make the N-methyl-p-nitroaniline and the carboxylic acid chloride reaction (method 2D) of suitable replacement, produce corresponding nitro arylamino acid amides, or;
E) at coupling agent (as benzotriazole-1-base oxygen base-three-(dimethylamino)-phosphorus phosphofluoric acid, 2-(1H-benzotriazole-1-base oxygen base)-1,1,3,3-tetramethyl- phosphofluoric acid, dicyclohexylcarbodiimide etc.) existence under and in the presence of tertiary amine (as triethylamine or diisopropylethylamine), in suitable solvent (as methylene dichloride, dimethyl formamide etc.), at room temperature make the aniline and the carboxylic acid reaction (method 2E) of suitable replacement, produce corresponding arylamino acid amides, or;
F) in the presence of suitable alkali (as pyridine), in suitable solvent (as methylene dichloride, dimethyl formamide etc.), 0 ℃ in the temperature range of room temperature, make suitable protection aniline (as arylamino-tertiary butyl-carbamate etc., R wherein
1-R
12In at least one substituting group be defined as-W-Y-(CH
2)
n-Z, wherein W, X and Z as above define) and carboxylic acid anhydride reaction (method 2F), produce the corresponding carboxylic acid ester, or;
G) one or the tertiary amine of several molar equivalents (as triethylamine or N, the N-diisopropylethylamine) under the non-existent condition, in suitable solvent (as acetone, tetrahydrofuran (THF), dimethyl formamide, methylene dichloride etc.), in the scope of solvent refluxing temperature, make the aniline (R wherein of suitable replacement in room temperature
1-R
5In at least one substituting group be defined as hydroxyl) and Di-tert butyl pyrocarbonate reaction (method 2G), produce corresponding arylamino-tertiary butyl one carbamate.
Can be according to method 4A, 4C, 4E-4F, preparation finally is converted into the oil of mirbane intermediate of amine 2 and 5 by the method that shows among the method 1A-1G.
According to method 4A, 4C and 4E-4H; available following method; 2-, 4-by making suitable replacement and/or 6-fluoro-, chloro-, bromo-, iodo-, trifluoromethyl sulfonyl-or the oil of mirbane generation nucleophilic substitution of (4-aminomethyl phenyl) alkylsulfonyl-replacement, prepare the oil of mirbane intermediate (R that finally changes into amine 2
2And R
4As above definition, R
1, R
3And/or R
5Be defined as alkoxyl group, thio alkoxy, alkyl sulphinyl, alkyl sulfinyl and dialkyl amido):
A) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, one the alkali (as yellow soda ash, salt of wormwood, sodium hydroxide, potassium hydroxide, sodium hydride, potassium hydride KH etc.) of several molar equivalents exists or not in the presence of, in the scope of solvent refluxing temperature, make the oil of mirbane of pure and mild suitable replacement or 2-or the 4-halides or the sulphonate reaction (method 4A) of benzonitrile in room temperature;
B) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in room temperature arrives the scope of solvent refluxing temperature, make 2-or the 4-halides or the sulphonate reaction (method 4H) of the oil of mirbane or the benzonitrile of ready-formed phenoxy group sodium, lithium or potassium and suitable replacement, or;
C) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in the scope of solvent refluxing temperature, make the oil of mirbane of ammonia, primary amine or secondary amine and suitable replacement or 2-or the 4-halides or the sulphonate reaction (method 4C, F) of benzonitrile in room temperature;
D) in suitable solvent (as tetrahydrofuran (THF)), 0 ℃ in the scope of solvent refluxing temperature, make sodium, lithium or sylvite and the oil of mirbane of suitable replacement or 2-or the 4-halides or sulphonate reaction (method 4G) reaction of benzonitrile of ready-formed amine, or;
E) solvent-free or at suitable solvent (as tetrahydrofuran (THF), diox, acetonitrile, N, dinethylformamide or dimethyl sulfoxide (DMSO)) in, in room temperature arrives the scope of solvent refluxing temperature, make 2-or the 4-halides or the sulphonate reaction of the oil of mirbane or the benzonitrile of sodium sulphite and suitable replacement, then direct direct adding alkyl halide (method 4E) in reaction mixture.
In addition, according to method 5C and 6, available following method finally changes into amine 2 (R wherein from the hydroxyl of corresponding replacement-oil of mirbane preparation
1-R
5In at least one substituting group be defined as alkoxyl group) the oil of mirbane intermediate:
A) at suitable solvent (as acetone, N, dinethylformamide, tetrahydrofuran (THF) or dimethyl sulfoxide (DMSO)) in, in the presence of alkali (as salt of wormwood, yellow soda ash, potassium hydroxide, sodium hydroxide, potassium hydride KH or sodium hydride etc.), in room temperature arrives the scope of solvent refluxing temperature, make hydroxyl-oil of mirbane and alkyl halide or sulfonic acid dialkyl reaction (method 5C), or;
B) in anhydrous aprotonic solvent (as ether or tetrahydrofuran (THF)), arrive in the scope of solvent refluxing temperature at 0 ℃, mainly according to Mitsunobu, O, Synthesis 1981,1 and reference, make hydroxyl-oil of mirbane and alkyl alcohol, triphenyl phosphine and azo-2-carboxylic acid's dialkyl reagent (as the diethylazodicarboxylate) reaction (method 6).
In addition, according to method 5A and 5E, can be at suitable solvent (acetone, toluene or N, dinethylformamide) in, in room temperature arrives the scope of solvent refluxing temperature, in the presence of suitable alkali (as salt of wormwood), reaction such as hydroxyaryl amino-tertiary butyl-carbamate by making corresponding replacement and halogenated alkyl thing, trifluoromethane-sulphonate, 4-toluene sulfonic acide ester, sulfonic acid dialkyl, ethylene carbonate prepares and finally changes into amine 2 (R wherein
1-R
5Be defined as alkoxyl group) the carbamyl sulfonamide derivatives as the parent material of method 3A-3C.
In addition, according to method 7A-G, can finally change into amine 2 (R by the standard halogenating reaction preparation that comprises following reaction
1And/or R
3Be alkoxyl group, R
2And/or R
4Be halogen, X equals key) the oil of mirbane intermediate:
A) at room temperature make 2-or 4-hydroxyl oil of mirbane and aqueous sodium hypochlorite solution reaction (method 7A and 7B), or;
B) in suitable solvent (as chloroform, methylene dichloride, Glacial acetic acid etc.),, at room temperature make 2-hydroxyl-4-methoxyl group or 2 in the existence of trifluoroacetic acid silver or not, 4-dimethoxy oil of mirbane and bromine reaction (method 7C and 7D), or;
C) in the presence of Zinc Chloride Anhydrous, in suitable solvent (as Glacial acetic acid), at room temperature make 2,4-dimethoxy oil of mirbane and phenmethyl trimethylammonium dichloro ammonium iodate reaction (method 7E), or;
D) in the presence of sodium bicarbonate, in suitable solvent mixture (as methylene dichloride and methyl alcohol), at room temperature make 2-hydroxyl-4-methoxy nitrobenzene and phenmethyl trimethylammonium dichloro ammonium iodate reaction (method 7F), or;
E) in suitable solvent (as tetrachloroethane), in the scope of solvent refluxing temperature, make 2 in room temperature, 4-dimethoxy oil of mirbane and 3,5-two chloro-1-fluorine pyridine fluoroform sulphonates (triflate) reactions (method 7G).
According to method 8, can be at suitable solvent (as N, dinethylformamide etc.) in, in room temperature arrives the scope of solvent refluxing temperature, in sealed reaction vessel, react in the presence of cuprous iodide and Potassium monofluoride by 4-iodo-oil of mirbane and trimethylammonium (trifluoromethyl) silane that makes corresponding replacement, prepare and finally change into amine 2 (R wherein
4=-CF
3, R
1-R
3And R
5-R
8As above the definition, X equals key) the oil of mirbane intermediate.
According to method 19A and 19B; 4-(N-the chloracetyl)-N-methyl-p-nitroaniline that can make corresponding replacement is in suitable solvent (as tetrahydrofuran (THF) and/or water mixture); in room temperature arrives the scope of solvent refluxing temperature; with suitable secondary amine (as dimethyl amine, morpholine etc.) reaction; or at suitable solvent (as tetrahydrofuran (THF), 1; 4-diox etc.) in; in the presence of suitable alkali (as yellow soda ash or salt of wormwood etc.); in room temperature arrives the scope of solvent refluxing temperature; with suitable thiol reactant, prepare and finally change into amine 2 (R wherein
4=-HNCOCH
2NR
7R
8Or-HNCOCH
2SR
6, R
1-R
3And R
5As above the definition, X equals key) the oil of mirbane intermediate.
According to method 25, can in suitable solvent (as methylene dichloride), arrive in the temperature range of room temperature, in the presence of tertiary amine (triethylamine or diisopropyl ethyl amine etc.) at 0 ℃, finally change into amine 2 (R wherein by making the reaction of corresponding phenol and trifluoromethane-sulphonic acid anhydride, preparing
1-R
5In at least one substituting group be defined as the trifluoromethanesulfonic acid base, X equals key) the oil of mirbane intermediate.
According to method 9; 9B and 10; can be in suitable solvent mixture (as acetone and methylene dichloride or water); at room temperature; make the reaction of suitable 4-alkylthio acyl group-arylamino or formamyl arylamino derivative and suitable oxygenant (as dimethyl ethylene oxide (dimethyloxirane) or sodium periodate), prepare and finally change into amine 2 (R wherein
1-R
5At least one substituting group is defined as alkyl sulphinyl or alkyl sulfinyl) the carbamyl sulfonamide derivatives as the parent material of method 3A-3C.
According to method 12, can be in suitable solvent (as tetrahydrofuran (THF), diox etc. and water), at room temperature, in the presence of mercuric acetate, finally change into amine 2 (R wherein by making the reaction of corresponding 4-vinyl formamyl aniline and sodium borohydride, preparing
4Be defined by the 1-hydroxyethyl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 13, can be in suitable solvent (as tetrahydrofuran (THF), 1,4-diox etc.), 0 ℃ under room temperature, in the presence of Glacial acetic acid, finally change into amine 2 (R wherein by making the reaction of corresponding 4-vinyl formamyl aniline and sodium borohydride, preparing
4Be defined by the 2-hydroxyethyl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 14; can be in suitable solvent mixture (as tetrahydrofuran (THF) and methylene dichloride); at 0 ℃ under room temperature; in the presence of azo-2-carboxylic acid's dialkyl (as the diethylazodicarboxylate) and triphenyl phosphine; finally change into amine 2 (R wherein by making the reaction of corresponding 4-(1-hydroxyethyl) formamyl aniline and hydrazoic acid, preparing
4Be defined by the 1-azidoethyl, and R
1-R
3And R
5As above the definition, X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 15; can be in suitable tertiary amine solvent (as triethylamine or diisopropyl ethyl amine); in temperature range from room temperature to the solvent refluxing temperature; in the presence of two (triphenyl phosphine) Palladous chloride (II) and cuprous iodide; finally change into amine 2 (R wherein by making the reaction of corresponding 4-iodo formamyl aniline and 1-dimethylamino-2-propine, preparing
4Be defined by 3-dimethylamino third-1-alkynyl, and R
1-R
3And R
5As above the definition, X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 16; can be in suitable solvent mixture (as methylene dichloride and methyl alcohol); at 0 ℃ under the temperature between the room temperature; make the reaction of corresponding 4-(3-dimethylamino third-1-alkynyl) formamyl aniline and suitable peracid (as the 3-chloroperoxybenzoic acid), prepare and finally change into amine 2 (R wherein
4Be defined by 3-dimethylamino acryl, and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 17 and 18; can be in suitable solvent (as 1,4-diox or ethanol etc.), at room temperature; make the reaction of corresponding 4-(3-dimethylamino-acryl) formamyl aniline and hydroxylamine hydrochloride or hydrazine hydrate, prepare and finally change into amine 2 (R wherein
4Be defined by 4-isoxazole-5-base or 4-(1H-pyrazole-3-yl), and R
1-R
3And R
5As above the definition, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 20; can be in suitable solvent mixture (as tetrahydrofuran (THF) and methylene dichloride etc.); under the temperature in room temperature arrives the solvent refluxing temperature range; make the amino formamyl aniline and 1 of corresponding 4-; 1-carbonyl-two-(1; 2,4)-and the alcohol reaction of triazole and suitable replacement, prepare and finally change into amine 2 (R wherein
4Be defined by-HNCO
2Z, and R
1-R
3, R
5As above define with Z, X equals key) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 26 and 30, can be in suitable solvent (as water, methyl alcohol, tetrahydrofuran compound or toluene etc.), at room temperature, in the presence of sodium cyanoborohydride or hydrogen and 10% palladium carbon, by making the aldehyde reaction of suitable replacement, prepare and finally change into amine 2 (R wherein
1-R
5At least one substituting group is defined as dialkyl amido, and X as above defines) the carbamyl sulfonamide derivatives as method 3A-3C parent material.
According to method 27 and 28, can be in suitable solvent mixture (as methanol-water mixtures), under the temperature of room temperature between the solvent refluxing temperature, corresponding ester (as acetic ester) and suitable alkali (as sodium bicarbonate or sodium hydroxide) are reacted, prepare amine 2 (R wherein
1-R
5At least one substituting group be defined as hydroxyl, X as above defines).
According to method 29, can be in suitable solvent (as tetrahydrofuran (THF), ether etc.), at room temperature, make the reaction of corresponding N-(4-aminophenyl) phthalic imidine and lithium borohydride, prepare amine 2 (R wherein
1-R
5In at least one substituting group be defined as 2-hydroxybenzene amido, X as above defines).
Can prepare intermediate amine 2 (R wherein according to following process
1-R
5As above definition, X equals-CH
2Or-(CH
2)
2):
A) with borine-dimethyl thioether mixture in suitable solvent (as glycol dimethyl ether, tetrahydrofuran (THF) etc.), under the temperature of room temperature in the solvent refluxing temperature, reduce the benzonitrile or the phenylacetonitrile of suitable replacement.(method 44);
B) in suitable solvent (as methyl glycol, ethyl acetate, ethanol etc.), at room temperature, appropriate catalyst (palladium carbon) as 5% or 10% and acid (4-methyl-Phenylsulfonic acid, hydrochloric acid etc.)) in the presence of, under one or more normal atmosphere hydrogen atmosphere, reduce.(method 50);
C) in suitable solvent (as tetrahydrofuran (THF) or ether), under 0 ℃ of temperature in the room temperature, use lithium aluminium hydride reduction.(method 51);
Can be in suitable solvent (as acetate), under the temperature of room temperature in the solvent refluxing temperature, in the presence of ammonium acetate, react by phenyl aldehyde and the Nitromethane 99Min. that makes suitable replacement, prepare and finally change into amine 2 (R wherein
1-R
5As above definition, X equals-(CH
2)
2-) the unsaturated nitro precursor as method 51 parent materials.(method 53); Can reduce the benzonitrile of suitable replacement by diisobutyl aluminium hydride, come the phenyl aldehyde of preparation method's 53 parent materials.(method 52); Can be in suitable solvent (as N, dinethylformamide), under the temperature in room temperature arrives the solvent refluxing temperature, from corresponding aryl bromide and cupric cyanide reaction, preparation is as the benzonitrile of the replacement of method 52 parent materials.(method 59).
According to method 49, for amine 2 (R wherein
1-R
5As above definition, X equals-O (CH
2)
2NH
2Or-S (CH
2)
2NH
2), can be in suitable solvent (as acetone), at room temperature, in the presence of suitable alkali (as salt of wormwood), phenol or thiophenol and bromination acetonitrile reaction by making suitable replacement prepare essential nitrile precursor.
In addition, according to Wilk, B., Synthetic Comm., 23,2481 (1993), for amine 2 (R wherein
1-R
5As above definition, X equals-(CH
2)
3-), can be in suitable solvent (as ether or tetrahydrofuran (THF) etc.), at 0 ℃ under the temperature between the room temperature, in the presence of suitable azodicarboxylate (as azodicarboxylate's diethyl ester), phenylethyl alcohol and acetone cyanohydrin and triphenyl phosphine reaction by making suitable replacement prepare the nitrile precursor.(method 54)
In addition, can be in suitable solvent mixture (as water and methyl alcohol or water and ethanol), under the temperature of room temperature between the solvent refluxing temperature, with suitable acid catalyst (as 6N hydrochloric acid) or suitable alkaline catalysts (as 5N sodium hydroxide or potassium hydroxide) acid or the corresponding methane amide of alkali catalyzed hydrolysis, prepare intermediate amine 2 (R wherein
1-R
5As above definition, X equals-(CH (CH
3))-).(method 46)
According to method 45, can be under the temperature between the solvent refluxing temperature in room temperature, the phenyl methyl ketone with the suitable replacement of ammonium formiate, formic acid and methane amide processing prepares the parent material as method 46, and finally changes into the methane amide precursor of amine 2.
In addition, method 48 is basically according to Itsuno, S., Sakurai, Y., Ito, K., Synthesis, 1988,995 program, can be in suitable solvent (as tetrahydrofuran (THF) or ether), at room temperature, in the presence of sodium borohydride and zirconium tetrachloride, by reducing the O-methyloxime of suitable replacement, prepare amine 2 (R wherein
1-R
5As above definition, X equals-(CH (CH
3))-).Can in suitable solvent (as ethanol or methyl alcohol), under the temperature between the solvent refluxing temperature, make the reaction of corresponding phenyl methyl ketone and methoxy amine hydrochlorate and pyridine, prepare essential O-methyloxime in room temperature.(method 47)
Available aforesaid method (method 45,47 and 48) prepares amine 2 (R wherein by reducing the ketone of suitable replacement
1-R
5As above definition, X equals-CH (J)-, wherein J as above defines).When can not commodity buying, phenyl aldehyde that can be by making suitable replacement and suitable organometallic reagent (as phenyl lithium, sec.-propyl bromination magnesium or ethylmagnesium bromide etc.) are in suitable solvent (as ether or tetrahydrofuran (THF) etc.), under the temperature between-78 ℃-0 ℃, react, prepare these ketone.(method 57).Available suitable oxygenant (as chromium trioxide in the aqueous solution of sulfuric acid and acetone or pyridinium chlorochromate or dichromic acid pyridine in suitable solvents such as methylene dichloride), the alcohol that oxidation at room temperature obtains makes corresponding ketone.(method 58).
Available preceding method 3A prepares intermediate aniline 5.Use pure trifluoroacetic acid, at room temperature handle the phenylcarbamic acid tert-butyl ester 6 (wherein G as mentioned above), with the aqueous sodium hydroxide solution neutralization, obtain desired aniline 5 then.Shown in method 2C, isoxazolecarboxylic acid 8 (wherein G is as mentioned above) by making replacement and 4-aminophenyl t-butyl carbamate 7 (R wherein
9-R
12As mentioned above) in the presence of triethylamine, in suitable solvent (as methylene dichloride, dimethyl sulfoxide (DMSO) or dimethyl formamide or its mixture), prepared required carbamate 6 (R wherein
9-R
12With G as mentioned above).Carboxyl acyl chloride 8 can be used as commodity and buys, or passes through suitable solvent (as methylene dichloride) from corresponding carboxylic acid, and at room temperature reaction makes with oxalyl chloride.
Method 2C, 3A
In addition, shown in method 2E, can be at suitable solvent (as methylene dichloride, dimethyl formamide etc.) in, at room temperature, in suitable coupling agents (as benzotriazole-1-base oxygen base-three-(dimethylamino) Phosphonium phosphofluoric acid, 2-(1H-benzotriazole-1-oxygen base)-1,1,3,3- phosphofluoric acid, dicyclohexylcarbodiimide etc.) under the existence, and tertiary amine base (as triethylamine or diisopropyl ethyl amine etc.) exists down, 4-aminophenyl t-butyl carbamate 7 reactions of carboxylic acid 8a (wherein G as mentioned above) by making replacement and suitable replacement prepare carbamate 6 (R wherein
9-R
12With G as mentioned above), produce corresponding arylamino acid amides.
Commodity are buied or are prepared carboxylic acid 8a according to literature method.For example, when G is the thiadiazoles that replaces, can at room temperature make corresponding carboxylic acid ester and suitable alkali (as sodium hydroxide or potassium hydroxide) reaction, preparation acid by in suitable solvent mixture (as methyl alcohol or second alcohol and water).
Similarly, when G replaces or unsubstituted thiazole, replacement or do not replace De oxazole, replacement or during for the isothiazole that replaces or replacement or unsubstituted isoxazole, when can not commodity buying, can be from corresponding ethyl ester or methyl esters by at room temperature reacting preparation corresponding carboxylic acid 8a at suitable solvent mixture (as methyl alcohol or second alcohol and water) with suitable alkali (as sodium hydroxide or potassium hydroxide).These esters can be that commodity are buied or prepare according to literature method.When can not commodity buying the carboxylicesters precursor that finally changes into acid 8, they can be according to known method preparation in the document.For example, can be basically according to Caron, M.J.Org.Chem., 51,4075 (1986) and Taber, D.F., Ruckle, R.E.J.Amer.Chem., 108,7686 (1986) program prepares 5-and replaces 1,2,3-thiadiazoles-4 carboxylicesters.Therefore,, in the presence of tertiary amine base (as triethylamine or diisopropyl ethyl amine), in suitable solvent (as acetonitrile), handle β-esters of keto-carboxylic acid, obtain corresponding two azos-β-esters of keto-carboxylic acid with 4-Methyl benzenesulfonyl nitrine or methylsulfonyl nitrine according to method 21.In suitable solvent (as benzene or toluene etc.), under the temperature in room temperature arrives the scope of solvent refluxing temperature, with 2,4-two (4-p-methoxy-phenyl)-1,3-two thiophenes-2,4-two phospha butane-2, the 4-disulfide is handled this compound, obtain desired 5-and replace-1,2,3-thiadiazoles-4-carboxylicesters.
In addition, can be substantially according to Shafiee, A., Lalezari, I., Yazdami, S., Shahbazian, F.M., Patovi, the program of T.J.Pharmaceutical Sci.65.304 (1976), preparation 4-replaces-1,2,3-thiadiazoles-5-carboxylicesters.Therefore, according to method 22 and 23, in suitable alcoholic solvent (as methyl alcohol or ethanol), make the β-esters of keto-carboxylic acid of suitable replacement and the carbamylhydrazine hydrochloride aqueous solution in room temperature under the temperature between the solvent refluxing temperature, reaction obtains corresponding semicarbazide derivative in the presence of suitable alkali (as pyridine).Handle this compound at 0 ℃ with pure thionyl chloride, handle with the excess bicarbonate aqueous solution then, obtain corresponding 4-and replace-1,2,3-thiadiazoles-5-carboxylicesters.
Can be substantially according to Sch llkopf, U., Porsch, P., Lau, H., the program of Liebigs Ann.Chem 1444 (1979), preparation 4-carbalkoxy thiazole.Therefore,, make isocyano acid B ester in suitable alcoholic solvent (as ethanol) according to method 55 and 56, at room temperature, and N, the reaction of dinethylformamide dimethyl acetal obtains corresponding 3-dimethylamino-2-isocyano--ethyl propenoate.In the presence of suitable tertiary amine base (as triethylamine or diisopropyl ethyl amine etc.), at room temperature handle the solution that this compound is dissolved in suitable solvent (as tetrahydrofuran (THF)) with hydrogen sulfide, obtain corresponding 4-ethoxycarbonyl-thiazole.
Can be substantially according to Bredenkamp, M.W., Holzafel, C.W., van Zyl, W.J.Synthetic Comm.20,2235 (1990) program prepares the thiazole of other suitable replacement.Basically according to Henneke, K.H., Sch llkopf, U., Neudecker, the program of T.Liebigs Ann.Chem 1979 (1979) prepares suitable unsaturated De oxazole.Can be substantially according to Galeotti, N., Montagene, C., Poncet, J., Jouin, P.Tetrahedron Lett.33,2807 (1992) and Shin, C., Okumura, K., Ito, A., Nakamura, Y.Chemistry Lett.1305, (1994) preparation replaces the De oxazole.
Following specific embodiment is illustrative, and does not mean that and will limit the present invention.
Embodiment 1 (method 1A)
4-methoxyl group-3-trifluoromethyl-phenyl amine
The suspension in ethanol (35 milliliters) and water (15 milliliters) with concentrated hydrochloric acid (0.42 milliliter) solution-treated 4-methoxyl group-3-trifluoromethyl-oil of mirbane that is dissolved in ethanol (6 milliliters) and water (3 milliliters) (2.2 gram) and iron powder (1.68 restrain), then with mixture heating up to refluxing about 1 hour.Cooling mixture and filtration then, concentrating under reduced pressure.The oil that obtains is dissolved in ethyl acetate also with 5% aqueous hydrochloric acid extraction 3 times.In ice bath, cool off the acid extraction thing that merges then, and, use ethyl acetate extraction then with solid-state carbonic acid potashization.Wash these organic extracts with saturated sodium-chloride water solution, use anhydrous sodium sulfate drying, concentrating under reduced pressure by short silicagel column (using ethyl acetate as elutriant), obtains desired amber oily compound then.
Use said procedure and suitable parent material to prepare following compounds:
2,6-two chloro-benzene-1,4-diamines
3-chloro-4-methylthio group (sulfanyl)-aniline
2,6-two bromo-benzene-1,4-diamines
3-chloro-4-trifluoromethyl-phenyl amine
3-chloro-4-ethylmercapto group-phenyl amine
4-methoxyl group-3-trifluoromethyl-phenyl amine
3,5-two chloro-4-methoxyl group-2-methyl-phenyl amine
5-chloro-2-oxyethyl group-4-methoxyl group-phenyl amine
5-chloro-4-oxyethyl group-2-methoxyl group-phenyl amine
5-iodo-2,4-dimethoxy-phenyl amine
3,5-two iodo-2,4-dimethoxy-phenyl amine
3,5-two bromo-2,4-dimethoxy-phenyl amine
5-chloro-2-methoxyl group-4-methyl-phenyl amine
2-chloro-N (1), N (1)-dimethyl-benzene-1,4-diamines
3-chloro-4-piperidines-1-base-phenyl amine
3-chloro-4-tetramethyleneimine-1-base-phenyl amine
N (1)-benzyl-2-chloro-benzene-1, the 4-diamines
3-chloro-4-(4-methyl-piperazine-1-yl)-aniline
2-chloro-N (1)-methyl-N (1)-(1-methyl-piperidin-4-yl)-benzene-1, the 4-diamines
2-chloro-N (1)-methyl-N (1)-(1-methyl-tetramethyleneimine-3-yl)-benzene-1, the 4-diamines
2-chloro-N (1)-methyl-N (1)-phenyl-benzene-1, the 4-diamines
N (1)-(1-benzyl-tetramethyleneimine-3-yl)-2-chloro-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-cyclopentyl-N (1)-methyl-benzene-1, the 4-diamines
2-[(4-amino-2-chloro-phenyl)-(2-hydroxyethyl)-amino]-ethanol
2-chloro-N (1)-hexyl-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-isobutyl--N (1)-methyl-benzene-1, the 4-diamines
2-[(4-amino-2-chloro-phenyl)-methyl-amino]-ethanol
2-chloro-N (1)-(3-dimethylamino-propyl group)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(2-dimethylamino-ethyl)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(2-dimethylamino-ethyl)-benzene-1, the 4-diamines
N (1)-(1-benzyl-piperidin-4-yl)-2-chloro-benzene-1, the 4-diamines
2-chloro-N (1)-(2-methoxyl group-ethyl)-N (1)-methyl-benzene-1, the 4-diamines
2-chloro-N (1)-(3-dimethylamino-propyl group)-benzene-1, the 4-diamines
N (1)-(1-benzyl-tetramethyleneimine-3-yl)-2-chloro-benzene-1, the 4-diamines
3-chloro-4-(1-methyl-piperidin-4-yl oxygen base)-phenyl amine
3-chloro-4-(2-dimethylamino-oxyethyl group)-phenyl amine
3-chloro-4-(3-dimethylamino-propoxy-)-phenyl amine
3-chloro-4-(1-methyl-tetramethyleneimine-3-base oxygen base)-phenyl amine
3-chloro-4-cyclohexyloxy-phenyl amine
Embodiment 2 (method B)
4-bromo-2,4-dimethoxy-phenyl amine
With 4-bromo-2,4-dimethoxy-oil of mirbane (0.48 gram) and iron powder (0.42 restrains) suspension in acetate (10 milliliters) and ethanol (10 milliliters) be heated to 120 ℃ about 5 hours.Cooling mixture and filtration then, concentrating under reduced pressure.Add entry, cooling mixture in ice bath, and, use dichloromethane extraction then with solid-state carbonic acid potashization.Wash these organic extracts with saturated sodium-chloride water solution, use anhydrous sodium sulfate drying, concentrating under reduced pressure is used silica gel (hexane solution of 20% ethyl acetate is as elutriant) chromatography then, obtains desired amber oily compound.
Embodiment 3 (method 1C)
(4-amino-2,6-two chloro-phenoxy groups)-tert.-butyl acetate
Handle the ethanol (17 milliliters) of (4-nitro-2,6-two chloro-phenoxy groups)-tert.-butyl acetate (1 gram) and the solution of water (8.6 milliliters) with iron powder (0.861 gram) and ammonium chloride (86 milligrams).With mixture heating up to refluxing about 1 hour.Mixture filters and concentrating under reduced pressure then.Distribute the oil that obtains between water and ethyl acetate, wash organic phase with saturated sodium-chloride water solution then, use anhydrous sodium sulfate drying, concentrating under reduced pressure obtains desired faint yellow solid-state compound.
Use said procedure and suitable parent material to prepare following compounds:
4-chloro-benzene-1, the 2-diamines
N-(4-amino-2-chloro-phenyl)-ethanamide
(4-amino-2,6-two chloro-phenoxy groups)-acetonitrile
(4-amino-2,6-two chloro-phenoxy groups)-tert.-butyl acetate
(2-amino-4-chloro-5-methoxyl group-phenoxy group)-acetonitrile
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-methyl acetate
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-tert.-butyl acetate
(2-amino-4-chloro-5-methoxyl group-phenoxy group)-tert.-butyl acetate
N (1)-benzyl-4-chloro-5-methoxyl group-benzene-1, the 2-diamines
N-(4-amino-2-chloro-phenyl)-2-fluoro-benzamide
N-(4-amino-5-chloro-2-hydroxyl-phenyl)-ethanamide
N-(4-amino-5-chloro-2-hydroxyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-chloro-phenyl)-acid amides
(4-amino-2-chloro-phenyl) urethanum
N-(4-amino-5-chloro-2-methyl-phenyl)-ethanamide
N-(4-amino-5-chloro-2-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-5-chloro-2-methyl-phenyl)-acid amides
N-(4-amino-3-chloro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-chloro-phenyl)-acid amides
N-(4-amino-2-chloro-phenyl)-2-dimethylamino-ethanamide
N-(4-amino-2-chloro-phenyl)-2-piperidines-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-morpholine-4-base-ethanamide
N-(4-amino-2-chloro-phenyl)-Toluidrin
N-(4-amino-2-chloro-phenyl)-benzamide
N-(4-amino-2-chloro-phenyl)-2-diethylamino-ethanamide
N-(4-amino-2-chloro-phenyl)-2-tetramethyleneimine-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-nitrogen heterocyclic heptan (azepanyl)-1-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-(2-methyl-piperidines-1-yl)-ethanamide
N-(4-amino-2-chloro-phenyl)-2-(3-methyl-piperidines-1-yl)-ethanamide
3-chloro-benzene-1, the 2-diamines
4-chloro-N, N-dimethyl-benzene-1,2-diamines
Embodiment 4 (method 1D)
3,5-two chloro-4-phenoxy group-phenyl amine
3, drip concentrated hydrochloric acid (60 milliliters) in the slurries of 5-two chloro-4-phenoxy group-oil of mirbane (6.1 gram) and glass putty (12 gram).Add ethanol (60 milliliters), and heated mixt is to refluxing about 1 hour.The alkalization of the solid sodium hydroxide of cooling mixture in ice bath, and adding then.With the suspension filtration over celite plate that obtains, and with ethyl acetate extraction 3 times.The organic extract that merges with the saturated sodium-chloride water solution washing is used anhydrous magnesium sulfate drying then, and concentrating under reduced pressure, obtains desired yellow solid product.Recrystallization obtains faint yellow solid-state product from ethyl acetate-hexane.
Use said procedure and suitable parent material to prepare following compounds:
1-furans-2-base-ethylamine
3-chloro-4-isopropoxy-phenyl amine
2-butoxy-5-chloro-4-methoxyl group-phenyl amine
3,5-two chloro-2-methoxyl group-4-methyl-phenyl amine
2-benzyloxy-5-chloro-2-methoxyl group-phenyl amine
4-benzyloxy-5-chloro-2-methoxyl group-phenyl amine
5-fluoro-2,4-dimethoxy-phenyl amine
(4-amino-2,6-two chloro-phenoxy groups)-ethyl acetate
3,5-two chloro-4-phenoxy group-phenyl amine
2-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-ethanamide
(4-amino-2-chloro-5-methoxyl group-phenoxy group)-acetonitrile
2-(2-amino-4-chloro-5-methoxyl group-phenoxy group)-ethanol
2-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-ethanol
4-(4-amino-2-chloro-5-methoxyl group-phenoxy group)-butyronitrile
4-amino-2-chloro-5-methoxyl group-phenol
2-amino-4-chloro-5-methoxyl group-phenol
5-chloro-4-methoxyl group-2-morpholine-4-base-phenyl amine
4-chloro-5-methoxyl group-N (1), N (1)-dimethyl-benzene-1,2-diamines
5-chloro-4-methoxyl group-2-piperidines-1-base-phenyl amine
5-chloro-4-methoxyl group-2-tetramethyleneimine-1-base-phenyl amine
2-chloro-N (1)-cyclohexyl-N (1)-methyl-benzene-1, the 4-diamines
N (2)-benzyl-4-methoxyl group-benzene-1, the 2-diamines
2-(4-amino-2-chloro-phenoxy group)-ethanol
2-chloro-N (1)-cyclohexyl-N (1)-ethyl-benzene-1, the 4-diamines
4-butoxy-3-chloro-phenyl amine
(4-amino-2-chloro-phenoxy group)-acetonitrile
2-chloro-N (1)-cyclohexyl-benzene-1, the 4-diamines
2-chloro-N (1), N (1)-dipropyl-benzene-1,4-diamines
3-chloro-4-(2,2,2-three fluoro-oxyethyl groups)-phenyl amine
3-chloro-4-(octahydro-quinoline-1-yl)-phenyl amine
N (1)-allyl group-2-chloro-N (1)-cyclohexyl-benzene-1, the 4-diamines
N-(4-amino-2-methoxyl group-5-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methoxyl group-5-methyl-phenyl) acid amides
N-(4-amino-naphthalene-1-yl)-2-fluoro-benzamide
3-chloro-N, N-dimethyl-benzene-1,2-diamines
3-chloro-4-propoxy--phenyl amine
3-iodo-4-methoxyl group-phenyl amine
3-chloro-2,4-dimethoxy-aniline
3-bromo-4-methoxyl group-phenyl amine
3-chloro-4-oxyethyl group-phenyl amine
Embodiment 5 (method 1E)
(4-amino-phenyl)-isobutyl carbamate
In 100 milliliters of methyl glycols (100ml) solution of N-(4-nitro-phenyl)-isobutyramide (2.0 gram), add 10% palladium carbon (275 milligrams).Hydrogenated mixture is 2 hours under the hydrogen at 30psi on the Parr hydrogenation instrument.Filtration over celite is removed catalyzer then, and decompression is extremely done with 3 evaporated filtrates of heptane azeotropic.Grind residuum with heptane and obtain desired white solid product.
Prepared following compounds with said procedure and suitable parent material:
2-methyl-3H-benzoglyoxaline-5-base amine
N-(4-amino-phenyl)-methane amide
1H-benzoglyoxaline-5-base amine
(4-amino-phenyl)-isobutyl carbamate
N-(4-amino-phenyl)-isobutyramide
N-(5-amino-pyridine-2-yl)-2-methyl-benzamide
Furans-2-carboxylic acid (5-amino-pyridine-2-yl)-acid amides
N-(5-amino-pyridine-2-yl)-2-fluoro-benzamide
[6-(2,2,2-three fluoro-acetylamino)-pyridin-3-yl]-t-butyl carbamate
N-(5-amino-pyridine-2-yl)-2,2,2-three fluoro-ethanamides
(4-amino-benzyl) t-butyl carbamate
2-(3,5-di-trifluoromethyl-phenyl)-ethamine
The 1-tertiary butyl-1H-imidazoles-2-base amine
3-(3-dimethylamino-propyl group)-5-trifluoromethyl-phenyl amine
Embodiment 6 (method 1F)
N-(4-amino-2-methyl phenyl)-2-fluorobenzamide
The mixture heating up of heating 2-fluoro-N-(2-methyl-4-nitrophenyl) benzamide (4.55 gram), tetrahydrobenzene (30 milliliters), ethanol (70 milliliters), water (30 milliliters) and 10% palladium carbon (3 gram) is to refluxing 30 minutes.With the mixture filtration over celite, and concentrating under reduced pressure.The oil that obtains is dissolved in 50 milliliters of ethyl acetate, and 4 ℃ were cooled off 12 hours.Filtration obtains the tawny solid product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-2-methyl-phenyl)-ethanamide
2-methyl-benzoxazoles-6-base amine
N-(4-amino-3-methoxyl group-phenyl)-ethanamide
2-acetylamino-5-amino-phenylformic acid
N-(4-amino-phenyl)-ethanamide
[4-(3-amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-amino-benzoyl-amido)-phenyl]-t-butyl carbamate
N-(4-amino-2-cyano group-phenyl)-ethanamide
N-(4-amino-2,5-dimethoxy-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2,5-dimethoxy-phenyl)-acid amides
N-(4-amino-2-cyano group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methoxyl group-phenyl)-acid amides
N-(4-amino-2-methoxyl group-phenyl)-2-fluoro-benzamide
N-(4-amino-2-methoxyl group-5-methyl-phenyl)-ethanamide
N-(4-amino-2-benzoyl-phenyl)-ethanamide
N-(4-amino-2-benzoyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-benzoyl-phenyl)-acid amides
N-(4-amino-3-methyl-phenyl)-ethanamide
N-(4-amino-3-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-methyl-phenyl)-acid amides
5-amino-2-[(2-fluoro benzoyl) amino]-the N-phenylbenzamaide
Furans-2-carboxylic acid (4-amino-2-phenyl amino formyl radical-phenyl) acid amides
N-(4-amino-naphthalene-1-yl)-ethanamide
Furans-2-carboxylic acid (4-amino-naphthalene-1-yl)-acid amides
N-(4-amino-2-trifluoromethyl-phenyl)-ethanamide
Furans-2-carboxylic acid (4-amino-2-cyano group-phenyl)-acid amides
Furans-2-carboxylic acid (4-amino-2-trifluoromethyl-phenyl)-acid amides
N-(4-amino-2-methyl-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-2-methyl-phenyl)-acid amides
5-amino-2-(2-fluoro-benzoyl-amido)-phenylformic acid
5-amino-2-[(furans-2-carbonyl)-amino]-phenylformic acid
N-(4-amino-2-cyano group-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-3-methyl-phenyl)-2,6-two fluoro-benzamide
N-(4-amino-3-trifluoromethyl-phenyl)-ethanamide
N-(4-amino-3-trifluoromethyl-phenyl)-2-fluoro-benzamide
N-(4-amino-2-trifluoromethyl-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-2-methoxyl group-phenyl)-2,2,2-three fluoro-ethanamides
N-(4-amino-2-trifluoromethyl-phenyl)-2-fluoro-N-(2-fluoro-benzoyl)-benzamide
N-(4-amino-2-trifluoromethyl-phenyl)-2-fluoro-benzamide
Embodiment 7 (method 1G)
N-(4-amino-2-chloro-phenyl-)-2-thiomorpholine-4-base-ethanamide
Ethanol (200 milliliters) solution of N-(2-chloro-4-nitrophenyl)-2-thiomorpholine-4-base-ethanamide (3.02 gram) is added in water (60 milliliters) solution of Sulfothiorine (12 gram).Reflux mixture 12 hours cools off and pours in the water.Use the ethyl acetate extraction mixture then.Wash ethyl acetate solution 2 times with saturated nacl aqueous solution, use the Anhydrous potassium carbonate drying, filtration over celite plate, and concentrating under reduced pressure obtain oil.Add toluene, frozen soln obtains desired greenish orange look lenticular solid product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-2-chloro-phenyl)-2-thiomorpholine-4-base-ethanamide
N-(4-amino-2-chloro-phenyl)-2-dipropyl amino-ethanamide
Embodiment 8 (method 2A)
(3-chloro-4-iodo-phenyl)-t-butyl carbamate
Add Di-tert butyl pyrocarbonate (8.6 gram) in the solution of the tetrahydrofuran (THF) (40 milliliters) (containing diisopropyl ethyl amine (6.9ml)) of 3-chloro-4-iodo-aniline (10 gram), heated mixt is to refluxing.Add another part diisopropyl ethyl amine (6.9 milliliters) and Di-tert butyl pyrocarbonate (21 gram) after about 15 hours, continue about 24 hours of heating.Cooling solution then, concentrating under reduced pressure with the ethyl acetate dilution, and is used 5% salt acid elution 3 times continuously, with saturated sodium-chloride washing 1 time.Use anhydrous sodium sulfate drying solution, concentrating under reduced pressure obtains desired brown oily crude product then.Cause crystallization by adding hexane, the solid matter that recrystallization is collected from hexane obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
N '-(4-nitro-benzoyl)-hydrazine carboxylic acid's tert-butyl ester
(3-chloro-4-iodo-phenyl)-t-butyl carbamate
(4-bromo-3-chloro-phenyl)-t-butyl carbamate
(3-chloro-4-vinyl-phenyl)-t-butyl carbamate
(3-chloro-4-methylthio group-phenyl)-t-butyl carbamate
(4-amino-3-chloro-phenyl)-t-butyl carbamate
(4-chloro-2-nitro-phenyl)-t-butyl carbamate
(3-tert-butoxycarbonyl amino-5-chloro-phenyl)-t-butyl carbamate
(4-nitro-benzyl)-t-butyl carbamate
(3-bromo-5-trifluoromethyl-phenyl)-t-butyl carbamate
(2-amino-3-chloro-5-trifluoromethyl-phenyl)-t-butyl carbamate
Embodiment 9 (method 2B)
(3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS ethyl ester
N at 3-chloro-4-vinyl-phenyl amine (3.4 gram), in the solution of dinethylformamide (44 milliliters) (containing diisopropyl ethyl amine (5.8 milliliters)), add 1-[2-(TMS)-ethoxy carbonyl-oxygen base] benzotriazole (7.1 gram), under the room temperature, under argon gas, stirred the mixture 3.Dilute with water solution is used extracted with diethyl ether 3 times then.The organic extract that water, saturated sodium-chloride water solution continuous washing merge is used anhydrous magnesium sulfate drying, concentrating under reduced pressure.With silica gel (hexane solution of 10% ethyl acetate is as the elutriant) residuum that chromatography obtains, provide desired yellow oil product.
Embodiment 10 (method 2C)
[4-(2-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
At one-N-(tert-butoxycarbonyl)-1, add fluorobenzoyl chloride (1.20 gram) in 25 milliliters of dichloromethane solutions of 4-phenylenediamine (1.58 gram) and triethylamine (1.50 milliliters).Form solid immediately, filter and wash, obtain white solid 1.90 grams with fresh solvent.
Use said procedure and suitable parent material to prepare following compounds:
N-(3-methoxyl group-4-nitro-phenyl)-ethanamide
N-(4-aminophenyl)-isobutyramide
2,2,2-three fluoro-N-(2-methoxyl group-4-nitro-phenyl)-ethanamide
[4-(2-methyl-benzoyl-amido)-phenyl]-t-butyl carbamate
Acetate 2-(4-tert-butoxycarbonyl amino-phenyl amino formyl radical)-phenyl ester
[4-(4-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-fluoro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-methoxyl group-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,2-dimethyl-propionyl amino)-phenyl]-t-butyl carbamate
[4-(2-bromo-acetylamino)-phenyl]-t-butyl carbamate
[4-(2,2,2-three fluoro-acetylamino)-phenyl]-t-butyl carbamate
(4-benzoyl-amido-phenyl)-t-butyl carbamate
(4-methylsulfonyl amino-phenyl)-t-butyl carbamate
(4-phenyl acetyl amino-phenyl)-t-butyl carbamate
4-[(thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(3-nitro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-acetylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-methylsulfonyl amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[3-[[[4-[[(1,1-dimethyl oxyethyl group) carbonyl] amino] phenyl] amino] carbonyl]-phenyl] urethanum
[4-(2-trifluoromethyl-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,6-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-bromo-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-nitro-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(benzo [b] thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyridine-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(naphthalene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(naphthalene-1-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(3-bromo-thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(xenyl-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-(4-tert-butoxycarbonyl amino-phenyl)-phthalamic acid
[4-(2,3-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,5-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,4-two fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2-acetylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2-methylsulfonyl amino-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(2,3,4-three fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
[4-(2,3,4,5,6-five fluoro-benzoyl-amidos)-phenyl]-t-butyl carbamate
N-(4-tert-butoxycarbonyl amino-phenyl)-isophthalamic acid methyl esters
2-methylthio group (sulfanyl)-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-benzamide
[4-(3-benzyloxy-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(3-butoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(5-difluoromethyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(thiophene-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-bromo-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
(4-caproyl amino-phenyl)-t-butyl carbamate
[4-(2-thiophene-2-base-acetylamino)-phenyl]-t-butyl carbamate
4-[(pyridine-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-bromo-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(furans-3-carbonyl)-amino]-phenyl }-t-butyl carbamate
(4-phenyloxycarbonyl amino-phenyl)-t-butyl carbamate
4-[(benzo [1,3] dioxole-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(3-trifluoromethoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
N-(2,5-dimethoxy-4 '-nitro-phenyl)-2-fluoro-benzamide
4-[(furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-phenoxy group-acetylamino)-phenyl]-t-butyl carbamate
4-[(5-nitro-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-chloro-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(3-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-methoxyl group-acetylamino)-phenyl]-t-butyl carbamate
4-[(4-furans-3-base-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
The 4-[(5-tertiary butyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-[3-cyano group-4-(2,2,2-three fluoro-acetylamino)-phenyl]-2-fluoro-benzamide
Furans-2-carboxylic acid [3-cyano group-4-(2,2,2-three fluoro-acetylamino)-phenyl] acid amides
N-(4-acetylamino-2-cyano group-phenyl)-2,2,2-three fluoro-ethanamides
2,2,2-three fluoro-N-(4-nitro-2-trifluoromethyl-phenyl)-ethanamide
N-(4-acetylamino-2-trifluoromethyl-phenyl)-2,2,2-three fluoro-ethanamides
2-fluoro-N-[4-(2,2,2-three fluoro-acetylamino)-3-trifluoromethyl-phenyl] benzamide
Furans-2-carboxylic acid [4-(2,2,2-three fluoro-acetylamino)-3-trifluoromethyl-phenyl] acid amides
2-fluoro-N-(2-methyl-benzoxazoles-6-yl)-benzamide
4-(2-fluoro-benzoyl-amido)-2-hydroxy-benzoic acid phenyl ester
4-[(isoxazole-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
N-(4-acetylamino-2-methoxyl group-phenyl)-2,2,2-three fluoro-ethanamides
2-fluoro-N-[3-methoxyl group-4-(2,2,2-three fluoro-acetylamino)-phenyl] benzamide
2-fluoro-N-(2-fluoro-benzoyl)-N-(4-nitro-2-trifluoromethyl-phenyl) benzamide
4-[(1H-pyrazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1H-imidazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-[1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-furans-3-base-[1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
2,2,2-three fluoro-N-(5-nitro-pyridine-2-yl)-ethanamide
4-[(1-methyl isophthalic acid H-pyrazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-(2-fluoro-benzoyl-amido)-2-hydroxy-benzoic acid methyl esters
N-(5-chloro-2,4-dimethoxy-phenyl)-oxalyl amino acid
Isoxazole-5-carboxylic acid (4-amino-phenyl)-acid amides
2-fluoro-N-(4-nitro-benzyl)-benzamide
Furans-2-carboxylic acid 4-nitrobenzyl acid amides
N-[3-chloro-5-(2,2,2-three fluoro-acetylamino)-phenyl]-2,2,2-three fluoro-ethanamides
N-(3-amino-5-chloro-phenyl)-2,2,2-three fluoro-ethanamides
[4-(2-fluoro-benzoyl-amido)-benzyl]-t-butyl carbamate
[4-(2,6-two fluoro-benzoyl-amidos)-benzyl]-t-butyl carbamate
2,6-two fluoro-N-(4-nitro-benzyl)-benzamide
4-[(furans-2-carbonyl)-amino]-benzyl }-t-butyl carbamate
N-(3-amino-5-chloro-phenyl)-ethanamide
[4-(3-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-chloro-benzoyl-amido)-phenyl]-t-butyl carbamate
[4-(4-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
(4-benzenesulfonyl amino-phenyl)-t-butyl carbamate
[4-(3-trifluoromethyl-benzoyl-amido)-phenyl]-t-butyl carbamate
2,2,2-three fluoro-N-(5-nitro-pyrimidine-2-base)-ethanamide
Embodiment 11 (method 2D)
2-chloro-N-(2-chloro-4-nitrophenyl) ethanamide
Tetrahydrofuran (THF) (150 milliliters) solution of reflux 2-chloro-4-N-methyl-p-nitroaniline (19.0 gram) and chloroacetyl chloride (30 milliliters) 1 hour.Cooling solution and concentrating under reduced pressure obtain wet yellow solid.Add ether (250 milliliters), and collect yellow solid.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-nitro-3-trifluoromethyl-phenyl)-ethanamide
(2-chloro-4-nitro-phenyl)-urethanum
2-acetylamino-5-nitro-phenylformic acid
Furans-2-carboxyl (5-chloro-2-hydroxyl-4-nitro-phenyl)-acid amides
Furans-2-carboxylic acid (2-methyl-4-nitro-phenyl)-acid amides
Furans-2-carboxylic acid (2-methoxyl group-4-nitro-phenyl)-acid amides
N-(2-chloro-4-nitro-phenyl)-benzamide
2-methoxyl group-N-(4-nitro-phenyl)-ethanamide
N-(4-nitro-phenyl)-acrylamide
N-(4-nitro-phenyl)-isobutyramide
[4-(acryl amino)-phenyl] t-butyl carbamate
(4-nitro-phenyl)-isobutyl carbamate
[1,2,3] thiadiazoles-4-carboxylic acid (5-nitro-pyridine-2-yl)-acid amides
Furans-2-carboxylic acid (5-nitro-pyridine-2-yl)-acid amides
2-fluoro-N-(5-nitro-pyridine-2-yl)-benzamide
N-(2-chloro-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2,5-dimethoxy-4 '-nitro-phenyl)-acid amides
N-(2-cyano group-4-nitro-phenyl)-2-fluoro-benzamide
2-fluoro-N-(2-methoxyl group-4-nitro-phenyl)-benzamide
2-methyl-N-(5-nitro-pyridine-2-yl)-benzamide
Furans-2-carboxylic acid (2-methoxyl group-5-methyl-4-nitro-phenyl)-acid amides
2-furans-N-(2-methoxyl group-5-methyl-4-nitro-phenyl)-benzamide
N-(2-benzoyl-4-nitro-phenyl)-ethanamide
N-(2-benzoyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2-benzoyl-4-nitro-phenyl)-acid amides
N-(3-methyl-4-nitro-phenyl)-ethanamide
2-fluoro-N-(3-methyl-4-nitro-phenyl)-benzamide
Furans-2-carboxylic acid (3-methyl-4-nitro-phenyl)-acid amides
2-acetylamino-5-nitro-N-phenyl-benzamide
The 2-[(2-fluoro benzoyl) amino]-5-nitro-N-phenylbenzamaide
Furans-2-carboxylic acid (4-nitro-2-phenyl amino formyl radical-phenyl)-acid amides
2-fluoro-N-(4-nitro-naphthalene-1-yl)-benzamide
Furans-2-carboxylic acid (4-nitro-naphthalene-1-yl)-acid amides
N-(5-chloro-2-hydroxyl-4-nitro-phenyl)-ethanamide
N-(5-chloro-2-hydroxyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (2-chloro-4-nitro-phenyl)-acid amides
N-(4-nitro-2-trifluoromethyl-phenyl)-ethanamide
Furans-2-carboxylic acid (2-cyano group-4-nitro-phenyl)-acid amides
2-fluoro-N-(4-nitro-2-trifluoromethyl-phenyl)-benzamide
Furans-2-carboxylic acid (4-nitro-2-trifluoromethyl-phenyl)-acid amides
2-fluoro-N-(2-methyl-4-nitro-phenyl)-benzamide
N-(5-chloro-2-methyl-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (5-chloro-2-methyl-4-nitro-phenyl)-acid amides
2-(2-fluoro-benzoyl-amido)-5-nitro-phenylformic acid
2-[(furans-2-carbonyl)-amino]-5-nitro-phenylformic acid
N-(3-chloro-4-nitro-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (3-chloro-4-nitro-phenyl)-acid amides
2,6-two fluoro-N-(3-methyl-4-nitro-phenyl)-benzamide
2-fluoro-N-(4-nitro-3-trifluoromethyl-phenyl)-benzamide
Furans-2-carboxylic acid (4-nitro-3-trifluoromethyl-phenyl)-acid amides
2-chloro-N-(2-chloro-4-nitro-phenyl)-ethanamide
N-(2-chloro-4-nitrophenyl) Toluidrin
Furans-2-carboxylic acid [3-methoxyl group-4-(2,2,2-three fluoro-acetylamino)-phenyl]-acid amides
N-(2-chloro-4-nitro-phenyl)-2,2,2-three fluoro-ethanamides
Embodiment 12
4-[(4-phenyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
Handle 1-(N-tert-butoxycarbonyl)-1 with triethylamine (1.3 milliliters) and benzotriazole-1-base oxygen base-three (dimethylamino)-phosphorus hexafluorophosphate (1.6 gram), 4-phenylenediamine (0.8 gram) and 4-phenyl-[1,2,3] methylene dichloride (10 milliliters) solution of thiadiazoles-5-carboxylic acid (0.7 gram).After at room temperature stirring, the dilute with water reactant, and use dichloromethane extraction.Organic layer is used dried over mgso then with 0.5N hydrochloric acid, saturated sodium bicarbonate and water washing, filters, and concentrating under reduced pressure, obtain desired product.
Use said procedure and suitable parent material to prepare following compounds:
4-[(1H-pyrroles-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyrazine-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(5-methyl-thiophene-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1-methyl isophthalic acid H-pyrroles-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(quinoline-8-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(cumarone-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(isoquinoline 99.9-1-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(quinoline-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(pyridine-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(isoquinoline 99.9-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(1H-[1,2,3] triazole-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
[4-(2-methylthio group-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[(quinoline-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-methyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
4-[(4-phenyl-[1,2,3] thiadiazoles-5-carbonyl)-amino]-phenyl }-t-butyl carbamate
The 4-[(1H-indole-2-carbonyl)-amino]-phenyl }-t-butyl carbamate
[1,2,3] thiadiazoles-4-carboxylic acid 4-nitrobenzyl acid amides
4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-t-butyl carbamate
Acetate 4-(4-tert-butoxycarbonyl amino-phenyl amino formyl radical)-phenyl ester
4-[(quinoline-6-carbonyl)-amino]-phenyl }-t-butyl carbamate
Embodiment 13 (method 2F)
Acetate 2-(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-ethyl ester
Handle pyridine (14 milliliters) solution of [3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-t-butyl carbamate (0.85 restrains), stirring at room mixture 15 hours with diacetyl oxide (1.24 milliliters).Removal of solvent under reduced pressure is dissolved in ethyl acetate with residuum.Use 5% salt acid elution 2 times then, with saturated sodium bicarbonate aqueous solution washing 1 time, then with saturated sodium-chloride water solution washing 1 time.Use anhydrous magnesium sulfate drying solution, removal of solvent under reduced pressure obtains desired colorless oil product.
Use said procedure and suitable parent material to prepare following compounds:
Thiophenyl-acetonitrile
Acetate 2-(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-ethyl ester
Embodiment 14 (method 2G)
(3,5-two chloro-4-hydroxyl-phenyl)-t-butyl carbamate
2, add Di-tert butyl pyrocarbonate (11.7 gram) in tetrahydrofuran (THF) (130 milliliters) solution of 6-two chloro-4-amino-phenols (9.5 gram), and with mixture heating up to refluxing about 15 hours.Cooling mixture then, concentrating under reduced pressure with the ethyl acetate dilution, and with 5% hydrochloric acid continuous washing 3 times, washs 1 time with saturated sodium-chloride water solution.Use anhydrous sodium sulfate drying solution, concentrating under reduced pressure obtains desired crude product then.Then this material is ground with cold methylene dichloride, obtain the white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
(3-amino-5-chloro-phenyl)-t-butyl carbamate
Embodiment 15 (method 3A)
3,5-two chloro-4-oxyethyl group-phenyl amine
In solid (3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate (0.97 gram), add trifluoroacetic acid (5 milliliters), stirred the mixture under the room temperature about 45 minutes.Add entry then, cooling mixture in ice bath, and with solid carbonic acid potashization.With this solution of ethyl acetate extraction 3 times,, use anhydrous sodium sulfate drying then with the organic phase that the saturated sodium-chloride water solution washing merges.Concentrating under reduced pressure, recrystallization from hexane obtains desired faint yellow crystalline solid-state product.
Use said procedure and suitable parent material to prepare following compounds:
5-bromo-pyridin-3-yl amine
3-chloro-4-methylsulfonyl-phenyl amine
N-(4-amino-phenyl)-2-methyl-benzamide
Acetate 2-(4-amino-phenyl amino formyl radical)-phenyl ester
N-(4-amino-phenyl)-4-fluoro-benzamide
N-(4-amino-phenyl)-3-fluoro-benzamide
N-(4-amino-phenyl)-2-fluoro-benzamide
N-(4-amino-phenyl)-2-methoxyl group-benzamide
N-(4-amino-phenyl)-3-methoxyl group-benzamide
N-(4-amino-phenyl)-4-methoxyl group-benzamide
N-(4-amino-phenyl)-2-phenyl-ethanamide
N-(4-amino-phenyl)-2,2-dimethyl-propionic acid amide
N-(4-amino-phenyl)-2,2,2-three fluoro-ethanamides
Thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
1H-pyrroles-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-nitro-benzamide
3-acetylamino-N-(4-amino-phenyl)-benzamide
N-(4-amino-phenyl)-3-dimethylamino-benzamide
N-(4-amino-phenyl)-3-methylsulfonyl amino-benzamide
N-(4-amino-phenyl)-2-trifluoromethyl-benzamide
N-(4-amino-phenyl)-2,6-two fluoro-benzamide
N-(4-amino-phenyl)-2-chloro-benzamide
N-(4-amino-phenyl)-2-bromo-benzamide
N-(4-amino-phenyl)-2-nitro-benzamide
Pyrazine-2-carboxylic acid (4-amino-phenyl)-acid amides
5-methyl-thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
Quinoline-8-carboxylic acid (4-amino-phenyl)-acid amides
1-methyl isophthalic acid H-pyrroles-2-carboxylic acid (4-amino-phenyl)-acid amides
Benzo [b] thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
Cumarone-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-Isonicotinamide
Naphthalene-2-carboxylic acid (4-amino-phenyl)-acid amides
Naphthalene-1-carboxylic acid (4-amino-phenyl)-acid amides
Isoquinoline 99.9-1-carboxylic acid (4-amino-phenyl)-acid amides
Quinaldic acid's (4-amino-phenyl)-acid amides
3,5-two chloro-4-oxyethyl group-phenyl amine
4-butoxy-3,5-two chloro-phenyl amine
Isoquinoline 99.9-4-carboxylic acid (4-amino-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-amino-phenyl)-acid amides
1H-[1,2,3] triazole-4-carboxylic acid (4-amino-phenyl)-acid amides
3-bromo-thiophene-2-carboxylic acid (4-amino-phenyl)-acid amides
4-benzyloxy-3,5-two chloro-phenyl amine
2-(4-amino-2,6-two chloro-phenoxy groups)-ethanamide
(4-amino-2,6-two chloro-phenoxy groups)-methyl acetate
[3-(4-amino-phenyl amino formyl radical)-phenyl]-urethanum
2-amino-N-(4-amino-phenyl)-benzamide
Xenyl-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-2,3-two fluoro-benzamide
N-(4-amino-phenyl)-2,5-two fluoro-benzamide
N-(4-amino-phenyl)-2,4-two fluoro-benzamide
2-acetylamino-N-(4-amino-phenyl)-benzamide
N-(4-amino-phenyl)-2-methylsulfonyl amino-benzamide
N-(4-amino-phenyl)-2,3,4-three fluoro-benzamide
N-(4-amino-phenyl)-2,3,4,5,6-five fluoro-benzamide
N-(4-amino-phenyl)-2-methylthio group-benzamide
Acetate 2-(4-amino-2,6-two chloro-phenoxy groups)-ethyl ester
N-(4-amino-phenyl)-isophthalamic acid methyl esters
N-(4-amino-phenyl)-3-benzyloxy-benzamide
N-(4-amino-phenyl)-3-butoxy-benzamide
[3-(4-amino, phenyl amino formyl radical)-phenoxy group]-ethyl acetate
Pyridine-2-carboxylic acids (4-amino-phenyl)-acid amides
Cinchonic Acid's (4-amino-phenyl)-acid amides
5-methyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-difluoromethyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
1H-Indoline-2-carboxylic acid (4-amino-phenyl)-acid amides
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
Thiophene-3-carboxylic acid (4-amino-phenyl)-acid amides
5-chloro-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-nitro-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-2-benzene sulphur (thiophen)-2-base-ethanamide
3-methyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
5-bromo-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
4-bromo-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-niacinamide
N-(4-amino-phenyl)-3-furans carboxylic acid amides
4-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
Acetate 3-(4-amino-phenyl amino formyl radical)-phenyl ester
Benzo [1,3] dioxole-4-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-(2-dimethylamino-oxyethyl group)-benzamide
N-(4-amino-phenyl)-3-trifluoromethoxy-benzamide
N-(4-amino-phenyl)-3-(2-morpholine-4-base-oxyethyl group)-benzamide
The own ester of (4-amino-phenyl)-carboxylamine
Furans-2-carboxylic acid (4-amino-phenyl)-acid amides
(4-amino-phenyl)-phenyl carbamate
Caproic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-acrylamide
N-(4-amino-phenyl)-2-methoxyl group-ethanamide
4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid (4-amino-phenyl)-acid amides
The 5-tertiary butyl-furans-2-carboxylic acid (4-amino-phenyl)-acid amides
3-chloro-4-methanesulfinyl-phenyl amine
5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid (4-amino-phenyl)-acid amides
2-(4-amino-2-chloro-phenyl)-ethanol
(4-amino-2-chloro-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester
5-chloro-N, N-dimethyl-benzene-1,3-diamines
3-(2-methyl-butyl)-5-trifluoromethyl-phenyl amine
3-isobutyl--5-trifluoromethyl-phenyl amine
Furans-2-carboxylic acid (4-amino methyl-phenyl)-acid amides
N-(4-amino methyl-phenyl)-2-fluoro-benzamide
[1,2,3] thiadiazoles-4-carboxylic acid (4-amino methyl-phenyl)-acid amides
N-(4-amino methyl-phenyl)-2,6-two fluoro-benzamide
Oxazole-4-carboxylic acid (4-amino-phenyl)-acid amides
N-(4-amino-phenyl)-3-chloro-benzamide
N-(4-amino-phenyl)-4-chloro-benzamide
Acetate 4-(4-amino-phenyl amino formyl radical)-phenyl ester
N-(4-amino-phenyl)-4-dimethylamino-benzamide
1-(4-amino-phenyl)-3-(3,5-di-trifluoromethyl-phenyl)-thiocarbamide
N-(4-amino-phenyl)-2-iodo-benzamide
N-(4-amino-phenyl)-3-trifluoromethyl-benzamide
Embodiment 16 (method 3B)
1-(4-amino-2-chloro-phenyl)-ethanol
Tetrahydrofuran (THF) (5.7 milliliters) solution of 1M tetrabutyl ammonium fluoride is added in [3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS ethyl ester (0.5 gram) about 3.5 hours of stirring at room mixture.Concentrating under reduced pressure mixture then is dissolved in 1: 1 the ethyl acetate and hexanes mixtures, water continuously, and the saturated sodium-chloride water solution washing, and use anhydrous magnesium sulfate drying.Removal of solvent under reduced pressure is used silica gel (with the hexane solution of 40% ethyl acetate as elutriant) chromatography then, obtains amber oily product.
Embodiment 17 (method 3C)
N-(4-amino-3-cyano-phenyl)-2-fluoro-benzamide
Salt of wormwood (5.0 gram) is added to N-[3-cyano group-4-(2,2,2-trifluoroacetyl group-amino)-phenyl]-methyl alcohol (270 milliliters) of 2-fluoro-benzamide (2.5 gram) and the solution of water (16 milliliters) in, the backflow mixture overnight.After the removal of solvent under reduced pressure, residuum is suspended in water, use dichloromethane extraction.Merge organic extract, water with the saturated sodium-chloride water solution washing, is used anhydrous magnesium sulfate drying then, filters and concentrating under reduced pressure, obtains desired white solid state compound.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-amino-phenyl)-2-methanesulfinyl-benzamide
N-(4-amino-3-cyano group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-cyano group-phenyl)-acid amides
N-(4-amino-3-cyano group-phenyl)-ethanamide
Furans-2-carboxylic acid (4-amino-3-trifluoromethyl-phenyl)-acid amides
N-(4-amino-3-methoxyl group-phenyl)-ethanamide
N-(4-amino-3-methoxyl group-phenyl)-2-fluoro-benzamide
Furans-2-carboxylic acid (4-amino-3-methoxyl group-phenyl)-acid amides
Embodiment 17 (method 4A)
2-chloro-1-cyclohexyl oxygen base-4-oil of mirbane
Under the argon gas, slowly dimethyl sulfoxide (DMSO) (20 milliliters) solution with hexalin (2.9 gram) is added in the flask that contains potassium hydride KH (0.90 gram washs 3 times in advance with hexane) stirring at room solution 1 hour.Add dimethyl sulfoxide (DMSO) (10 milliliters) solution of 3-chloro-4-fluoro-oil of mirbane (1 gram), then about 100 degree were arrived in the dark red solution heating that obtains in 3 hours.Reaction mixture with ether (300 milliliters) dilution, and with saturated aqueous ammonium chloride, water (3 times), is the saturated sodium-chloride water solution washing then then.Use the anhydrous magnesium sulfate drying organic layer then, removal of solvent under reduced pressure with silica gel (with the hexane solution of 5% ethyl acetate as the elutriant) oil that chromatography obtains, obtains desired orange solid product.
Embodiment 18 (method 4C)
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-tetramethyleneimine-3-yl)-amine
Merge 3-chloro-4-fluoronitrobenzene (1.0 gram) and N, N '-dimethyl-3-amino-pyrrolidine (1.72 gram), stir about 24 hours.Use ethyl acetate diluted mixture thing then, wash with water 2 times,, use anhydrous sodium sulfate drying with saturated sodium-chloride washing 1 time.After removal of solvent under reduced pressure,, obtain desired yellow oil product with silica gel column chromatography residuum (is that pure methyl alcohol is as elutriant then with pure ethyl acetate).
Use said procedure and suitable parent material to prepare following compounds:
(2-chloro-4-nitro-phenyl)-dipropyl-amine
1-(2-chloro-4-nitro-phenyl)-piperidines
1-(2-chloro-4-nitro-phenyl)-tetramethyleneimine
(2-chloro-4-nitro-phenyl)-cyclohexyl-methylamine
Benzyl-(2-chloro-4-nitro-phenyl)-amine
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-piperidin-4-yl)-amine
(2-chloro-4-nitro-phenyl)-cyclohexyl-ethyl-amine
(2-chloro-4-nitro-phenyl)-cyclohexyl-amine
(2-chloro-4-nitro-phenyl)-methyl-(1-methyl-tetramethyleneimine-3-yl)-amine
(1-benzyl-tetramethyleneimine-3-yl)-(2-chloro-4-nitro-phenyl)-methyl-amine
(2-chloro-4-nitro-phenyl)-cyclopentyl-methyl-amine
1-(2-chloro-4-nitro-phenyl)-decahydro-quinoline
Allyl group-(2-chloro-4-nitro-phenyl)-cyclohexyl-amine
2-[(2-chloro-4-nitro-phenyl)-(2-hydroxyl-ethyl)-amino]-ethanol
(2-chloro-4-nitro-phenyl)-isobutyl--methyl-amine
(2-chloro-4-nitro-phenyl)-base-methyl-amine
2-[(2-chloro-4-nitro-phenyl)-methyl-amino]-ethanol
N-(2-chloro-4-nitro-phenyl)-N, N ', N '-trimethylammonium-ethane-1,2-diamines
N-(2-chloro-4-nitro-phenyl)-N, N ' N '-trimethylammonium-propane-1,3-diamines
(1-benzyl-piperidin-4-yl)-(2-chloro-4-nitro-phenyl)-amine
N-(2-chloro-4-nitro-phenyl)-N, N '-dimethyl-ethane-1,2-diamines
N-(2-chloro-4-nitro-phenyl)-N ', N '-dimethyl-propane-1,3-diamines
(2-chloro-4-nitro-phenyl)-(2-methoxyl group-ethyl)-methyl-amine
(1-benzyl-tetramethyleneimine-3-yl)-(2-chloro-4-nitro-phenyl)-amine
4-piperidines-1-base-3-trifluoromethyl-benzonitrile
4-dimethylamino-3-trifluoromethyl-benzonitrile
4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzonitrile
Embodiment 19 (method 4E)
Butyl-(2-chloro-4-nitro-phenyl) thioether
At room temperature stir the N of 3-chloro-4-fluoro-oil of mirbane (5.0 gram) and sodium sulphite (2.5 gram), dinethylformamide (30 milliliters) solution 1 hour uses 1-iodate butane (12.6 gram) to handle then.Removal of solvent under reduced pressure is handled the residuum that obtains with ethyl acetate and hexane then, precipitates inorganic salt.Solids removed by filtration, concentrating under reduced pressure filtrate.Make the residuum that obtains by hydrous magnesium silicate then, as elutriant, obtain desired yellow solid compounds with methylene dichloride.
Use said procedure and suitable parent material to prepare following compounds:
1-butylthio-2-chloro-4-oil of mirbane
2-chloro-1-hexamethylene sulfenyl-4-oil of mirbane
2-chloro-1-ethylmercapto group-4-oil of mirbane
Embodiment 20 (method 4F)
(4-chloro-5-methoxyl group-2-nitro-phenyl)-dimethyl-amine
In tetrahydrofuran (THF) (2.0 milliliters) solution of trifluoromethanesulfonic acid 4-chloro-5-methoxyl group-2-nitro-phenyl ester (1.0 gram), add dimethyl amine (40% aqueous solution, 4 milliliters), at room temperature stirred the mixture about 15 hours.Decompression concentrated solution is dissolved in ethyl acetate with residuum then, washes with water then.With ethyl acetate extraction water layer 1 time,, use anhydrous sodium sulfate drying with the organic layer that the saturated sodium-chloride water solution washing merges.Solvent removed by evaporation at reduced pressure is ground residuum and hexane altogether, obtains desired colourless solid product.
Use said procedure and suitable parent material to prepare following compounds:
(4-chloro-2-nitro-phenyl)-dimethyl-amine
4-(4-chloro-5-methoxyl group-2-nitro-phenyl)-morpholine
(4-chloro-5-methoxyl group-2-nitro-phenyl)-dimethyl-amine
1-(4-chloro-5-methoxyl group-2-nitro-phenyl)-piperidines
1-(4-chloro-5-methoxyl group-2-nitro-phenyl)-tetramethyleneimine
Benzyl-(4-chloro-5-methoxyl group-2-nitro-phenyl)-amine
(2-chloro-6-nitro-phenyl)-dimethyl-amine
Embodiment 21 (method 4G)
(2-chloro-4-nitro-phenyl)-methyl-phenyl-amine
At 0 ℃, in tetrahydrofuran (THF) (75 milliliters) solution of methylphenylamine (3.0 gram), drip n-Butyl Lithium (12.3 milliliters 2.5M hexane solutions).Make mixture be slowly to warm to room temperature, be cooled to 0 ℃ then again, and be added to intubate in tetrahydrofuran (THF) (35 milliliters) solution of the 3-chloro-4-fluoronitrobenzene (4.9 gram) that remains on-78 ℃.After adding, make mixture warm to room temperature in 1 hour, concentrating under reduced pressure by adding the saturated aqueous ammonium chloride cancellation, is used ethyl acetate extraction 3 times then.With 5% hydrochloric acid (3 times), water (1 time), usefulness saturated sodium bicarbonate aqueous solution (1 time), the organic layer of using saturated sodium-chloride water solution (1 time) washing to merge is again used anhydrous magnesium sulfate drying then.After the removal of solvent under reduced pressure,, obtain desired clear colorless oil shape product with silica gel (with the hexane solution of 5% ether as elutriant) chromatography residuum.
Embodiment 22 (method 4H)
2,6-two chloro-4-nitrophenolss
With 3,4,5-trichloronitrobenzene (14.86 gram) is added in ethylene glycol (66 milliliters) solution of phenoxy group potassium (8.66 gram), heated mixt to 160 ℃ about 15 hours.The dark brown solution that obtains is chilled to room temperature, pours in 100 milliliters of cold water, use extracted with diethyl ether 2 times.Water, 10% aqueous sodium hydroxide washes are washed the organic extract of merging, use anhydrous magnesium sulfate drying then.After the removal of solvent under reduced pressure, in the Kugelrohr device, distill, solidify when the yellow oil that obtains is placed.Recrystallization obtains desired faint yellow solid-state product from alcohol-water.
Embodiment 23 (method 5A)
(3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate
In acetone (18 milliliters) solution of (3,5-two chloro-4-hydroxyl-phenyl)-t-butyl carbamate (1.0 gram) and salt of wormwood (1.0 gram), add ethyl iodide (0.36 milliliter), about 15 hours of stirring at room mixture.Filtering solution then, concentrating under reduced pressure, and between ethyl acetate and water, distribute.Then use the isolating water layer of ethyl acetate extraction 2 times again, the organic extract that merges with 10% aqueous sodium hydroxide solution, water washing is used anhydrous sodium sulfate drying then continuously.Solvent evaporated under reduced pressure obtains desired brown solid product.
Use said procedure and suitable parent material to prepare following compounds:
(3,5-two chloro-4-oxyethyl group-phenyl)-t-butyl carbamate
(4-butoxy-3,5-two chloro-phenyl)-t-butyl carbamate
(4-benzyloxy-3,5-two chloro-phenyl)-t-butyl carbamate
(4-carbamyl ylmethoxy-3,5-two chloro-phenyl)-t-butyl carbamate
[3,5-two chloro-4-(2-nitrilo oxyethyl group)-phenyl]-t-butyl carbamate
(4-tert-butoxycarbonyl amino-2,6-two chloro-phenoxy groups)-methyl acetate
3-butoxy-methyl benzoate
3-tert-butoxycarbonyl methoxyl group-methyl benzoate
3-carbamyl ylmethoxy-methyl benzoate
[4-(3-carbamyl ylmethoxy-benzoyl-amido)-phenyl]-t-butyl carbamate
4-[3-(2-chloro-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
Embodiment 24 (method 5C)
(2,6-two chloro-4-nitro-phenoxy groups)-tert.-butyl acetate
2, in dimethyl formamide (50 milliliters) solution of 6-two chloro-4-nitrophenolss (2.5 gram) and salt of wormwood (3.3 gram), add bromo-acetic acid tert-butyl (10 milliliters), stirring at room mixture 2 days.Then solution is poured in 500 ml waters, used hexane extraction 3 times,, use anhydrous magnesium sulfate drying then with the organic extract that the saturated aqueous ammonium chloride washing merges.Solvent evaporated under reduced pressure makes the oil and the hexane that obtain grind altogether then, obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
3-dimethylamino-1-(4-nitro-phenyl)-acrylketone
2-chloro-1-isopropoxy-4-oil of mirbane
1,3-two chloro-2-methoxyl groups-4-methyl-5-nitro benzene
1-chloro-4-oxyethyl group-2-methoxyl group-5-nitro-benzene
1-butoxy-4-chloro-5-methoxyl group-2-nitro-benzene
1-chloro-2-methoxyl group-5-nitro-4-(phenyl methoxyl group) benzene (CA title)
1-chloro-4-methoxyl group-5-nitro-2-(phenyl methoxyl group) benzene (CA title)
(2,6-two chloro-4-nitro-phenoxy groups)-tert.-butyl acetate
(2,6-two chloro-4-nitro-phenoxy groups)-acetonitrile
1-chloro-4-methoxyl group-2-methyl-5-nitro-benzene
2-(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-ethanamide
2-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-ethanamide
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-acetonitrile
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-acetonitrile
4-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-butyronitrile
2-(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-ethanol
2-(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-ethanol
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-tert.-butyl acetate
(2-chloro-5-methoxyl group-4-nitro-phenoxy group)-methyl acetate
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-methyl acetate
(4-chloro-5-methoxyl group-2-nitro-phenoxy group)-tert.-butyl acetate
(2-chloro-4-nitro-phenoxy group)-acetonitrile
1-butoxy-2-chloro-4-nitro-benzene
2-chloro-4-nitro-1-(2,2,2-three fluoro-oxyethyl groups)-benzene
2-chloro-4-nitro-1-propoxy--benzene
2-chloro-1-oxyethyl group-4-nitro-benzene
1,3-two iodo-2,4-dimethoxy-5-nitro-benzene
1,3-two bromo-2,4-dimethoxy-5-nitro-benzene
3-chloro-2,4-dimethoxy-oil of mirbane
Embodiment 25 (method 5E)
[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-t-butyl carbamate
In toluene (20 milliliters) solution of (3,5-two chloro-5-hydroxyl-phenyl)-t-butyl carbamate (1.0 gram) and salt of wormwood (0.55 gram), add ethylene carbonate (1.6 gram), heated mixt is to refluxing 3 hours.Add 2.5M aqueous sodium hydroxide solution (50 milliliters) in the refrigerative reaction mixture, water, the saturated isolating organic layer of sodium chloride aqueous solution continuous washing are used anhydrous sodium sulfate drying then then.Solvent removed by evaporation at reduced pressure then with silica gel (with the hexane solution of 30% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired white foam shape product.
Embodiment 26 (method 6)
3-(2-chloro-4-nitro-phenoxy group)-1-methyl-tetramethyleneimine
In tetrahydrofuran (THF) (60 milliliters) solution of 2-chloro-4-nitrophenols (2.0 gram), add 1-methyl-3-pyrrolidinol (2.3 gram), triphenyl phosphine (6.0 gram) and diethylazodicarboxylate's (3.6 milliliters), in argon gas atmosphere, at room temperature stirred the mixture 1.5 hours.Decompression concentrated solution then with the ethyl acetate dilution, is used 10% saturated aqueous sodium hydroxide solution, water, saturated sodium chloride aqueous solution continuous washing then, uses anhydrous sodium sulfate drying.Solvent removed by evaporation at reduced pressure then, the residuum that obtains with silica gel (use ethyl acetate earlier, the dichloromethane solution of using 10% methyl alcohol again is as elutriant) chromatography.The product component that recrystallization goes out to merge from hexane obtains desired yellow solid product then.
Use said procedure and suitable parent material to prepare following compounds:
4-(2-chloro-4-nitro-phenoxy group)-1-methyl-piperidines
3-(2-chloro-4-nitro-phenoxy group)-1-methyl-tetramethyleneimine
[2-(2-chloro-4-nitro-phenoxy group)-ethyl]-dimethyl-amine
[3-(2-chloro-4-nitro-phenoxy group)-propyl group]-dimethyl-amine
Embodiment 27 (method 7A)
2-chloro-3-methoxyl group-6-nitro-phenol and 2,4-two chloro-3-methoxyl group-6-nitro-phenol
In the flask that contains 3-methoxyl group-6-nitro-phenol (0.5 gram), add aqueous sodium hypochlorite solution (5.25% aqueous solution, 21 milliliters), about 24 hours of stirring at room mixture.Cooling mixture in ice bath is used the concentrated hydrochloric acid acidifying then, then uses ethyl acetate extraction 2 times.Use the anhydrous magnesium sulfate drying organic extract.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 15% acetone as elutriant) chromatography residuum, provides one solid-state-or two-chlorating product of yellow.
Use said procedure and suitable parent material to prepare following compounds:
3-chloro-2-hydroxyl-4-methoxyl group-oil of mirbane
3,5-two chloro-2-hydroxyl-4-methoxyl group-oil of mirbane
Embodiment 28 (method 7B)
2,4-two chloro-3-methyl-6-nitro-phenol
In water (150 milliliters) solution of 3-methyl-4-nitro-phenol (5.0 gram), add aqueous sodium hypochlorite solution (5.25% aqueous solution, 230 milliliters), about 15 hours of stirring at room mixture.Add aqueous sodium hypochlorite solution (5.25% aqueous solution, 230 milliliters) once more, stirring at room mixture 2.5 days.Cooling mixture in ice bath is used the concentrated hydrochloric acid acidifying then, then uses ethyl acetate extraction 2 times.With these organic extracts of dried over mgso, solvent removed by evaporation at reduced pressure,, obtain desired yellow solid product with silica gel (using ethyl acetate) chromatography residuum as elutriant.Recrystallization obtains analytically pure sample 1 time from chloroform.
Embodiment 29 (method 7C)
1-bromo-2,4-dimethoxy-5-nitro-benzene
2, chloroform (1 milliliter) solution of dripping bromine (0.23 gram) in chloroform (3 milliliters) solution of 4-dimethoxy-oil of mirbane (0.50 gram), about 15 hours of stirring at room mixture.Chloroform (1 milliliter) solution that adds bromine (0.15 gram) once more, restir mixture 4 hours.Mixture is poured in 5% aqueous solution of sodium bisulfite then, then used chloroform extraction.Use 5% aqueous solution of sodium bisulfite then continuously, the organic extract that merges with the saturated sodium-chloride washing is used anhydrous sodium sulfate drying then then.Removal of solvent under reduced pressure, recrystallization from toluene obtains desired yellow solid product.
Embodiment 30 (method 7D)
2,4-two bromo-3-methoxyl group-6-nitro-phenol
Glacial acetic acid (3 milliliters) solution of dripping bromine (1.42 gram) in Glacial acetic acid (3 milliliters) solution of 5-methoxyl group-2-nitro-phenol (0.25 gram) and trifluoroacetic acid silver (0.49 gram), about 24 hours of stirring at room mixture.Then solution is distributed between ethyl acetate and water, organic layer is continuously with 5% aqueous solution of sodium bisulfite washing 3 times, with saturated sodium bicarbonate aqueous solution washing 3 times, with saturated sodium-chloride water solution washing 1 time.Use the anhydrous magnesium sulfate drying organic layer then, removal of solvent under reduced pressure.With silica gel (with the hexane solution of 20% ethyl acetate as elutriant) chromatography residuum, recrystallization from chloroform obtains desired orange solid-state dibrominated product then.
Embodiment 31 (method 7E)
1-iodo-2,4-dimethoxy-5-nitro-benzene
2, add two chloriodic acid benzyltrimethylammon.um (1.90 gram) and Zinc Chloride Anhydrous (1.0 gram) in Glacial acetic acid (30 milliliters) solution of 4-dimethoxy-oil of mirbane (1.0 gram), stirring at room mixture under one deck argon gas.After 5 hours, add two chloriodic acid benzyltrimethylammon.um (0.4 gram) once more, add again 1 time after 24 hours.After 24 hours, add zinc chloride (0.5 gram) and Glacial acetic acid (15 milliliters) once more.Stirring at room mixture 3 days filters then, with the dilution of 5% aqueous solution of sodium bisulfite, uses ethyl acetate extraction 3 times.Wash the organic extract of these merging with 5% sulfurous hydracid sodium water solution, saturated sodium-chloride water solution, use anhydrous magnesium sulfate drying then.Removal of solvent under reduced pressure, residuum and hexane grind altogether, obtain desired faint yellow solid-state product.
Embodiment 32 (method 7F)
2,4-two iodo-3-methoxyl group-6-nitro-phenol
In the solution of the methylene dichloride (15 milliliters) of 5-methoxyl group-2-nitro-phenol (0.25 gram) and methyl alcohol (6 milliliters), add two chloriodic acid benzyltrimethylammon.um (1.08 gram) and sodium bicarbonate (0.85 restrains), stirring at room mixture 24 hours.Filtering solution then, concentrating under reduced pressure filtrate is dissolved in ethyl acetate with residuum, then with 5% sodium bicarbonate aqueous solution, 5% sulfurous hydracid sodium water solution and saturated sodium-chloride water solution continuous washing.Behind anhydrous magnesium sulfate drying, solvent removed by evaporation at reduced pressure, recrystallization residuum from toluene obtains the acicular product of desired yellow.
Embodiment 33 (method 7G)
1-fluoro-2,4-dimethoxy-5-nitro-benzene
2, add 3 in tetrachloroethane (10 milliliters) solution of 4-dimethoxy-oil of mirbane (1.0 gram), 5-two chloro-1-fluoro-pyridine fluoroform sulphonates (85%, 5.07 gram), heated mixt to 120 ℃ 5 hours.Add 3 again, 5-two chloro-1-fluorine pyridine fluoroform sulphonates (85%, 0.25 gram) continue to stir 1 hour.Then solution is cooled to room temperature, by silicagel column (is that the hexane solution of 30% ethyl acetate is as elutriant then with hexane).Merge the product that contains component, reduction vaporization, recrystallization from hexane obtains desired brown solid product.
Embodiment 34 (method 8)
3-chloro-4-trifluoromethyl-oil of mirbane
With the N of 3-chloro-4-iodo-oil of mirbane (2.26 gram), trimethylammonium (trifluoromethyl) silane (5.68 gram), cupric iodide (I) (2.28 gram) and Potassium monofluoride (0.56 gram), dinethylformamide (8 milliliters) solution was tube sealing internal heating to 80 ℃ 40 hours.Cooling solution dilutes with ether then, filtration over celite, and water, saturated sodium-chloride water solution wash filtrate are used anhydrous sodium sulfate drying then continuously.Removal of solvent under reduced pressure with silica gel (with the hexane solution of 1% ether, the hexane solution of using 10% ethyl acetate then is as elutriant) chromatography residuum, obtains desired colorless oil product.
Embodiment 35 (method 9)
(3-chloro-4-methanesulfinyl-phenyl)-t-butyl carbamate
In methylene dichloride (15 milliliters) solution of (3-chloro-4-methylthio group-phenyl)-t-butyl carbamate (0.89 gram), add dimethyl ethylene oxide (the dimethyldioxirane) (acetone soln of~0.11M at 0 ℃, 34 milliliters), 0 ℃ stirred the mixture 1 hour.Removal of solvent under reduced pressure is dissolved in methylene dichloride with residuum, with the saturated sodium-chloride water solution washing, uses colourless dried over mgso then.Removal of solvent under reduced pressure obtains desired orange spumescence product.
Embodiment 36 (method 9B)
[4-(2-methylsulfinyl-benzoyl-amido)-phenyl]-t-butyl carbamate
At 2-methylthio group-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-add the saturated solution (5 milliliters) of sodium periodate in the solution of benzamide (234 milligrams), stirred the mixture 12 hours.The purple mixture is poured in the water, used ethyl acetate extraction, use the Anhydrous potassium carbonate drying, evaporation obtains 101 milligrams of red solid.
Use said procedure and suitable parent material to prepare following compounds:
[4-(2-methanesulfinyl-benzoyl-amido)-phenyl]-t-butyl carbamate
2-methanesulfinyl-N-[4-(2,2,2-three fluoro-acetylamino)-phenyl]-benzamide
Embodiment 37 (method 10)
(3-chloro-4-methylsulfonyl-phenyl)-t-butyl carbamate
In methylene dichloride (30 milliliters) solution of (3-chloro-4-methylthio group-phenyl)-t-butyl carbamate (0.90 gram), add dimethyl ethylene oxide (acetone soln of~0.11M, 80 milliliters) at 0 ℃, 0 ℃ stirred the mixture 1 hour.Removal of solvent under reduced pressure is dissolved in methylene dichloride with residuum, with the saturated sodium-chloride water solution washing, uses anhydrous magnesium sulfate drying then.Removal of solvent under reduced pressure obtains desired orange spumescence product.
Embodiment 38 (method 11)
3-chloro-4-vinyl-phenyl amine
In tetrahydrofuran (THF) (120 milliliters) solution of 3-chloro-4-iodo-aniline (6.95 gram), triphenylarsine (0.67 gram) and three (dibenzalacetone) palladium (0) (0.50 gram), add tributylvinyl tin (10 gram) at 50 ℃, 50 ℃ stirred the mixture under argon gas about 15 hours.Cool off reactant then, filtration over celite, reduction vaporization filtrate is to doing.Residuum is dissolved in hexane, then with 5% aqueous hydrochloric acid extraction 3 times.Use these acid extraction thing aqueous solution of solid-state carbonic acid potashization then, and with ethyl acetate extraction 3 times.Wash the organic extract of these merging then with saturated sodium-chloride water solution, use anhydrous magnesium sulfate drying, removal of solvent under reduced pressure.Residuum with silica gel (hexane, the hexane solution that is 10% ethyl acetate then is as elutriant) chromatography obtains obtains desired amber oily product.
Embodiment 39 (method 12)
[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS-ethyl ester
(3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS-ethyl ester (2.6 gram) is added in the water (7 milliliters) and tetrahydrofuran (THF) (5.25 milliliters) solution of mercuric acetate (3.48 gram), stirred the mixture about 15 hours.Add the solution of the 3N aqueous sodium hydroxide solution (8.7 milliliters) of 3N aqueous sodium hydroxide solution (8.7 milliliters) and 0.5M sodium borohydride then, then stirred 6 hours.Use sodium chloride saturated solution then, use ethyl acetate extraction.Wash these organic extracts with saturated sodium-chloride water solution then, and use anhydrous sodium sulfate drying.Removal of solvent under reduced pressure with silica gel (with the hexane solution of 20% ethyl acetate as elutriant) chromatography residuum, obtains desired white solid state product.
Embodiment 40 (method 13)
[3-chloro-4-(2-hydroxyl-ethyl)-phenyl]-t-butyl carbamate
In the stirring suspension of the tetrahydrofuran (THF) (13 milliliters) of sodium borohydride (0.45 gram),, stirred the mixture 1 hour at 0 ℃ at 0 ℃ of adding Glacial acetic acid (0.75 milliliter).Then with the solution temperature to room temperature, add (3-chloro-4-vinyl-phenyl)-carboxylamine 2-TMS-ethyl ester (1.0 gram).About 15 hours of stirring at room reactant is heated to then and refluxed about 20 hours.Cooling mixture then adds the solution of 5N aqueous sodium hydroxide solution (0.80 milliliter) and 30% aqueous hydrogen peroxide solution (0.56 milliliter).After stirring 15 hours once more, separating layer is used extracted with diethyl ether water layer 3 times, uses the anhydrous magnesium sulfate drying organic extract.After the removal of solvent under reduced pressure,, obtain desired amber oily product with silica gel (with the hexane of 40% ethyl acetate as elutriant) chromatography residuum.
Embodiment 41 (method 14)
[4-(1-azido--ethyl)-3-chloro-phenyl]-carboxylamine 2-TMS-ethyl ester
In tetrahydrofuran (THF) (20 milliliters) solution of [3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-carboxylamine 2-TMS-ethyl ester (1.25 gram), at 0 ℃, under argon gas, add triphenyl phosphine (2.6 gram), the hydrazoic acid (dichloromethane solution of about 2.5 molar equivalents, according to Fieser and Fierser, Reagents for Organic Synthesis, Vol.1, pg.446; Wiley, the method preparation of New York) and diethylazodicarboxylate's (1.72 gram).After about 10 minutes, removal of solvent under reduced pressure with silica gel (with the hexane solution of 5% ethyl acetate as elutriant) chromatography residuum, obtains desired colorless oil product.
Embodiment 42 (method 15)
[3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate
In the deoxidation solution of the triethylamine (120 milliliters) of (3-chloro-4-iodo-phenyl)-t-butyl carbamate (10.0 gram), add 1-dimethylamino-2-propine (2.82 gram), chlorination two (triphenyl phosphine) palladium (II) (0.4 gram) and cuprous iodide (0.054 gram).Under the argon gas, about 6 hours of stirring at room mixture, short period of time heating (about 10 minutes) is to 60 ℃ then.Reaction mixture then, filtration over celite, solvent removed by evaporation at reduced pressure.Residuum is dissolved in ethyl acetate, washes with water 3 times,, use anhydrous magnesium sulfate drying with saturated sodium-chloride water solution washing 1 time.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 80% ethyl acetate as elutriant) chromatography residuum, obtains the amber oily product of purifying, and it solidifies in placement.
Use said procedure and suitable parent material to prepare following compounds:
[3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate
[3-(4-methoxyl group-phenyl)-Propargyl]-dimethyl-amine
4-(3-dimethylamino-third-1-alkynyl)-benzonitrile
Dimethyl-[3-(4-nitro-phenyl)-Propargyl]-amine
Embodiment 43 (method 16)
[3-chloro-4-(3-dimethylamino-acryl)-phenyl]-t-butyl carbamate
In the freezing solution of the methylene dichloride (30 milliliters) of [3-chloro-4-(3-dimethylamino-third-1-alkynyl)-phenyl]-t-butyl carbamate (4.0 gram), divide and add 3-chlorine peroxybenzoic acid (2.34 gram) in a small amount.0 ℃ of reaction stirred is after 20 minutes, with the alkali alumina (Brockmann Grade I, 150 orders) of mixture by 20 weight equivalents, with the dichloromethane solution wash-out N-oxide compound of 5% methyl alcohol.Merge the component that all contain desired amine n-oxide, reduction vaporization is to approaching dry.Handle 3 times with small portion methyl alcohol (about 50 milliliters) continuously, reduction vaporization is adjusted to 250 milliliter by adding methyl alcohol with liquor capacity near dry then.Methanol solution with the N-oxide compound is heated to about 15 hours of backflow then, cooling then, and solvent evaporated under reduced pressure is to doing.With silica gel (with the hexane solution of 80% ethyl acetate as elutriant) chromatography residuum, obtain desired faint yellow solid-state product.
Embodiment 44 (method 17)
(3-chloro-4-isoxazole-5-base-phenyl)-t-butyl carbamate
Handle [3-chloro-4-(3-dimethylamino-acryl-phenyl]-t-butyl carbamate (270 milligrams of) De dioxs (3 milliliters) solution, stirring at room mixture 10 days with oxammonium hydrochloride (122 milligrams).With ethyl acetate diluted mixture thing, water, 5% sodium bicarbonate aqueous solution, saturated sodium-chloride water solution continuous washing are used anhydrous magnesium sulfate drying.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 33% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired colourless solid product.
Embodiment 45 (method 18)
[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-t-butyl carbamate
With ethanol (1.25 milliliters) solution of hydrazine hydrate (0.25 milliliter) processing [3-chloro-4-(3-dimethylamino-acryl)-phenyl]-t-butyl carbamate (250 milligrams), stirring at room mixture 3 hours.Use 30 milliliters of ether diluted mixture things then, wash with water 3 times,, use anhydrous magnesium sulfate drying with saturated sodium-chloride water solution washing 1 time.Solvent removed by evaporation at reduced pressure with silica gel (with the hexane solution of 67% ethyl acetate as the elutriant) residuum that chromatography obtains, obtains desired oily product.
Embodiment 46 (method 19A)
N-(2-chloro-4-nitrophenyl)-2-thiomorpholine-4-base-ethanamide
In tetrahydrofuran (THF) (50 milliliters) solution of N-(chloracetyl)-2-chloro-4-N-methyl-p-nitroaniline (3.80 gram), add thiomorpholine (10 milliliters), placed solution 1 hour.Reaction mixture is poured in the water, collected faint yellow solid, recrystallization from the 2-propyl alcohol of heat obtains faint yellow crystalline solid then.
Use said procedure and suitable parent material to prepare following compounds:
(4-{2-[two-(2-hydroxyl-ethyl)-amino]-acetylamino }-phenyl)-t-butyl carbamate
[4-(2-dimethylamino-acetylamino)-phenyl]-t-butyl carbamate
4-[3-(2-dimethylamino-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
4-[3-(2-morpholine-4-base-oxyethyl group)-benzoyl-amido]-phenyl }-t-butyl carbamate
N-(2-chloro-4-nitro-phenyl)-2-dimethylamino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-piperidines-1-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-morpholine-4-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-dipropyl amino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-thiomorpholine-4-base-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-diethylamino-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-tetramethyleneimine-1-base-ethanamide
2-nitrogen heterocyclic heptan-1-base-N-(2-chloro-4-nitro-phenyl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(2-methyl-piperidines-1-yl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(3-methyl-piperidines-1-yl)-ethanamide
N-(2-chloro-4-nitro-phenyl)-2-(4-methyl-piperidines-1-yl)-ethanamide
Embodiment 47 (method 19B)
N-(2-chloro-4-nitrophenyl)-2-(2-dimethylamino ethylmercapto group) ethanamide
At the N of N-(acetyl chloride base)-2-chloro-4-N-methyl-p-nitroaniline (3.01 gram), add powdered sodium carbonate (6.0 gram) and 2-dimethylaminoethyl thiolate hydrochlorate (6.0 gram) in the solution of dinethylformamide (100 milliliters).25 ℃ stirred the mixture 1 hour, poured in the water, used ethyl acetate extraction.With the dry ethyl acetate solution of Anhydrous potassium carbonate, concentrating under reduced pressure obtains oil.From toluene-hexane (3: 1) recrystallization, obtain faint yellow solid-state crystalline solid.
Embodiment 48 (method 20)
(4-tert-butoxycarbonyl amino-2-chloro-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester
1, in methylene dichloride (40 milliliters) suspension of 1-carbonyl-two-(1,2,4)-triazole (4.0 gram) with methylene dichloride (45 milliliters) solution that was added dropwise to (4-amino-3-chloro-phenyl) t-butyl carbamate (5.0 restrain) in 20 minutes.Stirring at room mixture 30 minutes forms precipitation at this time point.In this mixture, add piperidines ethanol (6.6 milliliters) and tetrahydrofuran (THF) (20 milliliters), to keep homogeneous phase.After reflux was spent the night, the cooling reactant was poured in the water then, separates organic layer, washs with saturated sodium-chloride water solution then.Use anhydrous sodium sulfate drying solution, filter and concentrating under reduced pressure, obtain thick oil,, obtain desired white foam shape product with silica gel (with the dichloromethane solution of 5% methyl alcohol as elutriant) chromatography purification.
Embodiment 49 (method 21)
5-phenyl-[1,2,3] thiadiazoles-4-carboxylate methyl ester
Handle acetonitrile (10 milliliters) solution of ethyl benzoylacetate (1.1 gram) with 4-Methyl benzenesulfonyl nitrine (1.3 gram) and triethylamine (1.6 gram).After the stirred overnight at room temperature, the concentrating under reduced pressure reactant, the crude product that obtains with acetic acid ethyl dissolution, and wash with 1N sodium hydroxide.Use the anhydrous magnesium sulfate drying organic layer then, filter and concentrating under reduced pressure, obtain yellow oil.Dissolve this oil with methylene dichloride, filter hydrated magnesium silicate, use the methylene dichloride wash-out, obtain partially purified colorless oil diazo-ketones.To be dissolved in toluene (25 milliliters) from the diazo-ketones sample (1.2 gram) that obtains, with 2,4-two (4-p-methoxy-phenyl)-1,3-dithia-2,4-two phosphorus heterocycle butane-2,4-disulphide (2.8 gram) is handled, and the reacting by heating thing is to refluxing.After 3 hours, reactant is cooled to room temperature, is added on the silicagel pad, use the methylene dichloride wash-out.After the removal of solvent under reduced pressure, with silica gel (with the petroleum ether solution of 30% ether as elutriant) chromatography, the oil that purifying obtains, recrystallization from hexane obtains desired faint yellow needle-like product then.
Use said procedure and suitable parent material to prepare following compounds:
5-phenyl-[1,2,3] thiadiazoles-4-carboxylic acid, ethyl ester
5-methyl-[1,2,3] thiadiazoles-4-carboxylate methyl ester
Embodiment 50
The ethyl benzoylacetate Urea,amino-
Ethyl benzoylacetate (5.0 gram) is dissolved in methyl alcohol (10 milliliters), is added to rapidly in water (13 milliliters) solution of hot carbamylhydrazine hydrochloride (29 gram).In this solution, add pyridine (4.1 gram), be heated to then and refluxed 5 minutes, reaction mixture is cooled to-20 ℃ and spends the night.Filter and collect the solid semicarbazone that obtains, wash with water, with the ether washing, obtain desired white crystalline product then.
Use said procedure and suitable parent material to prepare following compounds:
(Z)-and the 3-[(aminocarboxyl) hydrazone group]-4,4,4-trifluoroacetic acid ethyl ester
3-[(Z)-2-(aminocarboxyl) hydrazone group]-3-phenylpropionic acid ethyl ester
3-[(E)-2-(aminocarboxyl) hydrazone group]-3-(3-furyl) ethyl propionate
Embodiment 51
5-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
0 ℃ of pure thionyl chloride (5 milliliters) solution that stirs ethyl benzoylacetate semicarbazone (2.5 gram) 1 hour.Add methylene dichloride (25 milliliters) then, slowly destroy excessive thionyl chloride with saturated sodium bicarbonate aqueous solution.The precipitation that forms when removing by filter cancellation is used dichloromethane extraction filtrate.Organic extract with anhydrous magnesium sulfate drying merges filters and concentrating under reduced pressure.With silica gel (with the dichloromethane solution of 50% hexane as elutriant) chromatography, obtain desired colorless oil product.
Use said procedure and suitable parent material to prepare following compounds:
4-methyl-[1,2,3] thiadiazoles-5-carboxylate methyl ester
4-phenyl-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid, ethyl ester
Embodiment 52
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid
4-methyl-[1,2,3] thiadiazoles-5-carboxylate methyl ester (1.7 gram) is dissolved in methyl alcohol (15 milliliters), and handles with 1N sodium hydroxide (16 milliliters).After the stirring at room 1 hour, with concentrated hydrochloric acid (1.5 milliliters) processing reaction thing, and concentrating under reduced pressure.The muddy water layer that obtains with extracted with diethyl ether 2 times, the organic layer with anhydrous magnesium sulfate drying merges filters, and concentrating under reduced pressure, obtains desired white powder compound.
Use said procedure and suitable parent material to prepare following compounds:
3-ethoxycarbonyl methoxy-phenylformic acid
5-furans-3-base-[1,2,3] thiadiazoles-4-carboxylic acid
The thiazole-4-carboxylic acid
4-methyl-[1,2,3] thiadiazoles-5-carboxylic acid
5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid
Embodiment 53 (method 25)
Three fluoro-methylsulfonic acid 4-chloro-5-methoxyl group-2-nitro phenyl esters
In the solution of the methylene dichloride (150 milliliters) of 4-chloro-5-methoxyl group-2-nitrophenols (6.5 gram), at 0 ℃, under argon gas, add triethylamine (10 gram), add methylene dichloride (30 milliliters) solution of trifluoromethanesulfanhydride anhydride (13.5 gram) then.0 ℃ of stirred solution 10 minutes is then with the methylene dichloride dilution, with saturated sodium bicarbonate aqueous solution and saturated sodium-chloride water solution washing.Behind anhydrous sodium sulfate drying, solvent removed by evaporation at reduced pressure is dissolved in the hexane solution of 20% methylene dichloride with residuum, and by magnesium silicate hydrate short column (with the hexane solution of 20% methylene dichloride as elutriant).Merge the product that contains component, solvent removed by evaporation at reduced pressure obtains desired yellow oil product.
Use said procedure and suitable parent material to prepare following compounds:
Three fluoro-methylsulfonic acid 4-chloro-5-methoxyl group-2-nitro-phenyl esters
Three fluoro-methylsulfonic acid 4-chloro-2-nitro-phenyl esters
Three fluoro-methylsulfonic acid 2-chloro-6-nitro-phenyl esters
Embodiment 54 (method 26)
[4-(3-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
1: 2 tetrahydrofuran (THF)-methyl alcohol (15 milliliters) solution of stirring [4-(3-amino-benzoyl-amido)-phenyl]-t-butyl carbamate (505 milligrams), sodium cyanoborohydride (250 milligrams), acetate (3) and 40% formalin (4 milliliters) 15 minutes; pour into then in the saturated sodium bicarbonate aqueous solution, be extracted into ethyl acetate.With the dry ethyl acetate solution of Anhydrous potassium carbonate, concentrating under reduced pressure obtains solid, uses the acetonitrile recrystallization, obtains rose pink crystalline solid.
Use said procedure and suitable parent material to prepare following compounds:
[4-(3-dimethylamino-benzoyl-amido)-phenyl]-t-butyl carbamate
(3-bromo-5-trifluoromethyl-phenyl)-dimethyl-amine
N-(3-chloro-5-dimethylamino-phenyl)-ethanamide
Embodiment 55 (method 27)
N-(4-aminophenyl)-2-hydroxybenzamide
In methyl alcohol (10 milliliters) solution of acetate 2-(4-aminophenyl formamyl) phenyl ester (580 milligrams), add saturated sodium bicarbonate (2 milliliters) and water (3 milliliters).Mixture 80 ℃ of heating 30 minutes, is poured in the half saturated sodium chloride aqueous solution then, used ethyl acetate extraction.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains oil, then should oil and ether grind altogether, obtain desired white solid state product.
Embodiment 56 (method 28)
[4-(3-(hydroxy benzoyl amino) phenyl) } t-butyl carbamate
In methyl alcohol (75 milliliters) solution of acetate 3-(4-aminophenyl formamyl) phenyl ester (4.34 gram), add 0.1N aqueous sodium hydroxide solution (25 milliliters) and tetrahydrofuran (THF) (25 milliliters).40 ℃ were heated this solution 30 minutes, and cooling is poured in the 1M hydrochloric acid, and used ethyl acetate extraction then.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains white solid, and it is further by grinding purifying altogether with ether.
Embodiment 57 (method 29)
N-(4-aminophenyl)-2-hydroxymethyl benzamide
Add lithium borohydride (1.0 gram) in tetrahydrofuran (THF) (4 milliliters) solution of N-(4-aminophenyl) phthalic imidine (332 milligrams), 25 ℃ were stirred this mixture 1 hour.Mixture is poured in the water, used ethyl acetate extraction.Use the anhydrous sodium sulfate drying ethyl acetate solution, concentrating under reduced pressure obtains white foam, when it and ether grind altogether, obtains desired white powder product.
Embodiment 58 (method 30)
(3-chloro-5-dimethylamino-phenyl)-t-butyl carbamate
In toluene (10 milliliters) solution of (3-amino-5-chloro-phenyl)-t-butyl carbamate (0.32 gram), add formalin (37%, 1.5 milliliter), add 10% palladium carbon (0.50 gram) then, under hydrogen, stirred the mixture about 15 hours.Then with the solution filtration over celite, concentrating under reduced pressure filtrate.With silica gel (with the hexane solution of 50% methylene dichloride as elutriant) chromatography residuum, obtain desired white solid state product.
Embodiment 59 (method 35)
N-(4-{3-[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
At acetate 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2; 6-two chloro-phenoxy groups }-add 1N aqueous sodium hydroxide solution (1 milliliter), about 2 hours of stirring at room mixture in 1: 1 tetrahydrofuran (THF) of ethyl ester (0.16 gram) and the mixture solution of methyl alcohol (2.5 milliliters).Then solution is poured in the 2M aqueous hydrochloric acid (3 milliliters), be extracted into ethyl acetate, use anhydrous sodium sulfate drying.Solvent removed by evaporation at reduced pressure with residuum and ether azeotropic, obtains desired white solid state product.
Embodiment 60 (method 36)
4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-acetate
In the mixture solution of 1: 1 tetrahydrofuran (THF) of { 4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl acetate (0.29 gram) and methyl alcohol (4 milliliters), add 1N sodium hydroxide (2 milliliters), about 2 hours of stirring at room mixture.Then solution is poured in the 2M aqueous hydrochloric acid (5 milliliters), be extracted into ethyl acetate, use the anhydrous sodium sulfate drying extract.Solvent removed by evaporation at reduced pressure is ground residuum and ether altogether, obtains desired white solid state product.
Use said procedure and suitable parent material to prepare following compounds:
4-[3-(4-acetylamino-phenyl) thioureido] and-2,6-two chloro-phenoxy groups }-acetate
2-[3-(4-acetylamino-phenyl) thioureido]-4-chloro-5-methoxyl group-phenoxy group }-acetate
4-[3-(4-acetylamino-phenyl) thioureido]-2-chloro-5-methoxyl group-phenoxy group }-acetate
Embodiment 61 (method 37)
Phenylformic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2, the 6-dichlorophenoxy }-ethyl ester
At N-(4-{3-[3,5-dichloro-4,4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-add Benzoyl chloride (0.08 restrains) in the pyridine (2 milliliters) of ethanamide (0.20 gram) and the ice-cold solution of tetrahydrofuran (THF) (0.5 milliliter), 0 ℃ stirred the mixture 1.5 hours.Use ethyl acetate diluted mixture thing then,,, use anhydrous sodium sulfate drying then with saturated sodium-chloride water solution washing 1 time with 2% salt acid elution 2 times.After the removal of solvent under reduced pressure, with silica gel (with the dichloromethane solution of 5% methyl alcohol as elutriant) chromatography residuum, merging contains the branch that washes out of product, reduction vaporization, and recrystallization residuum from acetone-hexane obtains desired white powder product.
Embodiment 62 (method 38)
Methylsulfonic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester
At N-(4-{3-[3,5-two chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-add methylsulfonyl chloride (0.11 restrains) in the pyridine (2 milliliters) of ethanamide (0.20 gram) and the ice-cold solution of tetrahydrofuran (THF) (0.5 milliliter), 0 ℃ stirred the mixture 45 minutes.Use ethyl acetate diluted mixture thing then,,, use anhydrous magnesium sulfate drying then with saturated sodium-chloride water solution washing 1 time with 2% salt acid elution 2 times.After the solvent removed by evaporation at reduced pressure, recrystallization residuum from acetone-hexane obtains desired white powder product.
Embodiment 63 (method 39)
N-(4-{3-[3,5-two chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
At methylsulfonic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2, the 6-dichlorophenoxy }-add dimethylamine agueous solution (8.8M, 0.5 milliliter), stirring at room mixture 5 days in tetrahydrofuran (THF) (6 milliliters) solution of ethyl ester (0.33 gram).Use ethyl acetate diluted mixture thing then,, use anhydrous magnesium sulfate drying with the saturated sodium-chloride water solution washing.After the removal of solvent under reduced pressure, with silica gel (with pure methyl alcohol as elutriant) chromatography residuum.The branch that washes out that contains product that reduction vaporization merges, recrystallization residuum from acetonitrile obtains desired white powder product.
Use said procedure and suitable parent material to prepare following compounds:
N-(4-{3-[3,5-two chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide
Phenylformic acid 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester
Embodiment 64 (method 40)
Furans-2-carboxylic acid (4-{3-[4-(1-amino-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides
In methyl alcohol (2.5 milliliters) solution of two hydration tin chlorides (II) (0.25 gram), add furans-2-carboxylic acid (4-{3-[4-(1-azido--ethyl)-3-chloro-phenyl]-thioureido-phenyl)-acid amides (0.22 gram), stirred solution is about 15 hours under the room temperature.Use the ethyl acetate diluting soln, with saturated sodium bicarbonate aqueous solution, saturated sodium-chloride water solution washing, use anhydrous sodium sulfate drying then continuously.After the solvent removed by evaporation at reduced pressure,, obtain desired yellow solid product with silica gel (with the dichloromethane solution that contains 1% triethylamine of 8% methyl alcohol as elutriant) chromatography residuum.
Embodiment 65 (method 41)
[1,2,3] thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
1,1 '-add tetrahydrofuran (THF) (100 milliliters) solution of [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (9.0 gram) in the freezing solution of the tetrahydrofuran (THF) (50 milliliters) of thio-carbonyldiimidazole (7.28 gram).After about 1 hour, evaporation removes and desolvates, and residuum is dissolved in ethyl acetate.Add ether and precipitate crude product, collect crude product by filtering then, be dissolved in methylene dichloride, by the hydrated magnesium silicate pad.Except that after desolvating, go out residuum with ethyl acetate-hexane recrystallization, obtain desired faint yellow solid-state product.
Use said procedure and suitable parent material to prepare following compounds:
2-fluoro-N-(4-isothiocyanic acid base-phenyl)-benzamide
Furans-2-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
[1,2,3] thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
Thiadiazoles-4-carboxylic acid (4-isothiocyanic acid base-phenyl)-acid amides
Embodiment 66 (method 42)
N, N-dimethyl-5-trifluoromethyl-benzene-1,3-diamines
Tetrahydrofuran solution (the 2M that in tetrahydrofuran (THF) (2 milliliters) solution of the degassing (argon) of 3-amino-5-bromo-phenylfluoroform (1.0 gram), adds two-(three-adjacent toluene phosphino-) palladiums (0.15 gram), dimethyl amine, 4.2 milliliter) and the tetrahydrofuran solution (1M, 10.4 milliliters) of two (TMS) lithamide.In sealed vessel, reaction mixture is heated to 100 ℃, about 2.5 hours, finishes reaction.Cooling mixture adds entry and comes the cancellation reaction to room temperature then, dilutes with ethyl acetate.Extraction product 3 times, in 5% hydrochloric acid, cooling on one side then is Yi Bian add the acid extraction thing that the alkalization of 5N aqueous sodium hydroxide solution merges.With this basic solution of ethyl acetate extraction, with the organic extract that the saturated sodium-chloride water solution washing merges, use anhydrous magnesium sulfate drying then, reduction vaporization is to doing.With silica gel (with the hexane solution of 20-30% ethyl acetate as the elutriant) residuum that chromatography obtains, obtain desired light brown solid product.
Use said procedure and suitable parent material to prepare following compounds:
3-(4-methyl-piperazine-1-yl)-5-trifluoromethyl-phenyl amine
3-morpholine-4-base-5-trifluoromethyl-phenyl amine
3-piperidines-1-base-5-trifluoromethyl-phenyl amine
3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl amine
N, N-dimethyl-5-trifluoromethyl-benzene-1,3-diamines
N-isobutyl--N-methyl-5-trifluoromethyl-benzene-1, the 3-diamines
N-butyl-N-methyl-5-trifluoromethyl-benzene-1, the 3-diamines
Embodiment 67 (method 43)
(3-isobutyl--5-trifluoromethyl-phenyl)-t-butyl carbamate
Bubbling fed iso-butylene about 5 minutes in the sealing test tube that contains tetrahydrofuran (THF) (5 milliliters) (envelope has the rubber diaphragm separator plug, and cools off in dry ice acetone bath).The tetrahydrofuran solution (0.5M, 11 milliliters) that adds assorted two ring [3.3.1] nonanes of 9-boron with tetrafluoroethylene cap closure container, is slowly to warm to room temperature, at room temperature is incubated about 2.5 hours.Again cooling mixture in dry ice-propanone is bathed replaces the tetrafluoroethylene cap with the diaphragm of rubber plug then, on one side exhaust, the argon gas bubbling is fed mixture on one side, remove excessive iso-butylene.Tetrahydrofuran (THF) (12 milliliters) solution that adds (3-bromo-5-trifluoromethyl-phenyl)-t-butyl carbamate (1.7 gram), add [1 then, 1 '-two (diphenylphosphino)-ferrocene] Palladous chloride (II)-methylene dichloride mixture (0.12 gram), add the 3N aqueous sodium hydroxide solution then.Use tetrafluoroethylene cap sealed vessel once more, be heated to then 65 ℃ about 15 hours.Then mixture is cooled to room temperature, with the hexane dilution, anhydrous magnesium sulfate drying is used in water, saturated sodium-chloride water solution washing, and reduction vaporization.With silica gel (with the hexane solution of 5% ethyl acetate as the elutriant) oil that chromatography obtains, obtain desired white powder product.
Use said procedure and suitable parent material to prepare following compounds:
[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-t-butyl carbamate
(3-isobutyl--5-trifluoromethyl-phenyl)-t-butyl carbamate
Embodiment 68 (method 44)
2-(3,5-two chloro-thiophenyls)-ethylamine
Add 0.61 milliliter of 10M dimethyl thioether borane complexes in 3.0 milliliters of ethylene glycol dimethyl ether solutions of (3,5-dichlorobenzene sulfenyl) acetonitrile (1.2 gram), heated mixt is to refluxing 0.5 hour.In ice bath, cool off reactant, add 2.0 ml waters and 2.0 milliliters of concentrated hydrochloric acids.Heat this compound to refluxing 0.5 hour.Cool off then and, use extracted with diethyl ether with 5N sodium hydroxide alkalization settled solution.With the dry ether extract of salt of wormwood, filter and concentrate, obtain 1.0 gram water white oils.
Use said procedure and suitable parent material to prepare following compounds:
2-(3-bromo-thiophenyl)-ethylamine
2-(4-bromo-phenoxy group)-ethylamine
2-(4-iodo-phenoxy group)-ethylamine
2-(3,4-two chloro-phenoxy groups)-ethylamine
2-(3-chloro-thiophenyl)-ethylamine
2-(3,4-two chloro-thiophenyls)-ethylamine
3-(4-bromo-phenyl)-propyl group amine
2-(2-fluoro-phenoxy group)-ethylamine
2-(2-chloro-phenoxy group)-ethylamine
2-(3-bromo-phenoxy group)-ethylamine
2-(3-fluoro-phenoxy group)-ethylamine
2-(3-iodo-phenoxy group)-ethylamine
2-(3,5-two chloro-thiophenyls)-ethylamine
2-thiophenyl-ethylamine
1-(2-chloro-phenyl)-ethylamine
Embodiment 69 (method 45)
N-(1-naphthalene-2-base-ethyl)-methane amide
In the mixture of 190 ℃ of heating 2 acetyl naphthalenes (3.0 gram), ammonium formiate (11.0 gram), formic acid (3.3 milliliters) and methane amide (3.5 milliliters) 3 hours.Cooling mixture is poured in the water, uses extracted with diethyl ether.With the dry ether extract of Anhydrous potassium carbonate, filter, concentrate, obtain yellow oil, it obtains white solid from toluene-hexane recrystallization, 1.97 grams.
Use said procedure and suitable parent material to prepare following compounds:
N-[1-(4-fluoro-phenyl)-2-methyl-propyl group]-methane amide
N-(1-naphthalene-2-base-ethyl)-methane amide
Embodiment 70 (method 46)
1-(2-naphthyl) ethylamine
The mixture of heating N-(1-naphthalene-2-base-ethyl)-methane amide (1.12 gram), ethanol (10 milliliters) and 5N sodium hydroxide (10 milliliters) is to refluxing 1 hour.Cooling mixture is poured in the water, uses extracted with diethyl ether.With the dry ethereal solution of Anhydrous potassium carbonate, filter and concentrate, obtain faint yellow oily product (0.95 gram).
Use said procedure and suitable parent material to prepare following compounds:
1-(3-trifluoromethyl-phenyl)-ethylamine
1-(4-fluoro-phenyl)-2-methyl-propyl group amine
[3-(1-amino-ethyl)-phenyl]-dimethyl-amine
3-(1-amino-ethyl)-benzonitrile
Embodiment 71 (method 47)
1-(3-trifluoromethyl-phenyl)-ethyl ketone (ethenone) O-methyl-oxime
Methoxy-amine hydrochloride (2.33 gram) is added to 3 '-ethanol (20 milliliters) and pyridine (2 milliliters) solution of (trifluoromethyl)-acetylbenzene (1.5 gram).Heated solution is to refluxing 45 minutes, reaction mixture then, and concentrating under reduced pressure distributes between water and ethyl acetate.Use the ethyl acetate extraction water layer.With the organic layer that the saturated sodium-chloride water solution washing merges, use anhydrous magnesium sulfate drying, and concentrating under reduced pressure, obtain desired colorless oil product (1.61 gram).
Use said procedure and suitable parent material to prepare following compounds:
3,5-di-trifluoromethyl-benzaldoxime
1-(4-fluoro-phenyl)-third-1-ketone O-methyloxime
1-(2-chloro-phenyl)-ethyl ketone O-methyloxime
1-(3-bromo-phenyl)-ethyl ketone O-methyloxime
1-(3-chloro-phenyl)-ethyl ketone O-methyloxime
1-p-methylphenyl-ethyl ketone O-methyloxime
1-(4-fluoro-phenyl)-penta-1-ketone O-methyloxime
1-(4-fluoro-phenyl)-2-phenyl-ethyl ketone O-methyloxime
1-o-tolyl-ethyl ketone O-methyloxime
Tolyl between 1--ethyl ketone O-methyloxime
1-(2-fluoro-phenyl)-ethyl ketone O-methyloxime
3-(1-methoxyimino-ethyl)-benzonitrile
4-(1-methoxyimino-ethyl)-benzonitrile
1-(4-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(2-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(4-dimethylamino-phenyl)-ethyl ketone O-methyloxime
1-(2-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-(3-methoxyl group-phenyl)-ethyl ketone O-methyloxime
1-(3-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-(4-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-furans-2-base-ethyl ketone O-methyloxime
1-pyridin-4-yl-ethyl ketone O-methyloxime
1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethyl ketone O-methyloxime
1-thiene-3-yl-O-methyloxime
(4-fluoro-phenyl)-phenyl-ketone O-methyloxime
1-(4-p-methoxy-phenyl) ethyl ketone O-methyloxime
1-(3-chloro-4-methoxyl group-phenyl)-ethyl ketone O-methyloxime
4-(1-methoxyimino-ethyl)-benzsulfamide
4-(1-methoxyimino-ethyl)-N, N-dimethyl-benzene sulfanilamide (SN)
1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethyl ketone O-methyloxime
4-(1-methoxyl group-ethyl)-N, N-dipropyl-benzsulfamide
2-fluoro-N-[4-(1-methoxyimino-ethyl)-phenyl]-benzamide
1-(3,5-di-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime
1-[4-(1H-imidazoles-1-yl)-phenyl]-1-ethyl ketone O-methyloxime
1-[4-(trifluoromethyl)-phenyl]-1-ethyl ketone O-methyloxime
1-[1,1 '-xenyl]-4-base-1-ethyl ketone O-methyloxime
1-(4-aminomethyl phenyl)-1-ethyl ketone O-methyloxime
1-[4-fluoro-3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[3,5-two (trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[4-chloro-3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[3-fluoro-5-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-fluoro-4-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-fluoro-5-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(2,4 dichloro benzene base) ethyl ketone O-methyloxime
1-(2, the 4-3,5-dimethylphenyl) ethyl ketone O-methyloxime
1-[2,4-two (trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3-bromophenyl) ethyl ketone O-methyloxime
1-(3-aminomethyl phenyl) ethyl ketone O-methyloxime
1-[4-(4-morpholinyl) phenyl] ethyl ketone O-methyloxime
1-(2-chloro-4-fluorophenyl) ethyl ketone O-methyloxime
1-(4-bromo-2-fluorophenyl) ethyl ketone O-methyloxime
1-(3, the 4-difluorophenyl) ethyl ketone O-methyloxime
1-[3-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-[2-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(2,4 difluorobenzene base) ethyl ketone O-methyloxime
1-[3-fluoro-4-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3, the 4-dichlorophenyl) ethyl ketone O-methyloxime
1-[4-fluoro-2-(trifluoromethyl) phenyl] ethyl ketone O-methyloxime
1-(3-chloro-4-fluorophenyl) ethyl ketone O-methyloxime
1-(4-chloro-3-fluorophenyl) ethyl ketone O-methyloxime
1-(2, the 5-difluorophenyl) ethyl ketone O-methyloxime
1-(2-bromo-4-fluorophenyl) ethyl ketone O-methyloxime
1-(3, the 4-dibromo phenyl) ethyl ketone O-methyloxime
1-(2-bromophenyl) ethyl ketone O-methyloxime
Embodiment 72 (method 48)
1-(2-trifluoromethyl-phenyl)-ethylamine
Sodium borohydride (1.17 gram) slowly is added in the flask of tetrahydrofuran (THF) (27 milliliters) solution that contains zirconium tetrachloride (1.8 gram).The solution that tetrahydrofuran (THF) (7.7 milliliters) solution that adds 1-(2-trifluoromethyl-phenyl)-ethyl ketone O-methyloxime (1.34 gram), 25 ℃ of stirrings obtain 12 hours.Reaction mixture is chilled to 0 ℃ then, slowly adds entry (16 milliliters).Add the excessive hydrogen ammonium oxide, use ethyl acetate extraction solution 2 times.With 1N salt acid elution organic layer 2 times.With alkalize water (acid) layer of sodium hydroxide, with ethyl acetate extraction 2 times.Wash organic layer with saturated sodium-chloride water solution then, and use anhydrous magnesium sulfate drying.Removal of solvent under reduced pressure obtains desired yellow oil product (0.20 gram).
Use said procedure and suitable parent material to prepare following compounds:
1-(3-methoxyl group-phenyl)-ethylamine
1-(4-fluoro-phenyl)-propyl group amine
1-naphthalene-2-base-ethylamine
4-(1-amino-ethyl)-benzonitrile
1-(4-trifluoromethyl-phenyl)-ethylamine
1-(4-methoxyl group-phenyl)-ethylamine
1-propine-2-base-tetramethyleneimine
1-(2-methoxyl group-phenyl)-ethylamine
Tolyl-ethylamine between 1-
1-(2-bromo-phenyl)-ethylamine
1-o-tolyl-ethylamine
C-(4-fluoro-phenyl)-C-phenyl-methylamine
1-(4-fluoro-phenyl)-amylamine
1-(4-fluoro-phenyl)-2-phenyl-ethylamine
1-(2-trifluoromethyl-phenyl)-ethylamine
1-(3-bromo-phenyl)-ethylamine
1-(3-chloro-phenyl)-ethylamine
[4-(1-amino-ethyl)-phenyl]-dimethyl-amine
1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethylamine
1-[3,5-two (trifluoromethyl) phenyl] propyl group amine
1-[3,5-two (trifluoromethyl) phenyl]-1-butylamine or 1-[3,5-two (trifluoromethyl)-phenyl] butylamine
1-[3,5-two (trifluoromethyl) phenyl]-the 1-amylamine
1-(4-aminomethyl phenyl) ethamine
1-[3-(trifluoromethyl) phenyl] ethylamine
1-[4-(trifluoromethyl) phenyl] ethylamine
1-(3-aminomethyl phenyl) ethamine
1-(3, the 4-dichlorophenyl) ethamine
1-(2-bromo-phenyl)-ethylamine
1-(2-trifluoromethyl-phenyl)-ethylamine
1-(3-bromo-phenyl)-ethylamine
1-(3-chloro-4-methoxyl group-phenyl)-ethylamine
4-(1-amino-ethyl)-N, N-dimethyl-benzsulfamide
1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethylamine
1-quinoline-6-base-ethylamine
1-(3,5-di-trifluoromethyl-phenyl)-ethylamine
4-[(1S)-and the 1-amino-ethyl] benzonitrile
(S)-and Alpha-Methyl-3,5-two (trifluoromethyl)-benzene methanamine (S)-Alpha-Methyl-3,5-two (trifluoromethyl)-benzene methanamine
1-biphenyl-4-base-ethylamine
1-(4-fluoro-phenyl)-ethylamine
1-[4-fluoro-3-(trifluoromethyl) phenyl] ethamine
1-[4-chloro-3-(trifluoromethyl) phenyl] ethamine
N-{4-[(1R)-and the 1-amino-ethyl] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
N-{4-[(1S)-and the 1-amino-ethyl] phenyl }-1,2,3-thiadiazoles-4-carboxylic acid amides
1-[3-fluoro-5-(trifluoromethyl) phenyl] ethylamine
1-[2-fluoro-4-(trifluoromethyl) phenyl] ethylamine
1-[2-fluoro-5-(trifluoromethyl) phenyl] ethylamine
1-(2,4 dichloro benzene base) ethylamine
1-(2, the 4-3,5-dimethylphenyl) ethylamine
1-[2,4-two (trifluoromethyl) phenyl] ethylamine
1-(2-chloro-4-fluorophenyl) ethylamine
1-(3, the 4-difluorophenyl) ethylamine
1-(4-bromo-2-fluorophenyl) ethylamine
1-(3-fluorophenyl) ethylamine
1-(2,4 difluorobenzene base) ethylamine
1-[3-fluoro-4-(trifluoromethyl) phenyl] ethylamine
1-[4-fluoro-2-(trifluoromethyl) phenyl] ethylamine
1-(3-chloro-4-fluorophenyl) ethylamine
1-(4-chloro-3-fluorophenyl) ethylamine
1-(3, the 4-dibromo phenyl) ethylamine
1-(2-bromo-4-fluorophenyl) ethamine
1-(2-bromo-4-fluorophenyl) ethylamine
Embodiment 73 (method 49)
(2-fluoro-5-trifluoromethyl-phenoxy group)-acetonitrile
Reagent grade acetone (0.55L) solution with solid carbonic acid potassium (7.7 gram) processing 2-fluoro-5-trifloro methyl phenol (25 gram) adds pure bromoacetonitrile (10 milliliters) then rapidly.About 20 hours of vigorous stirring heterogeneous mixture is poured in the water then, is extracted into ether.With the ether extract of saturated sodium-chloride washing merging, and use the Anhydrous potassium carbonate drying.Filter and concentrating under reduced pressure, obtain greenish orange look solid, use silica gel column chromatography then, use the methylene dichloride wash-out, obtain desired white solid state product (28.3 gram).
Use said procedure and suitable parent material to prepare following compounds:
(3-bromo-thiophenyl)-acetonitrile
(3-chloro-thiophenyl)-acetonitrile
(4-iodo-phenoxy group)-acetonitrile
(3-trifluoromethyl-thiophenyl)-acetonitrile
(3,5-two chloro-thiophenyls)-acetonitrile
(3,4-two chloro-thiophenyls)-acetonitrile
(3,4-two chloro-phenoxy groups)-acetonitrile
(2-fluoro-phenoxy group)-acetonitrile
(3-fluoro-phenoxy group)-acetonitrile
(2-chloro-phenoxy group)-acetonitrile
(3-bromo-phenoxy group)-acetonitrile
(2-fluoro-5-trifluoromethyl-phenoxy group)-acetonitrile
(3-iodo-phenoxy group)-acetonitrile
(4-bromo-phenoxy group)-acetonitrile
Embodiment 74 (method 50)
Toluenesulphonic acids 3-fluoro-5-trifluoromethylbenzene ethylamine
At room temperature,, use 200 milligram of 10% palladium-carbon catalyst, 75 milliliters of methyl glycol solution of hydrogenation 2.5 gram 3-fluoro-5-trifluoromethyl acetonitriles and 2.34 gram (12.3 mmole) tosic acid 3 hours with 40psi.The elimination catalyzer, evaporating solvent to volume half.After the placement, the tosilate crystallization of desired 3-fluoro-5-trifluoromethylbenzene ethylamine.Filter and collect white crystal 4.26 grams (91%).
Use said procedure and suitable parent material to prepare following compounds:
2-(3,5-two fluoro-phenyl)-ethylamine
2-(4-trifluoromethyl-phenyl)-ethylamine
2-(3,4-two fluoro-phenyl)-ethylamine
2-(2-fluoro-phenyl)-ethylamine
2-(3-fluoro-5-trifluoromethyl-phenyl)-ethylamine
2-(2-fluoro-3-trifluoromethyl-phenyl)-ethylamine
2-(2,4-di-trifluoromethyl-phenyl)-ethylamine
2-(4-fluoro-3-trifluoromethyl-phenyl)-ethylamine
Embodiment 75 (method 51)
(4-amino methyl-2-trifluoromethyl-phenyl)-dimethyl-amine
Tetrahydrofuran (THF) (2 milliliters) solution of 4-dimethylamino-3-trifluoromethyl benzonitrile (0.35 gram) in 0 ℃ of tetrahydrofuran (THF) (2 milliliters) suspension that slowly is added to lithium aluminium hydride (0.1 gram), and was stirred 2 hours under argon gas.Slowly adding entry (0.1 milliliter) at 0 ℃, is 5% sodium hydroxide (0.1 milliliter) and water (0.3 milliliter) then.The gray solid that filtration obtains is washed with tetrahydrofuran (THF).Collect filtrate, concentrating under reduced pressure with silica gel (with the dichloromethane solution of 15% methyl alcohol as the elutriant) oil that chromatography obtains, obtains desired greenish orange look oily product (0.164 restrains).
Use said procedure and suitable parent material to prepare following compounds:
4-piperidines-1-base-3-trifluoromethyl-benzyl amine
(4-amino methyl-2-trifluoromethyl-phenyl)-dimethyl-amine
4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl amine
(3-amino methyl-5-trifluoromethyl-phenyl)-dimethyl-amine
[3-(2-amino-ethyl)-5-trifluoromethyl-phenyl]-dimethyl-amine
[4-(2-amino-ethyl)-2-methyl-phenyl]-dimethyl-amine
Embodiment 76 (method 52)
3-dimethylamino-5-trifluoromethyl-phenyl aldehyde
Diisobutyl aluminium hydride (10 milliliters of 1M dichloromethane solutions) in 0 ℃ of methylene dichloride (25 milliliters) solution that is added drop-wise to 3-dimethylamino-5-trifluoromethyl benzonitrile (1.06 gram), was stirred the mixture 2 hours.At 0 ℃, slowly add saturated sodium tartrate aqueous solutions of potassium (8 milliliters), stirred solution 1.5 hours.Use the ethyl acetate extraction reaction mixture then, use anhydrous magnesium sulfate drying, concentrating under reduced pressure obtains desired yellow solid product (0.97 gram).
Use said procedure and suitable parent material to prepare following compounds:
3-dimethylamino-5-trifluoromethyl-phenyl aldehyde
4-dimethylamino-3-methyl-phenyl aldehyde
Embodiment 77 (method 53)
Dimethyl-[3-(2-nitro-vinyl)-5-trifluoromethyl-phenyl]-amine
Nitromethane 99Min. (0.473 gram) is added in acetate (3.4 milliliters) solution of 3-dimethylamino-5-trifluoromethyl-phenyl aldehyde (0.885 gram) and ammonium acetate (0.339 restrains) 110 ℃ of heated solutions 6 hours.Reaction mixture is cooled to 0 ℃, leaches the solid of formation, with water-acetate washing in 1: 1.This solid recrystallization from ethanol obtains desired red solid product (0.39 gram).
Use said procedure and suitable parent material to prepare following compounds:
Dimethyl-[3-(2-nitro-vinyl)-5-trifluoromethyl-phenyl]-amine
Dimethyl-[2-methyl-4-(2-nitro-vinyl)-phenyl]-amine
Embodiment 78 (method 54)
3-(4-bromo-phenyl)-propionitrile
With diethylazodicarboxylate (5.2 gram) in the solution of 0 ℃ of ether (16 milliliters) that is added drop-wise to 4-bromo-styroyl alcohol (2.01 gram) and triphenyl phosphine (7.9 restrain).Stirred reaction mixture 10 minutes, ether (10 milliliters) solution of adding acetone cyanohydrin (2.6 gram).0 ℃ was stirred clear orange solution 5 minutes, stirred 12 hours at 25 ℃ then.Filter reaction mixture washs with ether then.Concentrating under reduced pressure filtrate with silica gel (with 10% ethyl acetate-hexane as elutriant) chromatography, obtains desired faint yellow oily product (2.04 restrain).
Embodiment 79 (method 55)
3-dimethylamino-2-isocyano--ethyl propenoate
Drip N in ethanol (100 milliliters) solution of isocyano acid B ester (5.0 gram), N-dimethyl-methane amide dimethylacetal (6.5 gram) stirs more than 10 minutes.Reaction stirred 24 hours, ethanol evaporation.The oil that obtains uses 50%7 acetoacetic esters-hexane as eluent by Magnesium Silicate q-agent.Remove and desolvate, the oil that recrystallization obtains from ethyl acetate-hexane obtains faint yellow spicule, 3.0 grams.
Embodiment 80 (method 56)
4-ethoxy carbonyl thiazole
Tetrahydrofuran (THF) (30 milliliters) solution with hydrogen sulfide processing 3-dimethylamino-2-isocyano--ethyl propenoate (1.0 gram) and triethylamine (3.0 gram) has been consumed up to parent material.Enriched mixture is used column chromatography purification to oily, uses silicon-dioxide and 25% ethyl acetate-hexane as elutriant.The material (0.61 gram) that separates the buttery purifying.
Embodiment 81 (method 34)
N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide
With 5-chloro-2,4-dimethoxy benzene based isocyanate (0.40 gram) is handled acetonitrile (4 milliliters) suspension of N-(4-amino-phenyl)-2-fluoro-benzamide (0.43 gram).Mixture becomes solution, places 12 hours.Form white solid, filter and collect (0.79 gram).[M+H]444。
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | ?M+H | The compound title |
81 | ?445 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
82 | ?441 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-2-methyl-benzamide |
83 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-urea groups]-phenyl }-acid amides |
84 | ?443 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
85 | ?453 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
86 | ?409 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-urea groups]-phenyl }-acid amides |
87 | ?486 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-2-fluoro-benzamide |
88 | ?458 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
89 | ?476 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-urea groups]-phenyl }-acid amides |
90 | ?423 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-urea groups]-benzyl }-acid amides |
Embodiment 91 (method 31)
[1,2,3]-thiadiazoles-4-carboxylic acid 4-[3 (3,5-di-trifluoromethyl phenyl)-thioureido]-phenyl } acid amides
In acetonitrile (50ml) solution of [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (2.0g), drip rapidly 1-isothiocyanic acid-3, acetonitrile (50ml) solution of 5-di-trifluoromethyl-benzene (2.5 gram), and reaction stirred at room temperature.After 90 minutes, removal of solvent under reduced pressure, the brown solid that recrystallization obtains from ethyl acetate/hexane obtains pure products.[M+H]492。
Use said procedure and suitable parent material to prepare following compounds:
Embodiment 815 (method 32)
Embodiment number | M+H | The compound title |
92 | ?506 | [3-chloro-5-(3-{4-([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-t-butyl carbamate |
93 | ?409 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-morpholine-4-base-phenyl)-thiocarbamide |
94 | ?370 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-methylthio group-phenyl)-thiocarbamide |
95 | ?338 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-p-methylphenyl-thiocarbamide |
96 | ?414 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-thiophenyl }-acetate |
97 | ?384 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-[4-(2-hydroxyl-oxyethyl group)-phenyl]-thiocarbamide |
98 | ?340 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-hydroxyl-phenyl)-thiocarbamide |
99 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-N-methyl-ethanamide |
100 | ?381 | N-{3-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
101 | ?411 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-urethanum |
102 | ?319 | 1-(2,4-dimethoxy-phenyl)-3-(4-methoxyl group-phenyl)-thiocarbamide |
103 | ?346 | N-{4-[3-(2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
104 | ?316 | N-{4-[3-(4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
105 | ?316 | N-{4-[3-(2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
106 | ?351 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
107 | ?351 | N-{4-[3-(5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
108 | ?371 | N-{4-[3-(3,5-two chloro-4-hydroxyl-phenyl)-thioureido]-phenyl }-ethanamide |
109 | ?385 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
110 | ?381 | N-{4-[3-(4-chloro-2,5-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
111 | ?389 | N-{4-[3-(2-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
112 | ?389 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
113 | ?422 | Phenylformic acid 4-[3-(4-acetylamino-phenyl)-thioureido]-3-hydroxyl-phenyl ester |
114 | ?457 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
115 | ?501 | Acetate 2-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl-formamyl }-phenyl ester |
116 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide |
117 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
118 | ?461 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
119 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
120 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
121 | ?473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
122 | ?443 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
??123 | ??417 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-first-sulphonamide | |
??124 | ??331 | N-{4-[3-(3-nitro-phenyl)-thioureido]-phenyl }-ethanamide | |
??125 | ??339 | 1-(3-chloro-4-methoxyl group-phenyl)-3-(3-nitro-phenyl)-thiocarbamide | |
??126 | ??337 | N-{4-[3-(5-chloro-2-hydroxyl-phenyl)-thioureido]-phenyl }-ethanamide | |
??127 | ??439 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-t-butyl carbamate | |
??128 | ??351 | N-{4-[3-(3-chloro-4-hydroxy-5-methyl base-phenyl)-thioureido]-phenyl }-ethanamide | |
??129 | ??385 | N-{4-[3-(3,5-two chloro-4-hydroxy-2-methyl-phenyl)-thioureido]-phenyl }-ethanamide | |
??130 | ??318 | N-{4-[3-(2,4-dihydroxyl-phenyl)-thioureido]-phenyl }-ethanamide | |
??131 | ??414 | N-{4-[3-(2,4-dimethoxy-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide | |
??132 | ??332 | N-{4-[3-(2-hydroxyl-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide | |
??133 | ??465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide | |
??134 | ??500 | 3-acetylamino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide | |
??135 | ??488 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-nitro-benzamide | |
??136 | ??486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-dimethylamino-benzamide | |
??137 | ??536 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-methylsulfonyl-amino-benzamide | |
??138 | ??511 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-three fluoro-methyl-benzamide | |
??139 | ??459 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-hydroxyl-benzamide | |
??140 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide | |
??141 | ??477 | 2-chloro-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide | |
??142 | ??522 | 2-bromo-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide | |
??143 | ??488 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-nitro-benzamide | |
??144 | ??445 | Pyrazine-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides | |
??145 | ??463 | 5-methyl-thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides | |
??146 | ??494 | Quinoline-8-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides | |
??147 | ??446 | 1-methyl isophthalic acid H-pyrroles-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides | |
??148 | ??369 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(2-nitro-phenyl)-thiocarbamide | |
??149 | ??369 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(4-nitro-phenyl)-thiocarbamide | |
??150 | ??425 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide | |
??151 | ??376 | N-{4-[3-(3,4,5-trimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??152 | ??399 | N-{4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
??153 | ??499 | Benzo [b] thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??154 | ??483 | Cumarone-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??155 | ??444 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-Isonicotinamide |
??156 | ??493 | Naphthalene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??157 | ??493 | Naphthalene-1-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??158 | ??494 | Isoquinoline 99.9-1-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??159 | ??494 | The quinaldic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??160 | ??444 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-niacinamide |
??161 | ??478 | 5-nitro-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acyl ammonia |
??162 | ??459 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-phenyl carbamate |
??163 | ??467 | 5-chloro-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??164 | ??439 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-isobutyl carbamate |
??165 | ??397 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-Urethylane |
??166 | ??433 | Furans-3-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??167 | ??447 | 3-methyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??168 | ??512 | 5-bromo-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??169 | ??512 | 4-bromo-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??170 | ??433 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??171 | ??467 | 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the own ester of carboxylamine |
??172 | ??494 | Isoquinoline 99.9-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??173 | ??451 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??174 | ??434 | 1H-[1,2,3] triazole-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??175 | ??528 | 3-bromo-thiophene-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??176 | ??399 | N-{4-[3-(3,5-two chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-ethanamide |
??177 | ??427 | N-{4-[3-(4-butoxy-3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
??178 | ??461 | N-{4-[3-(4-benzyloxy-3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
??179 | ??381 | N-{4-[3-(3-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??180 | ??530 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenyl)-urethanum |
??181 | ??458 | 2-amino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
??182 | ??519 | Diphenyl-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??183 | ??469 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-[4-(1,3-dioxo-1,3-dihydro-isoindole-2-yl)-phenyl]-thiocarbamide |
??184 | ??487 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-phthalamic acid |
??185 | ??473 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-hydroxyl-methyl-benzamide |
??186 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3-two fluoro-benzamide |
??187 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,5-two fluoro-benzamide |
??188 | ??479 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,4-two fluoro-benzamide |
??189 | ??500 | 2-acetylamino-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
??190 | ??441 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(6-oxo-5,6-dihydro-phenanthridines-2-yl)-thiocarbamide |
??191 | ??536 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methylsulfonyl amino-benzamide |
??192 | ??497 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3,4-three fluoro-benzamide |
??193 | ??533 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2,3,4,5,6-five fluoro-benzamide |
??194 | ??489 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methylthio group-benzamide |
??195 | ??431 | 5-methyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??196 | ??467 | 5-difluoromethyl-furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
??197 | ??472 | N-{4-[3-(5-iodo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??198 | ??364 | N-{4-[3-(5-fluoro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
??199 | ??365 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
??200 | ??459 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??201 | ??455 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
??202 | ??392 | N-{4-[3-(3-chloro-4-diethylamino-phenyl)-thioureido]-phenyl }-ethanamide |
??203 | ??432 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
??204 | ??506 | 1-hydroxyl-naphthalene-2-carboxylic acid 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-acid amides |
??205 | ??406 | N-{4-[3-(3-chloro-4-morpholine-4-base-phenyl)-thioureido]-phenyl }-ethanamide |
??206 | ??443 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(3-chloro-4-morpholine-4-base-phenyl)-thiocarbamide |
??207 | ??372 | 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-chloro-2-methyl-phenyl)-thiocarbamide |
??208 | ??501 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the isophthalamic acid methyl esters |
??209 | ??487 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-isophthalamic acid |
210 | ?549 | 3-benzyloxy-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
211 | ?434 | N-(4-{3-[5-chloro-2-methoxyl group-4-(4-nitrilo-butoxy)-phenyl]-thioureido }-phenyl)-ethanamide |
212 | ?406 | N-(4-{3-[5-chloro-2-methoxyl group-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
213 | ?406 | N-(4-{3-[5-chloro-4-methoxyl group-2-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
214 | ?411 | N-(4-{3-[5-chloro-2-(2-hydroxyl-oxyethyl group)-4-methoxyl group-phenyl]-thioureido }-phenyl)-ethanamide |
215 | ?411 | N-(4-{3-[5-chloro-4-(2-hydroxyl-oxyethyl group)-2-methoxyl group-phenyl]-thioureido }-phenyl)-ethanamide |
216 | ?481 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-tert.-butyl acetate |
217 | ?439 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-methyl acetate |
218 | ?481 | 2-[3-(4-acetylamino-phenyl)-thioureido]-4-chloro-5-methoxyl group-phenoxy group }-tert.-butyl acetate |
219 | ?515 | 3-butoxy-N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-benzamide |
220 | ?505 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-methanesulfinyl-benzamide |
221 | ?545 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenoxy group)-ethyl acetate |
222 | ?517 | (3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the phenyl amino formyl radical }-phenoxy group)-acetate |
223 | ?367 | N-{4-[3-(5-chloro-4-hydroxyl-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
224 | ?444 | Pyridine-2-carboxylic acids 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
225 | ?494 | The Cinchonic Acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
226 | ?436 | N-{4-[3-(5-chloro-4-methoxyl group-2-morpholine-4-base-phenyl)-thioureido]-phenyl }-ethanamide |
227 | ?394 | N-{4-[3-(5-chloro-2-methylamino-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
228 | ?420 | N-{4-[3-(5-chloro-4-methoxyl group-2-tetramethyleneimine-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
229 | ?434 | N-{4-[3-(5-chloro-4-methoxyl group-2-piperidines-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
230 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
231 | ?415 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
232 | ?427 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
233 | ?387 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
234 | ?411 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
235 | ?433 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
236 | ?398 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
237 | ?502 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides |
238 | ?512 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
239 | ?404 | N-{4-[3-(3-chloro-4-piperidines-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
240 | ?364 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-ethanamide |
241 | ?426 | N-{4-[3-(4-benzylamino-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
242 | ?390 | N-{4-[3-(3-chloro-4-tetramethyleneimine-1-base-phenyl)-thioureido]-phenyl }-ethanamide |
243 | ?419 | N-(4-{3-[3-chloro-4-(4-methyl-piperazine-1-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
244 | ?469 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
245 | ?422 | N-{4-[3-(2-benzylamino-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
246 | ?484 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides |
247 | ?508 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-2-methyl-benzamide |
248 | ?530 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-2,6-two fluoro-benzamide |
249 | ?495 | Pyridine-2-carboxylic acids (4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-acid amides |
250 | ?524 | N-(4-{3-[3-chloro-4-(cyclohexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-3-methoxyl group-benzamide |
251 | ?376 | N-(4-{3-[3-chloro-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
252 | ?393 | N-{4-[3-(4-sec-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
253 | ?501 | Acetate 3-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl-formamyl }-phenyl ester |
254 | ?459 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-hydroxyl-benzamide |
255 | ?487 | Benzo [1,3] dioxole-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
256 | ?527 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-fluoro-methoxyl group-benzamide |
257 | ?530 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-(2-dimethylamino-oxyethyl group)-benzamide |
258 | ?572 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-3-(2-morpholine-4-base-oxyethyl group)-benzamide |
259 | ?406 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-ethanamide |
260 | ?521 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2,5-dimethoxy-phenyl }-2-fluoro-benzamide |
261 | ?441 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2,5-dimethoxy-phenyl }-ethanamide |
262 | ?527 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenoxy group }-5-chloro-Phenylsulfonic acid |
263 | ?562 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenoxy group }-4,5-two chloro-Phenylsulfonic acids |
264 | ?527 | 4-phenyl-[1-2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
265 | ?381 | N-(4-{3-[3-chloro-4-(2-hydroxyl-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
266 | ?393 | N-{4-[3-(4-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
267 | ?446 | N-(4-{3-[3-chloro-4-(cyclohexyl-ethyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
268 | ?365 | N-{4-[3-(3-chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-ethanamide |
269 | ?427 | N-{4-[3-(4-benzyloxy-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
270 | ?317 | 4-[(3-methyl-furans-2-carbonyl)-amino]-phenyl }-t-butyl carbamate |
271 | ?456 | N-{4-[3-(2-benzylamino-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
272 | ?420 | N-{4-[3-(3-chloro-4-dipropyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
273 | ?458 | N-(4-{3-[4-(allyl group-cyclohexyl-amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
274 | ?411 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the 2-p-methoxy-phenyl }-ethanamide |
275 | ?415 | N-{2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
276 | ?493 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido] and-2,5-dimethoxy-phenyl }-acid amides |
277 | ?486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-2-fluoro-benzamide |
278 | ?495 | N-{2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
279 | ?465 | 5-methyl-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
280 | ?517 | 5-furans-3-base-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
281 | ?527 | 5-phenyl-[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
282 | ?458 | N-(4-{3-[3-chloro-4-(octahydro quinoline-1-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
283 | ?458 | N-[5-[[[(5-chloro-2,4-dimethoxy-phenyl) amino] sulphomethyl] amino]-the 2-pyridyl]-the 2-methyl benzamide |
284 | ?434 | Furans-2-carboxylic acid 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
285 | ?425 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-ethanamide |
286 | ?505 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-2-fluoro-benzamide |
287 | ?477 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-acid amides |
288 | ?517 | 4-furans-3-base-[1,2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
289 | ?462 | N-{5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-2-fluoro-benzamide |
290 | ?384 | N-{4-[3-(4-methoxyl group-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
291 | ?394 | N-[4-(3-{3-chloro-4-[(2-hydroxyl-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
292 | ?485 | N-{2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
293 | ?565 | N-{2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
294 | ?537 | Furans-2-carboxylic acid 2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
295 | ?475 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-2-fluoro-benzamide |
296 | ?447 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-acid amides |
297 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-ethanamide |
298 | ?435 | N-[4-(3-{3-chloro-4-[(3-dimethylamino-propyl group)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
299 | ?418 | N-{4-[3-(3-chloro-4-cyclohexyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
300 | ?421 | N-[4-(3-{3-chloro-4-[(2-dimethylamino-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
301 | ?580 | 5-[[[(5-chloro-2, the 4-Dimethoxyphenyl) amino] sulphomethyl] amino]-the 2-[(2-fluoro benzoyl) amino]-N-phenyl-benzamide |
302 | ?552 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-phenyl amino formyl radical-phenyl }-acid amides |
303 | ?491 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-the 2-p-methoxy-phenyl }-2-fluoro-benzamide |
304 | ?463 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-phenyl }-acid amides |
305 | ?449 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-ethanamide |
306 | ?458 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-acid amides |
307 | ?467 | Furans-2-carboxylic acid 2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
308 | ?501 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-acid amides |
309 | ?395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-ethanamide |
310 | ?475 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
311 | ?447 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides |
312 | ?378 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-ethanamide |
313 | ?408 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-urethanum |
314 | ?382 | N-{5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-ethanamide |
315 | ?509 | N-(4-{3-[4-(1-benzyl-piperidin-4-yl amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
316 | ?407 | N-(4-{3-[3-chloro-4-(2-dimethylamino-ethylamino)-phenyl]-thioureido }-phenyl)-ethanamide |
317 | ?408 | N-[4-(3-{3-chloro-4-[(2-methoxyl group-ethyl)-methyl-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
318 | ?421 | N-(4-{3-[3-chloro-4-(3-dimethylamino-propyl group amino)-phenyl]-thioureido }-phenyl)-ethanamide |
319 | ?495 | N-(4-{3-[4-(1-benzyl-tetramethyleneimine-3-base is amino)-3-chloro-phenyl]-thioureido }-phenyl)-ethanamide |
320 | ?483 | Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-acid amides |
321 | ?431 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-ethanamide |
322 | ?511 | 5H, 11H-benzo [e] pyrrolo-[1,2-a] [1,4] two azepines-10-yl)-(2-chloro-4-imidazoles-1-base-phenyl)-ketone |
323 | ?451 | [1,2,3] thiadiazoles-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
324 | ?483 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-acid amides |
325 | ?511 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-2-fluoro-benzamide |
326 | ?429 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-ethanamide |
327 | ?509 | N-{5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
328 | ?481 | Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides |
329 | ?431 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-ethanamide |
330 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
331 | ?561 | Furans-2-carboxylic acid [4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-acid amides |
332 | ?513 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
333 | ?463 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
334 | ?420 | N-(4-{3-[3-chloro-4-(1-methyl-tetramethyleneimine-3-base oxygen base)-phenyl]-thioureido }-phenyl)-ethanamide |
335 | ?434 | N-(4-{3-[3-chloro-4-(1-methyl-piperidin-4-yl oxygen base)-phenyl]-thioureido }-phenyl)-ethanamide |
336 | ?422 | N-(4-{3-[3-chloro-4-(3-dimethylamino-propoxy-)-phenyl]-thioureido }-phenyl)-ethanamide |
337 | ?425 | 2-acetylamino-5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenylformic acid |
338 | ?505 | 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-(2-fluoro-benzoyl-amido)-phenylformic acid |
339 | ?477 | 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-[(furans-2-carbonyl)-amino]-phenylformic acid |
340 | ?545 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2,6-two fluoro-benzamide |
341 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
342 | ?443 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
343 | ?408 | N-(4-{3-[3-chloro-4-(2-dimethylamino-oxyethyl group)-phenyl]-thioureido }-phenyl)-ethanamide |
344 | ?499 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
345 | ?419 | N-{4-[3-(3-chloro-4-cyclohexyl oxygen base-phenyl)-thioureido]-phenyl }-ethanamide |
346 | ?440 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
347 | ?493 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-2,6-two fluoro-benzamide |
348 | ?462 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
349 | ?531 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-2,6-two fluoro-benzamide |
350 | ?427 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-dimethylamino-phenyl }-thioureido)-phenyl }-acid amides |
351 | ?430 | Pyridine-2-carboxylic acids 4-[3-(3-chloro-4-methylthio group-phenyl }-thioureido)-phenyl }-acid amides |
352 | ?428 | Pyridine-2-carboxylic acids 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl }-thioureido)-phenyl }-acid amides |
353 | ?417 | Furans-2-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl }-thioureido)-phenyl }-acid amides |
354 | ?496 | Pyridine-2-carboxylic acids [4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
355 | ?495 | N-{3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
356 | ?467 | Furans-2-carboxylic acid 3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
357 | ?515 | N-{4-[3-(3-chloro-4-hexamethylene sulfenyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
358 | ?449 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-ethanamide |
359 | ?529 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-2-fluoro-benzamide |
360 | ?421 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-dimethyl-amino-ethanamide |
361 | ?473 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-dimethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
362 | ?501 | N-(4-{3-[3-chloro-4-(2-dimethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
363 | ?461 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-piperidines-1-base-ethanamide |
364 | ?541 | N-(4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
365 | ?513 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
366 | ?463 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-morpholine-4-base-ethanamide |
367 | ?543 | N-(4-{3-[3-chloro-4-(2-morpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
368 | ?515 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-morpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
369 | ?414 | N-{4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
370 | ?494 | N-{4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
371 | ?466 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methylsulfonyl amino-phenyl)-thioureido]-phenyl }-ethanamide |
372 | ?481 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-(2-dimethylamino-ethylmercapto group)-ethanamide |
373 | ?561 | N-[4-3-{3-chloro-4-[2-(2-dimethylamino-ethylmercapto group)-acetylamino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
374 | ?585 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-2-methyl-benzamide |
375 | ?523 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2-methyl-benzamide |
376 | ?510 | Pyridine-2-carboxylic acids [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
377 | ?347 | N-{4-[3-(3-chloro-4-vinyl-phenyl)-thioureido]-phenyl }-ethanamide |
378 | ?441 | Furans-2-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
379 | ?452 | Pyridine-2-carboxylic acids 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
380 | ?487 | N-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
381 | ?486 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-2-fluoro-benzamide |
382 | ?458 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-acid amides |
??383 | ??406 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-ethanamide |
??384 | ??395 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-2-methyl-isothioureido]-phenyl }-ethanamide |
??385 | ??396 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-2-methyl-isothioureido]-phenyl }-ethanamide |
??386 | ??461 | N-{4-[3-(3-chloro-4-ethylmercapto group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??387 | ??489 | N-{4-[3-(4-butylthio-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??388 | ??411 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-ethanamide |
??389 | ??491 | N-{4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide |
??390 | ??463 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-acid amides |
??391 | ??531 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(2-piperidines-1-base-ethanoyl-amino)-phenyl]-thioureido } phenyl)-acid amides |
??392 | ??481 | N-{4-[3-(3-chloro-4-methanesulfinyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
??393 | ??497 | N-{4-[3-(3-chloro-4-methylsulfonyl-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
??394 | ??459 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
??395 | ??429 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
??396 | ??533 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[2-(2-dimethylamino-ethylmercapto group)-acetylamino]-phenyl }-thioureido)-phenyl]-acid amides |
??397 | ??458 | N-{4-[3-(4-acetylamino-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??398 | ??460 | [2-chloro-4-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-urethanum |
??390 | ??488 | (2-chloro-4-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-phenyl]-urethanum |
??400 | ??440 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-benzamide |
??401 | ??520 | N-{4-[({[4-(benzoyl-amido)-3-chloro-phenyl]-amino }-sulphomethyl)-amino]-phenyl }-2-fluoro-benzamide |
??402 | ??529 | N-{4-[3-(5-chloro-2,4 dimethoxys-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-2-fluoro-benzamide |
??403 | ??492 | Furans-2-carboxylic acid 4-[3-(4-benzoyl-amido-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
??404 | ??416 | N-{4-[3-(4-amino-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??405 | ??479 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-thiomorpholine-4-base-ethanamide |
??406 | ??531 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-thiomorpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
??407 | ??559 | N-(4-{3-[3-chloro-4-(2-thiomorpholine-4-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??408 | ??461 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide |
??409 | ??430 | Furans-2-carboxylic acid 4-[3-(4-acetylamino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
??410 | ??477 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-dipropyl amino-ethanamide |
??411 | ??529 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-dipropyl amino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides |
412 | ?449 | N-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-diethylamino-ethanamide | |
413 | ?501 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-diethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides | |
414 | ?529 | N-(4-{3-[3-chloro-4-(2-diethylamino-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
415 | ?447 | N-{4-{3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenyl }-2-tetramethyleneimine-1-base-ethanamide | |
416 | ?499 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(2-tetramethyleneimine-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-acid amides | |
417 | ?527 | N-(4-{3-[3-chloro-4-(2-tetramethyleneimine-1-base-acetylamino)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
418 | ?475 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide | |
419 | ?445 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide | |
420 | ?477 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-3-methoxyl group-phenyl }-2-fluoro-benzamide | |
421 | ?388 | Furans-2-carboxylic acid 4-[3-(4-amino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides | |
422 | ?527 | Furans-2-carboxylic acid (4-{3-[4-(2-nitrogen heterocyclic heptan-1-base-acetylamino)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides | |
423 | ?555 | N-(4-{3-[4-(2-nitrogen heterocyclic heptan-1-base-acetylamino)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
424 | ?527 | Furans-2-carboxylic acid [4-(3-{3-chloro-4-[2-(2-methyl-piperidines-1-yl)-ethanoyl-amino]-phenyl }-thioureido)-phenyl]-acid amides | |
425 | ?555 | N-[4-(3-{3-chloro-4-[2-(2-methyl-piperidines-1-yl)-ethanoyl-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide | |
426 | ?339 | Furans-2-carboxylic acid [4-(3-pyridine-2-base-thioureido)-phenyl]-acid amides | |
427 | ?339 | Furans-2-carboxylic acid [4-(3-pyridin-4-yl-thioureido)-phenyl]-acid amides | |
428 | ?367 | 2-fluoro-N-[4-(3-pyridin-3-yl-thioureido)-phenyl]-benzamide | |
429 | ?339 | Furans-2-carboxylic acid [4-(3-pyridin-3-yl-thioureido)-phenyl]-acid amides | |
430 | ?353 | Furans-2-carboxylic acid 4-[3-(3-amino-phenyl)-thioureido]-phenyl }-acid amides | |
431 | ?406 | Furans-2-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides | |
432 | ?380 | 2-fluoro-N-[4-(tolyl-thioureido between 3-)-phenyl]-benzamide | |
433 | ?434 | 2-fluoro-N-{4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide | |
434 | ?381 | N-{4-[3-(3-amino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide | |
435 | ?388 | Furans-2-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides | |
436 | ?352 | Furans-2-carboxylic acid [4-(tolyl-thioureido between 3-)-phenyl]-acid amides | |
437 | ?416 | N-{4-[3-(2-amino-5-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide | |
438 | ?571 | (2-chloro-4-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-phenyl)-carboxylamine 2-piperidines-1-base-ethyl ester | |
439 | ?543 | [2-chloro-4-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-carboxylamine 2-piperidines-1-base-ethyl ester | |
440 | ?388 | Furans-2-carboxylic acid 4-[3-(2-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
441 | ?363 | Furans-2-carboxylic acid 4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-acid amides |
442 | ?416 | N-{4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
443 | ?367 | 2-fluoro-N-[4-(3-pyridine-2-base-thioureido)-phenyl]-benzamide |
444 | ?367 | 2-fluoro-N-[4-(3-pyridin-4-yl-thioureido)-phenyl]-benzamide |
445 | ?374 | Furans-2-carboxylic acid 4-[3-(6-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
446 | ?388 | Furans-2-carboxylic acid 4-[3-(2-amino-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
447 | ?396 | Furans-2-carboxylic acid 4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-acid amides |
448 | ?410 | 2-fluoro-N-(4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-benzamide |
449 | ?414 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-acid amides |
450 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-acid amides |
451 | ?380 | Furans-2-carboxylic acid 4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-acid amides |
452 | ?409 | 2-fluoro-N-{4-[3-(3-sec.-propyl-phenyl)-thioureido]-phenyl }-benzamide |
453 | ?381 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-acid amides |
454 | ?410 | N-{4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
455 | ?381 | Furans-2-carboxylic acid 4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
456 | ?370 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(tolyl-thioureido between 3-)-phenyl]-acid amides |
457 | ?424 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
458 | ?479 | N-{3-chloro-4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
459 | ?449 | N-{3-chloro-4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
460 | ?481 | N-{3-chloro-4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
461 | ?391 | N-{4-[3-(3-cyano group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
462 | ?395 | Furans-2-carboxylic acid 4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-acid amides |
463 | ?424 | 2-fluoro-N-{4-[3-(3-diazanyl carbonyl-phenyl)-thioureido]-phenyl }-benzamide |
464 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
465 | ?434 | N-{4-[3-(2-amino-3-chloro-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
466 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides |
467 | ?398 | Furans-2-carboxylic acid 4-[3-(3,5-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
468 | ?416 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
469 | ?454 | 5-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-dimethyl isophthalate |
470 | ?434 | Isoxazole-5-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
471 | ?392 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(6-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
472 | ?382 | Furans-2-carboxylic acid (4-{3-[3-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
473 | ?368 | Furans-2-carboxylic acid 4-[3-(3-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
474 | ?354 | Furans-2-carboxylic acid 4-[3-(3-hydroxyl-phenyl)-thioureido]-phenyl }-acid amides |
475 | ?382 | 2-fluoro-N-{4-[3-(3-hydroxyl-phenyl)-thioureido]-phenyl }-benzamide |
476 | ?396 | 2-fluoro-N-{4-[3-(3-hydroxymethyl-phenyl)-thioureido]-phenyl }-benzamide |
477 | ?423 | N-{4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
478 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-acetylamino-phenyl)-thioureido]-phenyl }-acid amides |
479 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
480 | ?340 | Furans-2-carboxylic acid [4-(3-pyrimidine-4-base-thioureido)-phenyl]-acid amides |
481 | ?378 | Furans-2-carboxylic acid 4-[3-(1H-indazole-5-yl)-thioureido]-phenyl }-acid amides |
482 | ?395 | Furans-2-carboxylic acid [4-(3-benzothiazole-5-base-thioureido)-phenyl]-acid amides |
483 | ?406 | 2-fluoro-N-{4-[3-(1H-indazole-5-yl)-thioureido]-phenyl }-benzamide |
484 | ?424 | N-[4-(3-benzothiazole-5-base-thioureido)-phenyl]-2-fluoro-benzamide |
485 | ?473 | 5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-dimethyl isophthalate |
486 | ?442 | Furans-2-carboxylic acid (4-{3-[4-(1-azido-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides |
487 | ?396 | 2-fluoro-N-{4-[3-(3-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
488 | ?368 | Furans-2-carboxylic acid 4-[3-(3-hydroxymethyl-phenyl)-thioureido]-phenyl }-acid amides |
489 | ?416 | Furans-2-carboxylic acid 4-[3-(5-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
490 | ?444 | N-{4-[3-(5-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
491 | ?506 | [3-chloro-5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-t-butyl carbamate |
492 | ?506 | N-(4-{3-[4-(1-azido-ethyl)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
493 | ?337 | Furans-2-carboxylic acid [4-(the 1H-thiazole is [5,4-b] pyridine-2-alkenyl amino also)-phenyl]-acid amides |
494 | ?378 | Furans-2-carboxylic acid 4-[3-(1H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-acid amides |
495 | ?392 | Furans-2-carboxylic acid 4-[3-(2-methyl isophthalic acid H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-acid amides |
496 | ?406 | N-{4-[3-(1H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-2-fluoro-benzamide |
497 | ?420 | 2-fluoro-N-{4-[3-(2-methyl isophthalic acid H-benzoglyoxaline-5-yl)-thioureido]-phenyl }-benzamide |
498 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
499 | ?445 | Pyridine-2-carboxylic acids 5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
500 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
501 | ?484 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(2-amino-pyrimidine-4-yl)-3-chloro-phenyl]-thioureido }-phenyl)-acid amides |
502 | ?494 | N-(4-{3-[4-(2-amino-pyrimidine-4-yl)-3-chloro-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
503 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
504 | ?462 | N-{4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
505 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-2-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
506 | ?445 | Pyridine-2-carboxylic acids 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
507 | ?462 | N-{6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-2-fluoro-benzamide |
508 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-phenyl)-thioureido]-phenyl }-acid amides |
509 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 3-tertiary butyl-phenyl)-thioureido]-phenyl }-acid amides |
510 | ?387 | Furans-2-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides |
511 | ?415 | N-{4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
512 | ?434 | Furans-2-carboxylic acid 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
513 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-phenyl)-thioureido]-phenyl }-acid amides |
514 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid 6-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-pyridin-3-yl }-acid amides |
515 | ?426 | [1,2,3] thiadiazoles-4-carboxylic acid 5-[3-(3,5-two chloro-phenyl)-thioureido]-pyridine-2-yl }-acid amides |
516 | ?474 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
517 | ?502 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
518 | ?450 | N-{4-[3-(4-amino-3,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
519 | ?539 | N-{4-[3-(4-amino-3,5-two bromo-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
520 | ?392 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
521 | ?529 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-amino-3,5-two bromo-phenyl)-thioureido]-phenyl }-acid amides |
522 | ?434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
523 | ?444 | N-{4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
524 | ?416 | Furans-2-carboxylic acid 4-[3-(3-chloro-5-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
525 | ?436 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-bromo-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
526 | ?379 | Furans-2-carboxylic acid 4-[3-(1H-benzotriazole-5-yl)-thioureido]-phenyl }-acid amides |
527 | ?425 | N-{4-[3-(1H-benzotriazole-5-yl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
528 | ?388 | N-[4-({ [2-(3-chloro-phenyl)-diazanyl]-sulphomethyl }-amino)-phenyl]-furans-2-carboxylic acid amides |
529 | ?416 | N-[4-({ [2-(3-chloro-phenyl)-diazanyl]-sulphomethyl }-amino)-phenyl]-2-fluoro-benzamide |
530 | ?456 | Furans-2-carboxylic acid 4-[3-(2-amino-3-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
531 | ?513 | N-{4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
532 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
533 | ?374 | 4-[(furans-2-carbonyl)-amino]-phenyl }-thiocarbamate O-(3-chloro-phenyl) ester |
534 | ?474 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-amino-3-chloro-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
535 | ?508 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
536 | ?380 | N-[4-(3-benzyl-thioureido)-phenyl]-2-fluoro-benzamide |
537 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
538 | ?449 | N-{4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
539 | ?370 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3 benzyls-thioureido)-phenyl]-acid amides |
540 | ?424 | N-[4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-2-fluoro-benzamide |
541 | ?414 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides |
542 | ?506 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
543 | ?516 | N-{4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
544 | ?352 | Furans-2-carboxylic acid [4-(3-benzyl-thioureido)-phenyl]-acid amides |
545 | ?421 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
546 | ?396 | Furans-2-carboxylic acid [4-(3-benzo [1,3] dioxole-5-ylmethyl-thioureido)-phenyl]-acid amides |
547 | ?488 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
548 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
549 | ?529 | N-{4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
550 | ?519 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
551 | ?473 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-trifluoromethylthio-phenyl)-thioureido]-phenyl }-acid amides |
552 | ?412 | 2-fluoro-N-(4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
553 | ?412 | 2-fluoro-N-(4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
554 | ?402 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
555 | ?402 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
556 | ?495 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[2-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
557 | ?481 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
558 | ?523 | [1,2,3]-thiadiazoles-4-carboxylic acid (4-{3-[3-(4-methyl-piperazine-1 base)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
559 | ?510 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
560 | ?494 | [1,2,3]-thiadiazoles-4-carboxylic acid 4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
561 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
562 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
563 | ?429 | N-(4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
564 | ?401 | Furans-2-carboxylic acid (4-{3-[2-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
565 | ?402 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
566 | ?504 | 2-fluoro-N-{4-[3-(3-tetramethyleneimine-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
567 | ?477 | N-{4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
568 | ?520 | 2-fluoro-N-{4-[3-(3-morpholine-4-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
569 | ?533 | 2-fluoro-N-(4-{3-[3-(4-methyl-piperazine-1-yl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
570 | ?518 | 2-fluoro-N-{4-[3-(3-piperidines-1-base-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
571 | ?468 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
572 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-benzyl)-thioureido]-phenyl }-acid amides |
573 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(3-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
574 | ?366 | Furans-2-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides |
575 | ?384 | 1,2,3] thiadiazoles-4-carboxylic acid [4-(3-styroyl-thioureido)-phenyl]-acid amides |
576 | ?394 | 2-fluoro-N-[4-(3-styroyl-thioureido)-phenyl]-benzamide |
577 | ?505 | 2-fluoro-N-(4-{3-[3-(2-methyl-butyl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
578 | ?491 | 2-fluoro-N-{4-[3-(3-isobutyl--5-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
579 | ?388 | Furans-2-carboxylic acid 4-[3-(3,5 two fluoro-benzyl)-thioureido]-phenyl }-acid amides |
580 | ?416 | N-{4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
581 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
582 | ?421 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
583 | ?449 | N-{4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
584 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
585 | ?438 | Furans-2-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
586 | ?466 | 2-fluoro-N-{4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
587 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
588 | ?384 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-phenylethyl)-thioureido]-phenyl }-acid amides |
589 | ?394 | 2-fluoro-N-{4-[3-(1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
590 | ?366 | Furans-2-carboxylic acid 4-[3-(1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
591 | ?412 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
592 | ?384 | Furans-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
593 | ?413 | N-{4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-2-fluoro-benzamide |
594 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
595 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(3-hydroxyl-tetramethyleneimine-1-yl)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
596 | ?520 | 2-fluoro-N-(4-{3-[3-(isobutyl--methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-benzamide |
597 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides |
598 | ?520 | N-(4-{3-[3-(butyl-methyl-amino)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
599 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
600 | ?442 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
601 | ?522 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
602 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
603 | ?381 | Furans-2-carboxylic acid (4-{3-[2-(4-amino-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
604 | ?445 | Furans-2-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
605 | ?380 | Furans-2-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides |
606 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
607 | ?396 | Furans-2-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
608 | ?403 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-acid amides |
609 | ?384 | Furans-2-carboxylic acid 4-[3-(the 1-tertiary butyl-1H-imidazoles-2-yl)-thioureido]-phenyl }-acid amides |
610 | ?492 | N-{4-[3-(4-dimethylamino-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
611 | ?427 | Furans-2-carboxylic acid (4-{3-[2-(3,4-dimethoxy-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
612 | ?380 | Furans-2-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides |
613 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-acid amides |
614 | ?502 | Furans-2-carboxylic acid (4-{3-[2-(3,5-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
615 | ?550 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-iodo-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
616 | ?532 | 2-fluoro-N-{4-[3-(4-piperidines-1-base-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
617 | ?537 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-thioureido }-phenyl)-acid amides |
618 | ?482 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
619 | ?488 | Furans-2-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
620 | ?421 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
621 | ?421 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
622 | ?455 | Furans-2-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
623 | ?466 | 2-fluoro-N-{4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide |
624 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
625 | ?410 | 2-fluoro-N-{4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-benzamide |
626 | ?382 | Furans-2-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides |
627 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenoxy group-ethyl)-thioureido]-phenyl }-acid amides |
628 | ?409 | 2-fluoro-N-{4-[3-(3-phenyl-propyl group)-thioureido]-phenyl }-benzamide |
629 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-trifluoromethyl-pyridin-3-yl)-thioureido]-phenyl }-acid amides |
630 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
631 | ?473 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
632 | ?381 | 2-fluoro-N-[4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-benzamide |
633 | ?353 | Furans-2-carboxylic acid [4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-acid amides |
634 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-pyridin-3-yl methyl-thioureido)-phenyl]-acid amides |
635 | ?439 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-acid amides |
636 | ?492 | N-{4-[3-(3-dimethylamino-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
637 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
638 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-p-methylphenyl-ethyl)-thioureido]-phenyl }-acid amides |
639 | ?445 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-dimethoxy-phenyl)-ethyl] thioureido }-phenyl)-acid amides |
640 | ?506 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-acid amides |
641 | ?516 | N-{4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
642 | ?449 | N-{4-[3-(3,5-two chloro-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
643 | ?449 | N-{4-[3-(3,4-two chloro-phenyl)-thioureido methyl]-phenyl }-2-fluoro-benzamide |
644 | ?448 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-acetylamino-5-chloro-phenyl)-thioureido]-phenyl }-acid amides | |
645 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl] thioureido }-phenyl)-acid amides | |
646 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl-3-phenyl-propyl group)-thioureido]-phenyl }-acid amides | |
647 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl] thioureido }-phenyl)-acid amides | |
648 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-phenyl-butyl)-thioureido]-phenyl }-acid amides | |
649 | ?397 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-indane-1-base-thioureido)-phenyl]-acid amides | |
650 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-methoxyl group-benzyl)-thioureido]-phenyl }-acid amides | |
651 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides | |
652 | ?415 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-methoxyl group-phenyl)-ethyl] thioureido }-phenyl)-acid amides | |
653 | ?506 | N-(4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
654 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-(3-dimethylamino-propyl group)-5-trifluoromethyl-phenyl]-thioureido }-phenyl)-acid amides | |
655 | ?417 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-acid amides | |
656 | ?427 | 2-fluoro-N-{4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-benzamide | |
657 | ?399 | Furans-2-carboxylic acid 4-[3-(2-thiophenyl-ethyl)-thioureido]-phenyl }-benzamide | |
658 | ?381 | 2-fluoro-N-[4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-benzamide | |
659 | ?353 | Furans-2-carboxylic acid [4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-acid amides | |
660 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-pyridin-4-yl methyl-thioureido)-phenyl]-acid amides | |
661 | ?506 | 2-fluoro-N-{4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-benzamide | |
662 | ?478 | Furans-2-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides | |
663 | ?496 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-iodo-benzyl)-thioureido]-phenyl }-acid amides | |
664 | ?479 | N-(4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
665 | ?451 | Furans-2-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides | |
666 | ?445 | N-(4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
667 | ?417 | Furans-2-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides | |
668 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides | |
669 | ?466 | 2-fluoro-N-{4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-benzamide | |
670 | ?438 | Furans-2-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides | |
671 | ?456 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides | |
672 | ?416 | N-{4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-2-fluoro-benzamide |
673 | ?452 | N-(4-{3-[2-(4-dimethylamino-3-methyl-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
674 | ?496 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-dimethylamino-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
675 | ?388 | Furans-2-carboxylic acid 4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
676 | ?406 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two fluoro-benzyls)-thioureido]-phenyl }-acid amides |
677 | ?433 | N-{4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
678 | ?495 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
679 | ?477 | Furans-2-carboxylic acid (4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
680 | ?505 | N-(4-{3-[2-(3-bromo-thiophenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
681 | ?493 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
682 | ?493 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(5-bromo-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
683 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
684 | ?402 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
685 | ?419 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
686 | ?475 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,3-phenylbenzene-propyl group)-thioureido]-phenyl }-acid amides |
687 | ?547 | 2-fluoro-N-(4-{3-[4-(4-methyl-piperazine-1-yl)-3-trifluoromethyl-benzyl]-thioureido }-phenyl)-benzamide |
688 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides |
689 | ?423 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
690 | ?427 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides |
691 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-dimethyl-benzyl)-thioureido]-phenyl }-acid amides |
692 | ?442 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-dimethylamino-3-methyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
693 | ?479 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
694 | ?526 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
695 | ?489 | N-(4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
696 | ?536 | 2-fluoro-N-(4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-benzamide |
697 | ?461 | Furans-2-carboxylic acid (4-{3-[2-(4-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
698 | ?508 | Furans-2-carboxylic acid (4-{3-[2-(4-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
699 | ?408 | Oxazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
700 | ?424 | The thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
701 | ?491 | The thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
702 | ?408 | Oxazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
703 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-phenoxy groups)-ethyl]-thioureido }-phenyl)-acid amides |
704 | ?424 | The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
705 | ?458 | The thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
706 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-phenyl amino-ethyl)-thioureido]-phenyl }-acid amides |
707 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
708 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
709 | ?453 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,6-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
710 | ?485 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two chloro-thiophenyls)-ethyl]-thioureido }-phenyl)-acid amides |
711 | ?503 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-thiophenyl)-ethyl]-thioureido }-phenyl)-acid amides |
712 | ?668 | N-(4-{3-[3-chloro-5-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-phenyl]-thioureido }-phenyl)-[1,2,3] thiadiazoles-4-carboxylic acid amides |
713 | ?413 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-ethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
714 | ?442 | Oxazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
715 | ?475 | Oxazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
716 | ?420 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,4-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
717 | ?452 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
718 | ?435 | Furans-2-carboxylic acid (4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
719 | ?463 | N-(4-{3-[2-(3,4-two chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
720 | ?420 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3,5-two fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
721 | ?412 | 2-fluoro-N-(4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
722 | ?429 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-nitro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
723 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl-2-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
724 | ?437 | N-{4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
725 | ?409 | N-{4-[3-(3,5-dimethyl-benzyl)-thioureido]-phenyl }-2-fluoro-benzamide |
726 | ?400 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-hydroxyl-1-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
727 | ?409 | 2-fluoro-N-{4-[3-(1-methyl isophthalic acid-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
728 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(1-methyl isophthalic acid-phenyl-ethyl)-thioureido]-phenyl }-acid amides |
729 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-chloro-benzyl)-thioureido]-phenyl }-acid amides |
730 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
731 | ?438 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
732 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
733 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
734 | ?479 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
735 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
736 | ?418 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-chloro-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
737 | ?486 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
738 | ?384 | Furans-2-carboxylic acid (4-{3-[2-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
739 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-phenyl)-thioureido]-phenyl }-acid amides |
740 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
741 | ?388 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-fluoro-benzyl)-thioureido]-phenyl }-acid amides |
742 | ?405 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-benzyl)-thioureido]-phenyl }-acid amides |
743 | ?449 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-benzyl)-thioureido]-phenyl }-acid amides |
744 | ?332 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-ethanamide |
745 | ?438 | The thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-benzyls)-thioureido]-phenyl }-acid amides |
746 | ?455 | The thiazole-4-carboxylic acid 4-[3-(2-fluoro-5-trifluoromethyl-benzyl)-thioureido]-phenyl }-acid amides |
747 | ?426 | The thiazole-4-carboxylic acid 4-[3-(the 4-tertiary butyl-benzyl)-thioureido]-phenyl }-acid amides |
748 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
749 | ?374 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
750 | ?526 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenoxy group)-ethyl]-thioureido }-phenyl)-acid amides |
751 | ?409 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-phenyl-ethanamide |
752 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
753 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-3-methoxyl group-benzamide |
754 | ?425 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-methoxyl group-benzamide |
755 | ?429 | 2-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
756 | ?429 | 4-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
757 | ?453 | Acetate 4-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-the phenyl amino formyl radical)-phenyl ester |
758 | ?394 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
759 | ?395 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-Isonicotinamide |
760 | ?410 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-hydroxyl-benzamide |
761 | ?429 | 3-chloro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
762 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
763 | ?520 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2,4-di-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
764 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
765 | ?438 | 4-dimethylamino-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
766 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
767 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(2-fluoro-5-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
768 | ?510 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-iodo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
769 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(4-fluoro-2-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
770 | ?463 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[2-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
771 | ?427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-propyl group]-thioureido }-phenyl)-benzamide |
772 | ?475 | 2-fluoro-N-(4-{3-[(4-fluoro-phenyl)-phenyl-methyl]-thioureido }-phenyl)-benzamide |
773 | ?455 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-amyl group]-thioureido }-phenyl)-benzamide |
774 | ?489 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-2-phenyl-ethyl]-thioureido }-phenyl)-benzamide |
775 | ?409 | 2-fluoro-N-{4-[3-(1-o-tolyl-ethyl)-thioureido]-phenyl }-benzamide |
776 | ?409 | 2-fluoro-N-{4-[3-(tolyl-ethyl between 1-)-thioureido]-phenyl }-benzamide |
777 | ?425 | 2-fluoro-N-(4-{3-[1-(4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
778 | ?412 | 2-fluoro-N-(4-{3-[1-(2-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
779 | ?429 | N-(4-{3-[1-(3-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
780 | ?473 | N-(4-{3-[1-(3-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
781 | ?429 | N-(4-{3-[1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
782 | ?409 | 2-fluoro-N-{4-[3-(1-p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
783 | ?473 | N-(4-{3-[1-(2-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
784 | ?429 | N-(4-{3-[1-(2-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
785 | ?462 | 2-fluoro-N-(4-{3-[1-(2-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
786 | ?462 | 2-fluoro-N-(4-{3-[1-(3-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
787 | ?462 | 2-fluoro-N-(4-{3-[1-(4-trifluoromethyl-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
788 | ?425 | 2-fluoro-N-(4-{3-[1-(2-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
789 | ?425 | 2-fluoro-N-(4-{3-[1-(3-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
790 | ?441 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-2-methyl-propyl group]-thioureido }-phenyl)-benzamide |
791 | ?419 | N-(4-{3-[1-(3-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
792 | ?419 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
793 | ?438 | N-(4-{3-[1-(4-dimethylamino-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
794 | ?438 | N-(4-{3-[1-(3-dimethylamino-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
795 | ?473 | 2-bromo-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
796 | ?446 | The quinaldic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
797 | ?410 | 2-fluoro-N-{4-[3-(2-hydroxyl-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
798 | ?332 | 2-fluoro-N-[4-(3-sec.-propyl-thioureido)-phenyl]-benzamide |
799 | ?445 | 2-fluoro-N-{4-[3-(1-naphthalene-2-base-ethyl)-thioureido]-phenyl }-benzamide |
800 | ?412 | 3-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
801 | ?412 | 4-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
802 | ?384 | 2-fluoro-N-{4-[3-(1-furans-2-base-ethyl)-thioureido]-phenyl }-benzamide |
803 | ?395 | 2-fluoro-N-{4-[3-(1-pyridin-4-yl-ethyl)-thioureido]-phenyl }-benzamide |
804 | ?397 | 2-fluoro-N-(4-{3-[1-(1-methyl isophthalic acid H-pyrroles-2-yl)-ethyl]-thioureido }-phenyl)-benzamide |
805 | ?401 | 2-fluoro-N-{4-[3-(1-thiene-3-yl--ethyl)-thioureido]-phenyl }-benzamide |
806 | ?445 | N-{4-[3-(3-chloro-4-oxyethyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
807 | ?459 | N-{4-[3-(3-chloro-4-propoxy--phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
808 | ?459 | N-{4-[3-(3-chloro-4-isopropoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
809 | ?473 | N-{4-[3-(4-butoxy-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
810 | ?522 | 2-fluoro-N-{4-[3-(3-iodo-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
811 | ?475 | N-{4-[3-(3-bromo-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
812 | ?520 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-iodo-benzamide |
813 | ?346 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-propionic acid amide |
814 | ?286 | N-[4-(3-phenyl-thioureido)-phenyl]-ethanamide |
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
2, add in tetrahydrofuran (THF) (20 milliliters) solution of 5-dichlorphenamide bulk powder (0.16 gram) 1,1 of prepared fresh '-thio-carbonyldiimidazole (0.20 gram), about 30 minutes of stirring at room mixture.In reaction flask, add [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (0.22 gram), stirred the mixture about 6 hours.Solvent removed by evaporation at reduced pressure adds warm acetonitrile (3 milliliters) then.After 15 hours, filtering mixt is used acetonitrile, and the precipitation of collecting with the ether washing is air-dry then, obtains desired white powder product.
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | M+H | The compound title |
816 | ?321 | N-{4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
817 | ?413 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
818 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
819 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
820 | ?443 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
821 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
822 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
823 | ?431 | N-{4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-fluoro-benzamide |
824 | ?437 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
825 | ?511 | 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-the own ester of carboxylamine |
826 | ?481 | Caproic acid 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
827 | ?505 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
828 | ?477 | Furans-2-carboxylic acid 4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides |
829 | ?501 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2 methyl-benzamide |
830 | ?517 | N-{4-[3-(5-bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
831 | ?395 | N-{4-[3-(5-chloro-2-oxyethyl group-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
832 | ?395 | N-{4-[3-(5-chloro-4-oxyethyl group-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
833 | ?423 | N-{4-[3-(2-butoxy-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
834 | ?423 | N-{4-[3-(2-butoxy-5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
??835 | ??457 | N-{4-[3-(2-benzyloxy-5-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
??836 | ??457 | N-{4-[3-(4-benzyloxy-5-chloro-2-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
??837 | ??421 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-acid amides |
??838 | ??424 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-5-methoxyl group-phenoxy group }-ethanamide |
??839 | ??367 | N-{4-[3-(5-chloro-2-hydroxyl-4-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
??840 | ??367 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-ethanamide |
??841 | ??447 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
??842 | ??426 | N-(4-{3-[3-chloro-4-(methyl-phenyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
??843 | ??509 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-ethanamide |
??844 | ??418 | N-(4-{3-[3-chloro-4-(cyclopentyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
??845 | ??433 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-tetramethyleneimine-3-yl)-amino]-phenyl }-thioureido)-phenyl]-ethanamide |
??846 | ??419 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-acid amides |
??847 | ??447 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??848 | ??465 | N-{4-[3-(3-chloro-4-methylthio group-phenyl)-thioureido]-phenyl }-2,6-two fluoro-benzamide |
??849 | ??445 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??850 | ??441 | N-{4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-2-methyl-benzamide |
??851 | ??434 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-acid amides |
??852 | ??444 | N-{4-[3-(3-chloro-4-dimethylamino-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
??853 | ??517 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-acid amides |
??854 | ??579 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-{4[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-acid amides |
??855 | ??527 | N-[4-(3-{3-chloro-4-[methyl-(1-methyl-piperidin-4-yl)-amino]-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
??856 | ??435 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(5-chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
??857 | ??589 | N-[4-(3-{4-[(1-benzyl-tetramethyleneimine-3-yl)-methyl-amino]-3-chloro-phenyl }-thioureido)-phenyl]-2-fluoro-benzamide |
??858 | ??501 | Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-acid amides |
??859 | ??366 | 2-fluoro-N-[4-(3-phenyl-thioureido)-phenyl]-benzamide |
??860 | ??338 | Furans-2-carboxylic acid [4-(3-phenyl-thioureido)-phenyl]-acid amides |
??861 | ??356 | [1,2,3] thiadiazoles-4-carboxylic acid [4-(3-phenyl-thioureido)-phenyl]-acid amides |
??862 | ??365 | N-(4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-ethanamide |
863 | ?435 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
864 | ?365 | N-(4-{3-[3-chloro-4-(2-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-ethanamide |
865 | ?445 | N-(4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
866 | ?417 | Furans-2-carboxylic acid (4-{3-[3-chloro-4-(1-hydroxyl-ethyl)-phenyl]-thioureido }-phenyl)-acid amides |
867 | ?371 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-amino-phenyl)-thioureido]-phenyl }-acid amides |
868 | ?501 | Furans-2-carboxylic acid 4-[3-(3-bromo-4-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
869 | ?423 | N-{4-[3-(the 3-tertiary butyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
870 | ?440 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
974 | ?485 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-trifluoromethyl-benzamide |
975 | ?412 | N-(4-fluoro-phenyl)-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-benzamide |
976 | ?446 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
977 | ?468 | Isoquinoline 99.9-1-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
978 | ?506 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
979 | ?453 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
980 | ?435 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
981 | ?457 | Cumarone-2-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
982 | ?495 | Cumarone-2-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
983 | ?442 | Cumarone-2-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
984 | ?446 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
985 | ?468 | Isoquinoline 99.9-3-carboxylic acid 4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-acid amides |
986 | ?453 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
987 | ?506 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
988 | ?446 | Quinoline-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
989 | ?446 | The Cinchonic Acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
990 | ?446 | QUINOLINE-6-CARBOXYLIC ACID (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
991 | ?446 | Quinoline-8-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
992 | ?462 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-methyl fluoride-benzamide |
993 | ?419 | 2-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
994 | ?473 | N-{4-[3-(3-chloro-4-isobutoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
995 | ?414 | 2-fluoro-N-{4-[3-(3-fluoro-4-methoxyl group-phenyl)-thioureido]-phenyl }-benzamide |
996 | ?475 | N-(4-{3-[3-chloro-4-(2-methoxyl group-oxyethyl group)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
997 | ?398 | 2-fluoro-N-{4-[3-(3-fluoro-4-methyl-phenyl)-thioureido]-phenyl }-benzamide |
998 | ?464 | 2-fluoro-N-{4-[3-(4-methyl-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
999 | ?449 | N-{4-[3-(2-amino-5-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1000 | ?459 | N-(4-{3-[1-(3-chloro-4-methoxyl group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1001 | ?417 | N-{4-[3-(5-chloro-2-hydroxyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1002 | ?435 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1003 | ?448 | 2-fluoro-N-{4-[3-(4-methyl-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-benzamide |
1004 | ?473 | (S)-N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1005 | ?473 | N-(4-{3-[(1 R)-1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1006 | ?494 | 2-fluoro-N-(4-{3-[2-methoxyl group-4-(2,2,2-three fluoro-oxyethyl groups)-phenyl]-thioureido }-phenyl)-benzamide |
1007 | ?399 | N-{4-[3-(2-amino-5-fluoro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
1008 | ?502 | N-(4-{3-[1-(4-dimethylamino alkylsulfonyl phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1009 | ?542 | 2-fluoro-N-[4-(3-{1-[4-(piperidines-1-alkylsulfonyl)-phenyl]-ethyl }-thioureido)-phenyl]-benzamide |
1010 | ?562 | N-(4-{3-[2,4-two (2,2,2-three fluoro-oxyethyl groups)-phenyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1011 | ?409 | 2-fluoro-N-{4-[3-((1S) little p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
1012 | ?409 | 2-fluoro-N-{4-[3-((1R)-1-p-methylphenyl-ethyl)-thioureido]-phenyl }-benzamide |
1013 | ?394 | 2-fluoro-N-{4-[3-((1S)-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
1014 | ?429 | N-(4-{3-[(1R)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1015 | ?429 | N-(4-{3-[(1S)-1-(4-chloro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
1016 | ?394 | 2-fluoro-N-{4-[3-((1R)-1-phenyl-ethyl)-thioureido]-phenyl }-benzamide |
1017 | ?432 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
1018 | ?447 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
1019 | ?485 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-phenyl)-2-methoxyl group-benzamide |
1020 | ?419 | 3-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
1021 | ?462 | N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-4-trifluoromethyl-benzamide |
1022 | ?419 | 4-cyano group-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-benzamide |
1023 | ?469 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,3,5,6-tetramethyl--phenyl)-benzamide |
??1024 | ??480 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-2-fluoro-benzamide | |
??1025 | ??473 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-benzamide | |
??1026 | ??530 | N-{3,5 two chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide | |
??1027 | ??447 | N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2,5-dimethoxy-phenyl)-2-fluoro-benzamide | |
??1028 | ??480 | 2,3,4,5-tetrafluoro-N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide | |
??1029 | ??462 | 2,4,5-three fluoro-N-(3-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide | |
??1030 | ??427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-benzamide | |
??1031 | ??457 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methoxyl group-5-methyl-phenyl)-benzamide | |
??1032 | ??443 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methoxyl group-phenyl)-benzamide | |
??1033 | ??570 | N-(2,6-two bromo-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-3-methyl-phenyl)-2-fluoro-benzamide | |
??1034 | ??480 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-benzamide | |
??1035 | ??541 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-2-fluoro-benzamide | |
??1036 | ??487 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-2-fluoro-benzamide | |
??1037 | ??503 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-trifluoromethyl-phenyl }-2-fluoro-benzamide | |
??1038 | ??447 | N-(2-chloro-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1039 | ??454 | N-(2-chloro-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1040 | ??437 | N-(2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1041 | ??498 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-the 2-cyano-phenyl)-2-fluoro-benzamide | |
??1042 | ??445 | N-(2-cyano group-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1043 | ??460 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-cyano group-phenyl }-2-fluoro-benzamide | |
??1044 | ??517 | N-(2-benzoyl-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1045 | ??427 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-benzamide | |
??1046 | ??487 | N-(4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-2-fluoro-benzamide | |
??1047 | ??434 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-2-fluoro-benzamide | |
??1048 | ??449 | N-{4-[3-(1-cumarone-2-base-ethyl)-thioureido]-2-methyl-phenyl }-2-fluoro-benzamide | |
??1049 | ??456 | N-(2-dimethylamino-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1050 | ??526 | N-(2-benzyloxy-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1051 | ??519 | N-(2-benzyloxy-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide | |
??1052 | ??603 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-2-fluoro-benzamide |
??1053 | ??603 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-2-fluoro-benzamide |
??1054 | ??542 | 2-fluoro-N-[4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-(2-morpholine-4-base-oxyethyl group)-phenyl]-benzamide |
??1055 | ??485 | N-(2-butoxy-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1056 | ??492 | N-(2-butoxy-4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1057 | ??589 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-diethylamino-oxyethyl group)-phenyl]-2-fluoro-benzamide |
??1058 | ??528 | N-(2-(2-diethylamino-oxyethyl group)-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1059 | ??589 | N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-diethylamino-oxyethyl group)-phenyl]-2-fluoro-benzamide |
??1060 | ??457 | N-(2-oxyethyl group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-2-fluoro-benzamide |
??1061 | ??464 | N-(4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-oxyethyl group-phenyl)-2-fluoro-benzamide |
??1062 | ??468 | 2-fluoro-N-[4-{3-[1-(4-bromo-phenyl)-ethyl]-thioureido }-2-(2-nitrilo-oxyethyl group)-phenyl]-benzamide |
??1063 | ??475 | N-[4-{3-[1-(4-cyano group-phenyl)-ethyl]-thioureido }-2-(2-nitrilo-oxyethyl group)-phenyl]-2-fluoro-benzamide |
??1064 | ??443 | 2-fluoro-N-(4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methoxyl group-phenyl)-benzamide |
??1065 | ??489 | 2-fluoro-N-(5-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-biphenyl-2-yl)-benzamide |
??1066 | ??514 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
??1067 | ??503 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
??1068 | ??514 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-trifluoromethyl-phenyl)-acid amides |
??1069 | ??471 | Isoquinoline 99.9-1-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1070 | ??460 | Cumarone-2-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1071 | ??471 | Isoquinoline 99.9-3-carboxylic acid (2-cyano group-4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1072 | ??460 | Isoquinoline 99.9-1-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
??1073 | ??449 | Cumarone-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
??1074 | ??460 | Isoquinoline 99.9-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-2-methyl-phenyl)-acid amides |
??1075 | ??396 | Pyrazine-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1076 | ??401 | Thiophene-2-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1077 | ??401 | Thiophene-3-carboxylic acid (4-{3-[1-(4-fluoro-phenyl)-ethyl]-thioureido }-phenyl)-acid amides |
??1078 | ??500 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1079 | ??466 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1080 | ??466 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1081 | ??534 | 2-sec.-propyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1082 | ??480 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1083 | ??514 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1084 | ??480 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1085 | ??548 | 2-butyl-thiazole-4-carboxylic acid 4-[3-(3,4-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1086 | ??438 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1087 | ??438 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1088 | ??505 | 2-methyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1089 | ??534 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(4-chloro-3-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1090 | ??500 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1091 | ??500 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
??1092 | ??568 | 2-phenyl-thiazole-4-carboxylic acid 4-[3-(3,5-di-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
??1093 | ??401 | 2-fluoro-N-{4-[3-(1-thiazol-2-yl-ethyl)-thioureido]-phenyl }-benzamide |
??1094 | ??588 | 2-fluoro-N-[4-(3-{1-[1-(toluene-4-alkylsulfonyl)-1H-indoles-2-yl]-ethyl }-thioureido)-phenyl]-benzamide |
??1095 | ??446 | 2-fluoro-N-{4-[3-(1-quinoline-2-base-ethyl)-thioureido]-phenyl }-benzamide |
??1096 | ??446 | 2-fluoro-N-{4-[3-(1-quinolyl-4-ethyl)-thioureido]-phenyl }-benzamide |
??1097 | ??446 | 2-fluoro-N-{4-[3-(1-isoquinoline 99.9-3-base-ethyl)-thioureido]-phenyl }-benzamide |
??1098 | ??446 | 2-fluoro-N-{4-[3-(1-isoquinolyl-1-ethyl)-thioureido]-phenyl }-benzamide |
??1099 | ??446 | 2-fluoro-N-{4-[3-(1-quinoline-6-base-ethyl)-thioureido]-phenyl }-benzamide |
??1100 | ??446 | 2-fluoro-N-{4-[3-(1-quinoline-3-base-ethyl)-thioureido]-phenyl }-benzamide |
??1101 | ??413 | 2-methoxyl group-N-{4-[3-(1-thiene-3-yl--ethyl)-thioureido]-phenyl }-benzamide |
Embodiment 871 (method 33)
[1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides
3, add in tetrahydrofuran (THF) (20 milliliters) solution of 5-dichlorphenamide bulk powder (0.16 gram) 1,1 of prepared fresh '-thiocarbonyl-two-(1,2,4)-triazole (0.20 gram), about 30 minutes of stirring at room mixture.In reaction flask, add [1,2,3]-thiadiazoles-4-carboxylic acid (4-amino-phenyl) acid amides (0.22 gram), stirred the mixture about 6 hours.Solvent removed by evaporation at reduced pressure adds hot acetonitrile (3 milliliters) then.15 hours after-filtration mixtures are used acetonitrile, and the precipitation of collecting with the ether washing is air-dry then, obtains desired white powder product.[M+H]424。
Use said procedure and suitable parent material to prepare following compounds:
Embodiment number | ??M+H | The compound title |
872 | ?465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-fluoro-benzamide |
873 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-methoxyl group-benzamide |
874 | ?465 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
875 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-3-methoxyl group-benzamide |
876 | ?399 | N-{4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
877 | ?365 | N-{4-[3-(3-chloro-4-methoxyl group-5-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
878 | ?331 | N-{4-[3-(2-nitro-phenyl)-thioureido]-phenyl }-ethanamide |
879 | ?331 | N-{4-[3-(4-nitro-phenyl)-thioureido]-phenyl }-ethanamide |
880 | ?477 | N-{4-[3-(3,5-two chloro-4-methoxyl group-phenyl)-thioureido]-phenyl }-4-methoxyl group-benzamide |
881 | ?351 | N-{4-[3-(2-chloro-5-methoxyl group-phenyl)-thioureido]-phenyl }-ethanamide |
882 | ?428 | 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethanamide |
883 | ?443 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-methyl acetate |
884 | ?457 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-ethyl acetate |
885 | ?447 | N-{4-[3-(3,5-two chloro-4-phenoxy group-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethanamide |
886 | ?410 | N-(4-{3-[3,5-two chloro-4-(2-nitrilo-oxyethyl group)-phenyl]-thioureido }-phenyl-ethanamide |
887 | ?485 | 4-[3-(4-acetylamino-phenyl)-thioureido] and-2,6-two chloro-phenoxy groups }-tert.-butyl acetate |
888 | ?469 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,5-two chloro-2-methoxyl group-4-methyl-phenyl)-thioureido]-phenyl }-acid amides |
889 | ?335 | N-{4-[3-(3-chloro-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
890 | ?335 | N-{4-[3-(5-chloro-2-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
891 | ?703 | N-{4-[3-(4-{4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-diphenyl disulfide base }-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
892 | ?369 | N-{4-[3-(3,5-two chloro-4-methyl-phenyl)-thioureido]-phenyl }-ethanamide |
893 | ?598 | N-{4-[3-(3,5-two iodo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
894 | ?504 | N-{4-[3-(3,5-two bromo-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-ethanamide |
895 | ?317 | N-{4-[3-(6-methoxyl group-pyridin-3-yl)-thioureido]-phenyl }-ethanamide |
896 | ?347 | N-{4-[3-(2,6-dimethoxy-pyridin-3-yl)-thioureido]-phenyl }-ethanamide |
897 | ?457 | Acetate 2-{4-[3-(4-acetylamino-phenyl)-thioureido]-2,6-two chloro-phenoxy groups }-ethyl ester |
898 | ?365 | 4-[3-(4-acetylamino-phenyl)-thioureido]-2-chloro-phenylformic acid |
899 | ?346 | N-{4-[3-(3-chloro-4-cyano group-phenyl)-thioureido]-phenyl }-ethanamide |
900 | ?512 | N-(4-{3-[5-chloro-2-(4-chloro-phenoxy group)-4-pyrroles-1-base-phenyl]-thioureido }-phenyl)-ethanamide |
901 | ?355 | N-{4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
902 | ?339 | N-{4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-ethanamide |
903 | ?447 | N-{4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-ethanamide |
904 | ?400 | N-{4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-ethanamide |
905 | ?424 | N-[4-(3-{4-[two-(2-hydroxyl-ethyl)-amino]-3-chloro-phenyl }-thioureido)-phenyl]-ethanamide |
906 | ?434 | N-(4-{3-[3-chloro-4-(hexyl-methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
907 | ?406 | N-(4-{3-[3-chloro-4-(isobutyl--methyl-amino)-phenyl]-thioureido }-phenyl)-ethanamide |
908 | ?389 | N-{4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-ethanamide |
909 | ?441 | Furans-2-carboxylic acid 4-[3-(3-bromo-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
910 | ?459 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-acid amides |
911 | ?469 | N-{4-[3-(3-chloro-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
912 | ?435 | N-{4-[3-(3,4-dichlor-4-trifluoromethyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
913 | ?407 | Furans-2-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
914 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
915 | ?480 | N-{4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
916 | ?527 | N-{4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
917 | ?452 | Furans-2-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
918 | ?499 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides |
919 | ?391 | Furans-2-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
920 | ?470 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-bromo-3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
921 | ?517 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-iodo-phenyl)-thioureido]-phenyl }-acid amides |
922 | ?419 | N-{4-[3-(3-chloro-4-f fluoro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
923 | ?409 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
924 | ?388 | N-{4-[3-(3-chloro-4-isoxazole-5-base-phenyl)-thioureido]-phenyl }-ethanamide |
925 | ?387 | N-(4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-ethanamide |
926 | ?355 | N-{4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
927 | ?435 | N-{4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-ethanamide |
928 | ?407 | Furans-2-carboxylic acid 4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
929 | ?425 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(2,3-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
930 | ?355 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
931 | ?435 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
932 | ?407 | Furans-2-carboxylic acid 4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
933 | ?355 | N-{4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-ethanamide |
934 | ?435 | N-{4-[3-(2,5-two chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
935 | ?407 | Furans-2-carboxylic acid 4-[3-(3,5-two chloro-phenyl)-thioureido]-phenyl }-acid amides |
936 | ?390 | N-{4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-ethanamide |
937 | ?470 | 2-fluoro-N-{4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-benzamide |
938 | ?442 | Furans-2-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides |
939 | ?460 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3,4,5-three chloro-phenyl)-thioureido]-phenyl }-acid amides |
940 | ?458 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-4-isoxazole-5-base-phenyl)-thioureido]-phenyl }-acid amides |
941 | ?457 | [1,2,3] thiadiazoles-4-carboxylic acid (4-{3-[3-chloro-4-(1H-pyrazole-3-yl)-phenyl]-thioureido }-phenyl)-acid amides |
942 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
943 | ?373 | Furans-2-carboxylic acid 4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-acid amides |
944 | ?401 | N-{4-[3-(3-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
945 | ?373 | Furans-2-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides |
946 | ?401 | N-{4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
947 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(4-chloro-phenyl)-thioureido]-phenyl }-acid amides |
948 | ?401 | N-{4-[3-(2-chloro-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
949 | ?396 | 3-(3-{4-[(4-furans-2-carbonyl)-amino]-phenyl }-thioureido)-methyl benzoate |
950 | ?424 | 3-{3-[4-(2-fluoro-benzoyl-amido)-phenyl]-thioureido }-methyl benzoate |
951 | ?414 | 3-(3-{4-[([1,2,3] thiadiazoles-4-carbonyl)-amino]-phenyl }-thioureido)-methyl benzoate |
952 | ?409 | N-[4-[[[[3-(aminocarboxyl)-phenyl] amino] sulphomethyl] amino] phenyl]-2-fluoro-benzamide |
953 | ?373 | Furans-2-carboxylic acid 4-[3-(2-chloro-phenyl)-thioureido]-phenyl }-acid amides |
954 | ?381 | Furans-2-carboxylic acid 4-[3-(3-formamyl-phenyl)-thioureido]-phenyl }-acid amides |
955 | ?399 | [1,2,3] thiadiazoles-4-carboxylic acid 4-[3-(3-formamyl-phenyl)-thioureido]-phenyl }-acid amides |
956 | ?391 | [1,2,3] thiadiazoles-4-carboxylic acid { 4-[3-(2-chloro-phenyl)-} thioureido]-phenyl }-acid amides |
957 | ?356 | Furans-2-carboxylic acid 4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-acid amides |
958 | ?383 | Furans-2-carboxylic acid 4-[3-(3-nitro-phenyl)-thioureido]-phenyl }-acid amides |
959 | ?411 | 2-fluoro-N-{4-[3-(3-nitro-phenyl)-thioureido]-phenyl }-benzamide |
960 | ?422 | Furans-2-carboxylic acid 4-[3-(3-trifluoromethoxy-phenyl)-thioureido]-phenyl }-acid amides |
961 | ?450 | 2-fluoro-N-{4-[3-(3-trifluoromethoxy-phenyl)-thioureido]-phenyl }-benzamide |
962 | ?384 | 2-fluoro-N-{4-[3-(3-fluoro-phenyl)-thioureido]-phenyl }-benzamide |
963 | ?410 | 3-{3-[4-(2-fluoro-benzoyl-amido)-thioureido]-phenyl }-phenylformic acid |
964 | ?382 | 3-(3-{4-[(furans-2-carbonyl)-amino]-phenyl }-thioureido)-phenylformic acid |
965 | ?408 | N-{4-[3-(3-ethanoyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
966 | ?502 | N-{4-[3-(3-butyl amino-sulfonyl-phenyl)-thioureido]-phenyl }-2-fluoro-benzamide |
967 | ?380 | Furans-2-carboxylic acid 4-[3-(3-ethanoyl-phenyl)-thioureido]-phenyl }-acid amides |
968 | ?447 | Furans-2-carboxylic acid (4-{3-[3-(2-hydroxyl-ethylsulfonyl)-phenyl]-thioureido }-phenyl)-acid amides |
969 | ?475 | 2-fluoro-N-(4-{3-[3-(2-hydroxyl-ethylsulfonyl)-phenyl]-thioureido }-phenyl)-benzamide |
970 | ?474 | Furans-2-carboxylic acid 4-[3-(3-butyl amino-sulfonyl-phenyl)-thioureido]-phenyl }-acid amides |
Embodiment 971 (method 57)
1-(4-fluoro-phenyl)-2-methyl-third-1-alcohol
In ether (40 milliliters) solution of 0 ℃ 4-fluorobenzaldehyde (2.0 gram), drip while stirring the bromination isopropyl-magnesium (2.0M, 9.6ml).1.5 after hour,, use extracted with diethyl ether with aqueous ammonium chloride solution cancellation reaction.Wash ethereal extract with saturated sodium-chloride, use anhydrous magnesium sulfate drying, filtration and evaporation obtain oil.With silica gel column chromatography purifying oil,, obtain yellow oil product (1.76 gram) with 10% methylene dichloride-hexane wash-out.
Embodiment 972 (method 58)
1-(4-fluoro-phenyl)-2-methyl-third-1-ketone
In acetone (10 milliliters) solution of 0 ℃ 1-(4-fluoro-phenyl)-2-methyl-third-1-alcohol (1.6 gram), drip Jones reagent (20ml) while stirring.After 10 minutes, add Virahol and destroy excessive Jones reagent.Add ether, add anhydrous magnesium then, filtering mixt, evaporation obtains yellow oil product (1.2 gram).
Embodiment 973 (method 59)
3-dimethylamino-5-trifluoromethyl-benzonitrile
At the N of 3-dimethylamino-5-methyl bromobenzene trifluoride (7.3 gram), add cuprous cyanide (2.7 gram) in dinethylformamide (20 milliliters) solution, reflux mixture 12 hours.Water (40 milliliters) diluting reaction thing adds methylene dichloride.Use dense ammonium hydroxide, wash the methylene dichloride component then with water.Use anhydrous magnesium sulfate drying solution, concentrate, obtain yellow solid,, obtain yellow solid (4.7 gram) its recrystallization in hexane.
Tested the activity of above-claimed cpd as the simplexvirus inhibitor.
Human cytomegalic inclusion disease virus
Volume analysis.With HCMV wild-type (usually to be equivalent to 0.2 infection multiplicity) infection human foreskin fibroblast monolayer culture thing under inhibitor compound (different concns).Infected back 3 days, and, be determined at the viral total amount that produces in these cultures in the 12-well culture plate by the human foreskin fibroblast virus (in the presence of the unrestraint agent, carrying out) of collecting and titration is cultivated.Infect the quantitative plaque in 2 week backs.By existing under the situation of compound and not having the minimizing that the titre in the presence of the compound compares the viral yield titre, identify the inhibitor of HCMV.In this test, a kind of HCMV-of antagonism mutually of inhibitor is active usually by calculating IC
50Or IC
90Value (that is, respectively viral yield being reduced by 50% or 90% required compound amount) is determined.Table I has been described the IC of the compound of measuring at HCMV
50Data.
The microtiter plate test.In the presence of inhibitor compound, (its genome contains protokaryon beta-Glucuronidase gene (Jefferson with a kind of HCMV recombination mutation virus, R.A., S.M.Burgess, and D.Hirsh, 1986, from intestinal bacteria, as the beta-Glucuronidase of gene fusion mark, Proc.Natl.Acad.Sci.USA83:8447-8451), its expression is controlled by viral promotors), the fibroblastic 96-orifice plate of infected person foreskin culture.An example of this virus be RV145 virus (Jones, T.R., V.P.Muzithras and Y.Gluzman1991, the displacement mutagenesis of human cytomegalovirus gene group: US10 and US11 gene product are nonessential, J.Virol.65:5860-5872).Because it is in the control of viral promotors, it is the indirect index that HCMV grows and duplicates that beta-Glucuronidase is expressed in this test.In infection back 96 hours, the cell lysate that preparation is infected is (with 50mM sodium phosphate [pH7.0], contain 0.1%Triton X-100 and 0.1% sodium lauryl sulphate), measure the beta-Glucuronidase activity with enzyme substrates (when cutting, obtaining under spectrophotometer, to measure or under microfluorimeter, using the product of fluoroscopic examination) with development process.The example of these substrates is respectively p-nitrophenyl-β-D-glucuronide and methyl Umbrella shape base glucuronide.The existence of the minimizing indication antiviral compound of comparing when residing the beta-Glucuronidase expression of gene with the unrestraint agent with the HCMV genome.Like this, the corresponding minimizing of generation of chromophoric group or fluorophore product in this test.The data that this test uses the inhibitor compound of different amounts to produce also are used for estimating the IC of inhibitor compound
50
HSV antiviral (ELISA) test
In the tissue culturing plate of 96-hole, replenished the tissue culture medium (TCM) DMEM (the improvement Eale substratum of Dulbecco) of 2% foetal calf serum (FBS) with every hole 100 microlitres, wherein contain 3.5 * 10
4Vero cell (ATCC#CCL-81).37 ℃ of overnight incubation are (at 5%CO
2In) after, infected preceding 30 minutes with HSV-1 (infection multiplicity is equivalent to 0.006), do not handle, or with the standard drug control treatment cell of test compounds (different concns) or reference.Infect the back at 37 ℃ (at 5%CO
2In) incubation is after about 24 hours, fixed cell is used for the ELISA test.First antibody is mouse anti-HSV glycoprotein D mono-clonal first antibody, and two anti-be that the goat that is connected with beta-galactosidase enzymes resists-mouse IgG.Therefore, after adding methyl Umbrella shape base β-D-galactoside (Sigma#M1633) substrate, go up quantitative 4-methylumbelliferone fluorescence cleaved products, measure the virus replication degree at microfluorimeter (excite 365 nanometers, launch 450 nanometers).Fluorescence that obtains when relatively not having compound and the fluorescence that obtains when compound is arranged are determined the antiviral activity (IC of test compounds
50).Table I has shown data.
VZV antiviral (ELISA) test
In order to produce the original seed VZV that uses in test, infect human foreskin fibroblast (HFF) cell with VZV strain Ellen (ATCC#VR-1367) with low infection multiplicity (less than 0.1), and at 37 ℃ of (5%CO
2) in be incubated overnight.Spend the night behind the incubation, collect the mixture of the HFF cells infected that has not infected and infected VZV, and be added in each hole of 96-well culture plate and go that (100 microlitres are supplemented with among the DMEM of 2%FBS and contain 3.5 * 10
4Individual cell), the standard drug contrast (100 microlitres in every hole have replenished among the DMEM of 2%FBS) of test compounds or reference is contained in each hole.At 37 ℃ of (5%CO
2) cultivated these cells 3, be fixed for the ELISA test then.First antibody be mouse anti-VZV glycoprotein I I monoclonal antibody (Applied Biosystems, Inc.#13-145-100), two anti-be that the goat that is connected with beta-galactosidase enzymes resists-mouse IgG.Therefore, after adding methyl Umbrella shape base β-D-galactoside (Sigma#M1633) substrate, go up quantitative 4-methylumbelliferone fluorescence cleaved products, measure the virus replication degree at microfluorimeter (excite 365 nanometers, launch 450 nanometers).Fluorescence that obtains when relatively not having compound and the fluorescence that obtains when compound is arranged are determined the antiviral activity (IC of test compounds
50).Table I has shown data.
Example I C50 IC50 suppresses % IC50
μg/ml????????(μg/ml)????????10μg/ml??????(μg/ml)
HCMV????????????HSV?????????????VZV???????????VZV
276????????????>10????????????>10????????????75????????????4
287????????????>50????????????8???????????????5?????????????>10
294????????????>10????????????>50????????????0?????????????>10
296????????????8???????????????1.2?????????????48????????????>10
302????????????>10????????????10??????????????5?????????????>10
304????????????7???????????????8???????????????44????????????11
306????????????2.5?????????????>10????????????33????????????>10
307????????????5???????????????>10????????????30????????????>10
308????????????10??????????????10??????????????100???????????4
311????????????6???????????????12??????????????13????????????>10
320????????????8???????????????8???????????????50????????????>10
324????????????8???????????????4???????????????24????????????>10
328????????????>10????????????>10????????????44????????????>10
339????????????50??????????????>50????????????11????????????>10
356????????????0.4?????????????0.5?????????????72????????????1.9
382????????????>10????????????>10????????????46????????????>10
390????????????>10????????????0.5?????????????61????????????>10
858????????????2???????????????2.5?????????????26????????????>10
Therefore, compound of the present invention is the potent inhibitor that simplexvirus (comprising HCMV, VZV and HSV) grows and duplicates, and effectively suppresses viral yield.
According to the present invention, compound of the present invention can be applied to the patient who infects simplexvirus (comprising HCMV, VZV and HSV) with significant quantity, suppress virus.Therefore, compound of the present invention can be used for improving or eliminating the herpesvirus infection symptom of Mammals (including but not limited to the people).
Compound of the present invention can be pure or and conventional medicine learn carrier and be applied to patient together.
Spendable solid carrier comprises one or more materials, and they are also as perfume compound, lubricant, solubilizing agent, suspension agent, filler, glidant, compression auxiliary material, tackiness agent or tablet-disintegrating agent or encapsulated materials.With powder type, carrier can be superfine solid, and it mixes with superfine activeconstituents.With tablet form, the carrier with required compression performance of activeconstituents and proper ratio mixes, and is pressed into desired shape and size.Powder and tablet preferably contain and reach 99% activeconstituents.Suitable solid-state carrier for example comprises: calcium phosphate, Magnesium Stearate, talcum, sugar, lactose, dextrin, starch, gelatin, Mierocrystalline cellulose, methylcellulose gum, carboxylic acid methyl sodium cellulosate, polyvinylpyrrolidone/, low melt wax and ion exchange resin.
Liquid vehicle can be used for preparing solution, suspension, emulsion, syrup and elixir.Activeconstituents of the present invention dissolves in or is suspended in acceptable carrier on the pharmacology, as water, organic solvent, both mixture or pharmacology in acceptable oil or the fat.Liquid vehicle can contain other suitable pharmacology additive, as solubilizing agent, emulsifying agent, buffer reagent, sanitas, sweeting agent, reodorant, suspension agent, thickening material, pigment, viscosity modifier, stablizer or Osmolyte regulator.Liquid vehicle oral or that the parenteral dispenser is suitable comprises that water (particularly contains above-mentioned additive, as derivatived cellulose, the preferably carboxymethyl cellulose sodium solution), alcohol (comprising monohydroxy-alcohol and polyvalent alcohol) and derivative thereof as glycol, and oil (as fractionated Oleum Cocois and peanut oil).For the parenteral dispenser, carrier can also be a grease, as ethyl oleate and Isopropyl myristate.Sterile liquid carrier is used for the sterile liquid form composition that parenteral is used.
But the liquid medicine composition of sterile liquid or suspensions is used in intramuscular, intraperitoneal or subcutaneous injection.Also but intravenously is used sterile solution.Oral dispenser can be liquid state or solid-state composition form.
Preferred pharmaceutical compositions is single agent form, as tablet or capsule.The composition of this form is divided into the unitary dose that contains an amount of activeconstituents again; Unit dosage form can be a packaged composition, as powder, tubule, ampoule, prepackage syringe of packing or the pouch that contains liquid.Unit dosage for example can be: capsule or tablet itself maybe can be these compositions of an amount of any packaged form.
Must in the treatment of herpesvirus infection, determine the used effective dosage of treatment according to the personal considerations by the doctor who participates in.Relevant factor comprises patient's situation, age and body weight.The novel method that the present invention treats herpesvirus infection comprises the compound of using (comprising the mankind) at least a formula I of significant quantity to individual, or it is nontoxic, acceptable salt on the pharmacology.But these compounds are used in oral cavity, rectum, parenteral or external application (to skin or mucous membrane).General consumption every day is determined by particular compound, methods of treatment and patient.General every day consumption for oral be 0.01-1000 milligram/kilogram, preferred 0.5-500 milligram/kilogram, using for parenteral is 0.1-100 milligram/kilogram, preferably 0.5-50 milligram/kilogram.
Claims (20)
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
R
9-R
12Be respectively perhaloalkyl radical, the halogen of alkyl, a 1-4 carbon atom of hydrogen, a 1-4 carbon atom, the alkoxyl group or the cyano group of a 1-4 carbon atom, or R
9And R
10Or R
11And R
12Can form the aryl of 5-7 carbon atom altogether; Condition is R
9-12In at least one is not a hydrogen;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 1-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology.
2. compound as claimed in claim 1 is characterized in that R
1-R
5Be respectively alkyl, the halogen of hydrogen, a 1-6 carbon atom, perhaloalkyl radical, the OR of a 1-6 carbon atom
6Or N (R
7R
8).
3. compound as claimed in claim 1 is characterized in that R
1, R
2And R
3Be hydrogen, and R
4And R
5Be respectively halogen or CF
3
4. compound as claimed in claim 1 is characterized in that R
1, R
2And R
4Be hydrogen, and R
3And R
5Be respectively halogen or CF
3
5. compound as claimed in claim 1 is characterized in that, G is thiazolyl, thiadiazolyl group, oxazolyl or furyl.
6. compound as claimed in claim 5 is characterized in that G is a furyl.
7. compound as claimed in claim 1 is characterized in that R
9-R
12Be respectively hydrogen, halogen, methyl, methoxyl group and cyano group.
8. compound as claimed in claim 1 is characterized in that X is a key.
9. compound as claimed in claim 1 is characterized in that X is a straight chained alkyl.
10. compound as claimed in claim 1 is characterized in that, X is the alkyl of 1-4 carbon atom.
11. compound as claimed in claim 1 is characterized in that, this compound is selected from:
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido] and-2,5-dimethoxy-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-trifluoromethyl-phenyl }-acid amides
Furans-2-carboxylic acid 3-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 5-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-hydroxyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-cyano group-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-5-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-3-methoxyl group-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-trifluoromethyl-phenyl }-acid amides
Furans-2-carboxylic acid 2-chloro-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-cyano group-phenyl }-acid amides
5-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-[(furans-2-carbonyl)-amino]-phenylformic acid
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-phenyl amino formyl radical-phenyl }-acid amides
Furans-2-carboxylic acid 2-benzoyl-4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methyl-phenyl }-acid amides
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-naphthalene-1-yl }-acid amides; With
Furans-2-carboxylic acid 4-[3-(5-chloro-2,4-dimethoxy-phenyl)-thioureido]-2-methoxyl group-phenyl }-acid amides, or the salt on its pharmacology.
12. a pharmaceutical composition is characterized in that, this pharmaceutical composition contains the compound of following formula:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R on the monocycle
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
R
9-R
12Be respectively perhaloalkyl radical, the halogen of alkyl, a 1-4 carbon atom of hydrogen, a 1-4 carbon atom, the alkoxyl group or the cyano group of a 1-4 carbon atom, or R
9And R
10Or R
11And R
12Can form the aryl of 5-7 carbon atom altogether; Condition is R
9-R
12In at least one is not a hydrogen;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 2-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or acceptable carrier or thinner on salt on its pharmacology and the pharmacology.
13. a method that suppresses herpes virus replication is characterized in that, this method comprises the compound that makes following formula:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
R
9-R
12Be respectively perhaloalkyl radical, the halogen of alkyl, a 1-4 carbon atom of hydrogen, a 1-4 carbon atom, the alkoxyl group or the cyano group of a 1-4 carbon atom, or R
9And R
10Or R
11And R
12Can form the aryl of 5-7 carbon atom altogether; Condition is R
9-R
12In at least one is not a hydrogen;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 2-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology, contact with simplexvirus.
14. method as claimed in claim 13 is characterized in that, described simplexvirus is a human cytomegalic inclusion disease virus.
15. method as claimed in claim 13 is characterized in that, described simplexvirus is a hsv.
16. method as claimed in claim 13 is characterized in that, described simplexvirus is a varicella zoster virus.
17. a method for the treatment of the patient who suffers from herpesvirus infection is characterized in that this method comprises the compound with following formula that is applied to the patient significant quantity:
Wherein
R
1-R
5Be selected from respectively cycloalkyl, a 3-10 carbon atom of perhaloalkyl radical, a 3-10 carbon atom of alkynyl, a 1-6 carbon atom of alkenyl, a 2-6 carbon atom of alkyl, a 2-6 carbon atom of hydrogen, a 1-6 carbon atom Heterocyclylalkyl, aryl, heteroaryl, halogen ,-CN ,-NO
2,-CO
2R
6,-COR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6,-CONR
7R
8,-NR
6N (R
7R
8) ,-N (R
7R
8) or W-Y-(CH
2)
n-Z, condition is R
1-R
5At least one is not a hydrogen; Or R
2And R
3, or R
3And R
4Form 3-7 unit's Heterocyclylalkyl or 3-7 unit heteroaryl altogether;
R
6And R
7Be respectively the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, or aryl;
R
8Be the alkyl of hydrogen, a 1-6 carbon atom, the perhaloalkyl radical of a 1-6 carbon atom, cycloalkyl, 3-10 unit Heterocyclylalkyl, aryl or the heteroaryl of a 3-10 carbon atom, or
R
7And R
8Can form 3-7 unit Heterocyclylalkyl altogether;
R
9-R
12Be respectively perhaloalkyl radical, the halogen of alkyl, a 1-4 carbon atom of hydrogen, a 1-4 carbon atom, the alkoxyl group or the cyano group of a 1-4 carbon atom, or R
9And R
10Or R
11And R
12Can form the aryl of 5-7 carbon atom altogether; Condition is R
9-R
12In at least one is not a hydrogen;
W is O, NR
6, or do not exist;
Y is-(CO)-or-(CO
2)-, or do not exist;
Z be 1-4 carbon atom alkyl ,-CN ,-CO
2R
6, COR
6,-CONR
7R
8,-OCOR
6,-NR
6COR
7,-OCONR
6,-OR
6,-SR
6,-SOR
6,-SO
2R
6, SR
6N (R
7R
8) ,-N (R
7R
8) or phenyl;
G is a bicyclic heteroaryl;
X be a key ,-alkylamino of the alkoxyl group of the alkyl of NH, a 1-6 carbon atom, the alkenyl of a 1-6 carbon atom, a 1-6 carbon atom, the alkylthio of a 1-6 carbon atom, a 1-6 carbon atom or (CH) J;
J is the alkyl of 2-6 carbon atom, cycloalkyl, phenyl or the benzyl of a 3-7 carbon atom; With
N is the integer of 1-6;
Or the salt on its pharmacology.
18. method as claimed in claim 17 is characterized in that, described simplexvirus is a human cytomegalic inclusion disease virus.
19. method as claimed in claim 17 is characterized in that, described simplexvirus is a hsv.
20. method as claimed in claim 17 is characterized in that, described simplexvirus is a varicella zoster virus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20816498A | 1998-12-09 | 1998-12-09 | |
US09/208,164 | 1998-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1367785A true CN1367785A (en) | 2002-09-04 |
Family
ID=22773466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99815998A Pending CN1367785A (en) | 1998-12-09 | 1999-12-06 | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1144399A3 (en) |
JP (1) | JP2002533301A (en) |
KR (1) | KR20010086091A (en) |
CN (1) | CN1367785A (en) |
AU (1) | AU2353900A (en) |
BR (1) | BR9916043A (en) |
CA (1) | CA2351690A1 (en) |
CZ (1) | CZ20012063A3 (en) |
EA (1) | EA200100639A1 (en) |
HU (1) | HUP0203405A2 (en) |
IL (1) | IL143263A0 (en) |
NO (1) | NO20012835L (en) |
WO (1) | WO2000034261A2 (en) |
ZA (1) | ZA200104322B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112807294A (en) * | 2019-11-18 | 2021-05-18 | 武汉大学 | Application of acylthiourea compound in preparation of medicine for treating or preventing herpes simplex virus I-type infection |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
ATE311366T1 (en) | 2000-02-29 | 2005-12-15 | Millennium Pharm Inc | BENZAMIDE AND SIMILAR FACTOR XA INHIBITORS |
NZ544674A (en) * | 2003-07-10 | 2009-03-31 | Achillion Pharmaceuticals Inc | Substituted arylthiourea derivatives useful as inhibitors of viral replication |
DE102004015007A1 (en) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituted imidazoles |
TW200600492A (en) | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
DE102005008183A1 (en) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | New heterocyclylamide-substituted imidazole compounds useful to treat or prevent viral infections |
PT2077995E (en) | 2006-11-02 | 2012-05-10 | Millennium Pharm Inc | Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
EP2914592B1 (en) | 2012-11-03 | 2017-10-11 | Boehringer Ingelheim International GmbH | Inhibitors of cytomegalovirus |
EP2914591B1 (en) | 2012-11-03 | 2017-10-11 | Boehringer Ingelheim International GmbH | Inhibitors of cytomegalovirus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001519808A (en) * | 1997-04-10 | 2001-10-23 | ファルマシア・アンド・アップジョン・カンパニー | Polyaromatic antibacterial composition |
-
1999
- 1999-12-06 WO PCT/US1999/028916 patent/WO2000034261A2/en not_active Application Discontinuation
- 1999-12-06 JP JP2000586708A patent/JP2002533301A/en active Pending
- 1999-12-06 CN CN99815998A patent/CN1367785A/en active Pending
- 1999-12-06 CZ CZ20012063A patent/CZ20012063A3/en unknown
- 1999-12-06 HU HU0203405A patent/HUP0203405A2/en unknown
- 1999-12-06 IL IL14326399A patent/IL143263A0/en unknown
- 1999-12-06 EP EP99967213A patent/EP1144399A3/en not_active Withdrawn
- 1999-12-06 BR BR9916043-9A patent/BR9916043A/en not_active Application Discontinuation
- 1999-12-06 AU AU23539/00A patent/AU2353900A/en not_active Abandoned
- 1999-12-06 KR KR1020017007117A patent/KR20010086091A/en not_active Application Discontinuation
- 1999-12-06 CA CA002351690A patent/CA2351690A1/en not_active Abandoned
- 1999-12-06 EA EA200100639A patent/EA200100639A1/en unknown
-
2001
- 2001-05-25 ZA ZA200104322A patent/ZA200104322B/en unknown
- 2001-06-08 NO NO20012835A patent/NO20012835L/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112807294A (en) * | 2019-11-18 | 2021-05-18 | 武汉大学 | Application of acylthiourea compound in preparation of medicine for treating or preventing herpes simplex virus I-type infection |
CN112807294B (en) * | 2019-11-18 | 2023-09-05 | 武汉大学 | Application of acyl thiourea compound in preparation of medicines for treating or preventing herpes simplex virus type I infection |
Also Published As
Publication number | Publication date |
---|---|
EA200100639A1 (en) | 2002-06-27 |
NO20012835L (en) | 2001-07-19 |
EP1144399A3 (en) | 2002-09-11 |
CZ20012063A3 (en) | 2001-10-17 |
EP1144399A2 (en) | 2001-10-17 |
WO2000034261A2 (en) | 2000-06-15 |
KR20010086091A (en) | 2001-09-07 |
ZA200104322B (en) | 2002-10-25 |
HUP0203405A2 (en) | 2003-02-28 |
AU2353900A (en) | 2000-06-26 |
WO2000034261A3 (en) | 2002-01-31 |
BR9916043A (en) | 2001-12-04 |
JP2002533301A (en) | 2002-10-08 |
NO20012835D0 (en) | 2001-06-08 |
CA2351690A1 (en) | 2000-06-15 |
IL143263A0 (en) | 2002-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1171872C (en) | Compounds for modulation of PPAP gamma activity | |
CN1219768C (en) | Quinoline derivatives as inhibitors of MEK enzymes | |
CN1211382C (en) | Quinazoline ditosylate salt compounds | |
CN1169795C (en) | Nitrogenous heterocyclic compounds | |
CN1252054C (en) | Qinoline derivatives inhibiting effect of growth factors such as VEGF | |
CN1267431C (en) | Substituted quinazoline derivatives and their use as inhibitors | |
CN1234358C (en) | Benzothiazole derivatives | |
CN1151140C (en) | Glucokinase activators | |
CN1114402C (en) | Isothiazolones | |
CN1926103A (en) | Sulphonylpyrroles as HDAC inhibitors | |
CN1333750A (en) | Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses | |
CN1906155A (en) | Novel hydroxamic acid esters and pharmaceutical use thereof | |
CN1331688A (en) | Aminopyrazole derivatives | |
CN1214041A (en) | Sulfonated amino acid derivatives and metalloproteinase inhibitors contg. same | |
CN1351590A (en) | Compounds | |
CN1942445A (en) | Novel quinoline-carbaxamides as JACK3 kinase modulators | |
CN1413210A (en) | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases | |
CN1678586A (en) | Substituted quinoline CCR5 receptor antagonists | |
CN1531527A (en) | Carbazole derivatives and their use as neuropeptide Y5 receptor ligands | |
CN1747936A (en) | Substituted azole derivatives as therapeutic agents | |
CN1348446A (en) | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group | |
CN1070173C (en) | Benzoylaguanidine derivatives as medicaments | |
CN101068797A (en) | Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof | |
CN1658857A (en) | NF-kB activation inhibitors | |
CN1768040A (en) | Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |